Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,40327,0.1073723262989,0.00251787765405242,0.102437286096957,0.112307366500842,0
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LDLR,Low-density lipoprotein receptor,40351,0.157849434141436,0.00425081841994261,0.149517830038348,0.166181038244523,1.58366709913204e-289
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLTP,Phospholipid transfer protein,40456,-0.0811732623781637,0.00282176703036656,-0.0867039257576821,-0.0756425989986452,1.77531353835346e-177
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,40406,0.0752197067875955,0.00261785888358077,0.0700887033757772,0.0803507101994138,4.58550182615804e-177
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TFPI,Tissue factor pathway inhibitor,40304,0.0674253386033857,0.00258347820833104,0.0623617213150569,0.0724889558917145,4.73762695984921e-147
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,37937,0.0738054575808898,0.0030420485306815,0.0678430424607541,0.0797678727010256,2.60986725617986e-127
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,40223,-0.117017783016346,0.0049779106388037,-0.126774487868401,-0.10726107816429,3.95027255476784e-120
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APCS,Serum amyloid P-component,37877,0.0616444803034869,0.0029899839628231,0.0557841117363536,0.0675048488706202,5.29465907324565e-93
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LGALS9,Galectin-9,40345,0.0514672192347753,0.00269547404933846,0.0461840900980719,0.0567503483714787,2.24871887916334e-80
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",40531,0.0443906182985548,0.00239617636711681,0.0396941126190058,0.0490871239781037,7.89192600920301e-76
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PAMR1,Inactive serine protease PAMR1,40327,0.0417179468619294,0.0023409855007356,0.0371296152804876,0.0463062784433712,2.36481200954779e-70
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,40419,0.0678676901775277,0.00386888933287037,0.0602846670851018,0.0754507132699536,2.99309860657226e-68
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,40398,0.0613107320377942,0.0035351692394308,0.0543818003285099,0.0682396637470786,9.11375907798625e-67
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C4BPB,C4b-binding protein beta chain,40406,0.0590329431397832,0.0034686395298633,0.0522344096612512,0.0658314766183153,2.19423864637738e-64
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APOA1,Apolipoprotein A-I,38008,-0.0390865748273859,0.00231088971902745,-0.0436159186766797,-0.0345572309780921,1.58614726949087e-63
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CFP,Properdin,38008,0.0304578860008189,0.00183033860715024,0.0268704223308045,0.0340453496708334,1.44389835818577e-61
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD300LG,CMRF35-like molecule 9,40327,-0.0519314456363573,0.00316353375248178,-0.0581319717912216,-0.045730919481493,4.61766435439992e-60
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNCA,Alpha-synuclein,37666,0.155235371811301,0.00954605358914941,0.136525106776568,0.173945636846034,6.87389686575713e-59
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CFH,Complement factor H,37296,0.0315432509368158,0.00194034676637494,0.0277401712747209,0.0353463305989107,7.75829977460629e-59
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD4,T-cell surface glycoprotein CD4,40304,0.0398038869262369,0.00256316224271572,0.0347800889305141,0.0448276849219597,5.49751347221458e-54
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGA,Fibrinogen alpha chain,37693,0.0396004313769916,0.00258423141861715,0.034535337796502,0.0446655249574813,1.49512124870107e-52
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL23,C-C motif chemokine 23,40417,0.0527033012304046,0.00344864910345035,0.0459439489876419,0.0594626534731673,2.35477887881422e-52
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LGALS1,Galectin-1,40354,0.0431568384596154,0.00282974274703142,0.0376105426754338,0.0487031342437969,3.78288152546214e-52
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AGRN,Agrin,40417,0.0421502052539708,0.00279341973152295,0.0366751025801858,0.0476253079277558,4.29890824545137e-51
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GOLM2,Protein GOLM2,40466,0.0284107122050111,0.00188389785389249,0.0247182724113818,0.0321031519986404,4.85385127149013e-51
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,37937,0.0948205279970631,0.00631001617700177,0.0824528962901397,0.107188159703987,1.25514563139084e-50
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,40372,0.050121322921539,0.00335569732728673,0.043544156160057,0.0566984896830209,4.18567191059349e-50
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LPL,Lipoprotein lipase,40354,-0.0573942518296445,0.00385737706509851,-0.0649547108772376,-0.0498337927820514,9.73541654984814e-50
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,40484,0.0412188279263641,0.00277272227896374,0.0357842922595951,0.046653363593133,1.17622038077395e-49
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,40037,0.0677520064934875,0.00458188475073524,0.0587715123820465,0.0767325006049286,3.82950226556794e-49
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL22,C-C motif chemokine 22,40199,0.0637789615106697,0.00433250004031398,0.0552872614316543,0.0722706615896851,9.95400011217195e-49
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXCL10,C-X-C motif chemokine 10,40417,0.0830091921370315,0.00568563050207673,0.0718653563529611,0.0941530279211019,5.73777771138744e-48
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD72,B-cell differentiation antigen CD72,37666,0.0519733219037682,0.00356106604191103,0.0449936324616226,0.0589530113459138,7.13532401909943e-48
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,40511,0.0314608976583819,0.0021804952133152,0.0271871270402841,0.0357346682764797,6.74479146721488e-47
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PROC,Vitamin K-dependent protein C,40367,0.0305618977682478,0.00212635169262644,0.0263942484507,0.0347295470857957,1.4971070693715e-46
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BPIFB1,BPI fold-containing family B member 1,40256,-0.074494888783968,0.0051905869602299,-0.0846684392260186,-0.0643213383419174,2.02883590954171e-46
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FST,Follistatin,40391,0.0627956685215896,0.00437876056801879,0.0542132978082727,0.0713780392349064,2.3576729118924e-46
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,37666,-0.0367208832101749,0.00256287458838967,-0.0417441174034187,-0.0316976490169312,3.24491078271186e-46
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXCL13,C-X-C motif chemokine 13,40466,0.0754456180308075,0.00532578830012607,0.0650070729625604,0.0858841630990546,2.7880926689542e-45
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C2,Complement C2,40367,0.0284824100570161,0.00202123425760534,0.0245207909121096,0.0324440292019225,7.95639409861136e-45
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BPIFA2,BPI fold-containing family A member 2,37145,-0.131186549985767,0.00930604904031573,-0.149426406104786,-0.112946693866749,8.63380574381349e-45
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,P4HB,Protein disulfide-isomerase,40261,0.0452411967786504,0.00325613050311817,0.0388591809925388,0.051623212564762,1.24059000234105e-43
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRIP2,Cysteine-rich protein 2,40223,0.0420712827189098,0.00303739451133353,0.0361179894766961,0.0480245759611236,2.24803558331055e-43
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",37896,0.119681902428917,0.00865280874552024,0.102722397287697,0.136641407570136,3.24917036021548e-43
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,40386,0.0269344064053998,0.00194908455337059,0.0231142006807935,0.0307546121300061,3.47397792998384e-43
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,38008,0.0313455487025956,0.00226772222559897,0.0269008131404216,0.0357902842647696,3.65954683033656e-43
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,40406,0.0386542962546537,0.00280283114724578,0.0331607472060519,0.0441478453032554,5.08547202544523e-43
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",37955,0.104702381212192,0.00762330617483879,0.0897607011095083,0.119644061314876,1.22006552070803e-42
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",39956,0.0630830891356619,0.00460415433296231,0.0540589466430558,0.072107231628268,1.7618688304031e-42
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DPY30,Protein dpy-30 homolog,40409,0.0678495899861273,0.00500077571419141,0.0580480695863121,0.0776511103859425,1.05860510081398e-41
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,40325,0.115571405848192,0.00868314962790951,0.0985524325774896,0.132590379118895,3.33234141277095e-40
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",37623,0.101645488294455,0.00765318047537216,0.0866452545627259,0.116645722026185,5.35995903820714e-40
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MARCO,Macrophage receptor MARCO,40354,0.0296727929931939,0.00223957848866922,0.0252832191554022,0.0340623668309855,7.40973466848859e-40
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CA6,Carbonic anhydrase 6,40290,-0.0708737835955324,0.00537456067308703,-0.0814079225147829,-0.0603396446762818,1.68588983063479e-39
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",40531,0.0542484137744797,0.00413201059053705,0.0461496730170271,0.0623471545319323,3.58067063598165e-39
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,40336,0.0362091165617948,0.00277282989934741,0.0307743699590738,0.0416438631645157,8.99610785090596e-39
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",37896,0.0953950751485417,0.00733187720347407,0.0810245958297325,0.109765554467351,1.8084045143692e-38
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,40308,0.0600982810504816,0.00464761295961705,0.0509889596496321,0.069207602451331,4.68579411324889e-38
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPCAM,Epithelial cell adhesion molecule,40353,-0.108076732378427,0.00842713928486697,-0.124593925376767,-0.0915595393800882,1.82529290598811e-37
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,37875,0.0940781510846716,0.0073531214340325,0.0796660330739679,0.108490269095375,2.91153343029184e-37
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,40484,0.0624719759900459,0.00488562082449989,0.0528961591740261,0.0720477928060657,2.95072768767549e-37
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CFI,Complement factor I,38008,0.0215610945734005,0.00168923958619338,0.0182501849844615,0.0248720041623395,4.26996804965227e-37
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ICAM1,Intercellular adhesion molecule 1,40286,0.030685032355234,0.00240700186452319,0.0259673087007685,0.0354027560096994,4.84957288725656e-37
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDHR5,Cadherin-related family member 5,40354,0.0417941479069641,0.00328063909428496,0.0353640952821656,0.0482242005317626,5.39937672093867e-37
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",40272,0.11187558561772,0.00879635334939357,0.0946347330529091,0.129116438182532,7.08207150168918e-37
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD22,B-cell receptor CD22,40511,0.0438029263844002,0.00345539253409574,0.0370303570175726,0.0505754957512279,1.19304936412226e-36
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TREML2,Trem-like transcript 2 protein,40327,0.035799102771987,0.00282499044226818,0.0302621215051414,0.0413360840388327,1.26699210698683e-36
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CST3,Cystatin-C,40367,0.0299951471515789,0.00236990069600394,0.0253501417874111,0.0346401525157466,1.54062329000915e-36
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,40268,0.0286963929552325,0.00227969026333116,0.0242282000391034,0.0331645858713616,3.67144383489694e-36
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNF,Tumor necrosis factor,40009,0.042230936053507,0.00335613553570444,0.0356529104035263,0.0488089617034877,3.91730717407888e-36
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C3,Complement C3,37355,0.0498476737325644,0.00396449951652527,0.0420772546801748,0.0576180927849539,4.80320730033759e-36
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEMA4D,Semaphorin-4D,40466,0.0313606039174555,0.00251102438632899,0.0264389961202507,0.0362822117146603,1.25365408035988e-35
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL7,C-C motif chemokine 7,40336,0.063859257123402,0.00512291115995269,0.0538183512498947,0.0739001629969093,1.68947095085371e-35
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,40307,0.0212645560649102,0.00171391779201205,0.0179052771925666,0.0246238349372538,3.48828621534631e-35
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,37993,-0.0518473429439362,0.00418440916907527,-0.0600487849153237,-0.0436459009725486,4.55112104306091e-35
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLUL1,Clusterin-like protein 1,40333,-0.0474042147514998,0.00383606111283549,-0.0549228945326574,-0.0398855349703423,6.41938416398709e-35
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NOMO1,Nodal modulator 1,40327,0.0246406119889477,0.001994602903756,0.0207311902975859,0.0285500336803094,6.73458782670929e-35
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,40374,0.0345065694712917,0.00279570264158508,0.0290269922937849,0.0399861466487984,7.69569405817543e-35
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FXN,"Frataxin, mitochondrial",40484,0.0764002684756606,0.00623368028044562,0.0641822551259872,0.088618281825334,2.2222512994874e-34
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,37985,0.0745286269296977,0.00609641041214816,0.0625796625218873,0.0864775913375081,3.46175923024929e-34
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,37593,-0.124298905975478,0.0102147962550889,-0.144319906635452,-0.104277905315504,6.95750561732356e-34
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLAT,Tissue-type plasminogen activator,40485,0.0501957450222074,0.0041289395944561,0.0421030234170735,0.0582884666273414,7.41596824548285e-34
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,40306,0.019458422158061,0.00160103631541153,0.0163203909798544,0.0225964533362676,7.75906088723969e-34
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",37896,0.104039596992468,0.00857145596597597,0.0872395432991546,0.12083965068578,9.98169048065239e-34
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RBP5,Retinol-binding protein 5,40300,0.0566581027710818,0.00467183260972893,0.0475013108560131,0.0658148946861505,1.06374237745532e-33
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",37623,0.0263932809153324,0.00217664164111402,0.0221270632987489,0.0306594985319159,1.16669409951564e-33
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NUCB2,Nucleobindin-2,40442,0.0378153827361855,0.00312715675678158,0.0316861554928936,0.0439446099794774,1.61903581675671e-33
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GGH,Gamma-glutamyl hydrolase,40072,0.0348369452188277,0.0028867292177639,0.0291789559520105,0.040494934485645,2.19530982832876e-33
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD14,Monocyte differentiation antigen CD14,40043,0.0422864673469821,0.00351181448084419,0.0354033109645275,0.0491696237294367,3.03058530257832e-33
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMSB10,Thymosin beta-10,40327,0.0769432588547861,0.00639709473641209,0.0644049531714184,0.0894815645381538,3.53637529808053e-33
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,40336,-0.0348530703370244,0.00289961246108194,-0.040536310760745,-0.0291698299133038,3.88896510825846e-33
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,40484,0.0636617416873833,0.00531680328361755,0.0532408072514929,0.0740826761232737,6.7423948706461e-33
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MMP12,Macrophage metalloelastase,40341,0.0522565202482592,0.00436444538482646,0.0437022072939993,0.060810833202519,6.7987636990332e-33
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,37982,0.0260085237223029,0.00217691320225583,0.0217417738458815,0.0302752735987243,9.78276529966163e-33
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD83,CD83 antigen,40336,0.0338225448573599,0.00283469025399957,0.0282665519595208,0.0393785377551991,1.11648912933949e-32
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GIP,Gastric inhibitory polypeptide,37623,-0.051716711355499,0.00433655838299528,-0.0602163657861697,-0.0432170569248282,1.27904535507638e-32
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,40278,0.0323017064401511,0.00272069940214646,0.0269691356119441,0.0376342772683582,2.25500279554897e-32
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCN2,Ficolin-2,40286,0.0409920793753537,0.00346442722208903,0.0342018020200592,0.0477823567306482,3.63162952999783e-32
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,40327,0.0484746942585922,0.00409983336346565,0.0404390208661995,0.0565103676509849,4.02153670934426e-32
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DPT,Dermatopontin,40531,0.0263938583647921,0.00223386980286239,0.0220154735511818,0.0307722431784024,4.4164234043748e-32
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,40531,0.0215032183006489,0.00182512634577849,0.0179259706629231,0.0250804659383747,6.55617895324363e-32
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,40300,0.030610210877795,0.00259903523339793,0.0255161018203351,0.035704319935255,6.92174548387809e-32
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPIND1,Heparin cofactor 2,37976,0.027054562408829,0.00230178519968989,0.0225430634174368,0.0315660614002211,9.64122762257272e-32
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APOA4,Apolipoprotein A-IV,38008,-0.0364110068244367,0.00310153017109084,-0.0424900059597748,-0.0303320076890987,1.13546943413067e-31
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EFNA1,Ephrin-A1,40298,0.0270090383483691,0.00230332486416087,0.0224945216146137,0.0315235550821244,1.26547401643329e-31
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C1RL,Complement C1r subcomponent-like protein,37988,0.0191322846388187,0.00163223943410903,0.015933095347965,0.0223314739296724,1.40550387080951e-31
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCN1,CCN family member 1,40275,0.0770940712656188,0.00658446455716977,0.064188520733566,0.0899996217976715,1.55603278646725e-31
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,40223,0.0288676834849786,0.00247022858406568,0.0240260354602099,0.0337093315097474,2.01958790365755e-31
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,40327,0.0268891292245158,0.00230616677762123,0.0223690423403782,0.0314092161086534,2.74767731837015e-31
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL18R1,Interleukin-18 receptor 1,40511,0.0319835467124432,0.00274648501934428,0.0266004360745284,0.037366657350358,3.23810668716567e-31
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,40104,0.0203642754893588,0.00175049895462036,0.0169332975383028,0.0237952534404147,3.74429777316983e-31
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",40039,0.0705602504240118,0.00608052244635459,0.0586424264291568,0.0824780744188668,5.25492676601515e-31
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,40374,0.0291292440973639,0.00251240008973237,0.0242049399214884,0.0340535482732393,5.87230148828663e-31
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL18,C-C motif chemokine 18,40167,0.0685897254834963,0.00592922229161599,0.056968449791929,0.0802110011750636,7.97259468740936e-31
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,40406,0.0246392427223956,0.00213268260900358,0.0204591848087486,0.0288193006360426,9.43050915159545e-31
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDCD1,Programmed cell death protein 1,40450,0.0426723442023666,0.00369366163640963,0.0354327673950038,0.0499119210097295,9.45725942934817e-31
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,37589,0.0375655909628665,0.00325527636966507,0.0311852492783229,0.04394593264741,1.16658430639289e-30
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CFB,Complement factor B,37765,0.031796507892836,0.00276044398257003,0.0263860376869987,0.0372069780986733,1.48351573239029e-30
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGA5,Integrin alpha-5,40327,0.0241573415484869,0.00209927551228221,0.0200427615444138,0.0282719215525601,1.59875804742496e-30
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LPA,Apolipoprotein(a),37730,0.170615193815551,0.0148320044780947,0.141544465038486,0.199685922592617,1.77286616983375e-30
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DAB2,Disabled homolog 2,40484,0.106701361432354,0.00929067651298537,0.0884916354669031,0.124911087397806,2.069127003883e-30
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HGF,Hepatocyte growth factor,40511,0.033171094936561,0.00288904102878119,0.0275085745201499,0.0388336153529721,2.14260636633199e-30
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,40155,0.0444353127784572,0.00387094697311377,0.0368482567111542,0.0520223688457602,2.21889552689022e-30
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,40354,0.0299993493474128,0.00261647675064972,0.0248710549161393,0.0351276437786862,2.58521731389758e-30
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,40466,0.0503054456917925,0.00439237803426502,0.0416963847446331,0.058914506638952,2.9827133508967e-30
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,37623,0.0506947449800376,0.00442908794762651,0.0420137326026896,0.0593757573573855,3.42561742652254e-30
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MTDH,Protein LYRIC,37593,0.087974577076621,0.00768680701386806,0.0729084353294396,0.103040718823802,3.46699816479322e-30
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINF2,Alpha-2-antiplasmin,37750,0.0130778818481798,0.00114318595031423,0.0108372373855639,0.0153185263107957,3.65750082376394e-30
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCRL1,Fc receptor-like protein 1,40354,0.0433841985642232,0.00380055559918265,0.0359351095898252,0.0508332875386212,4.59588100482849e-30
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADIPOQ,Adiponectin,38008,-0.0637795729462476,0.00559300882421971,-0.0747418702417183,-0.052817275650777,5.50491588849459e-30
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FABP5,Fatty acid-binding protein 5,40427,0.0662341054928761,0.0058196793590117,0.0548275339492131,0.077640677036539,6.77454565771991e-30
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,40372,0.0217014064610488,0.00190789382831149,0.0179619345575583,0.0254408783645393,7.30273468537299e-30
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GRN,Progranulin,40257,0.0232871751067012,0.00204781692287564,0.0192734539378649,0.0273008962755374,7.55581296254657e-30
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,40327,0.0345247625420203,0.00303949267347017,0.0285673569020188,0.0404821681820219,8.74616882872787e-30
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,40484,0.0332047079948426,0.00292574605103764,0.0274702457348088,0.0389391702548764,9.72597404864777e-30
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SFRP1,Secreted frizzled-related protein 1,40173,0.0416758225787644,0.00367630064744414,0.0344702733097739,0.0488813718477549,1.13021128894482e-29
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD5,T-cell surface glycoprotein CD5,40465,0.0319403066278962,0.00281800808414023,0.0264170107829813,0.037463602472811,1.15046130710756e-29
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,40466,0.0439925199307543,0.00388888816745195,0.0363702991225485,0.0516147407389601,1.47562961136386e-29
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",37623,0.0822516601608974,0.00727613952525554,0.0679904266913965,0.0965128936303982,1.70829276958785e-29
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDHR2,Cadherin-related family member 2,40300,0.0733375261559645,0.00649266844733755,0.0606118959991829,0.0860631563127461,1.79150402860515e-29
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL27,C-C motif chemokine 27,40354,0.0566303440610415,0.0050174669610745,0.0467961088173355,0.0664645793047475,1.97678897365522e-29
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",37623,0.0923778477827911,0.00818981129957628,0.0763258176356216,0.108429877929961,2.25643689454704e-29
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,37896,0.0901121560966494,0.00801216285272972,0.0744083169052992,0.105815995288,3.23837681509104e-29
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",40327,0.0228134925849703,0.00203625212950342,0.0188224384111436,0.026804546758797,5.02678259250421e-29
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IST1,IST1 homolog,37807,0.0942327735229264,0.00842571459530569,0.0777183729161273,0.110747174129726,6.56782139421142e-29
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,40300,0.0415351991084703,0.00373808290962504,0.0342085566056053,0.0488618416113354,1.40854570520718e-28
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GBP1,Guanylate-binding protein 1,37926,0.0600618191068141,0.00541625509575392,0.0494459591191364,0.0706776790944918,1.87969399434568e-28
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SYAP1,Synapse-associated protein 1,37666,0.052719005684277,0.00476347996563167,0.0433825849516389,0.0620554264169151,2.40701382311183e-28
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,40300,0.0384622748110323,0.00348116367707143,0.0316391940039723,0.0452853556180923,2.82143610572957e-28
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MPI,Mannose-6-phosphate isomerase,40300,0.0801479428165118,0.00725738053802936,0.0659234769619742,0.0943724086710493,2.98293167316712e-28
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL3,C-C motif chemokine 3,40336,0.0570886379229673,0.00518933802040105,0.0469175354029812,0.0672597404429534,4.76402461619558e-28
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,40391,0.0481117196882124,0.00437424599449113,0.0395381975390098,0.056685241837415,4.88120926613507e-28
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,37955,0.0777800692139176,0.00707203168808431,0.0639188871052724,0.0916412513225629,5.12219025480685e-28
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,40352,0.0260501979473268,0.00237086984617211,0.0214032930488294,0.0306971028458241,5.52718707338761e-28
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MRC1,Macrophage mannose receptor 1,37982,0.0261794602053567,0.00238265866507377,0.0215094492218121,0.0308494711889013,5.76196749477983e-28
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL16,Pro-interleukin-16,40511,0.0373305359501646,0.00340627349384821,0.0306542399022222,0.0440068319981071,7.52145027874052e-28
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STXBP1,Syntaxin-binding protein 1,37955,0.0713203688116884,0.00650769537808435,0.0585652858706431,0.0840754517527337,7.84637177060651e-28
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNASE4,Ribonuclease 4,37570,0.02520087445313,0.00230554433784482,0.0206820075509541,0.0297197413553058,1.08401185764179e-27
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,37896,0.104101847150363,0.00953393329613374,0.0854153378899405,0.122788356410785,1.22045765683551e-27
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXCL11,C-X-C motif chemokine 11,40466,0.0730479778562227,0.00669713587887768,0.0599215915336224,0.0861743641788229,1.32949013807748e-27
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,39975,0.099697977984394,0.00917315600770809,0.0817185922092861,0.117677363759502,2.04544443058421e-27
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,40485,0.0191818751175195,0.00176778073286898,0.0157170248810963,0.0226467253539427,2.45965554424266e-27
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MINK1,Misshapen-like kinase 1,37937,0.0845073345033953,0.00778704372764568,0.0692447287972098,0.0997699402095809,2.5220971433649e-27
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,37953,0.0134677610371857,0.00124111334200641,0.0110351788868532,0.0159003431875183,2.54731332875589e-27
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,40223,0.0374237573140067,0.00345037191614752,0.0306610283583575,0.0441864862696558,2.59291102503369e-27
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DTYMK,Thymidylate kinase,37985,0.0630940131642936,0.00581782135643792,0.0516910833056753,0.0744969430229119,2.72870090798599e-27
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STC1,Stanniocalcin-1,40466,0.0378039752183925,0.00348788532024163,0.0309677199907189,0.0446402304460661,2.80779630624541e-27
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",40336,0.0751777017853792,0.00694698275599174,0.0615616155836354,0.088793787987123,3.38268905010216e-27
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MET,Hepatocyte growth factor receptor,40370,0.0183193518656426,0.00169721330179377,0.0149928137941268,0.0216458899371584,4.57008579037618e-27
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,YTHDF3,YTH domain-containing family protein 3,40039,0.0771280180162431,0.00715290089965818,0.0631083322529131,0.0911477037795732,5.17127214620013e-27
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NRP2,Neuropilin-2,40327,0.0264347195181554,0.00245319976522674,0.0216264479783109,0.0312429910579998,5.56413421906075e-27
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,40466,0.0745292300003501,0.00692387937281573,0.0609584264296313,0.088100033571069,6.28857218560354e-27
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,37623,0.0409032430926831,0.0037993498022534,0.0334565174802664,0.0483499687050998,6.45748322041617e-27
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,40414,0.0288422307978268,0.00268313165751415,0.0235832927490991,0.0341011688465546,7.36606197169534e-27
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,37982,0.0201042539386308,0.00187151364891854,0.0164360871867504,0.0237724206905111,8.26752432763086e-27
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTSL,Cathepsin L1,40354,0.0219349738336461,0.00204661120664581,0.0179236158686204,0.0259463317986719,1.03711095206816e-26
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL18,Interleukin-18,40288,0.0427727993767253,0.00400408065780096,0.0349248012874354,0.0506207974660152,1.51683254788505e-26
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,40466,0.0402080870329307,0.00376829518017899,0.0328222284797798,0.0475939455860815,1.72424122934375e-26
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KYNU,Kynureninase,40511,0.0401030824564463,0.00376404173184872,0.0327255606620228,0.0474806042508698,2.04083728239981e-26
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,37955,0.102161528449231,0.00959145042915331,0.0833622856080902,0.120960771290371,2.18808717644284e-26
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,40511,0.0502437364735593,0.00472067209808686,0.040991219161309,0.0594962537858095,2.29285634274655e-26
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,40466,0.0599871329719933,0.00564722527742321,0.0489185714282438,0.0710556945157428,2.86718377399612e-26
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CFHR5,Complement factor H-related protein 5,37780,0.0374088345948762,0.00352329114830788,0.0305031839441928,0.0443144852455597,3.14225491278004e-26
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPD52L2,Tumor protein D54,37666,0.0963833969746102,0.00910232589473751,0.0785428382209247,0.114223955728296,4.26937088781415e-26
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNPY4,Protein canopy homolog 4,40300,0.0668701207857504,0.00632234690484162,0.0544783208522608,0.0792619207192399,4.66359417210955e-26
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",40300,0.0621261486194149,0.00589014708820563,0.0505814603265318,0.0736708369122979,6.35975292658557e-26
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,37985,0.0547768670676002,0.00519576562093202,0.0445931664505734,0.0649605676846269,6.92440073071621e-26
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,40391,0.0406089813223184,0.00385709378653696,0.033049077500706,0.0481688851439308,7.77038846139481e-26
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCARB2,Lysosome membrane protein 2,40006,0.0273498170950768,0.00259811471497731,0.0222575122537212,0.0324421219364323,7.94029288995814e-26
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXCL9,C-X-C motif chemokine 9,40417,0.0601419272117939,0.00572722180211391,0.0489165724796507,0.0713672819439372,1.03590782438959e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXCL17,C-X-C motif chemokine 17,40511,0.0366414268793865,0.00349368418071661,0.0297938058851819,0.0434890478735911,1.18832486528343e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,37896,0.123129043405729,0.0117368042342521,0.100124907106594,0.146133179704863,1.1955035374094e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SDC1,Syndecan-1,40354,0.0354058096868095,0.00338068145904918,0.0287796740270731,0.0420319453465459,1.39257411700464e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SDC4,Syndecan-4,40354,0.0398925994379873,0.00381980052397032,0.0324057904110055,0.0473794084649691,1.8940237328853e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HPCAL1,Hippocalcin-like protein 1,40511,0.0646673152502467,0.0061926551908026,0.0525297110762736,0.0768049194242198,1.91144885758784e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TGFA,Protransforming growth factor alpha,40336,0.0422089442316267,0.00404371944275981,0.0342832541238175,0.0501346343394359,2.00634528720666e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYDGF,Myeloid-derived growth factor,37985,0.0878635772841043,0.00844135231792248,0.0713185267409762,0.104408627827232,2.81852828060958e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPB2,Carboxypeptidase B2,37976,0.019554817428811,0.00188312770883666,0.0158638871194912,0.0232457477381309,3.63716644414517e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AGRP,Agouti-related protein,40511,0.0467743963082385,0.0045094096713663,0.0379359533523605,0.0556128392641164,3.96568998461259e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXCL6,C-X-C motif chemokine 6,40511,0.0679543345921078,0.0065591574843453,0.055098385922791,0.0808102832614246,4.51096886705752e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,40039,0.0383352528378143,0.00370571700592952,0.0310720475061924,0.0455984581694361,5.31769864718358e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD274,Programmed cell death 1 ligand 1,40223,0.0303262704025125,0.00293169569355307,0.0245801468431485,0.0360723939618765,5.34034836992447e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,40039,0.0353079385673647,0.00342212195376609,0.0286005795379831,0.0420152975967462,7.05780045721406e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTSS,Cathepsin S,37054,0.0214249962614223,0.00207775035046134,0.0173526055745181,0.0254973869483265,7.8358993106822e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,37593,0.0729398065741803,0.00708942300946161,0.0590445374756355,0.086835075672725,9.85105345768911e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTN,Pleiotrophin,40037,0.0436296236105292,0.00424424583095459,0.0353109017818582,0.0519483454392002,1.04318295300201e-24
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,37896,0.0784496594261071,0.0076509706457199,0.0634537569604961,0.0934455618917181,1.40491883662268e-24
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAX,Protein max,39956,0.0903165457198401,0.00881386339644125,0.0730413734628153,0.107591717976865,1.46047445732348e-24
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,40417,0.114185805639116,0.0111473209593866,0.092337056558718,0.136034554719513,1.51014447017964e-24
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RILPL2,RILP-like protein 2,37985,0.0837622982292344,0.00818205111290186,0.0677254780479468,0.0997991184105221,1.65731810973699e-24
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RTN4R,Reticulon-4 receptor,40484,0.0292165394001321,0.00285757699823855,0.0236156884835846,0.0348173903166797,1.83592764931364e-24
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,F9,Coagulation factor IX,40367,0.0155084973680029,0.00151868556707,0.0125318736565457,0.0184851210794601,2.08828822420131e-24
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GFRA1,GDNF family receptor alpha-1,40448,0.0239501116495483,0.00234976990734867,0.0193445626311449,0.0285556606679516,2.54080442672488e-24
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL12A_IL12B,Interleukin-12,40300,0.0675496869002134,0.0066335505135289,0.0545479278936968,0.0805514459067301,2.80420216939811e-24
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,37945,0.0170232126993346,0.00167168028670502,0.0137467193373928,0.0202997060612764,2.88169055380394e-24
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,37896,0.0996197607350903,0.00980112875648963,0.0804095483723707,0.11882997309781,3.50651385991615e-24
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,37896,0.0762130709940574,0.00752315524988278,0.0614676867042871,0.0909584552838276,4.93651014268316e-24
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BID,BH3-interacting domain death agonist,40336,0.0571879432122893,0.00564755288340859,0.0461187395608084,0.0682571468637701,5.00366163020845e-24
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,40300,0.0751201239655588,0.00742127969467942,0.0605744157639872,0.0896658321671305,5.20702573409124e-24
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STX7,Syntaxin-7,37593,0.0427604436995152,0.00423650043348544,0.0344569028498837,0.0510639845491467,7.22320541859741e-24
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,37937,0.0910684838629987,0.00902715927313261,0.0733752516876588,0.108761716038339,7.56415456294472e-24
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NIT2,Omega-amidase NIT2,37931,0.0640692025573627,0.00635806940631614,0.0516073865209831,0.0765310185937424,8.49209288770086e-24
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MMP7,Matrilysin,40010,0.0410572646812746,0.00407941402251403,0.0330616131971471,0.0490529161654021,9.37366328894686e-24
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MDK,Midkine,40347,0.0429580167991624,0.00428257465470605,0.0345641704759386,0.0513518631223863,1.31083745332421e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,37937,0.0268963085756626,0.00268073980061983,0.0216420585664477,0.0321505585848774,1.31849547252638e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NPL,N-acetylneuraminate lyase,37985,0.0363873604181683,0.00362733186300109,0.0292777899666861,0.0434969308696504,1.34068736972481e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD300E,CMRF35-like molecule 2,40431,0.033792057562889,0.00337435118606123,0.027178329238209,0.0404057858875691,1.54612961364614e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",37623,0.0656075229834679,0.00654981075776128,0.0527698938982558,0.07844515206868,1.56265374257824e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PGF,Placenta growth factor,40511,0.0221950077963512,0.00221796704100457,0.0178477923959822,0.0265422231967201,1.66532667970334e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SOST,Sclerostin,40325,0.0326174618033762,0.0032634300740885,0.0262211388581627,0.0390137847485896,1.88335038957158e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL17RB,Interleukin-17 receptor B,40121,0.0450048544920202,0.00450458768428701,0.0361758626308177,0.0538338463532227,1.9634400274039e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GUSB,Beta-glucuronidase,40414,0.0488618724216601,0.0049240973162541,0.039210641681802,0.0585131031615181,3.85787875664816e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,37593,0.0739552898633389,0.00746071894894723,0.0593322807234024,0.0885782990032755,4.42098874048181e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,40039,0.0350939517356922,0.00354160097572838,0.0281524138232646,0.0420354896481198,4.44871320966397e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,37603,0.0471112901627756,0.00475643284178064,0.0377886817928855,0.0564338985326656,4.77979508192237e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,40037,0.0286895018410518,0.00290480356817314,0.0229960868474324,0.0343829168346711,6.14272490715569e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NT5E,5'-nucleotidase,40406,0.0483046248276514,0.00489174951930375,0.038716795769816,0.0578924538854867,6.23464989457346e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,37982,0.0598562512670967,0.00608228975613448,0.0479349633450731,0.0717775391891203,8.93264434411611e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C1S,Complement C1s subcomponent,38008,0.0171983663246876,0.0017492102374284,0.013769914259328,0.0206268183900473,9.75849675258635e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,40511,0.0240802608361205,0.00245695805611256,0.0192646230461399,0.0288958986261012,1.29205305831903e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ESYT2,Extended synaptotagmin-2,37937,0.0672934679095989,0.0068650372577638,0.0538379948843819,0.080748940934816,1.30892542463124e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,USO1,General vesicular transport factor p115,40300,0.075043804781054,0.00766565039562889,0.0600191300056214,0.0900684795564867,1.44564811734624e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,39975,0.0664265934513474,0.00678826782052084,0.0531215885231266,0.0797315983795683,1.5100141594697e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRYBB1,Beta-crystallin B1,37985,0.0533416154676414,0.0054538495046992,0.042652070438431,0.0640311604968518,1.62048642398202e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,37985,0.0739141997253195,0.00757224153323671,0.0590726063201756,0.0887557931304635,1.95871989026201e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STAB2,Stabilin-2,37993,0.022918324765755,0.00235117910994649,0.0183100137102598,0.0275266358212501,2.23769735351677e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MENT,Protein MENT,37666,-0.0177883891854512,0.00183081705565207,-0.0213767906145293,-0.0141999877563732,3.05593684336973e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,40039,0.0456906418159053,0.0047058623264743,0.0364671516560156,0.0549141319757949,3.18146641277651e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,39831,0.0988955124417491,0.0101926844039277,0.0789178510100507,0.118873173873447,3.40298669604959e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MIA,Melanoma-derived growth regulatory protein,40406,0.0303139230032844,0.00312875994959787,0.0241815535020726,0.0364462925044962,3.87207401895739e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,40223,0.046994440977623,0.00485467078790457,0.03747928623333,0.0565095957219159,4.21453218565867e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,40327,0.0296215516757921,0.00306750851586841,0.02360923498469,0.0356338683668942,5.30061200293216e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTSF,Cathepsin F,40406,-0.0326841533977538,0.00338494840214272,-0.0393186522659535,-0.026049654529554,5.33922870865454e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PYY,Peptide YY,37557,-0.0773838379867638,0.00801696256997784,-0.0930970846239204,-0.0616705913496073,5.67597338086086e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,40229,0.0240829177344823,0.00249879452977976,0.0191852804561139,0.0289805550128506,6.36153102951005e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,40398,0.0347102356832446,0.00360247200177379,0.027649390559768,0.0417710808067212,6.520328861649e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDCP1,CUB domain-containing protein 1,40223,0.0394048105565833,0.00409724260005041,0.0313742150604844,0.0474354060526821,7.75085937082546e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEP20,Centrosomal protein 20,39975,0.0597931631361586,0.00621807574814138,0.0476057346698015,0.0719805916025157,7.87168822710129e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DLL1,Delta-like protein 1,40406,0.0237965005215486,0.00247788658223023,0.0189398428203774,0.0286531582227199,8.84606161513873e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,37666,0.0512477179801259,0.00533580845669254,0.0407895334050085,0.0617059025552433,9.01494199405992e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC1,Sialoadhesin,40417,0.0351720565304003,0.00366494961823652,0.0279887552786567,0.0423553577821439,9.43343139989353e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD59,CD59 glycoprotein,39660,0.0182238181430278,0.00190036829073705,0.0144990962931831,0.0219485399928724,1.01840003791907e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,40333,0.075927221872712,0.0079268618830683,0.0603905725818981,0.0914638711635259,1.12712224903779e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,40531,0.0125593588355891,0.00131145097187741,0.00998891493070937,0.0151298027404688,1.14472640022496e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",40417,0.0894754176331952,0.00934354621828894,0.0711620670453489,0.107788768221042,1.15151789575016e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CALB2,Calretinin,39956,0.0254722642229455,0.00266031369199279,0.0202580493866396,0.0306864790592514,1.17023491107693e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GP5,Platelet glycoprotein V,37666,0.028962355184676,0.00303094700844201,0.0230216990481296,0.0349030113212223,1.44326759037947e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINH1,Serpin H1,37709,0.103779721467169,0.0108659136939832,0.082482530626962,0.125076912307376,1.50763019729052e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GZMA,Granzyme A,40511,0.0283878296666003,0.00297417482350014,0.02255844701254,0.0342172123206606,1.55578430842422e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,40286,0.0347999321343814,0.00364615623828676,0.0276534659073394,0.0419463983614235,1.56611911016775e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,INHBB,Inhibin beta B chain,37666,0.0415169840493771,0.00435502288323107,0.0329811391982442,0.05005282890051,1.78910058907181e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,40300,0.0721041895408824,0.00757038943188647,0.0572662262543849,0.0869421528273799,1.89266819745373e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,40484,0.0260805197361087,0.00274181157643439,0.0207065690462973,0.0314544704259201,2.12689033788496e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDH2,Cadherin-2,40354,0.0282884357115527,0.00297709064525293,0.022453338046857,0.0341235333762485,2.34506389672184e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDIA4,Protein disulfide-isomerase A4,37993,0.0483528793042957,0.00508770625601056,0.0383809750425151,0.0583247835660764,2.35736376785326e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APOD,Apolipoprotein D,37341,-0.0354981627314354,0.00374882363462581,-0.042845857055302,-0.0281504684075689,3.30652073855344e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RGCC,Regulator of cell cycle RGCC,37955,0.059698184376027,0.00630604885007597,0.0473383286298781,0.0720580401221759,3.35653183357805e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,40336,0.0268434762999733,0.00283728424867121,0.0212823991725777,0.0324045534273689,3.46891943580685e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SULT2A1,Bile salt sulfotransferase,40336,0.0425293167422566,0.00449547479689656,0.0337181861403393,0.0513404473441739,3.48554071724486e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PROS1,Vitamin K-dependent protein S,38008,0.020022525307062,0.00211623042995393,0.0158747136643523,0.0241703369497717,3.53129572330552e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DBI,Acyl-CoA-binding protein,40265,0.0629677212732702,0.00665901913705975,0.0499160437646331,0.0760193987819073,3.63886605542532e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,40203,0.0321223756248023,0.00340343574563178,0.025451641563364,0.0387931096862406,4.31062382764634e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,40300,0.0680229319900012,0.00721651292864538,0.0538785666498563,0.0821672973301462,4.83592486023103e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LMNB2,Lamin-B2,37937,0.0217287754768474,0.00230475347833356,0.0172114586593137,0.0262460922943812,4.86069955770033e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STK11,Serine/threonine-protein kinase STK11,40037,0.0580614986645433,0.00616300198282947,0.0459820147781975,0.070140982550889,5.08298169511288e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HMOX2,Heme oxygenase 2,39956,0.0362552422296923,0.00385153040528724,0.0287062426353293,0.0438042418240553,5.47476744736759e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,40511,0.0794358833021581,0.00844410993146936,0.0628854278364781,0.095986338767838,5.76620640072703e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,39975,0.0430851903240219,0.00458272317573334,0.0341030528995846,0.0520673277484593,6.10557817235621e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADA2,Adenosine deaminase 2,40253,0.0332226560696055,0.0035444058115725,0.0262756206789234,0.0401696914602876,7.96409994906478e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSTB,Cystatin-B,40092,0.0331019545474949,0.0035316791300494,0.0261798634525981,0.0400240456423918,8.00435188550433e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,F7,Coagulation factor VII,40371,0.0236894868578316,0.00252924197127173,0.0187321725941391,0.0286468011215242,8.50131278171827e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COLEC12,Collectin-12,40352,0.020223755864229,0.00216276034566184,0.0159847455867318,0.0244627661417262,9.8230687720607e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,40327,-0.0416424030444506,0.00445370087490096,-0.0503716567592565,-0.0329131493296447,9.902193510629e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXCL3,C-X-C motif chemokine 3,40345,0.0735014589928341,0.0078684974132619,0.0580792040628408,0.0889237139228274,1.07581026600261e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OTUD7B,OTU domain-containing protein 7B,37955,0.0497233469021381,0.00532181181693179,0.0392925957409518,0.0601540980633244,1.07795283673261e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL12B,Interleukin-12 subunit beta,40511,0.0428421886447887,0.004587098059151,0.0338514764488527,0.0518329008407247,1.08987901546614e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DAG1,Dystroglycan,40417,0.0373242882288443,0.00400153421663586,0.029481281164238,0.0451672952934506,1.22322590368028e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,37895,0.0624570039142503,0.0067137082969206,0.0492981356522859,0.0756158721762147,1.57490005375426e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPP3R1,Calcineurin subunit B type 1,40223,0.0324072763750757,0.0034873823874,0.0255720068957717,0.0392425458543797,1.69649999041502e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,40406,0.0167778110852219,0.00180787704483908,0.0132343720773373,0.0203212500931065,1.9009525291854e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BLNK,B-cell linker protein,37593,0.0299643084901145,0.00322882749319445,0.0236358066034534,0.0362928103767756,1.95229244723242e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,37937,0.0710839371556174,0.00766239691258711,0.0560656392069467,0.0861022351042881,2.00521380516567e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,37985,0.0211613488638903,0.00228212299462579,0.0166883877944238,0.0256343099333568,2.08667542314534e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,40497,0.0398551845257668,0.00430012134090634,0.0314269466975904,0.0482834223539433,2.12488272658434e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CETN3,Centrin-3,37896,0.0599247026526417,0.00646474165995242,0.047253808999135,0.0725955963061484,2.15166329164426e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BPIFB2,BPI fold-containing family B member 2,37946,0.0529083610553421,0.00571508952690051,0.0417067855826171,0.0641099365280671,2.40038383742211e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HLA_E,,40336,0.0225236640274793,0.00243430073284336,0.0177524345911063,0.0272948934638523,2.46392812498963e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LYN,Tyrosine-protein kinase Lyn,40300,0.0656999027631241,0.00710099311915372,0.0517819562495828,0.0796178492766653,2.47397364569847e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IFNLR1,Interferon lambda receptor 1,40336,0.0291739365927378,0.0031583105943482,0.0229836478278154,0.0353642253576603,2.84402068490517e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,37557,0.0530460205126827,0.0057425911921286,0.0417905417761106,0.0643014992492547,2.91234866457176e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BST2,Bone marrow stromal antigen 2,40466,0.0416854634245588,0.00451844228719885,0.0328293165416491,0.0505416103074686,3.16366879179592e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,37985,0.0696372845083516,0.00755849478762431,0.054822634724608,0.0844519342920953,3.62819716326873e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,37985,0.0500474541864889,0.00543223893313657,0.0394002658775412,0.0606946424954365,3.6306092355266e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,40327,0.0454181949601088,0.00493817437794321,0.0357393731793401,0.0550970167408775,4.11512232608153e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL8,C-C motif chemokine 8,40465,0.0468553628368582,0.00509702639833597,0.0368651910961197,0.0568455345775967,4.29297414431071e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,37552,0.0655615165832418,0.00713316353529122,0.051580516054071,0.0795425171124126,4.46801383349474e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,39975,0.0607511667993044,0.00662146806179162,0.0477730893981928,0.0737292442004159,5.07890011958681e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",40187,0.0737068365725377,0.00803724612309742,0.0579538341712667,0.0894598389738086,5.27241422021566e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIFBP,KIF-binding protein,40300,0.0639017528480428,0.00697151257038265,0.0502375882100928,0.0775659174859928,5.49314323648295e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NID1,Nidogen-1,40350,0.0306657633907801,0.0033467338409994,0.0241061650624213,0.037225361719139,5.65731685925803e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,37955,0.0763793574564366,0.00834225184947389,0.0600285438314677,0.0927301710814054,6.16530601000591e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MESD,LRP chaperone MESD,40327,0.0935184373745008,0.0102167962470194,0.0734935167303427,0.113543358018659,6.17548265762665e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FETUB,Fetuin-B,40367,0.0261404431133936,0.00285727716431466,0.0205401798713369,0.0317407063554503,6.44543038894352e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD63,CD63 antigen,40198,0.0402099013223475,0.00439865504271024,0.0315885374386354,0.0488312652060595,6.90267654323724e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,37955,0.0364554261660701,0.00398920447046419,0.0286365854039602,0.0442742669281799,7.22221457093034e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,40268,0.0260047818652712,0.00284713981986121,0.0204243878183432,0.0315851759121991,7.4093583315904e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAT,Linker for activation of T-cells family member 1,40511,0.0582508022509223,0.00638123283731686,0.0457435858897813,0.0707580186120634,7.75856871774981e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,37666,0.0964157645089922,0.0105711171590915,0.0756963748771729,0.117135154140811,8.53172562478918e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,40336,0.0859169814536234,0.00942920445144541,0.0674357407287904,0.104398222178456,9.05157546024134e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",37896,0.113146945879899,0.0124146830223593,0.0888141671560749,0.137479724603723,9.05301879917855e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,37896,0.0407356169658975,0.00447571863067528,0.0319632084497739,0.049508025482021,1.01503422753667e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,40531,-0.0265731552262512,0.00292171949861286,-0.0322997254435324,-0.02084658500897,1.05396092148102e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AP3B1,AP-3 complex subunit beta-1,37896,0.0584613022409823,0.00643031314003584,0.0458578884865121,0.0710647159954526,1.11178085420888e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TALDO1,Transaldolase,37961,0.0341054470788078,0.00375355643190787,0.0267484764722683,0.0414624176853472,1.16675822775324e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDCD5,Programmed cell death protein 5,40466,0.0445869978698806,0.004916697812095,0.0349502701581744,0.0542237255815868,1.34416126332551e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,40304,0.0298964432853916,0.0032968813747684,0.0234345557908455,0.0363583307799376,1.35039381373838e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LGMN,Legumain,40417,0.0272328481414063,0.00300342767952512,0.0213461298895371,0.0331195663932756,1.35976619564843e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,40406,0.0729876272477602,0.00805899555270447,0.0571919959644594,0.0887832585310609,1.49780885532489e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,37666,0.0905836522239392,0.0100026706453268,0.0709784177590987,0.11018888668878,1.54152681597604e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,37666,0.0290666902685579,0.00321405328688131,0.0227671458262706,0.0353662347108453,1.72447695502431e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SDHB,Succinate dehydrogenase,37896,0.0542170779961695,0.00599626067264544,0.0424644070777844,0.0659697489145546,1.7492418960691e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCRN1,Secernin-1,40336,0.0428685487252222,0.00474945501948941,0.0335596168870229,0.0521774805634214,1.98113797509487e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",37623,0.052048463861604,0.00576794906204119,0.0407432837000032,0.0633536440232047,2.06682996134918e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",40300,0.0246678053735141,0.00273633811146893,0.019304582675035,0.0300310280719932,2.19173271215443e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,37666,0.0541734196918425,0.00601432048354279,0.0423853515440987,0.0659614878395864,2.39579436370548e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FN1,Fibronectin,38008,0.0198758192733512,0.00221039584832231,0.0155434434106394,0.0242081951360629,2.74627530012242e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",37937,0.0798557846925564,0.00888644810909129,0.0624383463987375,0.0972732229863753,2.89419113224116e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,40354,0.0226751525982991,0.00252456845044653,0.0177269984354239,0.0276233067611743,2.95728428948697e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,40187,0.0555228949821018,0.00618176081313317,0.0434066437883608,0.0676391461758428,2.96230638586465e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,40327,0.0395627998155947,0.00440615829907873,0.0309267295494004,0.048198870081789,3.03407647420193e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,F2R,Proteinase-activated receptor 1,40391,0.0436427146132768,0.00486093604028668,0.0341152799743149,0.0531701492522387,3.05275624918487e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37937,0.0292458786136207,0.0032590955362631,0.022858051362545,0.0356337058646964,3.24387948860931e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EEF1D,Elongation factor 1-delta,37985,0.0691570824827761,0.00770823245166876,0.0540489468775053,0.0842652180880468,3.29473308603581e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLG,Plasminogen,37700,0.016953298093402,0.00189091546681436,0.0132471037784459,0.0206594924083581,3.49314052726166e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DSG2,Desmoglein-2,40327,-0.0203831895768678,0.00227500258586025,-0.0248421946451539,-0.0159241845085817,3.61335377921305e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CES1,Liver carboxylesterase 1,40347,0.0575242495378222,0.00642210172976544,0.044936930147482,0.0701115689281625,3.69204693958489e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",40300,0.0454524208238046,0.00507885543236155,0.035497864176376,0.0554069774712333,3.96540955489253e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,40417,0.0898582847507773,0.0100450009237732,0.0701700829401817,0.109546486561373,4.09937156331778e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",39975,0.0622407839867984,0.00695968043884344,0.0485998103266653,0.0758817576469315,4.20571091882701e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GFAP,Glial fibrillary acidic protein,39954,0.035338323955609,0.00396519660851846,0.0275665386029128,0.0431101093083052,5.55473017150028e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BCHE,Cholinesterase,37743,0.0212634559169284,0.00238654486821412,0.0165858279752287,0.0259410838586281,5.7741576616411e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NCAN,Neurocan core protein,40466,0.0280190914636483,0.00314582440328578,0.0218532756332082,0.0341849072940885,5.80959101769283e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,40300,0.051175809307265,0.00574906582727783,0.0399076402858005,0.0624439783287296,6.09166907853385e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,40531,0.020632434237753,0.00231983804463669,0.0160855516702651,0.0251793168052409,6.5160640897771e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",37666,0.0667660615547534,0.00751300516895101,0.0520405714236094,0.0814915516858974,7.09913469226792e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL17,C-C motif chemokine 17,40328,0.0679720176835575,0.00765216112858092,0.0529737818715389,0.0829702534955761,7.21185399420425e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ABHD14B,Protein ABHD14B,40166,0.0438212459040028,0.00493661784072012,0.0341454749361914,0.0534970168718143,7.61368383517309e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RTBDN,Retbindin,40300,0.021984347156167,0.00247799856680155,0.017127469965236,0.0268412243470981,7.9520514036437e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD80,T-lymphocyte activation antigen CD80,37985,0.0254387541152492,0.0028678159300677,0.0198178348923165,0.0310596733381818,8.18942021594266e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",37623,0.0483621314527838,0.00545261265398294,0.0376750106509772,0.0590492522545903,8.28148795638918e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STX8,Syntaxin-8,40336,0.0365517942896015,0.00412435996450941,0.0284680487591631,0.04463553982004,8.64665309172543e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLSCR3,Phospholipid scramblase 3,37914,0.0446310557944407,0.00504087238675233,0.0347509459164062,0.0545111656724753,9.50161603046239e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,40429,0.0540665679947081,0.00611082789935895,0.0420893453119646,0.0660437906774516,9.85701980637325e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NUMB,Protein numb homolog,37593,0.0621198632336746,0.00702085710703861,0.048358983303879,0.0758807431634703,1.00457104476972e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,40437,0.0207797006855377,0.0023518111007089,0.0161701509281482,0.0253892504429271,1.09735052868321e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,39975,0.046017327299497,0.00520869441583198,0.0358082862444663,0.0562263683545277,1.10939812106919e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,40275,0.01912987605606,0.00216711236362623,0.0148823358233526,0.0233774162887674,1.18220271219774e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,39882,0.0137762737628993,0.00156137195768107,0.0107159847258444,0.0168365627999542,1.22994255176378e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDH17,Cadherin-17,40354,-0.0505045640946961,0.00572697355655926,-0.0617294322655522,-0.0392796959238399,1.27596519062574e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,40327,0.0256517643588376,0.00290973407467759,0.0199486855724696,0.0313548431452057,1.30916860745931e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VWC2,Brorin,40162,0.0288433074883427,0.00328148486968267,0.0224115971437647,0.0352750178329208,1.65235907590524e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,40391,-0.0629903394560949,0.00717666506895405,-0.0770566029912448,-0.0489240759209449,1.84487464192375e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,40300,0.0778030462302691,0.00886978306643169,0.0604182714200629,0.0951878210404752,1.93629442527868e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FOLR2,Folate receptor beta,40466,0.0218111102345885,0.00248668556682402,0.0169372065236134,0.0266850139455636,1.94362959305162e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNAP29,Synaptosomal-associated protein 29,40406,0.0674918147673375,0.00770851649142485,0.0523831224441448,0.0826005070905302,2.23292958996281e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,40327,0.0213945991279355,0.00244501319544747,0.0166023732648585,0.0261868249910126,2.33856638945712e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANXA11,Annexin A11,40307,0.0496886180821637,0.00568365176949038,0.0385486606139626,0.0608285755503649,2.50807168851397e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAT2,Linker for activation of T-cells family member 2,40300,0.0904220729414592,0.0103459826383707,0.0701439469702527,0.110700198912666,2.56518425881589e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,40300,0.0284295513234827,0.00326611674132039,0.0220279625104948,0.0348311401364707,3.50281662952936e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DKK1,Dickkopf-related protein 1,40466,0.0437116611288341,0.00502916600165611,0.0338544957655881,0.0535688264920801,3.91365748029571e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,40495,0.0860291021445776,0.00990310580562424,0.0666190147655541,0.105439189523601,4.07210678995696e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,40223,0.054220636984637,0.0062421492058791,0.041986024541114,0.06645524942816,4.10966311962804e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,37623,0.0749554379594227,0.00864196353543838,0.0580171894299634,0.0918936864888819,4.67989513149086e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,39975,0.049368505758499,0.00569359670000494,0.0382090562264893,0.0605279552905087,4.70644050190538e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNM1,Dynamin-1,37896,0.0829102915522576,0.00956247200613197,0.064167846420239,0.101652736684276,4.79534242715454e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,37955,0.0498785144485557,0.00575591968188552,0.03859691187206,0.0611601170250513,4.99737785399822e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAMDC4,Apical endosomal glycoprotein,37895,-0.0398852255929215,0.00460270876403944,-0.0489065347704388,-0.0308639164154042,4.99994981555985e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,38480,-0.022920790019446,0.00264573031311953,-0.0281064214331603,-0.0177351586057318,5.07802533020182e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MLN,Promotilin,40336,0.0648292082843483,0.00749091920137207,0.050147006649659,0.0795114099190375,5.42496355024918e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATOX1,Copper transport protein ATOX1,40406,0.0524959728608715,0.00606628623593372,0.0406060518384414,0.0643858938833016,5.453565111078e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANG,Angiogenin,40304,0.0252108696358121,0.00291485577600527,0.0194977523148417,0.0309239869567824,5.68151612386698e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMPRSS15,Enteropeptidase,40300,-0.067325393775593,0.0077894681724031,-0.0825927513935031,-0.052058036157683,5.98495471129835e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,37741,0.0405660271156282,0.00469732724820999,0.0313592657091366,0.0497727885221198,6.48030006790079e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COCH,Cochlin,37985,0.033885181296107,0.00392603489267371,0.0261901529064665,0.0415802096857474,6.76059699059494e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,40058,0.0309231553247172,0.00358640629345548,0.0238937989895444,0.0379525116598899,7.18324439240972e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEC31A,Protein transport protein Sec31A,37623,0.0554038191151215,0.00643243882656765,0.0427962390150489,0.0680113992151941,7.90691097528661e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,40336,0.0890210702243348,0.010348485977681,0.06873803770808,0.10930410274059,8.5320532782555e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FURIN,Furin,40406,0.0244644687021242,0.00284678373722698,0.0188847725771593,0.0300441648270891,9.18954019675663e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FUOM,Fucose mutarotase,37666,0.0452765370805949,0.00526985681407722,0.0349476177250036,0.0556054564361863,9.53012762348004e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,40352,0.0289668086628291,0.00337245791005835,0.0223567911591148,0.0355768261665435,9.5573112579628e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHRDL1,Chordin-like protein 1,40391,0.0221917783184246,0.00258389509450263,0.0171273439331995,0.0272562127036498,9.6158364875295e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,37985,0.0708001966032906,0.00824538387868107,0.0546392442010757,0.0869611490055055,9.92357550848355e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEPTIN9,Septin-9,40300,0.0204580725875105,0.00238495779418097,0.0157835553109158,0.0251325898641052,1.05395550439715e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C9,Complement component C9,37982,0.0352422250447831,0.0041080884039235,0.027190371773093,0.0432940783164731,1.06261145073082e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAP3,Cytosol aminopeptidase,40039,0.03561354338836,0.00415545112979208,0.0274688591739675,0.0437582276027525,1.12758522715801e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,40320,0.0162032223275375,0.00189099632139231,0.0124968695376086,0.0199095751174664,1.14251551005816e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTGES2,Prostaglandin E synthase 2,37479,0.039499197438171,0.00461084548912727,0.0304619402794815,0.0485364545968604,1.18491281348393e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,40345,0.0357555573315534,0.0041785761176541,0.0275655481409514,0.0439455665221555,1.26427143177831e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CFHR4,Complement factor H-related protein 4,37968,0.0530131696546882,0.00620101458824463,0.0408591810617287,0.0651671582476477,1.37239045478461e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIAE,Sialate O-acetylesterase,40369,0.0338437391796385,0.00396198065677312,0.0260782570923632,0.0416092212669138,1.43557378536655e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",40037,0.0672132566107331,0.00786905606974402,0.0517899067140349,0.0826366065074314,1.44642105031615e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TBCA,Tubulin-specific chaperone A,37666,0.0628465017843669,0.00736003709168636,0.0484208290846616,0.0772721744840722,1.50219585083019e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SF3B4,Splicing factor 3B subunit 4,40300,0.0530364907124329,0.00621393356922587,0.0408571809167502,0.0652158005081156,1.52581525973524e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARSB,Arylsulfatase B,40300,0.0396648010368788,0.0046493345222067,0.0305521053733536,0.0487774967004039,1.57662638771592e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UBXN1,UBX domain-containing protein 1,37666,0.049706320987092,0.00583712246470258,0.0382655609562749,0.061147081017909,1.83573294035948e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,40336,0.0517807084583101,0.00608513418069035,0.039853845464157,0.0637075714524632,1.90293309667652e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GAL,Galanin peptides,40417,-0.0449657931663352,0.00528626508871133,-0.0553268727402094,-0.034604713592461,1.95546944579875e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,40325,-0.0349746677245289,0.00411246757111726,-0.0430351041639187,-0.0269142312851391,1.98363452145785e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ERBIN,Erbin,40300,0.0737258791850911,0.00866952489556016,0.0567336103897932,0.090718147980389,1.99273296154852e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,37623,0.0603454782919521,0.00709479994724294,0.046439670395356,0.0742512861885483,2.00011861280656e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLA2,Src-like-adapter 2,37955,0.0738746587956295,0.00868792178685241,0.0568463320933987,0.0909029854978602,2.037448501111e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HNMT,Histamine N-methyltransferase,40142,0.0332359916375539,0.003915470813392,0.0255616688433056,0.0409103144318022,2.28075127128209e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NAA80,N-alpha-acetyltransferase 80,37567,0.085248732938722,0.0100559896994715,0.0655389931277579,0.104958472749686,2.54688406547233e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PENK,Proenkephalin-A,37666,0.0220962375308939,0.00260672842307785,0.0169870498216614,0.0272054252401265,2.56224853143451e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,40417,0.0193636487007378,0.00229127057191961,0.0148727583797754,0.0238545390217003,3.13312410417574e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,37955,0.0608604458156042,0.00720179333380216,0.0467449308813519,0.0749759607498564,3.18869953689357e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTF1,Cardiotrophin-1,40037,0.0604006842356105,0.00715026572922359,0.0463861634063323,0.0744152050648888,3.24048607819622e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RBM17,Splicing factor 45,37955,0.0543221932004974,0.00643093518381934,0.0417175602402115,0.0669268261607833,3.29142184706692e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPING1,Plasma protease C1 inhibitor,37976,0.0132684677645753,0.00157144317936393,0.010188439133022,0.0163484963961286,3.39110122418983e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLK10,Kallikrein-10,40349,0.0280793649241475,0.0033269576556668,0.0215585279190405,0.0346002019292544,3.44520059454047e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BLMH,Bleomycin hydrolase,40531,0.0230304198713643,0.00272960246048625,0.0176803990488112,0.0283804406939173,3.5212672563631e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C5,Complement C5,38008,0.0108932059325593,0.00129134304383116,0.00836217356665028,0.0134242382984684,3.62698776939872e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HSPB1,Heat shock protein beta-1,40111,0.0482689274881478,0.0057266716239741,0.0370446511051585,0.059493203871137,3.79318311297955e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PAXX,Protein PAXX,37666,0.0322291287163953,0.0038280024497595,0.0247262439148667,0.0397320135179239,4.17452872104171e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLAMF8,SLAM family member 8,39975,0.038086917265128,0.00453157962923492,0.0292050211918276,0.0469688133384285,4.65483250279898e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,37982,0.0191477472555961,0.00228332474876576,0.0146724307480152,0.023623063763177,5.52775895162969e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,37810,0.0218780302027461,0.0026103932376372,0.0167616594569772,0.026994400948515,5.76275602419676e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,40438,0.0218000079013447,0.00260268337521899,0.0166987484859155,0.0269012673167739,5.92668545201692e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD244,Natural killer cell receptor 2B4,40511,0.0188605377257382,0.00225186788330983,0.0144468766744509,0.0232741987770254,5.9479416433391e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PARK7,Parkinson disease protein 7,40327,0.03783630944544,0.00452141360208277,0.0289743387853577,0.0466982801055222,6.33005239505775e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",37985,0.0381817621811404,0.00456234601917433,0.0292395639835587,0.0471239603787221,6.3825191369751e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,37985,0.0542455930998131,0.0064869824020211,0.0415311075918517,0.0669600786077744,6.75175845737441e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPI,Glucose-6-phosphate isomerase,37982,0.0330412139367762,0.00395133920264889,0.0252965890995844,0.040785838773968,6.76293772216512e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,40406,0.0514339489510775,0.0061554158801837,0.0393693338259175,0.0634985640762376,7.02359422039822e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,40497,0.0267910859880664,0.00321071879828934,0.0204980771434193,0.0330840948327135,7.74306287683927e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CERT,Ceramide transfer protein,39956,0.0433632173012598,0.00519681622090829,0.0331774575082796,0.0535489770942401,7.76887384208092e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,40300,0.0228707925930146,0.00274385371877807,0.0174928393042096,0.0282487458818196,8.35942082807658e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DCXR,L-xylulose reductase,40406,0.0368331516859964,0.00442121561068209,0.0281675690890595,0.0454987342829333,8.66145820840643e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAP2,Microtubule-associated protein 2,37937,0.0321812133708767,0.00386334735395504,0.0246090525571248,0.0397533741846286,8.86796665263441e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,37985,0.0496698790219851,0.00596748657139038,0.0379736053420599,0.0613661527019102,9.35957906134429e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FABP6,Gastrotropin,40012,0.0393028631896353,0.0047318313762253,0.0300284736922337,0.0485772526870369,1.07007858504279e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PODXL2,Podocalyxin-like protein 2,40406,0.0191980395129711,0.00231174539775562,0.0146670185333701,0.0237290604925721,1.08146611816442e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MERTK,Tyrosine-protein kinase Mer,40511,0.0183712683111003,0.00221302910648469,0.0140337312623903,0.0227088053598103,1.10987299618695e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AMBP,Protein AMBP,40465,0.0140329227089265,0.00169059711321248,0.0107193523670301,0.017346493050823,1.1179681514961e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL6,Interleukin-6,40300,0.0513085589825052,0.00618574125105746,0.0391845061304326,0.0634326118345779,1.17576290305919e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL18BP,Interleukin-18-binding protein,40398,0.0214072724167372,0.00258175357855498,0.0163470354027695,0.026467509430705,1.20403464470522e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,37623,0.0504266116576021,0.00608100608874546,0.038507839723661,0.0623453835915432,1.2160461471263e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,40395,0.0500121539443516,0.00603564419644791,0.0381822913193137,0.0618420165693895,1.26207718673815e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSAP,Prosaposin,37896,0.0198313449495825,0.0023933564852206,0.0151403662385502,0.0245223236606149,1.28139658331488e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SELP,P-selectin,40398,0.0402848432296675,0.00487530708123446,0.030729241350448,0.0498404451088871,1.53072966366511e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STAT2,Signal transducer and activator of transcription 2,37593,0.0534586605830273,0.00646977525213539,0.0407779010888419,0.0661394200772127,1.5580205354379e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,37895,0.0382209877176049,0.00463576301382185,0.029134892210514,0.0473070832246957,1.80666276947129e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNTN3,Contactin-3,40327,0.0243292902660879,0.00295368795222978,0.0185400618797175,0.0301185186524583,1.90349766112665e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD46,Membrane cofactor protein,40245,0.0199534358092897,0.00242479031150966,0.0152008467987307,0.0247060248198486,2.03499620772341e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEMA3F,Semaphorin-3F,40354,0.0179794041576085,0.00218604679832931,0.013694752432883,0.0222640558823339,2.10816965975422e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HPSE,Heparanase,37843,0.0642583930216378,0.00781892149454889,0.0489333068923219,0.0795834791509536,2.25218937881552e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EFNA4,Ephrin-A4,40198,0.0204237811928982,0.00248846646093607,0.0155463869294635,0.0253011754563329,2.43427471526726e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,37666,0.0280268355681267,0.00341588327676026,0.0213317043456765,0.0347219667905768,2.52095035200674e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,37973,0.0334040248692028,0.00407209143632552,0.0254227256540048,0.0413853240844008,2.55151621806647e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,37666,0.0336405158044261,0.00410159079810557,0.0256013978401392,0.041679633768713,2.58512210061534e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,40162,0.0194887797893042,0.00237877958088953,0.0148263718107607,0.0241511877678477,2.74795098856929e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,39975,0.032454680054323,0.0039630465380232,0.0246871088397975,0.0402222512688485,2.82974294282866e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,40336,0.0260813225601135,0.00318591417225497,0.0198369307824938,0.0323257143377332,2.89302157421627e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCN5,CCN family member 5,40327,0.0271470855325154,0.00331824962342518,0.0206433162706021,0.0336508547944288,3.02279047833116e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLRD1,Natural killer cells antigen CD94,40511,0.0315498772700442,0.003857124019785,0.0239899141912656,0.0391098403488228,3.05818073901391e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,40037,0.0666796644305448,0.00815787610469316,0.0506902272653462,0.0826691015957434,3.2200888117541e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CASC3,Protein CASC3,37567,0.0283675634268703,0.00347051328012974,0.021565357397816,0.0351697694559246,3.2587422506179e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RSPO3,R-spondin-3,40484,0.0197209586987113,0.00241678454385133,0.0149840609927627,0.0244578564046599,3.59681802307416e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NCK2,Cytoplasmic protein NCK2,40417,0.0721016652951584,0.00883701823470269,0.0547811095551411,0.0894222210351757,3.6261653306513e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD27,CD27 antigen,40406,0.0280922246541933,0.00344598689605086,0.0213380903379336,0.0348463589704529,3.83827017208357e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,40198,0.061081318722414,0.00750268346888988,0.0463760591233899,0.0757865783214382,4.20227870215304e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,39892,0.0393771308777652,0.00484220771672435,0.0298864037529854,0.0488678580025449,4.53890690080464e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,40323,0.0250050249994813,0.00307682376034586,0.0189744504292034,0.0310355995697592,4.72635602565477e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXCL5,C-X-C motif chemokine 5,40304,0.078799779539803,0.00969617888076026,0.0597952689335129,0.0978042901460931,4.72696469830236e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,37955,0.0356323635180843,0.00438673898401393,0.027034355109417,0.0442303719267516,4.95076364173809e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,40177,0.0197288208759828,0.0024328419687804,0.0149604506171732,0.0244971911347924,5.46060389430222e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TST,Thiosulfate sulfurtransferase,39918,0.0519813325375044,0.0064102000084113,0.0394173405210182,0.0645453245539905,5.47659526324445e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DXO,Decapping and exoribonuclease protein,37937,0.0313123813003929,0.00386092375918105,0.0237449707323981,0.0388797918683878,5.49313267017808e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,40336,0.0370560287321721,0.00457209074203345,0.0280947308777866,0.0460173265865577,5.66354093674064e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,40301,0.0246530667641645,0.00304472445613997,0.0186854068301301,0.0306207266981988,6.04061643942403e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,37896,0.0319393657747254,0.00394911066625537,0.0241991088688649,0.0396796226805859,6.59595201280476e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",37955,0.0495590266709886,0.0061308158999702,0.037542627507047,0.0615754258349302,6.82046354906741e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPRY2,Protein sprouty homolog 2,40039,0.0628793406370134,0.00778797644900197,0.0476149067969695,0.0781437744770572,7.3027670049835e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL5,C-C motif chemokine 5,40398,0.0683790599324824,0.00847265748646705,0.051772651259007,0.0849854686059578,7.4929269894492e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FKBPL,FK506-binding protein-like,37896,0.040099807399728,0.00496795078707242,0.030362623857066,0.0498369909423899,7.51814267251118e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,40223,0.064446469964259,0.00799133093482067,0.0487834613320105,0.0801094785965075,7.8751483200489e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PMVK,Phosphomevalonate kinase,39946,0.075438408505823,0.00935915206405994,0.0570944704602655,0.0937823465513804,8.15659946753329e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",40300,0.0236737561543545,0.00293755198321699,0.0179161542672493,0.0294313580414598,8.23602060977457e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STX4,Syntaxin-4,40300,0.0407106682337249,0.00505950173877598,0.0307940448257239,0.0506272916417258,9.12776723041724e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,40291,0.032584458741783,0.00405203504955505,0.0246424700446551,0.0405264474389109,9.49717679879889e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNAP25,Synaptosomal-associated protein 25,37536,0.0317856329293724,0.00395195639484325,0.0240397983954797,0.0395314674632652,9.51614349695636e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD302,CD302 antigen,40300,0.0204915794491281,0.00254977821465251,0.0154940141484091,0.025489144749847,9.88198529155507e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,40446,0.0235065715859299,0.00292656940758437,0.0177704955470645,0.0292426476247952,1.02425049391636e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ASAH1,Acid ceramidase,37878,0.0311910121883278,0.00388567686798334,0.0235750855270805,0.0388069388495752,1.07988914705737e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL1B,Interleukin-1 beta,39941,0.0383433787121211,0.00477777895366707,0.0289789319629336,0.0477078254613085,1.08444703854053e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL4,C-C motif chemokine 4,40371,0.045911326897345,0.00572384314892819,0.0346925943254457,0.0571300594692442,1.12076600180527e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",37955,0.0519871888307255,0.0064823053357272,0.0392818703727002,0.0646925072887509,1.14533848801083e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,THPO,Thrombopoietin,40037,0.025892984732071,0.00322929583559784,0.0195635648942992,0.0322224045698427,1.14920471293159e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,QDPR,Dihydropteridine reductase,40285,0.0296423016265601,0.00369870489987758,0.0223928400228,0.0368917632303201,1.18497907308766e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LGALS3,Galectin-3,40369,0.0200178888422872,0.0024980387735556,0.0151217328461182,0.0249140448384561,1.19222652558921e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",40511,0.0469867272264361,0.00586405550846383,0.035493178429847,0.0584802760230252,1.19902640402931e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,37709,0.0755220376941356,0.00942812549665333,0.0570429117206951,0.0940011636675761,1.23941295499713e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,40417,0.0846302060220311,0.0105723230786952,0.0639084527877885,0.105351959256274,1.27753819397133e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",40327,0.0523204795541338,0.00654320283548201,0.039495801996589,0.0651451571116786,1.37147952521101e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,40400,0.0344798548752886,0.00432107320332476,0.026010551396772,0.0429491583538051,1.56895201034657e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,39975,0.0516251100967147,0.00647318965462122,0.0389376583736571,0.0643125618197723,1.62651396726548e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ALCAM,CD166 antigen,40531,0.0130527061153528,0.00164002114986337,0.00983826466162058,0.016267147569085,1.85132850702514e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,40336,0.0544311283739338,0.00684129697383645,0.0410221863052143,0.0678400704426532,1.89204745019388e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LBP,Lipopolysaccharide-binding protein,40398,0.0392182076643368,0.00492938393997964,0.0295566151419767,0.0488798001866969,1.89542271508972e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,37874,0.0471691619417909,0.00593807534320456,0.0355305342691099,0.0588077896144718,2.12112345647782e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,39860,0.0254426704002019,0.00320468206799513,0.0191614935469315,0.0317238472534724,2.17409039431006e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,37895,0.0580350787133219,0.00731088474829024,0.043705744606673,0.0723644128199708,2.21366229216866e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD300C,CMRF35-like molecule 6,40466,0.0228323658154813,0.00287946180056917,0.0171886206863657,0.0284761109445969,2.34669299800917e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,40300,0.0777315709148565,0.00981730044822841,0.0584896620363288,0.0969734797933842,2.57643615132248e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPP1R9B,Neurabin-2,40511,0.062756551589187,0.00793369817945979,0.0472065031574458,0.0783066000209282,2.737723103305e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,37623,-0.0245652462798294,0.003106341619196,-0.0306536758534535,-0.0184768167062052,2.82093010799084e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPA33,Cell surface A33 antigen,40300,-0.0913052064949266,0.0115533912147093,-0.113949853275757,-0.0686605597140963,2.90319406854081e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,40354,0.0529483476827629,0.00670117622805331,0.0398140422757784,0.0660826530897474,2.93854583436234e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SRPK2,SRSF protein kinase 2,40336,0.0551529479969759,0.00698184434913588,0.0414685330726695,0.0688373629212822,2.9830075225891e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BAP18,Chromatin complexes subunit BAP18,37937,0.043150621532056,0.0054626460795457,0.0324438352161465,0.0538574078479656,3.0229584170592e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,40039,0.0442348944038096,0.00560410422986457,0.0332508501132751,0.0552189386943442,3.13765345666631e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNX15,Sorting nexin-15,37666,0.0361340320138718,0.00458001930033514,0.0271571941852149,0.0451108698425287,3.27178879625449e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,40210,0.0627853777272845,0.00796225162954284,0.0471793645333806,0.0783913909211885,3.34015703277396e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,40300,0.0630967789344033,0.00800198995273115,0.0474128786270502,0.0787806792417564,3.34546163229724e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FADD,FAS-associated death domain protein,40354,0.0508962908282809,0.00645494641965845,0.0382445958457504,0.0635479858108115,3.35236229762841e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,37623,0.0409784835453953,0.00519765447559553,0.030791080773228,0.0511658863175625,3.41817500049932e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,40037,0.0497947682199517,0.00632160848112803,0.0374044155969407,0.0621851208429626,3.57586522379751e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCG2,Secretogranin-2,40387,-0.0214610330174563,0.0027246288105003,-0.0268013054860369,-0.0161207605488757,3.57752334222036e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NUB1,NEDD8 ultimate buster 1,40336,0.0554904773356942,0.00705165305547359,0.041669237346966,0.0693117173244224,3.79961894503034e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACRBP,Acrosin-binding protein,37895,0.0251465807221508,0.00319510058713563,0.0188841835713649,0.0314089778729366,3.80571912451619e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,37985,0.0709195909702926,0.00901516778179659,0.0532498621179713,0.0885893198226139,3.91624449584064e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPM1F,Protein phosphatase 1F,37985,0.0346813118207466,0.00440863386215488,0.026040389450923,0.0433222341905702,3.91676592192964e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EGLN1,Egl nine homolog 1,40336,0.035241022361406,0.00448192139855411,0.0264564564202399,0.0440255883025721,3.99234778309703e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EHBP1,EH domain-binding protein 1,37985,0.0494261946702292,0.0062849686100133,0.0371076561946031,0.0617447331458552,3.99505918726789e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,37985,0.0197889738768145,0.00251777946598575,0.0148541261234824,0.0247238216301465,4.14048789373446e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,40354,0.0557288360555924,0.00709695816358588,0.041818798054964,0.0696388740562207,4.337252538194e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MIF,Macrophage migration inhibitory factor,40302,0.0457043791418154,0.00582190271877148,0.0342934498130233,0.0571153084706075,4.41028000516216e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LBR,Delta(14)-sterol reductase LBR,40466,0.0434342723953787,0.00553326812528911,0.032589066869812,0.0542794779209453,4.43418169123585e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",37937,0.0639080238103743,0.0081457828586991,0.047942289407324,0.0798737582134245,4.63429585274545e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINA7,Thyroxine-binding globulin,38008,0.0123898634187215,0.00157973439585534,0.009293584002845,0.0154861428345979,4.7264790749412e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,40300,0.0258083874561085,0.00329218597049213,0.0193557029539439,0.0322610719582731,4.81781377581793e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HS1BP3,HCLS1-binding protein 3,37623,0.0589552168289327,0.007521855371189,0.0442123803014023,0.0736980533564632,4.93368357097507e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,39530,0.025242926501035,0.00322146480029274,0.0189288554924613,0.0315569975096088,4.96622640463594e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",37557,0.0381378730553342,0.00487620940486443,0.0285805026217999,0.0476952434888684,5.63053300043034e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,39975,0.0378588521887637,0.00484197800678044,0.0283685752954741,0.0473491290820534,5.67028236757449e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,37666,0.0403641326624477,0.00516333034961162,0.030244005177209,0.0504842601476865,5.79658278422921e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TWF2,Twinfilin-2,37993,0.054538341426299,0.00697960427754042,0.0408583170423198,0.0682183658102782,5.9488404695751e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SUGT1,Protein SGT1 homolog,39975,0.0537949349532176,0.00688557400451499,0.0402992099043682,0.0672906600020669,5.95430202352481e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LACTB2,Endoribonuclease LACTB2,40354,0.0435562896411651,0.00558120035463235,0.0326171369460857,0.0544954423362445,6.36334863559076e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNCG,Gamma-synuclein,40223,0.0440941562538863,0.0056516830485355,0.0330168574787568,0.0551714550290159,6.47586326737656e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNM3,Dynamin-3,37955,0.0360526345945459,0.00462432189684415,0.0269889636767313,0.0451163055123604,6.83962219738463e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,40354,0.0183639581806834,0.002356580404044,0.0137450605887571,0.0229828557726096,6.96673788940751e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",37855,0.0710449759282663,0.00913026544496191,0.0531496556561409,0.0889402962003916,7.70436474740181e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLK14,Kallikrein-14,40484,0.0302375371530533,0.00388736717852096,0.0226182974831522,0.0378567768229543,7.7890181017876e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AAMDC,Mth938 domain-containing protein,37623,0.0351104041326744,0.00451294279968548,0.0262650362452909,0.043955772020058,7.79475720756155e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,40004,0.0339924452476746,0.00437710428849039,0.0254133208422334,0.0425715696531157,8.60559854479607e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,37937,0.0347730513447599,0.00447924945688067,0.0259937224092737,0.043552380280246,8.87999302937104e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATRN,"Attractin, Isoform 2",38008,0.0107151505592001,0.00138077516028193,0.0080088312450475,0.0134214698733527,9.08118669847514e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GSTA1,Glutathione S-transferase A1,40328,0.0542241319087682,0.00698878438580649,0.0405261145125875,0.0679221493049489,9.09750926741846e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,40352,0.0252027895532436,0.0032524322230075,0.0188280223961488,0.0315775567103383,9.82640007073577e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,37896,0.0384623420914596,0.00496279621016445,0.0287352615195373,0.048189422663382,9.836217990457e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,37955,0.0400113663349052,0.00516312400083755,0.0298916432932637,0.0501310893765468,9.88630513428343e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,37658,0.0297828210334453,0.00384347257003895,0.022249614796169,0.0373160272707217,9.94150161803102e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FAM13A,Protein FAM13A,37896,0.0439826232627935,0.00567694579609405,0.0328558095024492,0.0551094370231378,1.0034794125901e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD300LF,CMRF35-like molecule 1,40484,0.0397765999274627,0.00513607889286731,0.0297098852974428,0.0498433145574826,1.01632683164063e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CA13,Carbonic anhydrase 13,40168,0.0678442732847998,0.00876367037488525,0.0506674793500248,0.0850210672195749,1.04179534369418e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL26,C-C motif chemokine 26,40336,0.058114527425163,0.00750883026762976,0.0433972201006087,0.0728318347497174,1.05796699846703e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BRK1,Protein BRICK1,39956,0.0289090647887057,0.00373692255789732,0.021584696575227,0.0362334330021844,1.0883179380914e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,S100A4,Protein S100-A4,40406,0.037758437660987,0.00488389673205723,0.0281860000661549,0.0473308752558192,1.12855489451343e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RGS10,Regulator of G-protein signaling 10,37955,0.0390717939993719,0.0050538432386763,0.0291662612515664,0.0489773267471775,1.14134848117825e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCGB1A1,Uteroglobin,40379,0.0370752860199592,0.00480606616705078,0.0276553963325397,0.0464951757073788,1.2885377567245e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,40223,0.0357963931004631,0.00464092177784223,0.0267001864158923,0.0448925997850339,1.29999561554666e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,40335,0.0369427161113143,0.0047899694611322,0.0275543759674952,0.0463310562551334,1.30650400909334e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PCBP2,Poly(rC)-binding protein 2,37955,0.0466534443752758,0.00605064765017465,0.0347941749809335,0.0585127137696181,1.34080525086813e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,37623,0.0202938693195112,0.00263224633413508,0.0151346665046065,0.025453072134416,1.35119818745865e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,37896,0.0417769302902085,0.00541906249560664,0.0311555677988195,0.0523982927815975,1.35416919323045e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,40223,0.0385219784379918,0.0050008832255537,0.0287202473159065,0.048323709560077,1.40741121001876e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,40327,0.0274124178239293,0.00356091982833383,0.020433014960395,0.0343918206874636,1.46175004980514e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL20,C-C motif chemokine 20,40511,0.0577334660380153,0.00750452189271264,0.0430246031282986,0.0724423289477321,1.51849881779679e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,40327,0.0149078832630483,0.00193813914077395,0.0111091305471313,0.0187066359789652,1.53498859507265e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,METAP2,Methionine aminopeptidase 2,40448,0.038229814766684,0.00497261912434409,0.0284834812829696,0.0479761482503984,1.58028634157886e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIF22,Kinesin-like protein KIF22,37557,0.0794904372016005,0.0103419268342716,0.0592202606064281,0.0997606137967729,1.62295366077005e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANXA3,Annexin A3,40437,0.0453523747834062,0.00590388991024116,0.0337807505593335,0.0569239990074788,1.65957338217097e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CACYBP,Calcyclin-binding protein,37637,0.0664704396331417,0.00865994648494513,0.0494969445226492,0.0834439347436341,1.76177127476488e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,40327,-0.0263497896707594,0.00343524925138216,-0.0330828782034684,-0.0196167011380503,1.81353331047464e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GHR,Growth hormone receptor,37666,0.018690209658116,0.00243673389008616,0.0139142112335472,0.0234662080826849,1.83734759379812e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,40037,0.0545446927257753,0.00711344482200829,0.0406023408746391,0.0684870445769116,1.85223537034614e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NPPC,C-type natriuretic peptide,40336,0.0279216804416609,0.00364158574621114,0.0207841723790871,0.0350591885042348,1.85571462214189e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTSE,Cathepsin E,37666,-0.0334231888939511,0.00436010874701349,-0.0419690020380975,-0.0248773757498046,1.9028048261492e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,37666,0.0565378215110454,0.00737999641571826,0.0420730285362376,0.0710026144858532,1.97378764015482e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PZP,Pregnancy zone protein,38008,0.0421538945209067,0.00550490162475858,0.0313642873363798,0.0529435017054335,2.02363172513117e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRADD,Death domain-containing protein CRADD,40187,0.0494693170178266,0.0064616747034994,0.0368044345989678,0.0621341994366854,2.03229914235822e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,37895,0.0532251821949647,0.00695494148239928,0.0395934968894621,0.0668568675004673,2.09920737229518e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,39956,0.0487083855956428,0.00636690233989921,0.0362292570094403,0.0611875141818453,2.12349377792675e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,YWHAQ,14-3-3 protein theta,37666,0.0476820913983449,0.00623601444484615,0.0354595030864465,0.0599046797102434,2.21200530306431e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FABP1,"Fatty acid-binding protein, liver",40352,0.0601355081099373,0.00787163819339747,0.0447070972508783,0.0755639189689964,2.30423449934363e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,37955,0.061670535888313,0.0080740254257199,0.045845446053902,0.077495625722724,2.35177272015614e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LEP,Leptin,40354,0.0412380974798083,0.0054006227456559,0.0306528768983228,0.0518233180612939,2.37134885016473e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCARF1,Scavenger receptor class F member 1,40531,0.0273206386387398,0.00357891036686498,0.0203059743196844,0.0343353029577951,2.40717737925829e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ST13,Hsc70-interacting protein,37666,0.0367094523560614,0.00481562948357924,0.0272708185682461,0.0461480861438767,2.64762841381134e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,37666,0.0540813013467107,0.00710047537358969,0.0401643696144749,0.0679982330789465,2.78173787256906e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MPO,Myeloperoxidase,40327,0.0301008862909619,0.0039548810824342,0.0223493193693909,0.037852453212533,2.87063933973448e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,39975,0.0430876458735769,0.00566236206043535,0.0319894162351236,0.0541858755120302,2.90962183127682e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,40300,0.0231422984342224,0.00304188270620349,0.0171802083300636,0.0291043885383813,2.94228342675003e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WASHC3,WASH complex subunit 3,37937,0.0480548072015483,0.0063193788519918,0.0356688246516443,0.0604407897514522,3.0523118165557e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RWDD1,RWD domain-containing protein 1,40466,0.0413266571726342,0.00543568448921259,0.0306727155737775,0.0519805987714909,3.05713878920503e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,38008,0.0164179505722664,0.00216039938135716,0.0121835677848064,0.0206523333597265,3.16754314630295e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,40307,0.0569099012610373,0.00750428427972941,0.0422015040727677,0.071618298449307,3.54532543005826e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,37993,0.0165739739123019,0.00218598784214841,0.012289437741691,0.0208585100829128,3.62610912997068e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HEPACAM2,HEPACAM family member 2,37937,-0.0259804626129481,0.00343565075164384,-0.03271433808617,-0.0192465871397261,4.22471712255829e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ELOA,Elongin-A,40300,0.0326572172078531,0.00432110626997351,0.024187848918705,0.0411265854970012,4.32957274389335e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,37220,0.0690032716562336,0.00913872250239437,0.0510913755515406,0.0869151677609265,4.62493874024294e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,39975,0.022981782006708,0.00304687707295503,0.0170099029437161,0.0289536610696998,4.85667082874331e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DPEP2,Dipeptidase 2,40300,0.0183421745861234,0.00243293759370954,0.0135736169024527,0.0231107322697941,4.98768967958647e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GMPR2,GMP reductase 2,37666,0.0432032724983028,0.00573127981889859,0.0319699640532616,0.0544365809433441,5.07687602267353e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGA11,Integrin alpha-11,40336,-0.0217015686122604,0.00287980073404046,-0.0273459780509797,-0.0160571591735411,5.11509894085665e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,39975,0.0336644090264423,0.00446951184669225,0.0249041658069255,0.0424246522459591,5.27118676904115e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,37666,0.0523580968345361,0.00695278654387393,0.0387306352085432,0.065985558460529,5.38139745768145e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TOP2B,DNA topoisomerase 2-beta,37593,0.0501384709927376,0.00665903560210754,0.0370867612126068,0.0631901807728684,5.42988070379922e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,40286,0.0184874720487524,0.00245660653593156,0.0136725232383265,0.0233024208591782,5.52902598444695e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DCTD,Deoxycytidylate deaminase,37666,0.0600737743381108,0.0079838479753668,0.0444254323063918,0.0757221163698297,5.63781992060069e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,37593,0.0577872853794017,0.00768400903787724,0.0427266276651623,0.0728479430936411,5.81220999487007e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,THTPA,Thiamine-triphosphatase,37879,0.056099204599423,0.00747097234022734,0.0414560988125774,0.0707423103862686,6.33562856442794e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GMFG,Glia maturation factor gamma,37985,0.0453734216582547,0.00604296765328165,0.0335292050578227,0.0572176382586867,6.35622698411129e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,40302,0.0415271369402347,0.00553270543226241,0.0306830342930004,0.052371239587469,6.43158280876553e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,40466,0.0220120391292187,0.00293490317165871,0.0162596289127676,0.0277644493456697,6.71121288024445e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,40336,0.0753257100566203,0.0100804046873196,0.0555681168694739,0.0950833032437667,8.27846085929878e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GRSF1,G-rich sequence factor 1,37397,0.0499585136637959,0.00668487614117206,0.0368561564270987,0.0630608709004931,8.3187172335736e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL24,C-C motif chemokine 24,40391,0.0524093331914189,0.00702063254553891,0.0386488934021626,0.0661697729806751,8.75696320725071e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FAM20A,Pseudokinase FAM20A,37985,0.0177826700128037,0.00238245507780654,0.0131130580603029,0.0224522819653045,8.90479835364747e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DOK2,Docking protein 2,40354,0.0761190351755176,0.0102008012545883,0.0561254647165245,0.0961126056345106,8.95770865351471e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,40300,0.087006735169959,0.0116611088721438,0.0641509617805572,0.109862508559361,9.01292709630836e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AIF1,Allograft inflammatory factor 1,39975,0.0332901128317871,0.00446171601692501,0.0245451494386141,0.0420350762249602,9.02206641385545e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CYTL1,Cytokine-like protein 1,37993,0.0144700296028973,0.00193963983722652,0.0106683355219333,0.0182717236838612,9.16731624028562e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL16,C-C motif chemokine 16,40531,0.0333226833041901,0.00446976370156653,0.0245619464491197,0.0420834201592605,9.43452365441999e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TBCC,Tubulin-specific chaperone C,40223,0.0511319662826253,0.00686095204925659,0.0376845002660824,0.0645794322991682,9.62579591784302e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BCL2L1,Bcl-2-like protein 1,37937,0.0625960415123686,0.008410011919114,0.0461124181509052,0.0790796648738321,1.04352055538145e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NUDC,Nuclear migration protein nudC,40511,0.0397589744496531,0.00534733384501772,0.0292782001134184,0.0502397487858879,1.09598392098761e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEMA7A,Semaphorin-7A,40485,0.0168596635534833,0.00227490703439724,0.0124008457660647,0.0213184813409018,1.31454107432391e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,37666,-0.015684724403948,0.00211678488528818,-0.0198336227791129,-0.0115358260287832,1.34277165999883e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,37937,0.0389320642932712,0.00525441652958289,0.0286334078952887,0.0492307206912536,1.34415086856091e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARFIP1,Arfaptin-1,37955,0.0429197140941975,0.00579546328983897,0.0315606060461131,0.0542788221422819,1.38143660173643e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TBC1D23,TBC1 domain family member 23,40300,0.0561915003263755,0.00759226322969295,0.0413106643961773,0.0710723362565737,1.41778239721351e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,40336,0.0268325160891364,0.00362638279428054,0.0197248058123465,0.0339402263659263,1.438005500032e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NSFL1C,NSFL1 cofactor p47,40466,0.0416235967336946,0.00562641056752601,0.0305958320213436,0.0526513614460456,1.45213238337366e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",40336,0.0601857280659488,0.00814007528502545,0.0442311805072989,0.0761402756245987,1.49852023192179e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,40039,0.0238001970927283,0.00322225516094673,0.0174845769772727,0.0301158172081839,1.58737922062898e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMEM106A,Transmembrane protein 106A,37895,0.0436734110395657,0.00591225750700767,0.0320853863258307,0.0552614357533007,1.59112505735954e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,37955,0.0782134403112728,0.0105904072500626,0.0574562421011502,0.0989706385213955,1.61008880741396e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,40368,0.0167695305285847,0.00227138660909165,0.0123176127747651,0.0212214482824043,1.624764663804e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SHISA5,Protein shisa-5,37993,0.0154845021898108,0.00209783975871204,0.0113727362627352,0.0195962681168864,1.66054863714553e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,37955,0.0219245104968395,0.00297143604898039,0.016100495840838,0.0277485251528411,1.69524196933112e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PKD2,Polycystin-2,37557,0.0371176944151445,0.00503705197455144,0.0272450725450237,0.0469903162852654,1.82297685532567e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,37955,0.0470851298723266,0.00638992150489041,0.0345608837227414,0.0596093760219118,1.82362946630725e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,37917,0.0520620000591745,0.00706574141946854,0.0382131468770162,0.0659108532413329,1.82973957843498e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,37332,0.0307550568658795,0.00417449397505423,0.0225730486747732,0.0389370650569858,1.84618734196604e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMED8,Protein TMED8,37896,0.0637469213517995,0.008656323482327,0.0467805273264385,0.0807133153771604,1.88575018405289e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACYP1,Acylphosphatase-1,37617,0.0410950962019491,0.00558701353979086,0.030144549663959,0.0520456427399391,2.01514187338566e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPOCK1,Testican-1,40223,0.0156386978900976,0.00212686284747149,0.0114700467090535,0.0198073490711418,2.03411188741414e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSME1,Proteasome activator complex subunit 1,40211,0.0233940748665065,0.00318273924402735,0.0171559059482129,0.0296322437848001,2.07471789763511e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],39973,0.0304692137472443,0.00414555395061444,0.0223439280040399,0.0385944994904486,2.08309821777209e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LEFTY2,Left-right determination factor 2,40448,0.032163119256571,0.00438930809396281,0.0235600753924039,0.0407661631207381,2.45482459560903e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CIAPIN1,Anamorsin,40406,0.0395761216378718,0.0054013457534629,0.0289894839610846,0.0501627593146591,2.46464091839299e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,37567,0.0502800332880334,0.00686704688104154,0.036820621401192,0.0637394451748748,2.58680043923708e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,37895,0.0419218224620428,0.00572584362949703,0.0306991689482286,0.0531444759758569,2.59129059612116e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATG16L1,Autophagy-related protein 16-1,37896,0.0521864059397382,0.00713463006098432,0.0382025310202089,0.0661702808592674,2.72920357811694e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCLY,Selenocysteine lyase,40429,0.029445236261149,0.0040280112746465,0.0215503341628418,0.0373401383594561,2.79540133028419e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,40223,0.0277773995775327,0.00380355197496455,0.0203224377066021,0.0352323614484632,2.94830301038571e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DBNL,Drebrin-like protein,40417,0.0570278982232338,0.007811065317035,0.0417182102018452,0.0723375862446224,2.99293034432884e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,XCL1,Lymphotactin,40484,0.034800880354852,0.00476721914290889,0.0254571308347506,0.0441446298749534,3.01178913080373e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GP6,Platelet glycoprotein VI,40306,0.0542536741707912,0.00743341263805455,0.0396841854002042,0.0688231629413781,3.04508755147839e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANXA4,Annexin A4,40274,0.0442364538969246,0.00606729359298729,0.0323445584546695,0.0561283493391797,3.22286993955276e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,39975,0.0306168830803044,0.00420980582443211,0.0223656636644175,0.0388681024961913,3.69048574680267e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNASE6,Ribonuclease K6,37912,0.0180955853009663,0.00249229997224243,0.0132106773553712,0.0229804932465615,4.06533122665478e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",37985,0.0454511395873082,0.00626268648476744,0.033176274077164,0.0577260050974524,4.15940651098898e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APPL2,DCC-interacting protein 13-beta,37666,0.068387160662646,0.00943516278528037,0.0498942416034965,0.0868800797217955,4.4607513583162e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXCL1,Growth-regulated alpha protein,40324,0.059585854290303,0.00822301012840992,0.0434687544386196,0.0757029541419865,4.48229963689742e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,40511,0.0233895256375328,0.00322800196710192,0.017062641782013,0.0297164094930525,4.49357013119344e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,37955,0.0489322455796686,0.00675390945714101,0.0356945830436723,0.062169908115665,4.55801769939397e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,40300,0.041378474329574,0.00571725789657648,0.0301726488522841,0.0525842998068639,4.78093300450782e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TCOF1,Treacle protein,37985,0.0184523675815966,0.00254963941299705,0.0134550743321224,0.0234496608310708,4.82551843484587e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GSR,"Glutathione reductase, mitochondrial",37939,0.0135284331820191,0.0018701626670829,0.00986291435453656,0.0171939520095015,4.94903867165791e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPR37,Prosaposin receptor GPR37,40037,0.0410772308060194,0.00568028726425464,0.0299438677680803,0.0522105938439585,4.99739686791491e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,39975,0.0469856964959693,0.00649912789309321,0.0342474058255066,0.059723987166432,5.0723005811258e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ROBO1,Roundabout homolog 1,40374,0.0147382746170604,0.00203998655114883,0.0107399009768087,0.0187366482573121,5.24991921005093e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,39975,0.0516541109693243,0.00715416725644147,0.037631943146699,0.0656762787919496,5.43412994855429e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPART,Spartin,37666,0.0470817692092627,0.00652302792651961,0.0342966344732843,0.0598669039452412,5.57291926096861e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINC1,Antithrombin-III,37976,0.0089711302296998,0.00124390807278192,0.00653307040704724,0.0114091900523524,5.80441724300916e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,40417,0.0522590552056564,0.00725076162735426,0.0380475624160421,0.0664705479952708,5.95873003285954e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,40300,0.0464438675984763,0.00644705559560713,0.0338076386310863,0.0590800965658662,6.11525105292655e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,37895,0.0573635080279528,0.00796220255070718,0.0417575910285667,0.0729694250273389,6.13698198638634e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,YAP1,Transcriptional coactivator YAP1,37937,0.0161925070714239,0.00224773676486939,0.0117869430122799,0.0205980711305679,6.1612192856127e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,39956,0.0479832357859547,0.00666594645330054,0.0349179807374856,0.0610484908344237,6.37818416995495e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,40398,0.027000705683857,0.00375340624671518,0.0196440294402952,0.0343573819274187,6.58844896092663e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,37896,0.05934946677763,0.00825079901933522,0.0431779006997329,0.075521032855527,6.66497700076755e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GHRL,Appetite-regulating hormone,40354,0.0479632229424879,0.00667090125451767,0.0348882564836333,0.0610381894013426,6.77154690817807e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,37623,0.0286340984181096,0.00398480792686287,0.0208238748814583,0.0364443219547608,7.04019369978674e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VEGFC,Vascular endothelial growth factor C,40406,0.0339341237838599,0.00472546391505906,0.0246722145103442,0.0431960330573757,7.21937039211799e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,40223,0.0472743527383805,0.00658708041670786,0.0343636751216331,0.0601850303551279,7.45245998368423e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GNLY,Granulysin,40327,0.030807062350505,0.0042954131620121,0.0223880525529613,0.0392260721480488,7.71243459501388e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,37666,0.0174521893996938,0.00243307399745243,0.0126833643646871,0.0222210144347006,7.73369397249885e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLTA,Clathrin light chain A,40037,0.0287793442647721,0.00401386873849343,0.020912161537325,0.0366465269922192,7.83796366161125e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SORD,Sorbitol dehydrogenase,40412,0.0404649503036288,0.00564988205942346,0.0293911814671588,0.0515387191400988,8.29254859052484e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",40327,0.0276905404740145,0.00386878252540264,0.0201077267242253,0.0352733542238036,8.58013955106893e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,40354,0.0295658369075345,0.00413123018074687,0.0214686257532707,0.0376630480617984,8.62726205572019e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,40511,0.026749306701369,0.0037379050716753,0.0194230127608855,0.0340756006418526,8.6510996360854e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,40039,0.0331035885232036,0.00462659214178008,0.0240354679253146,0.0421717091210925,8.73549265374365e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,37896,0.0464463544286554,0.0064943773751045,0.0337173747734505,0.0591753340838602,9.00887696905726e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEP43,Centrosomal protein 43,39929,0.0417311320012149,0.00583983668351418,0.0302850521015271,0.0531772119009027,9.33699438929123e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLXNB3,Plexin-B3,40305,0.0281913445224438,0.00394648123200812,0.0204562413077079,0.0359264477371798,9.50008583948461e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,B2M,Beta-2-microglobulin,38008,0.019156812483958,0.00268147385692617,0.0139011237243827,0.0244125012435333,9.51867403505333e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRKL,Crk-like protein,40369,0.0644390730752235,0.00902146311999964,0.0467570053600242,0.0821211407904228,9.53644095584285e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PALM2,Paralemmin-2,37937,0.0222491265846945,0.00311492599121578,0.0161438716419115,0.0283543815274774,9.61754153596206e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINB6,Serpin B6,40428,0.0359745854685797,0.00504171341017088,0.0260928271846448,0.0458563437525146,1.00659458886194e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD160,CD160 antigen,40511,0.027580901975121,0.00386819747593679,0.0199992349222848,0.0351625690279571,1.04516312658637e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINA5,Plasma serine protease inhibitor,37830,0.0197991969211305,0.00277750032137346,0.0143552962912385,0.0252430975510224,1.06731866058133e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,40223,0.0478182373443435,0.00670951857285824,0.0346675809415414,0.0609688937471457,1.07081476168324e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLAMF6,SLAM family member 6,39975,0.02293121969445,0.00321764013259729,0.0166246450345593,0.0292377943543407,1.07313345114946e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAB2B,Ras-related protein Rab-2B,37895,0.0369266401474527,0.00518248363565969,0.0267689722215597,0.0470843080733457,1.09161269345965e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GAS6,Growth arrest-specific protein 6,40424,-0.0154738249595122,0.00217232711258039,-0.0197315861001697,-0.0112160638188546,1.09984186857785e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",37955,0.0286136304662321,0.00401755979076754,0.0207392132763277,0.0364880476561364,1.11641359296759e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SYTL4,Synaptotagmin-like protein 4,37985,0.0438828791839236,0.00616957104915271,0.0317905199275843,0.0559752384402629,1.19430927471426e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,40452,0.0157133563172065,0.00221285851754164,0.0113761536228249,0.0200505590115881,1.29131459623724e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VEGFA,Vascular endothelial growth factor A,40451,0.0352082793264069,0.00496453719068436,0.0254777864326656,0.0449387722201483,1.37763896391588e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STK24,Serine/threonine-protein kinase 24,39956,0.03702925735818,0.00522147631806252,0.0267951637747775,0.0472633509415826,1.38176931524822e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TBCB,Tubulin-folding cofactor B,40223,0.0604971811964278,0.00854124559696899,0.0437563398263686,0.0772380225664871,1.4708478400197e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FYB1,FYN-binding protein 1,40306,0.0546663162518203,0.00772072118340599,0.0395337027323446,0.0697989297712961,1.49698740136175e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,40336,0.0600776986720507,0.00849049018607144,0.0434363379073507,0.0767190594367508,1.54706854016065e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,40223,0.0567231205985035,0.00801723259111029,0.0410093447199274,0.0724368964770797,1.55567932218269e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,40531,0.0173347985638606,0.00245065368033615,0.0125315173504018,0.0221380797773195,1.57253682341763e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FUS,RNA-binding protein FUS,39955,0.0235659071828673,0.00333630844487939,0.0170267426309036,0.0301050717348309,1.69304324231851e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,40429,0.0201577527757663,0.00285724879754539,0.0145575451325774,0.0257579604189553,1.79747261347275e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FRZB,Secreted frizzled-related protein 3,40171,0.0158855196311586,0.00225317859645072,0.0114692895821152,0.020301749680202,1.86001817722885e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCRL2,Fc receptor-like protein 2,40437,0.0290631058545014,0.00412286586225395,0.0209822887644837,0.0371439229445192,1.87242497603415e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,37711,0.0250784004503795,0.00356299936821387,0.0180949216886803,0.0320618792120786,2.03783156793031e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APOC1,Apolipoprotein C-I,37976,-0.0215224764515763,0.00306110162736346,-0.0275222356412087,-0.0155227172619439,2.14964024251153e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,37666,0.0493498820777016,0.00702103342713228,0.0355886565605223,0.0631111075948809,2.18442995650261e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GRAP2,GRB2-related adapter protein 2,40354,0.0753806188923956,0.0107267556738796,0.0543561777715917,0.0964050600131996,2.19045934170228e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,37896,0.0455741305595333,0.00649081253421156,0.0328521379924787,0.058296123126588,2.30319956012639e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GM2A,Ganglioside GM2 activator,37710,0.0227803105020916,0.00324452120212974,0.0164210489459173,0.0291395720582659,2.30745129807824e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPC5,Glypican-5,40223,0.0332066035376404,0.00473147560435222,0.02393291135311,0.0424802957221707,2.33841846005104e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,40177,0.0176748293341918,0.00252031148392253,0.0127350188257036,0.0226146398426799,2.42841565980809e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RETN,Resistin,40278,0.0245421078260453,0.00350243798899162,0.0176773293676217,0.0314068862844689,2.53031375382859e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,40417,0.0168795798596769,0.00241171265750868,0.0121526230509599,0.0216065366683939,2.68051023265252e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,37558,0.0290351953036751,0.00415505678457622,0.0208912840059058,0.0371791066014445,2.92484356265863e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",40406,0.036286889013037,0.0051979580499009,0.0260988912352312,0.0464748867908427,3.04660092853497e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",37923,0.0239342009556801,0.00343745282390851,0.0171967934208195,0.0306716084905408,3.49100583375628e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL7,Interleukin-7,40336,0.0378935635064953,0.00544439803234533,0.0272225433630984,0.0485645836498921,3.53327622748575e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,39975,0.0399741597705945,0.00574379997580062,0.0287163118180253,0.0512320077231637,3.55070630182888e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STXBP3,Syntaxin-binding protein 3,39975,0.026034565891333,0.003741840771003,0.0187005579801672,0.0333685738024989,3.59729663561643e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",37985,0.0519356152613118,0.00746409255006859,0.0373059938631773,0.0665652366594462,3.60853923025458e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C8B,Complement component C8 beta chain,38008,0.0179557801724047,0.00258182436535675,0.0128954044163054,0.0230161559285039,3.6953806710213e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL14,C-C motif chemokine 14,40304,0.0229584508658563,0.00330167189425093,0.0164871739531245,0.0294297277785881,3.70028510201363e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DTNB,Dystrobrevin beta,37873,0.024461075232065,0.00352220636678623,0.017557550753164,0.031364599710966,3.96398274601028e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TEK,Angiopoietin-1 receptor,40406,0.0126596518690991,0.00182388585152064,0.00908483560011868,0.0162344681380796,4.04235310720748e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MITD1,MIT domain-containing protein 1,40223,0.0566501440949603,0.00816208068416635,0.0406524659539943,0.0726478222359264,4.0550734044558e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACHE,Acetylcholinesterase,37666,-0.0186655567912361,0.00270464621533526,-0.0239666633732933,-0.013364450209179,5.38813521139705e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",37993,0.0360825325505265,0.00523410112539106,0.02582369434476,0.046341370756293,5.67511330666048e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PMM2,Phosphomannomutase 2,37557,0.0352434094864164,0.00511665182227625,0.025214771914755,0.0452720470580779,5.9171736453825e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LGALS8,Galectin-8,40466,0.0351224610086679,0.00510024333258777,0.0251259840767959,0.04511893794054,5.9337542087597e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,40466,0.0559305470754148,0.00812682210253129,0.0400019757544535,0.0718591183963762,6.11140458139859e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSMG3,Proteasome assembly chaperone 3,40336,0.0297996140661512,0.0043313564044608,0.021310155513408,0.0382890726188943,6.20998455009192e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,40282,0.0516930866682211,0.00751514913085424,0.0369633943717468,0.0664227789646954,6.27432271788154e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,40398,0.0158387873740807,0.00230306993927579,0.0113247702931002,0.0203528044550613,6.32854325782895e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,40198,0.01405725101054,0.00204695451870868,0.0100452201538709,0.018069281867209,6.7829378761979e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OCLN,Occludin,37955,0.0252595905083908,0.00367883329768885,0.0180490772449206,0.0324701037718609,6.88185519571185e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DLG4,Disks large homolog 4,37937,0.0405287888504789,0.00591129695894971,0.0289426468109375,0.0521149308900204,7.38149563080894e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDGFC,Platelet-derived growth factor C,39975,0.017219985813384,0.00251311565705234,0.0122942791255614,0.0221456925012066,7.55392965629214e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,40354,-0.0229539179689201,0.00335166880766677,-0.029523188831947,-0.0163846471058932,7.7359681196363e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VASN,Vasorin,40111,0.0159069332542898,0.00232553772468973,0.011348879313898,0.0204649871946817,8.2062504532784e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",40391,0.0505165948389643,0.00738868948777129,0.0360347634429326,0.064998426234996,8.37943810575192e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DDT,D-dopachrome decarboxylase,37993,0.0235849931885605,0.00344918016668782,0.0168246000618524,0.0303453863152686,8.38340469224919e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NEXN,Nexilin,37982,0.039441096759535,0.00576907398810166,0.0281337117428557,0.0507484817762142,8.45466098008457e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,37896,0.0504739709514338,0.007395158602767,0.0359794600900105,0.0649684818128572,9.15208020200801e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SH3GLB2,Endophilin-B2,37937,0.0385253398981368,0.00564657251924571,0.0274580577604152,0.0495926220358584,9.31038522746172e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CASP8,Caspase-8,40429,0.0356881941498001,0.0052323415429062,0.0254328047257039,0.0459435835738962,9.38523172447752e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AHCY,Adenosylhomocysteinase,40354,0.0391093547813222,0.00573670117735146,0.0278654204737133,0.050353289088931,9.60412301956705e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,37709,0.0403058681028784,0.0059145917771641,0.0287132682196368,0.0518984679861201,9.85776081652482e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",40300,0.0444344977198851,0.006524309283753,0.0316468515237293,0.057222143916041,1.00682899104418e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,40037,0.0636027399662215,0.0093563814958279,0.0452642322343989,0.0819412476980442,1.10090166277921e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDIA3,Protein disulfide-isomerase A3,37666,0.0146932321804486,0.00216195238238287,0.0104558055109782,0.018930658849919,1.11960359901085e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,40427,0.0160479460611268,0.00236225779369918,0.0114179207854764,0.0206779713367772,1.13326751083e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD300A,CMRF35-like molecule 8,37666,0.0170037558173253,0.00250318745143886,0.0120975084125052,0.0219100032221455,1.14652464502951e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINA4,Kallistatin,37776,0.0137278179065378,0.00202135729036577,0.00976595761742088,0.0176896781956547,1.15771306782206e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,37567,0.0392439494251416,0.00577878359396193,0.0279175335809763,0.050570365269307,1.16125300594616e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGAL,Integrin alpha-L,37593,0.024946753024151,0.0036737244343584,0.0177462531328085,0.0321472529154935,1.16477736340797e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,40531,0.0139030772071072,0.00204833112448483,0.00988834820311697,0.0179178062110975,1.18069202821955e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,37666,0.0335950936023706,0.00495341528001288,0.0238863996535453,0.0433037875511958,1.2338738143803e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RP2,Protein XRP2,40300,0.0237453379714012,0.00350186822410061,0.016881676252164,0.0306089996906384,1.23766328657837e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TDRKH,Tudor and KH domain-containing protein,39956,0.0487491683405523,0.00718973446065118,0.0346572887976759,0.0628410478834286,1.24184879258108e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,39956,0.0387153269102255,0.00571192039395932,0.0275199629380653,0.0499106908823858,1.26256241683939e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EREG,Proepiregulin,40187,0.0459129894549193,0.00677545435244444,0.0326330989241282,0.0591928799857104,1.27606517475589e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLA2G15,Phospholipase A2 group XV,40406,0.0147648875984017,0.00217941536166247,0.0104932334895433,0.0190365417072602,1.29022752746694e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,39975,0.0273077710781496,0.00403326583491583,0.0194025700417145,0.0352129721145846,1.32817059036944e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RRAS,Ras-related protein R-Ras,37567,0.0748137814630032,0.0110529227092964,0.0531500529527823,0.096477509973224,1.35482228027825e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,40354,-0.0240783470253686,0.00355905217947703,-0.0310540892971436,-0.0171026047535936,1.37597031471393e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,37557,0.0359345846361039,0.00531151036596503,0.0255240243188125,0.0463451449533954,1.38571657516319e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,40300,0.032164155468124,0.00475698688600776,0.0228404611715488,0.0414878497646992,1.41384132383031e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,37414,0.0306631330256241,0.00453558245520244,0.0217733914134273,0.0395528746378209,1.43334815056581e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,37955,0.0674595270819577,0.00998282543585301,0.0478931892276858,0.0870258649362295,1.4609176001251e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,40497,0.0216522189493072,0.00320466289622063,0.0153710796727147,0.0279333582258996,1.46254126474463e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,37536,0.0568468379939299,0.00841750358216289,0.0403485309728907,0.0733451450149692,1.50512582593838e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,40531,0.0195610980025865,0.00290232759078542,0.0138725359246471,0.0252496600805259,1.63998554813041e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXCL16,C-X-C motif chemokine 16,40512,0.0135277538735812,0.00200949529985531,0.00958914308586478,0.0174663646612976,1.73113931507872e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNX9,Sorting nexin-9,40354,0.0391035887942852,0.00580983408091583,0.0277163139956902,0.0504908635928802,1.74757020123134e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",39975,0.0457020993004005,0.00679461568344249,0.0323846525608532,0.0590195460399478,1.802074916337e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CASP2,Caspase-2,40336,0.0383868607991154,0.00571233454298565,0.0271906850948635,0.0495830365033673,1.87910686159784e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,40259,0.015185806113992,0.00226053001821014,0.0107551672783001,0.0196164449496839,1.90775313721597e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,40336,0.035126437537557,0.00523903514643397,0.0248579286505464,0.0453949464245676,2.08546252078649e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,40354,0.0384865046168531,0.00574367665092682,0.0272288983810365,0.0497441108526696,2.14427250400567e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLSTN3,Calsyntenin-3,37937,0.0172871926551828,0.00257968294796075,0.0122310140771798,0.0223433712331859,2.14799328112069e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,F11,Coagulation factor XI,37805,0.0171551381172837,0.00256053377787843,0.012136491912642,0.0221737843219254,2.17027874233284e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYH9,Myosin-9,37993,0.0632365567661761,0.00946113618333314,0.0446927298468432,0.0817803836855091,2.41900447103987e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TREML1,Trem-like transcript 1 protein,37982,0.029789634541547,0.00445700258451334,0.0210539094759008,0.0385253596071931,2.41974655725627e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ICA1,Islet cell autoantigen 1,40039,0.0447984840092752,0.00670926939554468,0.0316483159940076,0.0579486520245428,2.51947151930635e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,37593,0.0273833450844906,0.00410127938306431,0.0193448374936845,0.0354218526752966,2.5406251282584e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,40392,0.0621157337258406,0.00930537475458614,0.0438771992068517,0.0803542682448294,2.54949461923267e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,37593,0.0505225874032445,0.00757317789174625,0.0356791587354218,0.0653660160710671,2.63786865725897e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,40417,0.0589491875400378,0.00883851629633062,0.0416256955992297,0.0762726794808458,2.64960443115366e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,YES1,Tyrosine-protein kinase Yes,40300,0.0641111131194383,0.00961297174384547,0.0452696885015012,0.0829525377373755,2.65654887195308e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,40039,0.038909419494979,0.00583828101464852,0.0274663887062679,0.0503524502836901,2.74412658256129e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NME3,Nucleoside diphosphate kinase 3,40374,0.0135163704988299,0.0020311218740643,0.00953537162566389,0.017497369371996,2.93275619590309e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,37985,0.0224582174365297,0.00337773850973291,0.0158378499574532,0.0290785849156062,3.06635356264468e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD84,SLAM family member 5,40336,0.017308992384825,0.00260414625634157,0.0122048657223955,0.0224131190472545,3.09484515997782e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,F11R,Junctional adhesion molecule A,40327,0.0317368902438545,0.00477717117474224,0.0223736347413597,0.0411001457463493,3.16390209798749e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TCN2,Transcobalamin-2,40492,0.0167705573211259,0.00252680008224967,0.0118180291599166,0.0217230854823353,3.30227682555193e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BECN1,Beclin-1,37623,0.034048395787892,0.00513081300928987,0.0239920022896839,0.0441047892861002,3.34778930180341e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,37937,0.0385807108099709,0.00581447717798263,0.0271843355411249,0.0499770860788168,3.36243570697505e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CREG1,Protein CREG1,40140,0.0202367612541533,0.00305404316551251,0.0142508366497488,0.0262226858585578,3.55608053393881e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CMIP,C-Maf-inducing protein,37895,0.0458724385881105,0.00692921684083329,0.0322911735800772,0.0594537035961438,3.72460826553531e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,40354,-0.0549261419018974,0.00830346499150025,-0.0712009332852379,-0.0386513505185569,3.83805140953789e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SUSD1,Sushi domain-containing protein 1,40037,0.027573551125199,0.00416875049702443,0.0194028001510311,0.0357443020993669,3.85350789583399e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,37985,0.0180407738549774,0.00273014421029088,0.0126896912028072,0.0233918565071475,4.04144823241168e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,40352,0.0281557022805745,0.00426185990582493,0.0198024568651576,0.0365089476959913,4.06182209811836e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IMPA1,Inositol monophosphatase 1,40223,0.0340173929757822,0.00515019791778221,0.0239230050569291,0.0441117808946353,4.100511152436e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENO1,Alpha-enolase,40294,0.0442311585965267,0.00670142779601814,0.0310963601163312,0.0573659570767223,4.23470508280148e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,40187,0.0132533169016424,0.00200815700201372,0.00931732917769547,0.0171893046255892,4.25037407815151e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HYAL1,Hyaluronidase-1,40209,0.0128327307480196,0.00194556030215433,0.00901943255579706,0.016646028940242,4.36126303875884e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RILP,Rab-interacting lysosomal protein,40429,0.033560189041404,0.00509234983387111,0.0235791833670167,0.0435411947157914,4.52626365110128e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",37623,0.0256223868801856,0.00388798239836013,0.0180019413793997,0.0332428323809715,4.56105344843086e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,37570,0.0198331486007846,0.00300986227158542,0.0139338185484772,0.025732478653092,4.58514991774367e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,37985,0.0260851979958874,0.00396245046945492,0.0183187950757558,0.0338516009160191,4.7773318296677e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,40417,0.0485000506422997,0.00737195267667157,0.0340510233960234,0.062949077888576,4.88363060096446e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACAN,Aggrecan core protein,40219,0.015796341127242,0.00240170418718901,0.0110890009203516,0.0205036813341325,4.94675090896996e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APRT,Adenine phosphoribosyltransferase,40211,0.0269175935564266,0.00409758748853878,0.0188863220788906,0.0349488650339626,5.2194599337573e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CASP7,Caspase-7,37937,0.046347993377352,0.00706108473178237,0.0325082673030585,0.0601877194516454,5.4348892449549e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,40374,0.0185797768755122,0.00283140452231808,0.0130302240117688,0.0241293297392557,5.47164573902696e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,37896,0.0567682266413682,0.0086537068412459,0.0398069612325262,0.0737294920502101,5.57810276561231e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,40223,0.030056400949107,0.00458514434015346,0.0210695180424062,0.0390432838558078,5.7303405587373e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LTA,Lymphotoxin-alpha,40336,0.0223199563041964,0.00340540457605797,0.0156453633351227,0.02899454927327,5.76348874882263e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NADK,NAD kinase,40354,0.0296700613389181,0.00453114276520722,0.020789021519112,0.0385511011587243,6.00873340370552e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,40417,0.0143339920615522,0.00218982827643046,0.0100419286397485,0.0186260554833559,6.10160170052364e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,40300,0.0132840562059559,0.00202978500271531,0.00930567760063386,0.0172624348112779,6.15004833054681e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BCR,Breakpoint cluster region protein,40336,0.0502435028745291,0.00769034431747374,0.0351704280122806,0.0653165777367776,6.62821580727898e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,37955,0.0593538997503868,0.00908696390426432,0.0415434504980287,0.0771643490027448,6.73278434279336e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TYMP,Thymidine phosphorylase,40252,0.0368272713027731,0.00563994406555449,0.0257729809342863,0.0478815616712599,6.79014412345256e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,37895,0.0226706241020349,0.00347176402287131,0.0158659666172071,0.0294752815868627,6.81328834109166e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,40485,0.0176860667204924,0.00270903032122945,0.0123763672908827,0.0229957661501021,6.83993984476045e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,37993,0.0123213717772665,0.001888394343907,0.00862011886320877,0.0160226246913242,7.05198597360486e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNMBP,Dynamin-binding protein,40223,0.0339420906420677,0.00520512590145369,0.0237400438752184,0.0441441374089169,7.20124599100545e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLU,Clusterin,38008,0.0182496061248191,0.00279856891154572,0.0127644110581895,0.0237348011914487,7.2291730222353e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",40327,0.0208709922104969,0.00320584044197884,0.0145875449442184,0.0271544394767754,7.72494759697351e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,39975,0.0348256066194875,0.00536365162756547,0.0243128494294592,0.0453383638095159,8.67614267499038e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HEG1,Protein HEG homolog 1,37666,0.0145062786904027,0.00223412415472372,0.0101273953471443,0.0188851620336612,8.71238588314944e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",40300,0.0241166517612879,0.00371555012152296,0.0168341735231029,0.0313991299994728,8.79551135318099e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,40409,0.0319321544931693,0.00492160428506409,0.0222858100944436,0.0415784988918949,8.9449596872536e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,37937,0.0194977537927125,0.00301145756981547,0.0135952969558742,0.0254002106295509,9.84053856164846e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLPS,Colipase,40306,0.0375547867347351,0.00580274649563737,0.0261814036032858,0.0489281698661843,9.96190189624461e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,40417,0.0209753761672913,0.00324466127347401,0.0146158400712822,0.0273349122633003,1.04526342065202e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,40398,0.020542327726879,0.00317905506070164,0.0143113798079038,0.0267732756458542,1.0648448204581e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,39956,0.0274509534720264,0.00424827682532262,0.0191243308943941,0.0357775760496587,1.06644092983385e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,40330,0.0246150847718756,0.00381010876395759,0.0171472715945187,0.0320828979492325,1.07416775564644e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,40336,0.0570184672413342,0.00883643444456487,0.0396990557299871,0.0743378787526813,1.13088253905738e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SWAP70,Switch-associated protein 70,37896,0.0191472817088506,0.00296740880378209,0.0133311604534377,0.0249634029642635,1.13771318248546e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,40406,0.0148468390658456,0.00230401671641949,0.0103309663016634,0.0193627118300278,1.19784102091202e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APOL1,Apolipoprotein L1,37982,0.0354187373505004,0.00549953188580968,0.0246396548543134,0.0461978198466873,1.2325241402716e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CAPG,Macrophage-capping protein,40180,0.0315986429172873,0.00490734778954762,0.021980241249774,0.0412170445848006,1.23711581607447e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAB27B,Ras-related protein Rab-27B,37985,0.0445033197276555,0.00691359010784468,0.03095268311628,0.0580539563390311,1.25902460589022e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NPY,Pro-neuropeptide Y,40484,0.036265276678339,0.00563573010592191,0.025219245670732,0.0473113076859459,1.27071306601142e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,37896,0.0146049578453157,0.00227390415507736,0.010148105701364,0.0190618099892673,1.38242087318988e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCGN,Secretagogin,40039,-0.0238836102001374,0.00372074170124422,-0.0311762639345761,-0.0165909564656987,1.41094418765419e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AGXT,Serine--pyruvate aminotransferase,40354,0.0417220201395479,0.00650208683298393,0.0289779299468994,0.0544661103321964,1.43186575985612e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,37557,0.0363755591907195,0.00567355920420298,0.0252553831504816,0.0474957352309573,1.49116317595337e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,37623,0.0403705928006194,0.00629865831749895,0.0280252224983214,0.0527159631029173,1.51075922315341e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37896,0.0116193131072245,0.00181444808669666,0.00806299485729908,0.01517563135715,1.56624940195376e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,37623,0.050248235167989,0.0078500207790669,0.0348621944410179,0.0656342758949601,1.5956167998929e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,40511,0.0367196132689676,0.00574458660584046,0.0254602235215203,0.0479790030164149,1.68203468360171e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DCTN6,Dynactin subunit 6,39956,0.0382627587031258,0.00598671001246822,0.0265288070786881,0.0499967103275635,1.69197771625688e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,40531,0.0364732588537554,0.00570697467963575,0.0252875884816693,0.0476589292258415,1.69343422565299e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,40220,0.031526601233699,0.00493580185439314,0.0218524295990885,0.0412007728683096,1.73533765471307e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,40336,0.0542925734949225,0.00850183346843356,0.0376289798967927,0.0709561670930522,1.75029286735778e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MEP1A,Meprin A subunit alpha,37896,-0.0368804571287027,0.00577506749815283,-0.0481995894250823,-0.0255613248323232,1.75708126699801e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,40037,0.0220379457878138,0.00345291105239549,0.0152702401251187,0.028805651450509,1.79230473595202e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,40531,0.0224238498192038,0.00351519757285516,0.0155340625764076,0.0293136370619999,1.82980390871944e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RGMB,RGM domain family member B,40466,0.0139859825564261,0.00219400203299681,0.00968573857175239,0.0182862265410999,1.88405022661757e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,THBD,Thrombomodulin,40354,0.0149569442259555,0.0023491768658336,0.0103525575689217,0.0195613308829894,1.98192179546039e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EHD3,EH domain-containing protein 3,37623,0.0627788330938684,0.00986159627435183,0.0434501043961388,0.082107561791598,2.00468520989605e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OGFR,Opioid growth factor receptor,40300,0.0178190304569701,0.0027998304730219,0.0123313627298472,0.023306698184093,2.01539013075646e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",40309,0.0588767643049269,0.00925703400977304,0.0407329776457717,0.077020550964082,2.06983245466543e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,37623,0.0299505666717708,0.00470944161152942,0.0207200611131731,0.0391810722303684,2.08846695388791e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,37896,0.0212485973226807,0.00334144484606278,0.0146993654243977,0.0277978292209638,2.09497249891689e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPP1,Tripeptidyl-peptidase 1,40250,0.0240886284168614,0.00379074405650108,0.0166587700661193,0.0315184867676035,2.14706174226302e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DCTN1,Dynactin subunit 1,40484,0.0352732228223595,0.00555750245850195,0.0243805180036957,0.0461659276410233,2.25515866772638e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,40512,0.0145909509633614,0.00230235823803849,0.0100783288168059,0.0191035731099168,2.39912353028402e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GDF15,Growth/differentiation factor 15,40531,0.0230137432344646,0.00363977778828349,0.015879778769429,0.0301477076995002,2.63568479875584e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,40336,0.0292754701573187,0.00463207613520192,0.0201966009323229,0.0383543393823144,2.68256420895767e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATXN2L,Ataxin-2-like protein,37955,0.0257173850924863,0.00407266667720559,0.0177349584051634,0.0336998117798093,2.79289225644395e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,40223,0.0200027497582732,0.00317038206859232,0.0137888009038322,0.0262166986127141,2.87859975532009e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LSP1,Lymphocyte-specific protein 1,40336,0.0212909726132387,0.00337673343469594,0.0146725750812346,0.0279093701452427,2.9542845425599e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,40325,0.016828591159518,0.00266953730073112,0.011596298050085,0.0220608842689509,2.97845258183079e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AP2B1,AP-2 complex subunit beta,37567,0.0261434587723368,0.00414823656264208,0.0180129151095583,0.0342740024351153,3.02635084407889e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,37593,0.0282172874934265,0.00447966760269192,0.0194371389921504,0.0369974359947027,3.09183657765559e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,S100A11,Protein S100-A11,40202,0.0239422599549433,0.0038033303270027,0.016487732514018,0.0313967873958686,3.15379473183265e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",37603,0.0426318430242926,0.00677437753061116,0.0293540630642947,0.0559096229842905,3.21061346098024e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRTG,Protogenin,40484,-0.0134064744242026,0.00213072496569289,-0.0175826953569606,-0.00923025349144449,3.21580346616446e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PVALB,Parvalbumin alpha,40412,0.0601236706578448,0.00955784119572483,0.0413903019142242,0.0788570394014655,3.2467152511503e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KAZN,Kazrin,37896,0.0550159165228024,0.00875471386288234,0.037856677351553,0.0721751556940518,3.39830352180054e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",37623,0.0265720682537339,0.00423002189374326,0.0182812253419971,0.0348629111654707,3.45248622713099e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,39971,0.0413171334401209,0.00659426802002646,0.028392368120869,0.0542418987593727,3.81156365514366e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNASE3,Eosinophil cationic protein,40283,0.057565642744201,0.00919066263187726,0.0395519439857216,0.0755793415026804,3.86169104587588e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD48,CD48 antigen,40391,0.0155620563727386,0.00248706521193303,0.0106874085573498,0.0204367041881273,4.01968860209741e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENO2,Gamma-enolase,40466,0.0347610366858974,0.00555539804065841,0.0238724565262069,0.0456496168455878,4.02005622110172e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,40446,0.0226292848619548,0.003618783590064,0.0155364690254294,0.0297221006984803,4.12111159677993e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,37896,0.0157613664698004,0.00252505731189776,0.0108122541384808,0.02071047880112,4.45039045435935e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TTR,Transthyretin,37866,0.0134506795883909,0.00215637193936096,0.00922419058724347,0.0176771685895384,4.57552974089215e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,40406,0.0441684292086898,0.00708768929626544,0.0302765581880095,0.05806030022937,4.72952175621662e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,37593,0.0513146052607403,0.00824115204717566,0.035161947248276,0.0674672632732045,4.91087601012682e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPM,Carboxypeptidase M,40410,0.0180037751563271,0.00289263571255954,0.0123342091597104,0.0236733411529438,4.96730643005259e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",40037,0.048329218268357,0.00776783961841206,0.0331042526162694,0.0635541839204447,5.04338597081005e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STAMBP,STAM-binding protein,40187,0.0339692860291428,0.005460024720321,0.0232676375773137,0.044670934480972,5.05031710574364e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HEPH,Hephaestin,37985,-0.0131510571739908,0.00211483986886843,-0.0172961433169729,-0.00900597103100866,5.16805992273035e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,39975,0.0260757452085561,0.00419633193973884,0.017850934606668,0.0343005558104442,5.29918008387339e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,37709,0.0291354359784212,0.00468986539413659,0.0199432998059135,0.0383275721509289,5.37337265210203e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEMA4C,Semaphorin-4C,40300,0.0149079668388231,0.00240379215408207,0.0101965342168222,0.0196193994608239,5.71859602936422e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,F3,Tissue factor,40388,-0.0147444956565365,0.00237766003750718,-0.0194047093300506,-0.0100842819830224,5.7392642041927e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UROD,Uroporphyrinogen decarboxylase,37666,0.0368417731059046,0.00595047156213989,0.0251788488441104,0.0485046973676987,6.13963450590156e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCN2,CCN family member 2,40353,0.0301756131600472,0.00487632904844558,0.0206180082250938,0.0397332180950005,6.2353233064501e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZBP1,Z-DNA-binding protein 1,37593,0.0210394785145902,0.00339962122101324,0.0143762209214043,0.0277027361077762,6.24374233775334e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SORT1,Sortilin,40325,0.0190051864110541,0.00307202277981853,0.0129840217626098,0.0250263510594985,6.30078201859711e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,40466,0.0343987698579054,0.0055702929121191,0.023480995750152,0.0453165439656589,6.75900142694288e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,A1BG,Alpha-1B-glycoprotein,38008,0.00912074301769658,0.00148001206182286,0.00621991937652377,0.0120215666588694,7.35806970755866e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD6,T-cell differentiation antigen CD6,40497,0.0276935921317792,0.00449544580670498,0.0188825183506375,0.036504665912921,7.43081396749139e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,40298,0.0251921698315068,0.00409545305639143,0.0171650818409796,0.033219257822034,7.87190722213582e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,37905,0.0213227144936584,0.00346615247401767,0.0145290556445837,0.028116373342733,7.8832027278638e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PON3,Serum paraoxonase/lactonase 3,40417,-0.0142709081051135,0.00232020950821498,-0.0188185187412148,-0.00972329746901211,7.89806578162243e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GOLGA3,Golgin subfamily A member 3,37955,0.0406661328505701,0.00661106004541968,0.0277084551615476,0.0536238105395927,7.90563152765039e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,37993,-0.0144187967774856,0.00234461815316471,-0.0190142483576885,-0.0098233451972828,7.97918607889559e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,39975,0.0231531434183264,0.00376585400642124,0.0157720695657407,0.030534217270912,8.02957523225665e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLKB1,Plasma kallikrein,37716,0.0130920744561483,0.00212944942243771,0.00891835358817037,0.0172657953241262,8.06647987669805e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",37955,0.0410375269807868,0.00668468174162701,0.0279355507671979,0.0541395031943757,8.53473946040398e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD40LG,CD40 ligand,40511,0.0397597093560496,0.0064776075865575,0.0270635984863969,0.0524558202257022,8.55173185756591e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GZMH,Granzyme H,40037,0.0388121874482331,0.00632376615328468,0.0264176057877951,0.0512067691086711,8.58533010954657e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAMA4,Laminin subunit alpha-4,40417,0.0170493814194962,0.00277918656264629,0.0116021757567094,0.0224965870822829,8.73507172925932e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PIGR,Polymeric immunoglobulin receptor,40149,0.0182519428813962,0.00297534939717062,0.0124202580629418,0.0240836276998506,8.75388967964112e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,37937,0.0207906471134308,0.00338989246647287,0.0141464578791439,0.0274348363477176,8.85751255173353e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARF6,ADP-ribosylation factor 6,37896,0.0543555704395772,0.00886375163757063,0.0369826172299387,0.0717285236492156,8.90197908195333e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TXLNA,Alpha-taxilin,40223,0.0460849360924861,0.00752877884009761,0.0313285295658948,0.0608413426190774,9.50892498596418e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CASP3,Caspase-3,40531,0.0455548552128245,0.00744404619523968,0.0309645246701548,0.0601451857554943,9.59639438410914e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,40327,0.0617098377325074,0.0100871086813223,0.0419391047171156,0.0814805707478992,9.71667498607846e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATP6AP2,Renin receptor,39975,0.0215930123206945,0.00353087376012724,0.0146724997508451,0.0285135248905439,9.85692811964249e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,37895,0.0253749671984472,0.00414964848910581,0.0172416561597998,0.0335082782370946,9.92520779123053e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DGKA,Diacylglycerol kinase alpha,37593,0.0279706495656937,0.00457997247016958,0.0189939035241613,0.0369473956072261,1.04276738053677e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,40466,0.0243292224255191,0.00398546227067629,0.0165177163749936,0.0321407284760446,1.05505949149794e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,37567,0.0319715536693828,0.00523882491127027,0.021703456843293,0.0422396504954725,1.07156950760453e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,37557,0.0348896459357873,0.00572282507180672,0.0236729087950461,0.0461063830765285,1.11407656768175e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NMI,N-myc-interactor,37852,0.0369168689600481,0.00605571981512203,0.0250476581224089,0.0487860797976873,1.1160332641515e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSME2,Proteasome activator complex subunit 2,40147,0.0190572968365841,0.00312909021075664,0.0129242800235011,0.0251903136496671,1.15281238031109e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTH,Parathyroid hormone,37567,0.0406523262121965,0.0066793416693076,0.0275608165403537,0.0537438358840394,1.18788541215938e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,37709,0.0190273638011204,0.00312927358328284,0.0128939875778861,0.0251607400243548,1.23145541491033e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,37623,-0.0185515305487906,0.00305144651654899,-0.0245323657212266,-0.0125706953763545,1.23824312001282e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,37896,0.0261204774424449,0.00429776835841502,0.0176968514599514,0.0345441034249383,1.25228080183711e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSF3,Granulocyte colony-stimulating factor,40039,0.0251594803071618,0.00414005850461117,0.017044965638124,0.0332739949761997,1.25237154675275e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FABP3,"Fatty acid-binding protein, heart",37985,0.0243839455109007,0.00401213678612612,0.0165201574100935,0.0322477336117079,1.25313589373977e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,40391,0.0456280612125707,0.00751701486190183,0.0308947120832431,0.0603614103418982,1.30831669926237e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,39956,0.0576273928045915,0.00949755646567484,0.0390121821318688,0.0762426034773142,1.3285411493597e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,37896,0.033271314485857,0.00548466409586874,0.0225213728579543,0.0440212561137598,1.3445011667769e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRSS2,Trypsin-2,40398,0.0257671449824859,0.00424982496892974,0.0174374880433836,0.0340968019215882,1.36526394044615e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,37557,0.0209158177572156,0.00345277148347726,0.0141483856496002,0.027683249864831,1.41873019992321e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STK4,Serine/threonine-protein kinase 4,40354,0.0439380249823951,0.00727532462696752,0.0296783887135388,0.0581976612512515,1.58208421928523e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OPHN1,Oligophrenin-1,37937,0.0544392221339906,0.00901378796291018,0.0367721977266866,0.0721062465412945,1.58608844934495e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RGMA,Repulsive guidance molecule A,40466,-0.0157942132725375,0.00261549268866168,-0.0209205789423144,-0.0106678476027606,1.58779048443755e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SARG,Specifically androgen-regulated gene protein,37926,0.0552013809879507,0.00914612264981385,0.0372749805943155,0.0731277813815858,1.62635669390957e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GMPR,GMP reductase 1,40511,0.0260256183350981,0.00431849133083681,0.017561375326658,0.0344898613435383,1.71153858937703e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TXN,Thioredoxin,37814,0.022709121962039,0.00376975351405531,0.0153204050744906,0.0300978388495875,1.74592835117643e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39881,0.02794302014838,0.00463903174461915,0.0188505179289265,0.0370355223678335,1.74605274961717e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,37666,0.0376458852814246,0.00625013696914308,0.0253956168219042,0.049896153740945,1.75532833687718e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,37709,0.0373020195953441,0.00619631930263181,0.0251572337621858,0.0494468054285025,1.78992682730625e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39920,0.023922488907129,0.00398240739061245,0.0161169704215286,0.0317280073927294,1.9317287027419e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,40271,0.0306445126663959,0.00510297090393304,0.0206426896946871,0.0406463356381046,1.9524228391037e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HAO1,Hydroxyacid oxidase 1,40484,0.0661907612230701,0.0110262869227519,0.0445792388544765,0.0878022835916638,1.97884963031069e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,37557,0.0314637790108104,0.00524469698060884,0.0211841729288171,0.0417433850928037,2.03568788947707e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,40531,0.0198409283217455,0.00330804336762209,0.0133571633212062,0.0263246933222848,2.04313766841919e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EZR,Ezrin,40466,0.0119823464974971,0.00199816377546315,0.0080659454975893,0.0158987474974048,2.05722485698546e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,37593,0.0290975265775027,0.00485267564343568,0.0195862823163688,0.0386087708386366,2.07310721526982e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AGR2,Anterior gradient protein 2 homolog,39834,-0.0514273920913046,0.00858030177449463,-0.068244783569314,-0.0346100006132951,2.0975674740878e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,39956,0.0135338367872353,0.00226129235982004,0.00910170376198799,0.0179659698124825,2.21157421399151e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CR1,Complement receptor type 1,37954,0.0183089679282086,0.0030621548771581,0.0123071443689787,0.0243107914874385,2.30020208862491e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FAM3B,Protein FAM3B,40300,-0.0183020259652113,0.0030621454048808,-0.0243038309587777,-0.012300220971645,2.32351301990567e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NRGN,Neurogranin,37982,0.045736940377412,0.00765325341670751,0.0307365636806653,0.0607373170741588,2.34225986585421e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,40398,0.0139234635629996,0.00233258284474441,0.00935160118730051,0.0184953259386986,2.43595423578116e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,37593,0.0204363208250239,0.00342794553506859,0.0137175475762895,0.0271550940737583,2.56057687789403e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MTSS2,Protein MTSS 2,37895,0.0494547111785184,0.00829862883435318,0.0331893986631862,0.0657200236938506,2.59527905252247e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEZ6L,Seizure 6-like protein,40406,0.0138625513777973,0.00232741638695725,0.00930081525936107,0.0184242874962335,2.63598253182445e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,37937,0.0445027800732678,0.0074739103006348,0.0298539158840236,0.0591516442625121,2.67490246048139e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",37666,0.0522203928798408,0.00878321578660246,0.0350052899381,0.0694354958215816,2.82610979538288e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",37637,0.0429569558609873,0.00722966378331533,0.0287868148456892,0.0571270968762853,2.89084082067657e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,S100A14,Protein S100-A14,37955,-0.0269723310506025,0.00454506255707742,-0.0358806536624742,-0.0180640084387307,3.02103980190031e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,40395,0.0262106136079801,0.00441948802845273,0.0175484170722127,0.0348728101437474,3.07899887501248e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL15,Interleukin-15,40336,-0.016452875405336,0.00277459766993822,-0.0218910868384149,-0.0110146639722571,3.09548385077817e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",40177,0.0205323872471196,0.00346414653023243,0.013742660047864,0.0273221144463752,3.14754012886635e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,37895,0.0361713079216967,0.00610333326490788,0.0242087747224772,0.0481338411209161,3.1706759680757e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,39975,0.0321740077794212,0.00542987267251806,0.0215314573412859,0.0428165582175566,3.18187367933746e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OGN,Mimecan,40327,0.0204164628272239,0.00344799345958123,0.0136583956464447,0.0271745300080031,3.26077170730931e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINB8,Serpin B8,40511,0.0273179948924003,0.00461769968574867,0.018267303508333,0.0363686862764677,3.36708343380851e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,37666,0.0272492499229791,0.00461083002982765,0.0182120230645169,0.0362864767814413,3.50886498247941e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,37567,0.0306406786925646,0.0051881231366385,0.0204719573447531,0.040809400040376,3.59352439092453e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LGALS3BP,Galectin-3-binding protein,38008,0.0147809571904762,0.00250344391418473,0.00987420711867414,0.0196877072622783,3.62731093489812e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,37593,0.0459920256424942,0.00779251202796928,0.0307187020676744,0.061265349217314,3.67796695123322e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,37955,0.0326925919184345,0.00554004539619659,0.0218341029418892,0.0435510808949798,3.69647746556769e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",40327,0.0185175723308096,0.00313859149479581,0.0123659330010098,0.0246692116606093,3.70979576145115e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GTPBP2,GTP-binding protein 2,37567,0.0398943560209121,0.00677204237082278,0.0266211529740994,0.0531675590677247,3.93188328880344e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MCAM,Cell surface glycoprotein MUC18,40398,-0.016957664073441,0.00288087177712311,-0.0226041727566023,-0.0113111553902797,4.0287150059139e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGA6,Integrin alpha-6,40336,0.026458105365161,0.00449490821419051,0.0176480852653476,0.0352681254649744,4.03040628783076e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GLA,Alpha-galactosidase A,37637,0.0180157102402351,0.00306034472453679,0.012017434580143,0.0240139859003272,4.03262213789367e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VSNL1,Visinin-like protein 1,37937,0.0186068471271546,0.00316124845151189,0.0124108001621913,0.024802894092118,4.05256934243129e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COMMD1,COMM domain-containing protein 1,37623,0.0304981208633967,0.00518298324242663,0.0203394737082405,0.0406567680185529,4.09508867577873e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,40448,0.0329125052106456,0.00559989213842227,0.021936716619338,0.0438882938019533,4.25184731426077e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,37666,0.0391395856818043,0.00667639921432028,0.0260538432217366,0.0522253281418721,4.67172813378012e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",40417,0.0136132205985396,0.00232317205362873,0.00905980337342732,0.0181666378236519,4.72675460117328e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,37709,0.0526425115665851,0.00898526332392001,0.0350313954517019,0.0702536276814684,4.77401447830951e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CETN2,Centrin-2,39956,0.033267662576506,0.00568168411695517,0.0221315617072738,0.0444037634457381,4.85932184071501e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IFNGR2,Interferon gamma receptor 2,40223,-0.0255429418471008,0.0043649219061114,-0.0340981887830792,-0.0169876949111224,4.95723758192517e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TSC22D1,TSC22 domain family protein 1,37955,0.0332410388725439,0.00568029292631262,0.0221076647369712,0.0443744130081166,4.96979976157803e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLXNB2,Plexin-B2,40467,0.0115389165031081,0.00197202831647333,0.00767374100282038,0.0154040920033958,4.97283686863965e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHMP6,Charged multivesicular body protein 6,37985,0.027475992105743,0.00469849928355667,0.0182669335099719,0.0366850507015141,5.09541230149442e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,40354,0.028439717035424,0.00486659508046013,0.0189011906777222,0.0379782433931259,5.20013711767903e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EGF,Pro-epidermal growth factor,40319,0.0507773353727875,0.00869717939745882,0.0337308637537683,0.0678238069918068,5.37440341325009e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL19,C-C motif chemokine 19,40466,0.0645903683028669,0.0110709440394146,0.0428913179856144,0.0862894186201194,5.50841555374363e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCRG1,Scrapie-responsive protein 1,37985,0.0134809359718405,0.00231658616004613,0.00894042709815006,0.0180214448455309,6.04282342977665e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OGA,Protein O-GlcNAcase,37896,0.0344105120162222,0.00592391362147977,0.0227996413181219,0.0460213827143226,6.4366479760318e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SYT1,Synaptotagmin-1,37937,0.0191981992980153,0.00330647903807111,0.0127175003833959,0.0256788982126347,6.53314549481891e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,37896,0.0532508612572393,0.00918362238676981,0.0352509613791705,0.0712507611353081,6.8430697670973e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGAV,Integrin alpha-V,40484,-0.00801063228973105,0.00138606102005664,-0.0107273118890421,-0.00529395269042004,7.63495637766306e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',37937,0.0192757705924657,0.00333559063835854,0.012738012941283,0.0258135282436485,7.68901132614311e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,40484,-0.0180866855478578,0.00313112182017898,-0.0242236843154086,-0.011949686780307,7.77194407142379e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,40284,0.0134489555127924,0.00232961379666999,0.00888291247131918,0.0180149985542655,7.9311547197527e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AFP,Alpha-fetoprotein,40177,0.0339419095563268,0.00587942698751657,0.0224182326607943,0.0454655864518593,7.93425205734071e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,37896,0.040497891734031,0.00702510760915164,0.0267286808200938,0.0542671026479682,8.35817030294298e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TP53,Cellular tumor antigen p53,39975,0.0210119190013071,0.00364748765566935,0.0138628431961952,0.028160994806419,8.53751721806136e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENAH,Protein enabled homolog,40039,0.0230540023540324,0.00400897906508567,0.0151964033864645,0.0309116013216003,9.05977288176465e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNAP23,Synaptosomal-associated protein 23,40354,0.0422619400823658,0.00735406961890834,0.0278479636293054,0.0566759165354261,9.26455533297926e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,37557,0.0359781071764201,0.00626998929475773,0.0236889281586949,0.0482672861941452,9.7837262797975e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGF21,Fibroblast growth factor 21,40448,0.0567806059009929,0.00990147399451334,0.0373737168717468,0.076187494930239,9.95303192691625e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,40300,0.0261562850445927,0.00456353276081187,0.0172117608334015,0.035100809255784,1.01304790410512e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,37895,-0.0186752781759772,0.00325958414282174,-0.0250640630959078,-0.0122864932560466,1.02981145184383e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,37858,0.0210034675333409,0.00366600693725544,0.0138180939363203,0.0281888411303616,1.0304442681565e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,40406,0.0167522048912651,0.00292443144953804,0.0110203192501706,0.0224840905323597,1.03232237012464e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNX2,Sorting nexin-2,37895,0.037742613023044,0.00659182859102427,0.0248226289846364,0.0506625970614515,1.05231408917863e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LCP1,Plastin-2,37993,0.0227490757083476,0.0039748824396415,0.0149583061266503,0.0305398452900449,1.0674679576974e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,F10,Coagulation factor X,37982,0.012542327983883,0.00219186543056051,0.00824627173998439,0.0168383842277816,1.07371765074414e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",39956,0.0133658518859896,0.00233790930782593,0.00878354964265082,0.0179481541293285,1.10410243310964e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,37955,0.0329788258970703,0.00576972145791296,0.0216701718395609,0.0442874799545798,1.1146916813524e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,39975,0.028717819456817,0.0050266525765686,0.0188655804067425,0.0385700585068914,1.12963989262667e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PCDH9,Protocadherin-9,37896,0.0163127198335554,0.0028553050848872,0.0107163218671764,0.0219091177999343,1.13270279227101e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AZI2,5-azacytidine-induced protein 2,37955,0.0265222505240944,0.0046489216023299,0.0174103641835278,0.035634136864661,1.18761932352388e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,37567,0.0260184616019189,0.00456561530191027,0.0170698556101748,0.034967067593663,1.23260890130931e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD5L,CD5 antigen-like,37929,0.0224705768067499,0.00394397369284982,0.0147403883687642,0.0302007652447355,1.24159608187033e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OPTC,Opticin,40300,0.0217772162275604,0.0038257456866088,0.0142787546818071,0.0292756777733136,1.27573075596691e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TTF2,Transcription termination factor 2,37567,0.0234960105240948,0.00412778295811985,0.0154055559261799,0.0315864651220097,1.2812789149306e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TSPAN8,Tetraspanin-8,37896,-0.0499454940033795,0.00878046159516652,-0.0671551987299059,-0.0327357892768532,1.31019470373013e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C1R,Complement C1r subcomponent,38008,0.00955189265414218,0.00168363424977489,0.0062519695245834,0.012851815783701,1.42872911485644e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,37666,0.0322557930482968,0.00568986619537865,0.0211036553053547,0.043407930791239,1.4664752131002e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLXNA4,Plexin-A4,40336,0.0395288767841964,0.00697609491062756,0.0258557307593664,0.0532020228090265,1.48416881018241e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,F2,Prothrombin,38008,0.00703938841942944,0.00124375494547076,0.00460162872630676,0.00947714811255213,1.54631664047234e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD164,Sialomucin core protein 24,40327,0.0127063864977644,0.0022456204889257,0.00830497033947003,0.0171078026560588,1.55522069747572e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UPB1,Beta-ureidopropionase,37985,0.0435458069351416,0.00769929134836427,0.0284551958923477,0.0586364179779356,1.58243301787547e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNXB,Tenascin-X,40327,-0.0121985805076164,0.00215737813110104,-0.0164270416445744,-0.00797011937065832,1.59126274888472e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GZMB,Granzyme B,40336,0.0300700785780612,0.00532482165933304,0.0196334281257684,0.0405067290303539,1.65920163577448e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,37709,0.0251819137273013,0.00445956759309008,0.0164411612448448,0.0339226662097579,1.66899691025575e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NCS1,Neuronal calcium sensor 1,40484,0.0136410403583111,0.00241629473864686,0.00890510267056322,0.0183769780460589,1.67553183489764e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,37896,0.0275167357067975,0.00487395635637322,0.017963781248306,0.0370696901652891,1.67871029196573e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANXA2,Annexin A2,37436,0.0339825226187116,0.00602533943751657,0.0221728573211791,0.0457921879162441,1.73665179191301e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEMA3G,Semaphorin-3G,37666,0.0206549692309291,0.00366268618112645,0.0134761043159212,0.0278338341459369,1.7424730014425e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AXIN1,Axin-1,40336,0.0446635957724607,0.00794113633357273,0.0290989685586582,0.0602282229862633,1.89364149679018e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,40300,0.0132065937940401,0.00234820764841688,0.00860410680314305,0.0178090807849372,1.89608373259325e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PALM,Paralemmin-1,37819,0.0139195878492662,0.00247476701770543,0.0090690444945636,0.0187701312039689,1.89661354469891e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,40300,0.0376450719274252,0.00670175229854119,0.0245096374222845,0.050780506432566,1.9734028085124e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KITLG,Kit ligand,40354,-0.0172953251825521,0.00308196492878392,-0.0233359764429686,-0.0112546739221356,2.03591177718167e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,37709,0.0170798388526392,0.00304698216523369,0.0111077538087811,0.0230519238964972,2.11806172624747e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BCAN,Brevican core protein,40223,0.0158936184031697,0.00283578558131126,0.0103354786637997,0.0214517581425398,2.12155645384956e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD69,Early activation antigen CD69,40283,0.0416684825276562,0.00743617292780221,0.0270935835891638,0.0562433814661485,2.1358531615814e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,39956,0.028982110198289,0.00517333152135858,0.0188423804164262,0.0391218399801518,2.15229410593945e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,40466,0.0270449396666446,0.00483809035513133,0.0175622825705872,0.036527596762702,2.30770890591027e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,40136,0.0701105834349739,0.0125520520972785,0.0455085613243081,0.0947126055456398,2.36780838776829e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,37895,0.0538460122406088,0.00964102363376992,0.0349496059184197,0.0727424185627978,2.38106077008889e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,39956,0.0180955034608181,0.00324234853091954,0.0117405003402158,0.0244505065814204,2.43164614783431e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ASPN,Asporin,37985,0.0128310208811963,0.00230334756469625,0.00831645965439164,0.017345582108001,2.58709808157257e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNASET2,Ribonuclease T2,40460,0.0124370539014056,0.00223294037246628,0.00806049077137171,0.0168136170314395,2.59121486701105e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KHK,Ketohexokinase,37623,0.0302214383995998,0.0054254870478973,0.0195874837857211,0.0408553930134785,2.59326101516206e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FOXO1,Forkhead box protein O1,40336,0.0397958888681382,0.00714996273529793,0.0257819619069543,0.0538098158293221,2.65040514657844e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LY6D,Lymphocyte antigen 6D,40263,0.0176247169719151,0.00316938300261678,0.0114127262867862,0.023836707657044,2.72686661568398e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL32,Interleukin-32,40336,-0.0200761599157139,0.00361283183776856,-0.0271573103177402,-0.0129950095136875,2.79015708692498e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IMMT,MICOS complex subunit MIC60,37895,0.0208536767229659,0.00375473145110956,0.0134944030787911,0.0282129503671406,2.84548211678576e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VEGFB,Vascular endothelial growth factor B,37593,0.0133819480959096,0.00240963263688367,0.00865906812761756,0.0181048280642015,2.85404726636209e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CES3,Carboxylesterase 3,40300,0.0322833145098913,0.00581663687202752,0.0208827062407173,0.0436839227790652,2.89970808332572e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",37993,0.0188245136777641,0.00339667728166197,0.0121670262057066,0.0254820011498215,3.04556952906848e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,40380,0.0561032750720529,0.0101379862393221,0.0362328220429815,0.0759737281011243,3.18006986155456e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC51B,Organic solute transporter subunit beta,37557,-0.037340098795598,0.00675226745148531,-0.0505745430005093,-0.0241056545906868,3.26344822451751e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,39975,0.032740042075746,0.00592294971667748,0.0211310606310581,0.0443490235204339,3.29763285670115e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNPEP,Aspartyl aminopeptidase,37937,0.0277210260644002,0.0050155190361442,0.0178906087535576,0.0375514433752429,3.31704313711039e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LMNB1,Lamin-B1,37869,0.0266234869684743,0.00481699515742839,0.0171821764599146,0.0360647974770339,3.31847811571838e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,37567,0.0322899240598385,0.00584431912368555,0.0208350585774148,0.0437447895422621,3.3574625170759e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLIN1,Perilipin-1,39956,0.0165527656436641,0.00299862761274087,0.010675455522692,0.0224300757646362,3.44217330883513e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAB10,Ras-related protein Rab-10,37985,0.0249840878182143,0.00452737627420145,0.0161104303207795,0.0338577453156492,3.48294861320677e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,39975,0.0306408131632545,0.00555460382708663,0.0197537896621648,0.0415278366643443,3.51762870646663e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GBP2,Guanylate-binding protein 2,40039,0.0278263479781987,0.00504621048310457,0.0179357754313137,0.0377169205250836,3.55725892714511e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SH2B3,SH2B adapter protein 3,39975,0.0455704713662407,0.00826630036581648,0.0293685226492404,0.061772420083241,3.58798672459336e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PF4,Platelet factor 4,37929,0.0453078220075828,0.00822879818489384,0.0291793775651908,0.0614362664499747,3.73779877933278e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SELL,L-selectin,38008,0.0107811079177673,0.00195871073851906,0.00694203487026992,0.0146201809652646,3.77615734094724e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AMIGO2,Amphoterin-induced protein 2,40300,0.010528403239334,0.00191347041472973,0.00677800122646373,0.0142788052522043,3.80775187051726e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,37623,0.0358857469293626,0.00652997704003797,0.0230869919308881,0.048684501927837,3.96757661486665e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CASP10,Caspase-10,39956,0.0333273029780094,0.00607106650221141,0.0214280126336751,0.0452265933223438,4.09333170927765e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,37895,0.0236896095284935,0.00431515870387033,0.0152318984689076,0.0321473205880793,4.09551245137523e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GSTA3,Glutathione S-transferase A3,39975,0.035146685022902,0.00640433209188531,0.0225941941228068,0.0476991759229972,4.1298474416882e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HEXIM1,Protein HEXIM1,40336,0.0378418109392743,0.00690437663661942,0.0243092327315002,0.0513743891470483,4.2974941953686e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLA2G1B,Phospholipase A2,40509,0.0194396312336779,0.00354971835061958,0.0124821832664635,0.0263970792008923,4.4061761908623e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",37709,0.0228455678884833,0.00417384727129649,0.0146648272367422,0.0310263085402244,4.49244450458877e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SH3BP1,SH3 domain-binding protein 1,37896,0.0215958233832379,0.0039464850459859,0.0138607126931055,0.0293309340733702,4.52527113966342e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,37874,0.0192290439404759,0.00351704053286822,0.0123356444960542,0.0261224433848977,4.64865127167296e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,40354,0.0162396088805892,0.00297568606524146,0.010407264192716,0.0220719535684625,4.90293764136958e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,37623,0.0469767044910517,0.0086269496080793,0.0300678832592163,0.0638855257228871,5.26326744310816e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,40336,0.0422737146653212,0.00776995332138305,0.0270446061554105,0.057502823175232,5.38676379101894e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BTD,Biotinidase,38008,0.00947605254804889,0.00174582946790127,0.00605422679096239,0.0128978783051354,5.80269661976653e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STX6,Syntaxin-6,39975,0.0316312042083733,0.00583450984657645,0.0201955649090835,0.0430668435076632,6.00178951403115e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APP,Amyloid-beta precursor protein,40304,0.0307041684032401,0.00566570992021144,0.0195993769596257,0.0418089598468546,6.070748796887e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TJAP1,Tight junction-associated protein 1,40406,0.0378346931709995,0.0069877545507251,0.0241386942515783,0.0515306920904207,6.23740473612399e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,40037,0.0422240163391318,0.00780054975163462,0.0269349388259279,0.0575130938523356,6.29102557062136e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,37709,0.0399555911675413,0.00738695856407649,0.0254771523819514,0.0544340299531312,6.4500284352819e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,37937,0.0212136205815583,0.0039328351696256,0.0135052636490922,0.0289219775140245,7.00781762723273e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CALCA,Calcitonin,40187,0.0250404842298704,0.00464860091467643,0.0159292264371046,0.0341517420226362,7.2806109091345e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,37982,-0.0117642897195677,0.00219048502930745,-0.0160576403770103,-0.00747093906212513,7.97584844566338e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,37593,0.0256810108151221,0.0047821759998265,0.0163079458554622,0.0350540757747821,8.00096408535635e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLK6,Kallikrein-6,40382,0.0138376502913805,0.00258005052445146,0.00878075126345562,0.0188945493193053,8.28439410754423e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,40531,0.0325726064183454,0.00607850682207035,0.0206587330470875,0.0444864797896033,8.50002220951331e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,40336,0.0468922573055569,0.00876130176151955,0.0297201058529786,0.0640644087581352,8.8096690042513e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,37937,0.0169914255108243,0.00317600298690387,0.0107664596564928,0.0232163913651559,8.9421364715807e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ICAM3,Intercellular adhesion molecule 3,40531,0.0114266918332718,0.00213720182480603,0.00723777625665202,0.0156156074098917,9.08626548389923e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD99L2,CD99 antigen-like protein 2,40327,0.0107538423771304,0.00201158913681453,0.00681112766897394,0.0146965570852869,9.1191004262768e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",37955,0.0278406072618215,0.00520865139711343,0.0176316505234792,0.0380495640001639,9.18519987649345e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HMCN2,Hemicentin-2,37643,-0.0258581663942761,0.00484660367992207,-0.0353575096069234,-0.0163588231816289,9.69547350126901e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IMPACT,Protein IMPACT,37937,0.0255868753274914,0.00480004058292165,0.0161787957849649,0.0349949548700178,9.94914160954865e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NGRN,Neugrin,37937,0.00991394124780165,0.00185984468469632,0.00626864566579686,0.0135592368298064,9.95094074455138e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IFNL1,Interferon lambda-1,39956,0.0204449855322819,0.00384186471191445,0.0129149306969295,0.0279750403676342,1.04271898495693e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,39975,0.0215827453456128,0.00405610792705992,0.0136327738085753,0.0295327168826502,1.04604099661336e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NPPB,Natriuretic peptides B,40037,-0.057889965774612,0.0108846262907674,-0.079223833304516,-0.036556098244708,1.060665749425e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BAX,Apoptosis regulator BAX,39929,0.0401850470348329,0.00756212752598834,0.0253632770838958,0.0550068169857701,1.08738705921461e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXCL12,Stromal cell-derived factor 1,40039,0.0182979332347034,0.00344539399044782,0.0115449610134257,0.0250509054559812,1.10619739485174e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HSPB6,Heat shock protein beta-6,40484,0.0163943140975511,0.00308746664627476,0.0103428794708525,0.0224457487242496,1.11113734169665e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNASE1,Ribonuclease pancreatic,37982,0.0108496333571815,0.00204382289477017,0.00684374048343193,0.014855526230931,1.12277901594373e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DOK1,Docking protein 1,37937,0.0610353170853192,0.0115005321768634,0.038494274018667,0.0835763601519715,1.13101943650313e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,40336,0.0359424636017944,0.00677332743239929,0.0226667418342917,0.049218185369297,1.13268899068905e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CORO1A,Coronin-1A,39985,0.0403059259801334,0.00760153050709907,0.0254069261862192,0.0552049257740476,1.15890714846848e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYO9B,Unconventional myosin-IXb,40039,0.0297786874668175,0.0056162346502929,0.0187708675522434,0.0407865073813915,1.15943725886314e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NFX1,Transcriptional repressor NF-X1,37557,0.0304396966714212,0.00574075164186785,0.0191878234533602,0.0416915698894821,1.16153942906069e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,40336,0.0274528476373734,0.00517924187065719,0.0173015335708853,0.0376041617038615,1.1699578220866e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CFD,Complement factor D,38008,0.0085367359680394,0.00161107918392398,0.00537902076754841,0.0116944511685304,1.18411902558208e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,THOP1,Thimet oligopeptidase,40283,0.013423968481354,0.00253528194937435,0.00845481586058029,0.0183931211021278,1.20697289799581e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,40395,-0.0287470036390215,0.00542946259101062,-0.0393887503174023,-0.0181052569606406,1.20838216516467e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,37985,0.0290667528744308,0.00550202976595809,0.018282774533153,0.0398507312157087,1.29116024838007e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,40187,0.0497861910398946,0.00943045306394679,0.0313025030345589,0.0682698790452303,1.31401398627098e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APOF,Apolipoprotein F,37982,0.010771412449082,0.00204149359117027,0.00677008501038823,0.0147727398877757,1.33895378776432e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL13,C-C motif chemokine 13,40478,0.0310724275451021,0.0058975410738162,0.0195132470404224,0.0426316080497819,1.39164802365647e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UNC5D,Netrin receptor UNC5D,37593,0.0119142083138229,0.00226191569450439,0.00748085355259434,0.0163475630750515,1.40623764417905e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HMOX1,Heme oxygenase 1,40179,-0.0208955447278535,0.00397095545448128,-0.0286786174186368,-0.0131124720370702,1.44292645866151e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AK1,Adenylate kinase isoenzyme 1,40354,0.028448289428638,0.00541302600586251,0.0178387584571474,0.0390578204001285,1.49510157717254e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,40037,0.0249282380704616,0.0047479171109401,0.015622320533019,0.0342341556079042,1.53802020104892e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,37955,0.0174208365804406,0.00331807380624911,0.0109174119201924,0.0239242612406889,1.54166735872386e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,39956,0.0295419336986648,0.00562730146360602,0.0185124228299971,0.0405714445673326,1.54314270666322e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,40465,0.02713529236646,0.00517213571241234,0.0169979063701318,0.0372726783627882,1.57043380061318e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,37557,0.0308424596978071,0.00588755229917119,0.0193028571914316,0.0423820622041826,1.64317526667499e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANPEP,Aminopeptidase N,40365,0.0125326576510176,0.00239754160025857,0.00783347611451082,0.0172318391875244,1.74182209737015e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BRDT,Bromodomain testis-specific protein,37557,0.0164750714589049,0.00315292636049492,0.0102953357923348,0.0226548071254749,1.76515161326758e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NIT1,Deaminated glutathione amidase,37623,0.0218214160927722,0.00417797820107985,0.0136325788186557,0.0300102533668887,1.78768336285355e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",40300,0.0430119128968025,0.0082367011555449,0.0268679786319345,0.0591558471616705,1.79255402982887e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEP170,Centrosomal protein of 170 kDa,37623,0.0339337832637778,0.00651101118450053,0.0211722013421568,0.0466953651853988,1.89891510764331e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DDHD2,Phospholipase DDHD2,37955,0.0290746440941081,0.00558493670039903,0.018128168161326,0.0400211200268902,1.95887621177342e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,39975,0.0407310196314474,0.00785240356768963,0.0253403086387757,0.056121730624119,2.16307538962973e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,40406,0.0106491236264125,0.00205426197045798,0.00662277016431486,0.0146754770885101,2.19925854295489e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EDF1,Endothelial differentiation-related factor 1,37955,0.0304365868339633,0.00587935913364682,0.0189130429320156,0.0419601307359111,2.28898351756955e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,37709,0.0152397876787467,0.00294387803552622,0.00946978672911529,0.0210097886283781,2.29058912409434e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MGLL,Monoglyceride lipase,40391,0.0377468461724246,0.00731008265448736,0.0234190841696294,0.0520746081752199,2.45070050986852e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPBP,Platelet basic protein,37929,0.0366350387303507,0.00709780117707707,0.0227233484232797,0.0505467290374218,2.48511887790627e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,37666,0.0116744320606823,0.00226255153330092,0.00723983105541248,0.0161090330659521,2.50725350005105e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,37955,0.0290761992445972,0.00563817628402353,0.0180253737279111,0.0401270247612833,2.54457804192381e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,37955,0.0163299514217048,0.003167163429655,0.010122311099581,0.0225375917438286,2.5582262804423e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CA14,Carbonic anhydrase 14,40484,0.0150499449695949,0.00292257391673873,0.00932170009278697,0.0207781898464028,2.64200898906196e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GCG,Pro-glucagon,39975,-0.0543012970327321,0.0105496566657616,-0.0749786240976249,-0.0336239699678394,2.67616562933231e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,37985,0.0144876781086641,0.00281986470122386,0.00896074329426537,0.0200146129230629,2.81958786075878e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAGED1,Melanoma-associated antigen D1,39975,0.0211337187775994,0.00411877360226714,0.0130609225171558,0.029206515038043,2.91572447044275e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTSO,Cathepsin O,40511,0.013062461821513,0.00254641669258146,0.00807148510405332,0.0180534385389726,2.93516604494956e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,40223,0.0150770373356894,0.00294027949126538,0.00931408953280926,0.0208399851385695,2.96686288783178e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PER3,Period circadian protein homolog 3,37593,0.0510902926194143,0.00996803187190746,0.0315529501504756,0.0706276350883529,3.0109859923583e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NTRK3,NT-3 growth factor receptor,40466,-0.00943625317807507,0.00184431778433872,-0.013051116035379,-0.00582139032077117,3.15034416340061e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GIMAP7,GTPase IMAP family member 7,37666,-0.0140332173183751,0.00274779475490697,-0.0194188950379928,-0.00864753959875745,3.31723739289344e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD70,CD70 antigen,40336,0.0179657434208531,0.00351982904763098,0.0110668784874964,0.0248646083542099,3.36116636971649e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OSM,Oncostatin-M,40263,0.0313074399417692,0.00613588743853167,0.0192811005622471,0.0433337793212912,3.39348510445138e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DBN1,Drebrin,37593,0.0222294395866846,0.00436721037126648,0.0136697072590023,0.0307891719143669,3.62863016465992e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD86,T-lymphocyte activation antigen CD86,37896,0.0125713505860287,0.00247090717772146,0.00772837251769461,0.0174143286543627,3.67227252482036e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,40162,0.0138626664526398,0.00272771137195209,0.00851635216361366,0.0192089807416658,3.77449822034043e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCRL5,Fc receptor-like protein 5,40327,0.0240697435564928,0.00473963161337366,0.0147800655942804,0.0333594215187052,3.84938545690925e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,40327,0.0113814540263786,0.00224120415209524,0.00698869388827189,0.0157742141644852,3.85188011324988e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,YJU2,Splicing factor YJU2,37895,0.0137139854606757,0.002703575805385,0.00841497688212105,0.0190129940392303,3.9778035438616e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,40273,0.0109926382323308,0.00216767981834526,0.0067439857883741,0.0152412906762875,3.998797366444e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAB6A,Ras-related protein Rab-6A,40336,-0.0204918981447318,0.00404208939071848,-0.02841439335054,-0.0125694029389235,4.03071453522039e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,37557,0.0289752489027055,0.00572029218047376,0.0177634762289769,0.0401870215764341,4.13206147006712e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINE2,Glia-derived nexin,37985,0.0274143256290033,0.00541648109018938,0.0167980226922321,0.0380306285657745,4.21917317010218e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BGN,Biglycan,39951,-0.0520983957323927,0.010296472509793,-0.072279481851587,-0.0319173096131985,4.24431557596376e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DKKL1,Dickkopf-like protein 1,40300,-0.0377503761896118,0.00746702714316058,-0.0523857493902065,-0.023115002989017,4.33800940127214e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,40328,0.0261638490978674,0.00517644551511777,0.0160180158882365,0.0363096823074982,4.36536646491466e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,37666,0.0177069688719701,0.00350350711815703,0.0108400949203823,0.0245738428235579,4.38275576611367e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LY75,Lymphocyte antigen 75,40336,0.016618052569619,0.00329260390255425,0.0101645489206126,0.0230715562186253,4.53559056623198e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,40350,0.0213039009313623,0.00422674555404018,0.0130194796454436,0.0295883222172811,4.70003813483125e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTSD,Cathepsin D,39238,0.0170652227600451,0.00338637009485375,0.0104279373741318,0.0237025081459585,4.72543953017324e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXCL8,Interleukin-8,40204,0.0288870935038685,0.00573494309532204,0.0176466050370373,0.0401275819706997,4.78033795557068e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NECTIN2,Nectin-2,40325,0.0123209847922635,0.00244823258108502,0.00752244893333685,0.0171195206511901,4.89154220184724e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,40466,0.0307153898587017,0.00610602370181931,0.0187475834031358,0.0426831963142675,4.94902898602112e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,37937,0.0131845204896595,0.00262177481568281,0.00804584185092124,0.0183231991283978,4.99760890873463e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,40511,0.0249477012795908,0.00496364025216736,0.0152189663853428,0.0346764361738389,5.0596578701486e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MMP9,Matrix metalloproteinase-9,40307,0.0260107564470503,0.00517560317646787,0.0158665742211733,0.0361549386729273,5.07201460982712e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,JAM3,Junctional adhesion molecule C,37666,0.0215409271170352,0.00428592702480162,0.013140510148424,0.0299413440856464,5.07455342322405e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,40336,0.0258274450060073,0.00513990611685535,0.0157532290169708,0.0359016609950438,5.09203061058521e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,40300,0.00879623659121271,0.0017516440967391,0.00536301416160407,0.0122294590208214,5.1771638910683e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MMP8,Neutrophil collagenase,40437,0.0310555109000109,0.00618884109533108,0.018925382353162,0.0431856394468599,5.27770011449953e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,37386,0.0148474755232088,0.00295986353628326,0.00904614299209358,0.0206488080543239,5.33831672736212e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RSPO1,R-spondin-1,40223,0.0150235850655462,0.00299692996961038,0.0091496023251098,0.0208975678059825,5.41712687440499e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BRAP,BRCA1-associated protein,37773,0.0463166067908942,0.0092408252560183,0.0282045892890983,0.0644286242926901,5.45100081623951e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SBSN,Suprabasin,37972,0.0142106906083947,0.00283720965849792,0.00864975967773876,0.0197716215390506,5.5494404195891e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FMNL1,Formin-like protein 1,39956,0.025393857578654,0.0050704200733212,0.0154558342349444,0.0353318809223635,5.55349893737482e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATXN3,Ataxin-3,37937,0.0263319826303508,0.0052601033502901,0.0160221800637822,0.0366417851969194,5.6279425594607e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",40354,0.0306785655100537,0.00613176850181443,0.0186602992464974,0.04269683177361,5.69832506944422e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,37593,0.0256280704287623,0.00512283497935909,0.0155873138692184,0.0356688269883061,5.72596227712821e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLC,Galectin-10,40328,0.0278586035154061,0.00557079493534421,0.0169398454421314,0.0387773615886807,5.76928295721575e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,40039,0.0254389107357561,0.0050948366275992,0.0154530309456617,0.0354247905258506,6.00668876862356e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ULBP2,UL16-binding protein 2,40223,0.0157376188472566,0.00315410495822756,0.00955557312913062,0.0219196645653827,6.11590411653354e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TSHB,Thyrotropin subunit beta,40354,0.0354268031664338,0.00710409496502703,0.0215027770349809,0.0493508292978868,6.20297716004295e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,40466,0.0190288352035007,0.0038235598885734,0.0115346578218968,0.0265230125851045,6.53378789209292e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,37895,0.0451946698198282,0.00911843082771359,0.0273225453975096,0.0630667942421468,7.26828509582554e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C2orf69,UPF0565 protein C2orf69,37567,0.0253573301730634,0.0051181218941172,0.0153258112605937,0.0353888490855331,7.34505699674733e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,40417,0.0118689639884746,0.00239585155782417,0.00717309493513926,0.01656483304181,7.34603102359402e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,37623,0.0233748209420369,0.00472196479758429,0.0141197699387717,0.0326298719453021,7.50423759047672e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPHA1,Ephrin type-A receptor 1,40395,0.0143154520689573,0.00289300625800516,0.00864515980326722,0.0199857443346474,7.56294534297161e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,37955,-0.0189254718071485,0.00382493656744588,-0.0264223474793424,-0.0114285961349545,7.59152476616813e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GRK5,G protein-coupled receptor kinase 5,40037,0.0220643553373371,0.00446061565796272,0.0133215486477301,0.030807162026944,7.63540515532113e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,40336,0.0196718884396864,0.00398165572325041,0.0118678432221156,0.0274759336572572,7.86628751192357e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,40354,-0.0141602243715597,0.00286614569354812,-0.0197778699309141,-0.00854257881220541,7.87099940831013e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,37896,0.0230799842011278,0.00467277707853332,0.0139213411272025,0.0322386272750531,7.93687562997472e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,37895,0.024033639697736,0.00486784330091566,0.0144926668279414,0.0335746125675307,8.01927860852867e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,37593,0.0331938957318353,0.0067250248797364,0.0200128469675519,0.0463749444961186,8.07699781455492e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,37830,0.0244726780006128,0.00495836855234078,0.0147542756380248,0.0341910803632007,8.08542009704705e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LPP,Lipoma-preferred partner,37557,0.0280213853202048,0.0056805385047553,0.0168875298508844,0.0391552407895251,8.20222550362334e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD248,Endosialin,37993,-0.0166830695332715,0.00338267058443168,-0.0233131038787576,-0.0100530351877854,8.23901614112378e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,40223,0.0106683182049634,0.00216559185222002,0.00642375817461219,0.0149128782353147,8.46579577327623e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPHB6,Ephrin type-B receptor 6,40187,0.01299679361996,0.00264019823564064,0.00782200507810437,0.0181715821618157,8.62412289693931e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CASP1,Caspase-1,39956,0.0279658737673089,0.00569609355065623,0.0168015304080227,0.0391302171265952,9.2163535767179e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],40300,0.0237562333440715,0.00484703534922204,0.0142560440595963,0.0332564226285467,9.62005371499662e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APOE,Apolipoprotein E,38008,-0.0310667854852422,0.00634347178478472,-0.0434999901834203,-0.0186335807870642,9.82120062832712e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,40531,0.0129559026340173,0.00264915204727239,0.00776356462136338,0.0181482406466712,1.01508416011895e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,37895,0.0226246895968156,0.00462616237728174,0.0135574113373434,0.0316919678562878,1.01694186440928e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,37666,0.0279032206208966,0.00570684862690539,0.016717797312162,0.0390886439296311,1.02318924792559e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,REEP4,Receptor expression-enhancing protein 4,37955,0.0256495013735962,0.00524712725168482,0.0153651319602939,0.0359338707868984,1.02882670440094e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLIT2,Slit homolog 2 protein,39956,0.0216952552547125,0.00444157077334827,0.0129897765389499,0.0304007339704751,1.04677897660042e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,37709,0.0277955110094658,0.00569084000242232,0.0166414646047181,0.0389495574142136,1.05032672291135e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,INHBC,Inhibin beta C chain,40327,0.0175867531719603,0.00360233517125302,0.0105261762363044,0.0246473301076162,1.06013442715205e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PI3,Elafin,40069,0.0220769574043001,0.0045233213610245,0.0132112475366921,0.0309426672719081,1.0675569562979e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FOXJ3,Forkhead box protein J3,37593,0.0179777516520868,0.00368591415383409,0.010753359910572,0.0252021433936016,1.08741181405171e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,37982,0.0162450830373352,0.00333303998333916,0.00971232466999044,0.0227778414046799,1.10627242266983e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPL,Periplakin,37593,0.0135750066664117,0.00278729016427166,0.0081119179444393,0.0190380953883842,1.12712837192753e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,37682,0.0265157555456401,0.00544682268698236,0.0158399830791547,0.0371915280121255,1.13969116991611e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPA2,Carboxypeptidase A2,40393,-0.0263614579586583,0.00541735541326925,-0.036979474568666,-0.0157434413486505,1.14903190835186e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,37895,0.0208382022715771,0.00428323078080142,0.0124430699412063,0.0292333346019479,1.15715377446707e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,40417,0.00849822041621365,0.00174707323290952,0.00507395687971098,0.0119224839527163,1.15980251941862e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPXM1,Probable carboxypeptidase X1,40406,0.02831980286281,0.00582488942916157,0.0169030195816533,0.0397365861439666,1.17394371812784e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CR2,Complement receptor type 2,40398,0.0191566304490373,0.00394121666174368,0.0114318457920197,0.026881415106055,1.18151286949333e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,37955,0.0380357536883961,0.00783650656306499,0.0226762008247887,0.0533953065520035,1.22557693093861e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,40336,0.0251058347535266,0.00517359813673556,0.0149655824055249,0.0352460871015283,1.22958213772205e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,37915,0.0340144914286798,0.0070197612468437,0.0202557593848662,0.0477732234724934,1.27678789097635e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,40300,0.024341749324953,0.00503101824415922,0.0144809535664009,0.034202545083505,1.3216323373028e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,40417,0.0108306971664952,0.00223977513195985,0.00644073790785388,0.0152206564251365,1.33969214922505e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RASSF2,Ras association domain-containing protein 2,39975,0.0224606064833135,0.00465761340785991,0.013331684203908,0.0315895287627189,1.43227485391619e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COPB2,Coatomer subunit beta',37557,0.0176460048447733,0.00366072307111564,0.0104709876253867,0.02482102206416,1.44907082645873e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,37709,0.0309563229635222,0.00642535084528225,0.018362635306769,0.0435500106202754,1.46725928532686e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NRCAM,Neuronal cell adhesion molecule,40354,0.0114121966708798,0.00237035926380974,0.00676629251381271,0.0160581008279469,1.48894103905507e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD58,Lymphocyte function-associated antigen 3,40330,-0.00722355235209967,0.00150143414955649,-0.0101663632852304,-0.00428074141896894,1.51479482929672e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,39975,0.0238896089194408,0.00497540054584306,0.0141378238495884,0.0336413939892932,1.5891444209642e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,40484,0.0144201896204608,0.0030042892607416,0.00853178266940722,0.0203085965715143,1.60202301230005e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYOM3,Myomesin-3,37666,-0.0366465809089184,0.00763574725011093,-0.0516126455191358,-0.021680516298701,1.60927702116669e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPY,Pancreatic prohormone,40332,-0.0410006597176866,0.00854777310617534,-0.0577542950057903,-0.0242470244295829,1.62807495096586e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,40327,0.0214334585794542,0.00446854954573282,0.0126751014698178,0.0301918156890905,1.62917129335634e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,37623,0.0167661061946959,0.00349959800859417,0.00990689409785129,0.0236253182915404,1.67873408937044e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EGFR,Epidermal growth factor receptor,40531,0.00663635802298895,0.00138568103018248,0.00392042320383129,0.00935229284214661,1.68906901676916e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TFF3,Trefoil factor 3,40304,0.0216607304204068,0.00452552506121357,0.0127907013004282,0.0305307595403853,1.71376827666345e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37896,0.0184077768237416,0.00384603221565832,0.0108695536810513,0.0259459999664319,1.71800098818593e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,40223,0.0204274540276031,0.00427082738066715,0.0120566323614955,0.0287982756937107,1.74242082113122e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLSTN2,Calsyntenin-2,40511,-0.0158138468733897,0.00330820272752505,-0.0222979242193388,-0.00932976952744061,1.76678640013482e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MSLN,Mesothelin,40266,0.0219446682302303,0.00459674392563065,0.0129350501359943,0.0309542863244664,1.82255963775009e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATXN10,Ataxin-10,39956,0.0292745551418503,0.00613441408693213,0.0172511035314633,0.0412980067522373,1.83900238717938e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C1QL2,Complement C1q-like protein 2,37593,0.0173159055395529,0.00363173349535066,0.0101977078886657,0.0244341031904402,1.88111200775779e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CES2,Cocaine esterase,40300,0.0215899050047774,0.00453897435093807,0.0126935152769388,0.030486294732616,1.98653846586552e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,37896,0.0204945075147937,0.00431211940906056,0.012042753473035,0.0289462615565524,2.02727642725379e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,40336,0.0425555691931761,0.00896022753412189,0.0249935232262972,0.060117615160055,2.05818854442821e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,40492,-0.0254980040238128,0.00537399006047549,-0.0360310245423448,-0.0149649835052808,2.10608763863847e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,37623,0.0293207616099361,0.00618608385784505,0.0171960372485599,0.0414454859713124,2.16173967052975e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BOLA1,BolA-like protein 1,37536,0.0219206901322222,0.00463756310393478,0.01283106644851,0.0310103138159343,2.30497424069921e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,39975,0.023317920558647,0.00496093342446465,0.0135944910466963,0.0330413500705977,2.61999246096742e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,XG,Glycoprotein Xg,40453,0.0118912746137686,0.00253580931927037,0.00692108834799863,0.0168614608795385,2.76349538289003e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,37666,0.00843129706399197,0.00179798967790873,0.00490723729529086,0.0119553568326931,2.76896089458807e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLAU,Urokinase-type plasminogen activator,40327,0.0116592254575963,0.00248749173672475,0.00678374165361578,0.0165347092615768,2.79349318622768e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,40511,0.0148024216793272,0.00316125155184249,0.0086063686377159,0.0209984747209385,2.85776852324163e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,40286,0.013674378199571,0.0029216482552469,0.00794794761928708,0.0194008087798549,2.88737677253352e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRYGD,Gamma-crystallin D,37937,0.0378905283128824,0.00810260092515253,0.0220094304995834,0.0537716261261813,2.9487088311667e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PROK1,Prokineticin-1,40336,0.0272674053435007,0.00583148591033103,0.0158376929592519,0.0386971177277495,2.9508471847532e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,40484,0.0133597593331008,0.00286288680307128,0.00774850119908113,0.0189710174671205,3.08800154874676e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLF4,Krueppel-like factor 4,37536,0.0154341546083145,0.00330784192726061,0.0089507844308837,0.0219175247857453,3.10271589943968e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,37895,0.0138151530754514,0.00296838952201378,0.00799710961230434,0.0196331965385984,3.28522699093497e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINA6,Corticosteroid-binding globulin,38008,0.00702669587939904,0.00151053261607468,0.00406605195189266,0.00998733980690542,3.32161018406852e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,INSR,Insulin receptor,37593,0.00662775864292684,0.00142700424884016,0.00383083031520012,0.00942468697065356,3.44162746880572e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,37557,0.0249499617926659,0.00537754769270873,0.0144099683149568,0.035489955270375,3.52372132158382e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MICALL2,MICAL-like protein 2,37567,0.0269294950911094,0.0058075018489947,0.0155467914670798,0.038312198715139,3.56883085353821e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39848,0.0348691798222192,0.00752062677759644,0.0201287513381302,0.0496096083063082,3.57317087363997e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD2AP,CD2-associated protein,40354,0.0250731849293064,0.00541085259991789,0.0144679138334674,0.0356784560251455,3.61741749377386e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,37623,0.0111433686487875,0.00240970987375535,0.00642033729622701,0.015866400001348,3.79329363019013e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,37985,0.0113206873250422,0.00244892842326073,0.00652078761545114,0.0161205870346332,3.82259650146147e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNST,Consortin,40354,0.0421301039178657,0.00912502363372301,0.0242450575957686,0.0600151502399628,3.92401195580558e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENSA,Alpha-endosulfine,37895,0.0205516238235801,0.00446401254961311,0.0118021592263384,0.0293010884208218,4.18560305181917e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RBKS,Ribokinase,39986,0.0193279017214395,0.00420236880818216,0.0110912588574024,0.0275645445854765,4.27285549131813e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,40406,-0.0174106981393903,0.00380258726234643,-0.0248637691735893,-0.00995762710519132,4.71532592694058e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ELOB,Elongin-B,37557,0.015565721489723,0.00340070600042496,0.00890033772889006,0.0222311052505559,4.75565617557639e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEP85,Centrosomal protein of 85 kDa,39975,0.0243994514036046,0.00533192115692795,0.0139488859360258,0.0348500168711834,4.77374646733601e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BDNF,Brain-derived neurotrophic factor,37993,0.0319097582683665,0.00697620823344853,0.0182363901308073,0.0455831264059256,4.82552497417686e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,40531,0.0235831559139813,0.00516196548417798,0.0134657035649924,0.0337006082629701,4.94550669586869e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",40336,0.0367823784482999,0.00805129748340431,0.0210018353808274,0.0525629215157723,4.9491521923598e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,37955,0.0190969281761825,0.00417988229096737,0.0109043588858865,0.0272894974664785,4.94935642507719e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,37593,0.0188170049566104,0.00412288654236653,0.010736147333572,0.0268978625796488,5.0634219918876e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GBA,Lysosomal acid glucosylceramidase,37567,0.0204805115361677,0.00448915320206452,0.0116817712601212,0.0292792518122141,5.10742424305638e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,37567,0.0210693101839231,0.0046320583687689,0.0119904757811361,0.0301481445867102,5.44921005910985e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,40223,-0.0138842950938536,0.00305305022532511,-0.0198682735354908,-0.0079003166522164,5.46444139592912e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTRB1,Chymotrypsinogen B,40327,0.0204316355338465,0.00450540721887075,0.0116010373848598,0.0292622336828332,5.80485627354464e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STX16,Syntaxin-16,39975,0.0226507105992484,0.00500751035265028,0.0128359903080538,0.0324654308904429,6.13202000548408e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDC27,Cell division cycle protein 27 homolog,39975,0.0232975485379958,0.00515419294627742,0.0131953303632921,0.0333997667126995,6.22626121701646e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",39975,0.0196042738134233,0.0043371334423119,0.011103492266492,0.0281050553603547,6.22674355139177e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",37623,0.0266734625212818,0.00590287155095708,0.0151038342814059,0.0382430907611577,6.27541933785952e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LGALS7_LGALS7B,Galectin-7,40265,0.0153282040792228,0.00340026732319996,0.00866368012575088,0.0219927280326947,6.59297976775551e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,40354,0.0222685721105081,0.00494657133468905,0.0125732922945175,0.0319638519264986,6.78526544955216e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,37666,0.0143192759180383,0.00318457693790372,0.00807750511974705,0.0205610467163296,6.96871761776906e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,37916,0.0146703820682133,0.00326298999857717,0.00827492167100203,0.0210658424654245,6.98240962355349e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VNN1,Pantetheinase,37982,0.0274828735649884,0.00611809244157645,0.0154914123794986,0.0394743347504783,7.11198299182918e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARSA,Arylsulfatase A,40327,0.0169229281842527,0.00377117934349071,0.00953141667101096,0.0243144396974945,7.25918488887395e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPO,Erythropoietin,40336,-0.0297172444097748,0.00662849487549122,-0.0427090943657376,-0.016725394453812,7.40268769232826e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINI1,Neuroserpin,37637,0.0120992376160132,0.00270258765970679,0.00680216580298789,0.0173963094290385,7.63670917739793e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,37623,0.0114360950131727,0.00255490441285938,0.00642848236396837,0.0164437076623771,7.66446820487156e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYL3,Myosin light chain 3,37623,-0.0257964910851641,0.00576798071551645,-0.0371017332875763,-0.0144912488827518,7.80079713185748e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,F12,Coagulation factor XII,38008,0.015768358955989,0.00353166725482221,0.00884629113653747,0.0226904267754405,8.0772533725383e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HSBP1,Heat shock factor-binding protein 1,37623,0.035879512204808,0.00805618759947329,0.0200893845098403,0.0516696398997756,8.51141671778638e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BMPER,BMP-binding endothelial regulator protein,37666,0.00845812147230304,0.00190260464824013,0.00472901636175239,0.0121872265828537,8.83822458642314e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NHLRC3,NHL repeat-containing protein 3,37365,0.0120186771357621,0.00270475254058775,0.00671736215621015,0.0173199921153141,8.92272232366472e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD7,T-cell antigen CD7,37562,0.0160957548053475,0.00362712483853282,0.00898659012182319,0.0232049194888718,9.17065333338221e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37955,0.0177720772833273,0.00400911326740182,0.00991421527921979,0.0256299392874349,9.36987481194153e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BOC,Brother of CDO,40037,-0.00887112776559836,0.00200199526200773,-0.0127950384791335,-0.0049472170520632,9.43741209696352e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,39975,0.0134893009105527,0.0030478150841809,0.00751558334555818,0.0194630184755473,9.66992160789525e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLXDC1,Plexin domain-containing protein 1,39975,-0.0127344232170982,0.00288011960245445,-0.0183794576379089,-0.00708938879628749,9.86877573878434e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LHB,Lutropin subunit beta,39975,0.0318267206558089,0.00719904461405902,0.0177165932122532,0.0459368480993646,9.89282979868384e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,40223,0.0391069786909547,0.00884629151556727,0.0217682473204429,0.0564457100614666,9.90295984334044e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TBC1D5,TBC1 domain family member 5,40336,0.0292885845696778,0.00662852544147095,0.0162966747043947,0.0422804944349608,1.0001511025761e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CA12,Carbonic anhydrase 12,40300,-0.0121094853432153,0.00274207917644161,-0.0174839605290409,-0.00673501015738977,1.0113064975618e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,39975,0.016992467080791,0.00385103508641751,0.00944443831141266,0.0245404958501693,1.02900093346669e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,39920,0.0246331642571838,0.00559163584087643,0.013673558009066,0.0355927705053016,1.06318472391438e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CA9,Carbonic anhydrase 9,40484,-0.0167834037256775,0.00381211618398095,-0.0242551514462802,-0.00931165600507483,1.07629531126576e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DPP4,Dipeptidyl peptidase 4,40063,0.0111319153953398,0.00253050968623208,0.00617211641032491,0.0160917143803547,1.09430505604894e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",37557,0.0184804718896221,0.00420479188799846,0.0102390797891451,0.0267218639900991,1.11593708640947e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GLO1,Lactoylglutathione lyase,40037,0.0220518832910499,0.00501837389963224,0.0122158704477707,0.0318878961343291,1.11900979088505e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IFNG,Interferon gamma,40039,0.0423513784402238,0.00964002949696719,0.0234569206261681,0.0612458362542795,1.12388403412203e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZNRD2,Protein ZNRD2,37896,0.025242029777309,0.00574706920597639,0.0139777741335953,0.0365062854210227,1.13089841666635e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ELN,Elastin,37985,0.0129972614704243,0.00296543922661703,0.00718500058625492,0.0188095223545937,1.17985397114258e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DAPK2,Death-associated protein kinase 2,37593,0.0193824092257637,0.00442325219733541,0.0107128349189863,0.0280519835325411,1.18541315731071e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HDGF,Hepatoma-derived growth factor,40466,0.0353857940849218,0.00808229400471331,0.0195444978356838,0.0512270903341599,1.20429244279084e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NPTXR,Neuronal pentraxin receptor,40354,0.0125835703030237,0.00287724652722111,0.00694416710967028,0.018222973496377,1.23060755232245e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,S100A12,Protein S100-A12,40134,0.0283948652758848,0.00649598692756123,0.0156627308978647,0.0411269996539048,1.24394947221171e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,39975,0.0214163840858502,0.00489989167628975,0.0118125964003223,0.0310201717713781,1.24603761328074e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,40039,0.0257837336676321,0.00590146135030179,0.0142168694210406,0.0373505979142236,1.25598928382625e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,40039,0.0252455299365985,0.00578279015644488,0.0139112612299665,0.0365797986432304,1.27572627006811e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NEDD9,Enhancer of filamentation 1,37593,0.0121961150834903,0.00279383213560522,0.00672020409770405,0.0176720260692765,1.27876775071627e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINB9,Serpin B9,40223,0.0123732302216946,0.00283806310340498,0.00681062653902088,0.0179358339043684,1.31039060424867e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,40352,0.0109611735701029,0.00251467153612477,0.00603241735929833,0.0158899297809074,1.31545114410907e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,37630,-0.0178977506019691,0.00411658228148076,-0.0259662518736714,-0.00982924933026682,1.38591717004153e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,40484,0.013940468695921,0.00320845700712172,0.00765189296196241,0.0202290444298796,1.40187262285854e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",37623,0.0125239037027897,0.00288282980852663,0.00687355727807755,0.0181742501275019,1.40760463153738e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COMT,Catechol O-methyltransferase,39872,0.0312930177788142,0.0072073622381517,0.0171665877920369,0.0454194477655916,1.42213004022177e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,37557,0.0249499682246943,0.00575141017164022,0.0136772042882795,0.0362227321611091,1.4482069069288e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPR,Nucleoprotein TPR,37557,0.0172427380773206,0.00397758811149546,0.00944666537878949,0.0250388107758517,1.46865520541944e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,39975,0.0212577203992703,0.00490557798240472,0.0116427875537571,0.0308726532447836,1.47762350044193e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD99,CD99 antigen,40327,-0.00712922554608635,0.00164521521037744,-0.0103538473584261,-0.00390460373374658,1.47787793215371e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,40354,0.0234898006131472,0.00542148825360627,0.0128636836360789,0.0341159175902155,1.48180475980585e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NECTIN4,Nectin-4,40406,0.0112328682736285,0.00259309732156541,0.00615039752336031,0.0163153390238967,1.48775444180046e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FSTL3,Follistatin-related protein 3,40288,0.0114780201785939,0.00265124377370215,0.00628158238213767,0.0166744579750501,1.50505037858328e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NID2,Nidogen-2,40327,0.0270144310075923,0.00624557438067621,0.014773105221467,0.0392557567937177,1.5320437663747e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,XRCC4,DNA repair protein XRCC4,39956,0.0136406138437151,0.00315457947896433,0.00745763806494497,0.0198235896224851,1.54134938181436e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,40419,0.0076977608006034,0.00178062663751519,0.00420773259107363,0.0111877890101332,1.54809892976723e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BACH1,Transcription regulator protein BACH1,40336,0.0264689054423135,0.00613867918036283,0.0144370942488024,0.0385007166358247,1.62889187567393e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,37557,0.0119887568154278,0.0027825620597695,0.00653493517827962,0.0174425784525761,1.65539758298207e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,37593,0.0114134425460296,0.00265222998749902,0.00621507177053154,0.0166118133215277,1.69461019961206e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",40288,0.0210677921561961,0.00489959609667225,0.0114645838067185,0.0306710005056737,1.71894524752754e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PXN,Paxillin,39956,0.0188192346304521,0.00437858567678835,0.010237206703947,0.0274012625569573,1.73384541089043e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ASAH2,Neutral ceramidase,40223,0.0190393724048369,0.00444306621602367,0.0103309626214305,0.0277477821882433,1.83667642909164e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHRDL2,Chordin-like protein 2,40354,-0.0206564605315231,0.00482470433895064,-0.0301128810358663,-0.0112000400271798,1.86814597106449e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPARC,SPARC,40406,0.0256652078949592,0.00599823152950247,0.0139086740971343,0.037421741692784,1.89002256899227e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTSV,Cathepsin L2,40439,-0.0153577416502398,0.00359450873222644,-0.0224029787654036,-0.00831250453507596,1.94362207695019e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MVK,Mevalonate kinase,40039,0.0275934255050054,0.00649038262111526,0.0148722755676195,0.0403145754423913,2.13643702645096e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNX5,Sorting nexin-5,37623,0.0107323034061422,0.0025281463745106,0.00577713651210146,0.015687470300183,2.19966374540438e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,37709,0.0238584321565141,0.00562622902996826,0.0128310232577763,0.0348858410552519,2.24462063224772e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,40406,0.00860273355296609,0.00202979615824321,0.00462433308280941,0.0125811340231228,2.26559673068897e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,39934,0.0206629221644264,0.00488924547591416,0.0110800010316346,0.0302458432972181,2.39033938336077e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,40391,0.0274292563258363,0.00649263281990612,0.0147036959988203,0.0401548166528523,2.40616709034374e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NXPH1,Neurexophilin-1,39956,0.0134835138516634,0.00319483684466668,0.00722163363611666,0.0197453940672101,2.45248780672041e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PCDHB15,Protocadherin beta-15,37895,-0.0143923336905457,0.00341058952047024,-0.0210770891506674,-0.00770757823042407,2.46018867323414e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,37937,0.0850463546825342,0.0201691344151102,0.0455148512289183,0.12457785813615,2.49566276447878e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,39975,0.0148425413035606,0.00352218669541037,0.0079390553805563,0.021746027226565,2.52290357464055e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,40300,0.0194672127610409,0.00462310253996209,0.0104059317827152,0.0285284937393666,2.55810588706578e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LARP1,La-related protein 1,37895,0.0225709043172507,0.00536421655082418,0.0120570398776353,0.0330847687568661,2.59680972735341e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,40484,0.0110948699176743,0.00264155816278992,0.0059174159186061,0.0162723239167426,2.68211086990072e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,37955,0.0207185266746405,0.00493801405455407,0.0110400191277146,0.0303970342215665,2.73744164299027e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAB33A,Ras-related protein Rab-33A,37557,0.0236817265208981,0.00564530264786583,0.0126169333310811,0.0347465197107151,2.74735860679229e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLXDC2,Plexin domain-containing protein 2,37937,-0.00947118482999438,0.0022591654859147,-0.0138991491823872,-0.00504322047760157,2.77856184843378e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CFHR2,Complement factor H-related protein 2,37906,0.0202363959677357,0.00483700072721715,0.0107558745423901,0.0297169173930814,2.88665427828308e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TAX1BP1,Tax1-binding protein 1,37937,0.0226355548864867,0.00541304269515075,0.0120259912039912,0.0332451185689822,2.9120515282602e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MANSC4,MANSC domain-containing protein 4,37557,0.0233144140453545,0.00557658011526854,0.0123843170194281,0.0342445110712808,2.92407769992586e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NCAM1,Neural cell adhesion molecule 1,40398,0.00978637448414565,0.00234337793019047,0.00519335374097232,0.014379395227319,2.98017368256972e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,40267,0.00819240377299287,0.00196625813149675,0.00433853783525925,0.0120462697107265,3.10962461952875e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,S100A16,Protein S100-A16,39929,-0.0219587747603588,0.00527366022474079,-0.0322951488008507,-0.0116224007198669,3.14608679416967e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEPTIN8,Septin-8,37916,0.0111963623128472,0.00269201948829646,0.00592000411578616,0.0164727205099083,3.21493191477697e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,40336,0.0160650894066374,0.00386585379662217,0.00848801596525796,0.0236421628480169,3.26079625620881e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,40300,0.00774804163800126,0.00186460173830072,0.00409342223093185,0.0114026610450707,3.26518115980258e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,40039,0.012709216130945,0.00306546494101714,0.00670090484655143,0.0187175274153386,3.40221046273828e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,37623,0.0175921744566259,0.0042467642795271,0.00926851646875284,0.0259158324444991,3.45701341149475e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,S100P,Protein S100-P,40037,0.0187935298272567,0.00454468291709452,0.00988595130975139,0.0277011083447619,3.56381544583104e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AMOTL2,Angiomotin-like protein 2,37850,0.0168140123614775,0.00406641151200511,0.00884384579794753,0.0247841789250076,3.57346681001763e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMTN,Smoothelin,37900,0.0335185750949389,0.00812987620487922,0.0175840177333757,0.0494531324565022,3.76396810856696e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,40379,0.0106740790170476,0.00259419622170397,0.00558945442250778,0.0157587036115874,3.89802419013749e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,40037,0.0111906009184553,0.00272122593563549,0.00585699808460976,0.0165242037523009,3.93681088993541e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPMT,Thiopurine S-methyltransferase,39975,0.0257780855262566,0.00627156961890257,0.0134858090732076,0.0380703619793057,3.97161845268448e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BCL2,Apoptosis regulator Bcl-2,37896,0.0187666324464359,0.00457054430109581,0.00980836561628807,0.0277248992765837,4.04958331045705e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FSHB,Follitropin subunit beta,37623,0.024196721356508,0.00589336267196848,0.0126457305194498,0.0357477121935662,4.05422783505904e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DMD,Dystrophin,37623,0.0179988742104252,0.00438503962134061,0.00940419655259758,0.0265935518682528,4.07440050895609e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AFAP1,Actin filament-associated protein 1,37666,0.0294552657686652,0.0071773885808302,0.015387584150238,0.0435229473870924,4.08686968156021e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,39975,0.01652639051436,0.00403019684054394,0.00862720470689392,0.0244255763218262,4.14106001348064e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL10,Interleukin-10,40039,0.0298999510978501,0.00730142824478756,0.0155891517380665,0.0442107504576338,4.24147949950649e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WNT9A,Protein Wnt-9a,40039,0.00995187174327344,0.0024335484223795,0.00518211683540962,0.0147216266511373,4.34570333432818e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,40223,0.0110674242808189,0.00270689121703079,0.00576191749543855,0.0163729310661992,4.36116122111725e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NAA10,N-alpha-acetyltransferase 10,37557,0.0177794204632741,0.00434906223283101,0.00925525848692535,0.0263035824396229,4.3750711398793e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,40223,-0.0403498052090986,0.00988749391153001,-0.0597292932756975,-0.0209703171424998,4.50838352803459e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APOB,Apolipoprotein B-100,37982,0.00770781133103583,0.00189040243492404,0.0040026225585847,0.011413000103487,4.58146728520852e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGAM,Integrin alpha-M,40327,-0.0109210436933376,0.00268345876218064,-0.0161806228672116,-0.00566146451946353,4.7288560921244e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,37593,0.0154169970236913,0.00378870750607181,0.00799113031179056,0.0228428637355921,4.74512304898793e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRELP,Prolargin,40352,0.00798233395466484,0.00196897041548407,0.00412315194031607,0.0118415159690136,5.05749126111479e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,40398,-0.0157073042439773,0.00387503704533463,-0.0233023768528332,-0.00811223163512139,5.0705296165047e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NINJ1,Ninjurin-1,39975,0.019342264086621,0.00477972178183619,0.00997400939422209,0.02871051877902,5.21887282836932e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GFRA3,GDNF family receptor alpha-3,40189,-0.00977544445083172,0.00241614292585039,-0.0145110845854985,-0.00503980431616497,5.23739449155835e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37896,-0.0103018067603968,0.00254847918967908,-0.0152968259721678,-0.00530678754862579,5.32164021164367e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CALCB,Calcitonin gene-related peptide 2,37937,0.0136286851691352,0.00337375829583292,0.00701611890930263,0.0202412514289677,5.38356103199576e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MST1,Hepatocyte growth factor-like protein,37782,0.0210385187348259,0.00520871391796379,0.0108294394556169,0.0312475980140349,5.39571893039142e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,39956,0.0290250799327974,0.00718798224662224,0.0149366347294178,0.043113525136177,5.41679363676775e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ROBO2,Roundabout homolog 2,40466,0.00794555293202022,0.00196921098694892,0.00408589939760034,0.0118052064664401,5.48811636246584e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COL3A1,Collagen alpha-1(III) chain,37993,-0.00786951172664852,0.00195270276186589,-0.0116968091399057,-0.00404221431339138,5.60672416379858e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,37937,0.0162903183557198,0.00404279629649539,0.00836643761458885,0.0242141990968508,5.62100128496806e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GLRX,Glutaredoxin-1,40255,0.0192980710698699,0.00479331047630002,0.00990318253632184,0.0286929596034179,5.69881721152894e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HLA_A,,37955,0.0111095916901996,0.00276641304734902,0.00568742211739548,0.0165317612630036,5.95440269439172e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,37666,0.0123823452059038,0.0030847476366664,0.00633623983803762,0.0184284505737699,6.0013995654864e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCARA5,Scavenger receptor class A member 5,40466,0.00994030054563708,0.00247800911770748,0.00508340267493042,0.0147971984163437,6.06323489370882e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37985,0.0250546998592421,0.00624781234861096,0.0128089876559646,0.0373004120625196,6.10045595206739e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,40517,0.0187574341216646,0.00467887376822898,0.0095868415359358,0.0279280267073934,6.12613057026834e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,40417,0.0142510804287337,0.00355643796241302,0.00728046202240421,0.0212216988350633,6.17420197995005e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,38008,-0.0065766155878802,0.00165668888923377,-0.00982372581077839,-0.00332950536498201,7.2323824682026e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,37985,0.00842882579911952,0.00212338996592505,0.00426698146590643,0.0125906701323326,7.23914930100398e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,40336,0.0125730570814598,0.00316891577706789,0.00636198215840672,0.0187841320045129,7.2912485199859e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ERMAP,Erythroid membrane-associated protein,37593,0.0150333175662714,0.00378998395857786,0.0076049490074588,0.022461686125084,7.32946670207902e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CIT,Citron Rho-interacting kinase,37567,0.0151590210904841,0.00382744120179818,0.00765723633495966,0.0226608058460085,7.51521352950352e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,37937,0.0100803928515377,0.00254648172821809,0.00508928866423027,0.0150714970388452,7.57908356187917e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,37536,0.0207054696887513,0.00524442421953942,0.010426398218454,0.0309845411590485,7.91889260305724e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C7orf50,Uncharacterized protein C7orf50,37937,0.00730069232204734,0.00185442822238936,0.00366601300616419,0.0109353716379305,8.29568956528261e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BGLAP,Osteocalcin,37993,0.0302739667968721,0.00770366726907862,0.015174778949478,0.0453731546442663,8.54347030229843e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,37623,0.0124426740779869,0.00317356587810085,0.00622248495690922,0.0186628631990645,8.8730735802167e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AMN,Protein amnionless,40039,0.0158206681938506,0.00403551698365373,0.00791105490588924,0.0237302814818119,8.87960208045283e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,37709,-0.0145730401221781,0.0037368713614549,-0.0218973079906297,-0.00724877225372652,9.67481168728136e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,39975,0.0325731593865651,0.00837060171438393,0.0161667800263726,0.0489795387467576,0.000100093581157427
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WDR46,WD repeat-containing protein 46,37895,0.0116851447653869,0.00300737906608027,0.00579068179586956,0.0175796077349042,0.000102613009879765
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPME1,Protein phosphatase methylesterase 1,40300,0.0202018793619095,0.00520106075618715,0.0100078002797826,0.0303959584440363,0.000103091012895911
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BTC,Probetacellulin,39975,0.0247822367556232,0.00638587402148701,0.0122659236735087,0.0372985498377378,0.000104548048553224
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",37623,0.0186938686736442,0.00481904182935766,0.00924854668810321,0.0281391906591852,0.000105324680191728
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PCDH12,Protocadherin-12,37955,-0.00839963769098626,0.00216618226818781,-0.0126453549366344,-0.00415392044533816,0.000105981913439111
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",40223,0.0191683220867358,0.00495881420187987,0.00944904625105127,0.0288875979224203,0.000111303844717952
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANGPT1,Angiopoietin-1,40258,0.0277451463571164,0.00719465266072163,0.013643627142102,0.0418466655721308,0.00011554574496145
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CABP2,Calcium-binding protein 2,37567,0.0214250390729393,0.00555736039624858,0.0105326126962921,0.0323174654495865,0.000116161096415142
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,37709,0.0241672965835941,0.00628462416748412,0.0118494332153252,0.036485159951863,0.000120887231493829
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC4A1,Band 3 anion transport protein,37993,-0.0149684986832986,0.00390367109759169,-0.0226196940345783,-0.00731730333201889,0.000126406743589924
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,39975,0.0277617097437064,0.00725299822822002,0.0135458332163951,0.0419775862710176,0.00012989682019765
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,37937,0.0107087325111543,0.00279887269177927,0.00522294203526697,0.0161945229870417,0.000130783193104013
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BIN2,Bridging integrator 2,40327,0.0293442862676432,0.0076771162787262,0.0142971383613398,0.0443914341739465,0.000132714166761675
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,40039,0.0115480718020589,0.00302270876678827,0.00562356261915389,0.0174725809849639,0.000133731703226936
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCRIB,Protein scribble homolog,37623,0.0297756423786892,0.00784587920065528,0.0143977191454049,0.0451535656119736,0.000148264297154782
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OPLAH,5-oxoprolinase,37623,0.0217664141759531,0.00573981689641632,0.0105163730589772,0.0330164552929291,0.000149998015876412
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LTB,Lymphotoxin-beta,37895,0.0113541090005384,0.00299938254093408,0.00547531922030758,0.0172328987807692,0.000154077656695807
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,THBS2,Thrombospondin-2,40327,-0.011478092699757,0.0030330486248778,-0.0174228680045174,-0.00553331739499648,0.000154682367890735
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,37993,-0.0105459994121673,0.00278681905096181,-0.0160081647520524,-0.00508383407228213,0.000154841819451064
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL19,Interleukin-19,39919,0.021779511803392,0.00576538821176015,0.0104793509083421,0.0330796726984419,0.000158920281265378
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,39975,0.0146822899839748,0.0038877763834852,0.0070622482723438,0.0223023316956058,0.000159623903329749
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NEFL,Neurofilament light polypeptide,39898,0.0136467456106828,0.00361823950398098,0.0065549961828801,0.0207384950384855,0.000162774303699091
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DLK1,Protein delta homolog 1,40531,0.0168208607872093,0.00448607358338167,0.00802815656378126,0.0256135650106374,0.000177756710742462
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,JUN,Transcription factor AP-1,40039,0.0164875479041752,0.00440019790214406,0.00786316001597288,0.0251119357923776,0.000179606451414043
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTRC,Chymotrypsin-C,40355,0.0199420644189288,0.00532296734724518,0.00950904841832823,0.0303750804195293,0.000180010756912427
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MBL2,Mannose-binding protein C,37805,0.0337953345319737,0.00902419919941828,0.0161079041011138,0.0514827649628335,0.000181175090900845
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD226,CD226 antigen,37593,0.0132274380729045,0.00353704969500395,0.00629482067069675,0.0201600554751122,0.000185036388095695
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,40300,0.00983779813838084,0.00263082886196857,0.00468137356892245,0.0149942227078392,0.000185087841927038
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GBP4,Guanylate-binding protein 4,39956,0.0155991854259451,0.00417794433651865,0.0074104145263686,0.0237879563255217,0.00018936321545429
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PARD3,Partitioning defective 3 homolog,37709,0.0234585748930397,0.00629028356338775,0.0111296191087997,0.0357875306772797,0.000192785617232772
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,THY1,Thy-1 membrane glycoprotein,40466,0.00883250709449481,0.00236958676527115,0.00418811703456337,0.0134768971544263,0.0001940955785935
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPA1,Carboxypeptidase A1,40531,0.0180383241968621,0.00484186155114658,0.00854827555661476,0.0275283728371093,0.00019560026200992
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SOD3,Extracellular superoxide dismutase,37982,-0.0186505756278335,0.00500693165154817,-0.0284641616648679,-0.00883698959079911,0.000196147012764429
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL17D,Interleukin-17D,40039,0.0108188149000328,0.00290670103698571,0.00512168086754083,0.0165159489325248,0.000198326203013585
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39920,0.0150153967857031,0.00403654515185081,0.00710376828807552,0.0229270252833307,0.000200035362812494
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,40354,0.0111225492669055,0.00299086630901795,0.00526045130123027,0.0169846472325806,0.000200828490955966
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEL1L,Protein sel-1 homolog 1,37623,0.0101552679224944,0.00273871752988838,0.00478738156391319,0.0155231542810756,0.000209728788236311
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,40398,0.0129639898496367,0.00350652472201073,0.00609120139449566,0.0198367783047777,0.000218803135806457
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VCAM1,Vascular cell adhesion protein 1,40367,0.00847641756212854,0.00229335002770538,0.003981451507826,0.0129713836164311,0.000219683873792699
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ING1,Inhibitor of growth protein 1,39920,0.0139422238422237,0.00377622946613936,0.0065408140885906,0.0213436335958569,0.000223172960341507
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GC,Vitamin D-binding protein,38008,0.00811369629674993,0.00219872032091574,0.00380420446775508,0.0124231881257448,0.000224963868414876
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37985,0.0095056556651074,0.00257937872908689,0.00445007335609709,0.0145612379741177,0.000229369879187906
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TGFBR2,TGF-beta receptor type-2,40406,0.00986089496218427,0.00267739205995666,0.00461320652466921,0.0151085833996993,0.000231246027711012
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,37567,0.0134519751491585,0.00366175184801589,0.00627494152704735,0.0206290087712696,0.000240066839496453
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MTPN,Myotrophin,40037,0.0103135577524689,0.0028109924414783,0.00480401256717138,0.0158231029377663,0.000244303559653589
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,40531,0.00710483829934146,0.00193832337340446,0.00330572448746872,0.0109039521112142,0.000247693230875747
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,37985,-0.0119932879640993,0.00327674570297742,-0.018415709541935,-0.00557086638626353,0.000253054414604534
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADA,Adenosine deaminase,40511,0.0105421221662089,0.00288107146523687,0.00489522209434465,0.0161890222380732,0.000253915067059312
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PI16,Peptidase inhibitor 16,37982,-0.00762617548747565,0.00208542852852385,-0.0117136154033824,-0.00353873557156891,0.000256265403393488
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,37955,0.0122131302453225,0.00335517689394619,0.00563698353318795,0.018789276957457,0.000273565501077249
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,37895,0.0146655850780933,0.00403023094177887,0.00676633243220674,0.0225648377239799,0.000274836809044063
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AREG,Amphiregulin,40300,-0.0152949917789003,0.00420416995218838,-0.0235351648851895,-0.00705481867261106,0.000275579332011373
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PKD1,Polycystin-1,37985,-0.00793404858538028,0.00218598984493845,-0.0122185886814596,-0.00364950848930092,0.000285018137468674
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,39975,0.00929679672303781,0.00256256999574357,0.00427415953138041,0.0143194339146952,0.000286631122667355
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTSH,Pro-cathepsin H,40008,0.0222454707908934,0.00613928250120587,0.0102124770885299,0.0342784644932569,0.000291609464278597
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,37623,0.0136140921674196,0.00375920617535539,0.00624604806372298,0.0209821362711161,0.000293961540886658
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,37993,0.0109288490137877,0.00301927799247556,0.00501106414853559,0.0168466338790398,0.000296032170107035
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRDX6,Peroxiredoxin-6,40484,-0.0183115217036152,0.00506413428672688,-0.0282372249055999,-0.0083858185016305,0.000300196803278632
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CBS,Cystathionine beta-synthase,37623,0.0154828259020527,0.00428173388768461,0.0070906274821909,0.0238750243219146,0.000300287107145026
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINF1,Pigment epithelium-derived factor,37785,0.00792170620928273,0.00219190068299667,0.00362558087060925,0.0122178315479562,0.000302524781387879
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCN4,CCN family member 4,40484,0.0125189121349749,0.00346520518931421,0.00572710996391904,0.0193107143060308,0.000303895646536275
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MFAP5,Microfibrillar-associated protein 5,40531,0.0125157772732418,0.00347205797063307,0.00571054365080098,0.0193210108956826,0.000313441036800466
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLIN3,Perilipin-3,40354,0.0129538747658128,0.00359543654518446,0.00590681913725126,0.0200009303943743,0.000315688359378495
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,37593,0.00980896833339313,0.00272613906630001,0.00446573576344511,0.0151522009033411,0.000321706645379188
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD36,Platelet glycoprotein 4,37593,0.0134279815082121,0.00374493071089535,0.00608791731485719,0.020768045701567,0.000337469212570737
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,37557,0.0116844272370075,0.00325900484976388,0.00529677773147035,0.0180720767425447,0.000337947817589403
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,40531,-0.0100176098664331,0.00279920325968313,-0.015504048255412,-0.00453117147745418,0.000346275596194845
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,40037,0.0178180396982639,0.00498236698405135,0.00805260040952326,0.0275834789870046,0.000349653867336662
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",40187,0.0223925395234565,0.00626621001091886,0.0101107679020555,0.0346743111448575,0.000353243205578625
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,40336,0.0121025247602441,0.0033993621793378,0.005439774888742,0.0187652746317462,0.000371606785601157
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LEPR,Leptin receptor,40354,-0.00924417591202431,0.00259798218102211,-0.0143362209868276,-0.00415213083722099,0.000374472518120137
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,S100G,Protein S100-G,37955,0.0133798503226669,0.00376251696569804,0.00600531706989875,0.0207543835754351,0.000377702620240594
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSNK1D,Casein kinase I isoform delta,37593,0.0191413548922966,0.00538338373483436,0.00858992277202127,0.0296927870125719,0.000378390468945506
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MATN2,Matrilin-2,40374,0.00893897129615694,0.00251729730912927,0.00400506857026356,0.0138728740220503,0.000384849731883885
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDZD2,PDZ domain-containing protein 2,37557,0.0184399585966945,0.00520341264910067,0.00824126980445723,0.0286386473889318,0.000395746754780192
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DSC2,Desmocollin-2,40172,0.0101031885061729,0.00285816617819543,0.0045011827969099,0.015705194215436,0.000409179240198922
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHCHD6,MICOS complex subunit MIC25,37895,0.00865539105429274,0.00245241880380157,0.00384865019884166,0.0134621319097438,0.000418007978148061
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CGA,Glycoprotein hormones alpha chain,40327,0.026758176825867,0.00758951236341599,0.0118827325935717,0.0416336210581623,0.000423590511978583
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,40300,0.0102779355106473,0.0029295441894407,0.0045360288993435,0.016019842121951,0.000452104902541194
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MMP3,Stromelysin-1,40327,-0.0143588147329631,0.00409386333004509,-0.0223827868598514,-0.00633484260607468,0.000453759662089075
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UNC79,Protein unc-79 homolog,37477,0.0167921423886263,0.00479527677933776,0.00739339990112428,0.0261908848761283,0.00046365881829578
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RBP2,Retinol-binding protein 2,40300,0.0225799226959716,0.00646160536915785,0.00991517617242225,0.035244669219521,0.000476290941075909
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LY96,Lymphocyte antigen 96,40223,0.010268234762541,0.00293868912360881,0.00450840408026777,0.0160280654448143,0.000476869631078425
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRLF1,Cytokine receptor-like factor 1,40417,0.00779129385773873,0.00222985910164701,0.00342077001851058,0.0121618176969669,0.000476997118369076
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,39956,0.0144027859057561,0.00412209540773436,0.00632347890659673,0.0224820929049154,0.000477088584774618
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD276,CD276 antigen,40352,-0.0106666940179549,0.00305319069213161,-0.0166509477745328,-0.00468244026137692,0.000477811028718943
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CASP9,Caspase-9,37593,0.0184217905381141,0.00527593409910476,0.00808095970386881,0.0287626213723595,0.000481597509772411
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",37895,0.0108851625179804,0.00312543362510302,0.00475931261277844,0.0170110124231823,0.000497834736634331
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL21,C-C motif chemokine 21,40417,0.0125545850586436,0.00360579702358746,0.00548722289241222,0.0196219472248751,0.000499428209823553
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACY1,Aminoacylase-1,40354,0.0175075143703793,0.00503483141913996,0.00763924478886499,0.0273757839518936,0.000507883429455985
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGF2,Fibroblast growth factor 2,40336,0.0194660306040921,0.00560334781529799,0.00848346888610803,0.0304485923220762,0.000514127614278908
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATG4A,Cysteine protease ATG4A,39975,0.0175019508405324,0.0050436201805428,0.00761645528666856,0.0273874463943963,0.000521645154948791
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,39975,0.0118469520985793,0.00342091449576605,0.00514195968687786,0.0185519445102808,0.000535439141024757
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HRG,Histidine-rich glycoprotein,37929,0.00922246525630779,0.00266716714625939,0.00399481764963939,0.0144501128629762,0.000546336616793143
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,37623,0.0154612900340546,0.00447826434353645,0.00668389192072315,0.024238688147386,0.000557124274919242
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCRL3,Fc receptor-like protein 3,40039,0.0160213602727413,0.00464363526310862,0.00691983515704841,0.0251228853884342,0.000561703707624622
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,37557,0.00816019112522031,0.00237169965472414,0.00351165980196099,0.0128087224484796,0.000582125063839623
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,37477,-0.014743717002514,0.00428722031695579,-0.0231466688237474,-0.0063407651812807,0.000585712035067381
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C19orf12,Protein C19orf12,39956,0.0180868322028703,0.00526065836735853,0.00777594180284754,0.028397722602893,0.000587283237935443
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CA2,Carbonic anhydrase 2,40286,0.0205481133664655,0.00598055743486383,0.00882622079413239,0.0322700059387986,0.0005922811623468
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TRAF2,TNF receptor-associated factor 2,40336,0.0206725976047296,0.00602217544672794,0.00886913372914283,0.0324760614803163,0.000599025162412609
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIF1C,Kinesin-like protein KIF1C,37557,0.0109420723001172,0.00318819390591658,0.00469321224452071,0.0171909323557137,0.000600865165544095
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CST7,Cystatin-F,40371,0.0267604827822696,0.00780341916458136,0.0114657812196902,0.0420551843448491,0.000606611535167166
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,37557,0.0103905740475562,0.00303011769607567,0.00445154336324787,0.0163296047318645,0.000607452344178563
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AGR3,Anterior gradient protein 3,39958,0.0172441498367879,0.00504030274597654,0.00736515645467387,0.0271231432189019,0.000624941270284022
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,40300,0.0107605850062849,0.00315882200432213,0.00456929387781355,0.0169518761347563,0.00065960522106764
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",40301,-0.0199485846516365,0.00586952459359471,-0.0314528528550821,-0.00844431644819084,0.000678807485810075
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,40466,0.0138801880031005,0.004088728379398,0.00586628037948041,0.0218940956267206,0.000688593312750023
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37985,-0.00759463967325353,0.00223820333881554,-0.011981518217332,-0.00320776112917506,0.000692827875052008
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UNG,Uracil-DNA glycosylase,37895,0.00973703258576979,0.00287003260584982,0.00411176867830415,0.0153622964932354,0.000694181814089203
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,40484,0.00724611363353359,0.00214407542419435,0.00304372580211266,0.0114485014649545,0.000727648549172886
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEPTIN7,Septin-7,37709,0.015036964085246,0.00445640880107422,0.00630240283514057,0.0237715253353515,0.0007423365825316
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANXA1,Annexin A1,37603,0.0118563888588527,0.00351426549201299,0.00496842849450723,0.0187443492231982,0.00074355355038011
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,37993,0.00602590046753471,0.00178982738550122,0.00251783879195232,0.0095339621431171,0.000762713756706402
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FAM3D,Protein FAM3D,37896,-0.0234224521659324,0.00695715099729974,-0.0370584681206399,-0.00978643621122492,0.000762940575638419
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,37623,0.0164786569160628,0.00489486978773256,0.006884712132107,0.0260726017000186,0.000763419086608001
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC16A1,Monocarboxylate transporter 1,39956,0.0171158673899445,0.00509149087509067,0.0071365452747668,0.0270951895051222,0.000776623190328383
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GFRA2,GDNF family receptor alpha-2,40300,0.00606056256404235,0.00180373129492865,0.0025252492259822,0.0095958759021025,0.000781223946343122
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCN3,CCN family member 3,40517,0.00959972291229035,0.00285943378322779,0.00399523269716388,0.0152042131274168,0.000789156610699903
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BSG,Basigin,40497,0.00572661835070294,0.00171138003941097,0.00237231347345743,0.00908092322794845,0.000821155811865486
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NBN,Nibrin,40039,0.014398530566284,0.00431733406203829,0.0059365558046889,0.022860505327879,0.000854826805784826
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TCTN3,Tectonic-3,37985,0.00821275411979373,0.00246325230867156,0.00338477959479748,0.01304072864479,0.000858025959343674
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINA1,Alpha-1-antitrypsin,37774,0.002283845514661,0.000686955611734629,0.000937412515661129,0.00363027851366087,0.000887877547608275
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,40466,0.00646579143938025,0.00194878187666406,0.0026461789611187,0.0102854039176418,0.000909110557735262
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,37477,-0.00848412477932047,0.00256444326093718,-0.0135104335707573,-0.00345781598788361,0.000940954544399231
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RALB,Ras-related protein Ral-B,37593,0.008285825894428,0.00250622924787952,0.00337361656858413,0.0131980352202719,0.00094860393201217
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FRMD4B,FERM domain-containing protein 4B,37557,0.0197228744590165,0.00596564616252328,0.00803020798047086,0.0314155409375621,0.000948669872195115
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPM1A,Protein phosphatase 1A,39975,0.00870164555798361,0.00263284411491182,0.00354127109275644,0.0138620200232108,0.000951792616556384
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,40131,-0.00828616652668684,0.00250793379095328,-0.0132017167569553,-0.00337061629641841,0.00095535759979525
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,L1CAM,Neural cell adhesion molecule L1,40406,-0.00793124176547134,0.00240111751653613,-0.0126374320978822,-0.00322505143306053,0.000958169292386956
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,39818,-0.0242628297166386,0.00734966035729398,-0.0386681640169348,-0.00985749541634241,0.000964855408655118
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHP1,Calcineurin B homologous protein 1,37536,0.0204455064146854,0.00619400540809349,0.00830525581482219,0.0325857570145487,0.000966490446445394
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,40223,0.00820643288673678,0.0024928486578933,0.00332044951726592,0.0130924162562076,0.00099699792160805
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,37557,0.013616386568558,0.00414496800192124,0.00549224928479239,0.0217405238523237,0.00102235456337736
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FIS1,Mitochondrial fission 1 protein,40349,0.0213843671998171,0.00654650125491781,0.00855322474017817,0.034215509659456,0.00109103504493135
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADD1,Alpha-adducin,37666,0.019410763461836,0.00594359540732634,0.00776131646347642,0.0310602104601957,0.00109422327617438
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARTN,Artemin,40039,0.0123446780512417,0.0037805156989929,0.00493486728121563,0.0197544888212678,0.00109567776765125
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GIMAP8,GTPase IMAP family member 8,37477,0.0143322746894827,0.00439155508813371,0.00572482671674065,0.0229397226622248,0.0011029031181217
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,37937,0.0127126164076925,0.00389674948417326,0.00507498741871288,0.0203502453966721,0.00110761746424165
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,40037,-0.00968281239452945,0.00296971438945541,-0.0155034525978621,-0.00386217219119684,0.00111446930486946
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSDE1,Cold shock domain-containing protein E1,37557,0.0323351188465447,0.00991961569272334,0.012892672088807,0.0517775656042825,0.00111808725062883
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPB1,Carboxypeptidase B,40531,0.0155413489429903,0.00476819031447615,0.00619569592661703,0.0248870019593635,0.00111887606256465
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATXN2,Ataxin-2,37536,0.0317604551224641,0.0097559953956252,0.0126387041470387,0.0508822060978895,0.00113488385446536
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C1QA,Complement C1q subcomponent subunit A,40437,-0.00626049680778642,0.00192547601964844,-0.0100344298062974,-0.00248656380927548,0.00115075158352162
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZNF830,Zinc finger protein 830,37895,-0.0222350298242576,0.00684283913458227,-0.0356469945280389,-0.0088230651204764,0.00115938394620728
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,39975,0.0145180218219978,0.0044682961299243,0.00576016140734619,0.0232758822366495,0.00116009672406491
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,40406,-0.00670925666073796,0.00206526854496412,-0.0107571830088676,-0.00266133031260829,0.00116209346813131
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FOXO3,Forkhead box protein O3,39975,0.0266907990689822,0.00821701438985744,0.0105854508648616,0.0427961472731027,0.00116369838887601
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAB39B,Ras-related protein Rab-39B,37557,0.0245587072344491,0.00756086488473276,0.00973941206037293,0.0393780024085253,0.00116456704445382
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHI3L1,Chitinase-3-like protein 1,40049,-0.0204512600073412,0.00630476811358916,-0.032808605509976,-0.00809391450470644,0.00118204398941936
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HJV,Hemojuvelin,37955,0.0126227292740601,0.00389307284819525,0.0049923064915974,0.0202531520565228,0.00118833428931604
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYO6,Unconventional myosin-VI,37955,0.0102689107583234,0.0031698455038794,0.00405601357071973,0.016481807945927,0.00120003098859015
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTBS,Di-N-acetylchitobiase,37814,0.00740470264538124,0.00229284078058993,0.00291073471542497,0.0118986705753375,0.00124311647378797
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STAM,Signal transducing adapter molecule 1,37895,0.0102419895490061,0.00317512602143372,0.00401874254699601,0.0164652365510162,0.0012596758675954
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRTN3,Myeloblastin,39892,0.0128419565969588,0.00398146151500375,0.0050382920275514,0.0206456211663661,0.00126041992670462
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",37567,0.0106408197860281,0.00330095300906769,0.00417095188825548,0.0171106876838008,0.00126917468706906
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,39975,0.0140931811143983,0.00437371310452693,0.00552070342952551,0.0226656587992711,0.00127452123444635
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,40039,-0.0119251077927219,0.00370453420468552,-0.0191859948339056,-0.00466422075153832,0.00128876074054607
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,39920,0.0119075595637929,0.00370796728112682,0.00463994369278429,0.0191751754348014,0.00132385677744273
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TOP1,DNA topoisomerase 1,37896,-0.0289478448443116,0.00903320240977037,-0.0466529215674615,-0.0112427681211617,0.00135563730399981
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COL1A1,Collagen alpha-1(I) chain,40531,-0.00704441166958537,0.00220080349958594,-0.0113579865287738,-0.00273083681039692,0.00137295659174743
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,37993,-0.0069952915582738,0.00218779343285764,-0.0112833666866748,-0.00270721642987282,0.00138982254199106
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,37896,-0.0139767421470462,0.00437336430589181,-0.0225485361865941,-0.00540494810749825,0.00139727862421167
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PQBP1,Polyglutamine-binding protein 1,39975,0.0149005017897483,0.00467619224659246,0.00573516498642707,0.0240658385930695,0.00144310305115577
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",37672,-0.0177858292967327,0.00559284395401474,-0.0287478034466016,-0.00682385514686378,0.00147561625293218
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IKBKG,NF-kappa-B essential modulator,40336,0.0247016485003223,0.00777568316042887,0.00946130950588167,0.0399419874947628,0.00149203964575987
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,40147,0.0312272252519649,0.00983222454727292,0.01195606513931,0.0504983853646198,0.00149605617360759
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCARF2,Scavenger receptor class F member 2,40466,-0.00797928774971089,0.0025150224361104,-0.0129087317244873,-0.00304984377493451,0.00151339411737839
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,37567,0.0279691166926849,0.00882552899131494,0.0106710798697076,0.0452671535156622,0.00153255064559632
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDH15,Cadherin-15,40430,-0.0118398598368479,0.0037455562456784,-0.0191811500783776,-0.00449856959531824,0.00157499520353387
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,40037,0.0130886269949398,0.00414275017493171,0.00496883665207366,0.021208417337806,0.00158393557765341
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCS,Copper chaperone for superoxide dismutase,40223,0.0128730069977308,0.00408619633519951,0.00486406218073978,0.0208819518147219,0.00163371705238712
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINA9,Serpin A9,40223,0.0192818929443943,0.0061268602480263,0.00727324685826279,0.0312905390305259,0.00165200806581566
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,37593,0.0232716099638494,0.0073973978775317,0.00877271012388724,0.0377705098038115,0.0016593561207681
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRYM,Ketimine reductase mu-crystallin,37536,0.0205144968001445,0.00652445082641215,0.00772657318037674,0.0333024204199124,0.00166886208275141
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPON1,Spondin-1,40374,0.00875922369700484,0.0027918346650832,0.00328722775344177,0.0142312196405679,0.00170738789879288
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",40354,0.0205232127046303,0.0065501115413451,0.0076849940835939,0.0333614313256667,0.00173189336506658
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGB5,Integrin beta-5,40406,-0.00983767467321606,0.00314370576777107,-0.0159993379780474,-0.00367601136838475,0.0017552461429709
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IDS,Iduronate 2-sulfatase,40511,0.00229121530689405,0.000733117289994382,0.000854305418505065,0.00372812519528304,0.00177937161083411
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ERC2,ERC protein 2,37567,0.0204230499891102,0.00654230056589915,0.00760014087994781,0.0332459590982725,0.00180205437654019
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TADA3,Transcriptional adapter 3,37895,0.0102545192129153,0.003289819457245,0.00380647307671513,0.0167025653491155,0.00183058086121854
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLGN,Calmegin,37567,0.0117678872193456,0.00377591602809224,0.0043670918042848,0.0191686826344064,0.0018336662163807
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COL5A1,Collagen alpha-1(V) chain,37666,-0.0105010376708041,0.00337047887618288,-0.0171071762681226,-0.00389489907348568,0.00183969034545376
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,40306,0.010707717061087,0.0034406386821125,0.00396406524414647,0.0174513688780275,0.00186072390836138
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NRN1,Neuritin,37955,-0.00962546116671709,0.00310078912138907,-0.0157030078446397,-0.0035479144887945,0.00191190509166388
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,37895,0.0114238728851423,0.00368026419224307,0.00421055506834593,0.0186371907019387,0.0019126128156696
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VGF,Neurosecretory protein VGF,37955,0.00799874302128547,0.00257778452032307,0.00294628536145226,0.0130512006811187,0.00191995892524476
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,37593,0.00537200762506869,0.0017315105313114,0.00197824698369836,0.00876576826643903,0.00192301805802467
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",37955,0.0111744786615301,0.00360766666547976,0.0041034519971898,0.0182455053258705,0.00195609817199219
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC39A5,Zinc transporter ZIP5,40336,-0.0140076526524628,0.00452777973345573,-0.0228821009300361,-0.00513320437488959,0.00198011445875103
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCG3,Secretogranin-3,40374,0.00875935210581658,0.00283151279323723,0.00320958703107161,0.0143091171805615,0.00198137117897314
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHIT1,Chitotriosidase-1,40393,0.0390401260223645,0.0126401618780502,0.0142654087413861,0.0638148433033429,0.00201462589908007
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FOLR1,Folate receptor alpha,40294,0.00742911028943814,0.00240679944503388,0.00271178337717172,0.0121464372017046,0.00202729016673251
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,37593,0.0100571378332674,0.00325832792211752,0.00367081510591705,0.0164434605606177,0.00202884637960703
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMS,Spermine synthase,37536,0.0166870826463203,0.00541092848738416,0.00608166281104733,0.0272925024815933,0.00204691101286772
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,37557,-0.014642870496404,0.00475943041923068,-0.0239713541180961,-0.00531438687471187,0.00209806681428711
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",39956,0.00788415819774086,0.00256793099023369,0.00285101345688284,0.0129173029385989,0.00214258425143461
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,37896,0.0109000220096083,0.00355941051644324,0.00392357739737957,0.0178764666218371,0.00220069016892976
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,40531,0.00818248347384802,0.00267571312726296,0.00293808574441263,0.0134268812032834,0.00223143216043166
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ICAM5,Intercellular adhesion molecule 5,40354,0.0114265561852159,0.00373920902732698,0.004097706491655,0.0187554058787767,0.00224776515598323
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",40406,-0.00899287223326012,0.00294674977787479,-0.0147685017978947,-0.00321724266862552,0.00227852346117861
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,POMC,Pro-opiomelanocortin,37623,0.0175530777353221,0.00575197296600946,0.00627921072194352,0.0288269447487006,0.00228031246321769
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPP1,Osteopontin,40492,0.0122945593958551,0.00403444485279501,0.00438704748437683,0.0202020713073333,0.00231207217579573
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CAPS,Calcyphosin,37937,0.0243702597280981,0.00802744645907196,0.0086364646683171,0.0401040547878792,0.00240302760222184
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,37896,0.00667128171147107,0.00220102156280667,0.00235727944837001,0.0109852839745721,0.00244214373522368
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD55,Complement decay-accelerating factor,39797,0.0067605385937217,0.00223075002040783,0.00238826855372234,0.0111328086337211,0.00244464959480328
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FZD8,Frizzled-8,37536,0.0115234115999712,0.00380880495346493,0.00405815389117994,0.0189886693087625,0.00248732033054519
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",40275,0.0194062795524357,0.00641997713035343,0.00682312437694295,0.0319894347279284,0.00250852064928509
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,40403,-0.0061958530363835,0.00205121589537955,-0.0102162361913274,-0.00217546988143958,0.00252694046686045
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,40223,-0.00578796329195325,0.00191880946484732,-0.009548829843054,-0.0020270967408525,0.00256173917372443
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,37785,0.014281016793443,0.00473671911798065,0.00499704732220091,0.0235649862646851,0.00257497075842479
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLK4,Kallikrein-4,40484,0.0155312924853036,0.00515461399258869,0.00542824905982972,0.0256343359107774,0.00259009796996876
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FBLN2,Fibulin-2,37993,0.00784372945090365,0.00260698364552707,0.00273404150567058,0.0129534173961367,0.00262818036231522
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SUSD4,Sushi domain-containing protein 4,37895,0.0113487153949583,0.00377742209680374,0.00394496808522301,0.0187524627046937,0.00266635268427056
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,40300,0.0139917664076787,0.00466362676399311,0.00485105795025222,0.0231324748651052,0.00270230718437064
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CFC1,Cryptic protein,39975,0.0117367711394822,0.00391471946566817,0.00406392098677262,0.0194096212921918,0.00272087075862914
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLIC5,Chloride intracellular channel protein 5,37567,0.00822952730607803,0.00274523728201926,0.00284886223332027,0.0136101923788358,0.00272492704023453
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,40465,0.00746309277035832,0.00249192837410182,0.00257891315711876,0.0123472723835979,0.00274948582297835
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",39956,0.0123785418938493,0.00413619788032546,0.0042715940484114,0.0204854897392872,0.00276925640149402
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",39956,0.0125518633137083,0.00419763374239254,0.0043245011786189,0.0207792254487977,0.00279211018285817
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MSMB,Beta-microseminoprotein,40231,0.0175283717435922,0.00586717065459339,0.00602871726058916,0.0290280262265953,0.0028167045498099
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,37993,0.0347171935880491,0.0116453049863559,0.0118923958147914,0.0575419913613067,0.00287614765515876
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,39975,-0.0129683419927352,0.00436456600924775,-0.0215228913708608,-0.00441379261460966,0.00297016912331566
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,37567,0.0181198776691303,0.00610424813234997,0.0061555513297244,0.0300842040085363,0.00299891098121126
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,40300,0.0104399208884114,0.00352021371850655,0.00354030200013859,0.0173395397766843,0.00302438600254158
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,40319,0.00610750693707,0.00206322263839026,0.00206359056582509,0.0101514233083149,0.00307915639724127
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEMIP2,Cell surface hyaluronidase,37593,0.00844044541877572,0.002853746591702,0.00284710209903979,0.0140337887385116,0.0031052385777161
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRUNE2,Protein prune homolog 2,37709,0.00740449556154622,0.00250752331923033,0.00248974985585478,0.0123192412672377,0.00315343921643723
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRSS27,Serine protease 27,40309,0.0100860940922671,0.00342715535474747,0.00336886959696206,0.0168033185875721,0.00325526659572907
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,37593,0.0110090551202738,0.00374839309436048,0.00366220465532728,0.0183559055852204,0.00331972110382646
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNN,Tenascin-N,37993,0.0108580626866884,0.00369890336785138,0.00360821208569967,0.0181079132876771,0.00333590106334545
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GUCA2A,Guanylin,40271,-0.00829125916385906,0.00283711426643295,-0.0138520031260676,-0.00273051520165049,0.00347806695472799
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",37477,0.0143892267084986,0.00492496368322366,0.00473629788938026,0.024042155527617,0.00348733655203414
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDH6,Cadherin-6,40354,-0.0093895140164237,0.00321458756604749,-0.0156901056458768,-0.00308892238697062,0.0034950355378309
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,37557,0.0137579468080168,0.00471337253863284,0.00451973663229643,0.0229961569837372,0.00351846438687652
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPRR3,Small proline-rich protein 3,37937,0.0175039994101191,0.00601726690959061,0.00571015626732147,0.0292978425529167,0.0036322333366061
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,40531,0.00725794260175078,0.00249922959333186,0.00235945259882033,0.0121564326046812,0.00368844802351714
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GSTP1,Glutathione S-transferase P,39866,0.017193238911702,0.00592352799481153,0.00558312404187143,0.0288033537815326,0.00370681997956936
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,37709,0.0168667354902689,0.00581996588757855,0.00545960235061493,0.0282738686299228,0.00376068195213215
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LIFR,Leukemia inhibitory factor receptor,40336,-0.00600322472048385,0.00207410603651661,-0.0100684725520564,-0.00193797688891129,0.00380440549336122
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,37937,0.00877728670999539,0.00303520292157138,0.00282828898371549,0.0147262844362753,0.00383618928109405
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RPL14,60S ribosomal protein L14,37623,0.0100768087893335,0.00348792635376375,0.00324047313595659,0.0169131444427105,0.00387032376174738
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AFM,Afamin,38008,0.0045504298529828,0.00157625750722316,0.0014609651388254,0.00763989456714019,0.00389725943414526
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VCAN,Versican core protein,40466,0.00733600854923512,0.00254377066832898,0.00235021803931032,0.0123217990591599,0.00393292909745674
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,40037,0.00807548563265405,0.00280449697629125,0.0025786715591232,0.0135722997061849,0.00398877188708614
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CALB1,Calbindin,40300,0.0103602377613117,0.00360245214753606,0.00329943155214099,0.0174210439704823,0.00403433585662677
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NFIC,Nuclear factor 1 C-type,37955,0.0105886355072702,0.00369029225935545,0.00335566267893351,0.0178216083356069,0.00411991447504231
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,POF1B,Protein POF1B,37593,-0.0112666276455398,0.00392687604001509,-0.0189633046839693,-0.0035699506071102,0.00412288551217359
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BMP4,Bone morphogenetic protein 4,40198,-0.0110328554875212,0.00384652725748355,-0.018572048912189,-0.00349366206285349,0.00413279411041617
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MB,Myoglobin,40531,0.0119322523319693,0.00416262651753028,0.00377350435760994,0.0200910003063286,0.00415550670330749
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,39929,0.0129826669514214,0.00454483032067506,0.00407479952289833,0.0218905343799446,0.00428803752682581
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DHPS,Deoxyhypusine synthase,37895,0.00991627853629107,0.00348383374782429,0.00308796439055547,0.0167445926820267,0.00442877724186276
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CAT,Catalase,37781,0.013061310633024,0.0046127580243395,0.00402030490531854,0.0221023163607294,0.00463906389254818
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCRL6,Fc receptor-like protein 6,40336,0.0161675630024631,0.00572034370457601,0.00495568934149416,0.0273794366634321,0.00471439363980381
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",37593,0.0106736365386268,0.00377887810279167,0.00326703545715515,0.0180802376200985,0.00474181159271909
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FOLR3,Folate receptor gamma,40350,0.0441717474308859,0.015647507872686,0.0135026320004215,0.0748408628613504,0.00476467557456963
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IDUA,Alpha-L-iduronidase,40484,0.0107747419105789,0.00382694636937583,0.00327392702660228,0.0182755567945555,0.00487618334257823
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DGKZ,Diacylglycerol kinase zeta,40039,0.0083521318202185,0.00297306521846734,0.00252492399202251,0.0141793396484145,0.00497163789172853
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EFHD1,EF-hand domain-containing protein D1,37955,0.00823328631392397,0.00293632410685923,0.00247809106447988,0.0139884815633681,0.00505538376300787
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RBP7,Retinoid-binding protein 7,37896,0.013792491874414,0.00494154737377653,0.004107059021812,0.023477924727016,0.0052598741867064
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DPP7,Dipeptidyl peptidase 2,40246,0.0136779331348446,0.00491067051286445,0.00405301892963025,0.0233028473400589,0.00535337726929167
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,S100A13,Protein S100-A13,37593,0.00818921326502989,0.00294554782005686,0.00241593953771844,0.0139624869923413,0.00544026317642109
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NPHS1,Nephrin,37593,0.00815242862666428,0.00293324197206822,0.00240327436141056,0.013901582891918,0.00545496234031498
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ASS1,Argininosuccinate synthase,37557,0.0188590582272867,0.00680359023089623,0.00552402137473012,0.0321940950798433,0.00558040942958342
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",40037,0.0205906031317847,0.00744591228505763,0.00599661505307173,0.0351845912104976,0.00569274769933626
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,37937,0.0178061551105456,0.00644347618930002,0.00517694177951759,0.0304353684415737,0.00572733054527665
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,40037,-0.00711020660694527,0.00257333063870359,-0.0121539346588043,-0.00206647855508625,0.00573335161188395
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,37982,0.00599345436671067,0.00217068067489705,0.00173892024391246,0.0102479884895089,0.00576856449858129
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NTF4,Neurotrophin-4,39975,0.0095593818810275,0.003464732345169,0.00276850648449626,0.0163502572775587,0.0058036949633165
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OTOA,Otoancorin,37536,0.0128068241664806,0.00465036762439487,0.00369210362266668,0.0219215447102946,0.00589642119101087
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GFRAL,GDNF family receptor alpha-like,37472,-0.0144450470599966,0.00525060085921698,-0.0247362247440619,-0.00415386937593135,0.00594734927012353
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NOP56,Nucleolar protein 56,37557,0.0258121142330007,0.00939600079331861,0.00739595267809621,0.0442282757879052,0.00601998969801119
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,39956,0.0169518732105892,0.00619752038202492,0.00480473326182033,0.029099013159358,0.00624005491626937
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DSG3,Desmoglein-3,40414,-0.00775610367814502,0.0028366241925184,-0.0133158870954811,-0.00219632026080896,0.00625872155140061
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TSPAN1,Tetraspanin-1,40037,0.007079825980479,0.00258996399771321,0.00200349654496111,0.0121561554159969,0.00627241131264081
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LIF,Leukemia inhibitory factor,39956,0.0121970384227362,0.00446300041372277,0.00344955761183961,0.0209445192336329,0.00628460702333191
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NTF3,Neurotrophin-3,40336,0.00807869970806829,0.00296026739548657,0.00227657561291462,0.013880823803222,0.00635881547188247
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CA7,Carbonic anhydrase 7,37709,-0.00811767468994507,0.00298421691456436,-0.0139667398424912,-0.00226860953739893,0.00653269667877753
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GLB1,Beta-galactosidase,40223,0.00937628656205258,0.00345168577915746,0.00261098243490396,0.0161415906892012,0.00660607184915073
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,37973,0.00558246503836343,0.00205555038705407,0.00155358627973746,0.0096113437969894,0.00661997276409407
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TFRC,Transferrin receptor protein 1,40386,0.00910427938173548,0.00335557673053243,0.00252734898989191,0.0156812097735791,0.0066712755557357
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,40485,-0.0103925667937496,0.00383789599863912,-0.0179148429510822,-0.0028702906364169,0.00677860364233157
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,37896,0.00995689584065745,0.00367900194791238,0.00274605202274918,0.0171677396585657,0.00681004031701033
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TLR3,Toll-like receptor 3,40511,0.0139469247138018,0.00516075575571689,0.00383184343259672,0.0240620059950069,0.006889323161799
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,40336,0.0107953754150734,0.00399475490281387,0.00296565580555817,0.0186250950245885,0.00689166399106893
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCT,Secretin,37567,-0.0105466982317263,0.00390590835619125,-0.0182022786098611,-0.00289111785359142,0.00693886201440155
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RFC4,Replication factor C subunit 4,37895,0.00467711501137707,0.00173602824866897,0.00127449964398589,0.00807973037876826,0.00706567030607212
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,40327,-0.00982561726248666,0.00365056911870528,-0.016980732735149,-0.00267050178982431,0.00711995756015051
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPAG1,Sperm-associated antigen 1,37955,0.0130612753983915,0.00486746773133084,0.00352103864498301,0.0226015121517999,0.00729705058363161
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PFDN2,Prefoldin subunit 2,39956,0.0127723345411375,0.00476024893395441,0.00344224663058686,0.0221024224516882,0.00730154945444932
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANXA5,Annexin A5,39891,0.00694527265762488,0.00259421105855638,0.00186061898285437,0.0120299263323954,0.0074314439119979
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RCOR1,REST corepressor 1,40037,0.0101270252798022,0.00380024676174849,0.00267854162677518,0.0175755089328293,0.00771057591716607
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PREB,Prolactin regulatory element-binding protein,40039,0.00670361676115614,0.00251581318610342,0.00177262291639343,0.0116346106059189,0.00771610367572127
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,37955,0.0106479319643307,0.00399970555017596,0.00280850908598583,0.0184873548426756,0.0077728556361719
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,40300,0.0044839496382148,0.00168910524892758,0.00117330335031674,0.00779459592611285,0.0079474738195858
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DRAXIN,Draxin,40223,0.00971727985420693,0.00366830044048884,0.00252741099084882,0.0169071487175651,0.00808138964600606
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENO3,Beta-enolase,37623,0.01266647185022,0.00478472157790396,0.00328841755752823,0.0220445261429118,0.00812400224320229
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,37557,0.0102448187577326,0.00387140589755849,0.002656863198518,0.0178327743169473,0.0081479977146792
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NPTX1,Neuronal pentraxin-1,40327,0.00880140423293578,0.00334288239598448,0.0022493547368062,0.0153534537290654,0.00847465473412284
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,37709,0.0103328911941623,0.00393711737615403,0.00261614113690041,0.0180496412514242,0.00868805483543157
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,37593,0.00868237496818531,0.00331007734731064,0.00219462336745645,0.0151701265689142,0.00872566389012679
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",37557,0.0197201664926414,0.00753084743964731,0.00495970551093269,0.0344806274743502,0.00883968107455381
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,37536,0.0126677255907419,0.00484891065929374,0.00316386069852613,0.0221715904829576,0.00899883333274233
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,37559,0.00628637839343008,0.00241201542213513,0.00155882816604522,0.0110139286208149,0.00916361742584881
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",37709,0.0158458444774616,0.00608848956056311,0.00391240493875786,0.0277792840161653,0.00926253903779821
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PCDH7,Protocadherin-7,37896,0.00766787428787658,0.00294741663555541,0.00189093768218798,0.0134448108935652,0.00929031676598837
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,37536,0.0238708620960367,0.00917846280216009,0.00588107500380289,0.0418606491882704,0.00931255848067149
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APOBR,Apolipoprotein B receptor,37623,-0.00928306923753287,0.00357711387313255,-0.0162942124288727,-0.00227192604619307,0.00946604752419315
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STX1B,Syntaxin-1B,37567,0.00946207173841653,0.0036561538470326,0.00229601019823264,0.0166281332786004,0.00966456033636635
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MUC16,Mucin-16,40300,0.0411159820357623,0.0159152622547807,0.00992206801639214,0.0723098960551325,0.00979117341311456
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANXA10,Annexin A10,39956,0.0180601528190519,0.00700037198445494,0.00433942372952024,0.0317808819085836,0.00989244609929114
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,37557,0.0221440312491859,0.00858718150387259,0.00531315550159559,0.0389749069967762,0.00992720145299778
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACRV1,Acrosomal protein SP-10,37593,0.00768358008817661,0.00298328919857784,0.00183633325896404,0.0135308269173892,0.010019202206972
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTTG1,Securin,37709,0.00903618659974235,0.00351002313818852,0.00215654124889284,0.0159158319505919,0.0100523020344053
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CKB,Creatine kinase B-type,37993,-0.0131536483412379,0.00511169105081355,-0.0231725628008325,-0.00313473388164332,0.010085444619523
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PKN3,Serine/threonine-protein kinase N3,37709,0.0167644555045393,0.0065393338674453,0.00394736112434646,0.029581549884732,0.0103692112917046
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,40417,0.0224980589784083,0.0087772977003771,0.00529455548566922,0.0397015624711475,0.0103800022704412
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",37567,0.0181977070648071,0.00711772833810773,0.00424695952211591,0.0321484546074982,0.0105789968344343
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BRD2,Bromodomain-containing protein 2,37536,0.00747929757056108,0.0029310131376656,0.0017345118207365,0.0132240833203856,0.0107287174545302
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KEL,Kell blood group glycoprotein,39956,-0.00769090067370233,0.00301997204524143,-0.0136100458823755,-0.00177175546502913,0.0108849092196174
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,40039,0.0129704765801934,0.00511274094916484,0.00294950431983028,0.0229914488405564,0.0111937812986089
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HGFAC,Hepatocyte growth factor activator,37844,0.00621205293033418,0.00245371130921596,0.0014027787642709,0.0110213270963975,0.0113625491512082
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,40037,-0.00732497073940416,0.00289640057619985,-0.0130019158687559,-0.00164802561005246,0.0114488790862232
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,37709,0.0149022550195745,0.00589780729818266,0.00334255271513645,0.0264619573240125,0.0115240417829283
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,37557,0.0143706875819526,0.00568995393898675,0.00321837786153853,0.0255229973023666,0.0115609703927846
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",37536,-0.0117887115804683,0.00467245733381033,-0.0209467279547366,-0.00263069520620007,0.011646870738066
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRG2,Bone marrow proteoglycan,37993,0.0111213460032908,0.00441032036261081,0.00247711809257361,0.019765573914008,0.0116914987244971
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DKK4,Dickkopf-related protein 4,40198,0.00970575051678395,0.00385919162406504,0.00214173493361646,0.0172697660999514,0.0119141345246783
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,37557,0.0054788777011016,0.00217916625434136,0.00120771184259254,0.00975004355961066,0.0119418791574481
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EP300,Histone acetyltransferase p300,37593,0.00630573816330594,0.00252408348310251,0.00135853453642503,0.0112529417901869,0.0124936795673289
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL15,C-C motif chemokine 15,40531,0.00940104381146572,0.00376645557895233,0.00201879087671916,0.0167832967462123,0.0125704724798006
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DEFB118,Beta-defensin 118,37536,0.0122982526486482,0.0049443997763436,0.00260722908701475,0.0219892762102817,0.0128836968318991
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,37567,0.0153857137425839,0.00619083364412212,0.00325167980010454,0.0275197476850632,0.0129587419881209
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TSNAX,Translin-associated protein X,37557,0.00830844628075842,0.00334372624878138,0.00175474283314691,0.0148621497283699,0.0129752949713361
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GNAS,Neuroendocrine secretory protein 55,37955,0.0189351458305936,0.00762468698817733,0.00399075933376609,0.0338795323274212,0.0130255380621528
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RBM19,Probable RNA-binding protein 19,37557,-0.0100594489702875,0.00406496203743331,-0.0180267745636568,-0.00209212337691824,0.0133484064124259
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,37666,0.0112210997118425,0.00453725854464992,0.0023280729643287,0.0201141264593564,0.0134071015445282
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39703,-0.00781705261117256,0.00316421564218349,-0.0140189152698522,-0.00161518995249291,0.0135049805441594
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,37477,-0.00915838871097392,0.00370709577041996,-0.016424296420997,-0.0018924810009508,0.0135050528305136
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IFNGR1,Interferon gamma receptor 1,40417,0.00428897455238587,0.00173817936962903,0.000882142987912974,0.00769580611685877,0.0136160618021835
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BAG6,Large proline-rich protein BAG6,40037,0.00749101767173254,0.003043886063644,0.0015250009869903,0.0134570343564748,0.0138656172638874
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TRIM5,Tripartite motif-containing protein 5,40336,0.0177020922468652,0.00720264010360349,0.00358491764380235,0.031819266849928,0.0139927117402955
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,37536,0.016840240359757,0.00685713691152852,0.00340025201316107,0.0302802287063529,0.0140672842178296
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,37955,0.0100641531852673,0.00410817924457952,0.00201212186589147,0.0181161845046432,0.014306787680324
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,39956,0.010877096333432,0.00446325297847489,0.00212912049562121,0.0196250721712428,0.0148194823053899
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSPN,Persephin,40336,0.0204499457027721,0.0084193580300587,0.00394800396385707,0.0369518874416872,0.0151548989670502
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TSPAN15,Tetraspanin-15,37557,0.0105279797217587,0.00433645273371996,0.00202853236366754,0.0190274270798498,0.0152046746498517
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FSTL1,Follistatin-related protein 1,37623,-0.0046080009163065,0.00189829918754079,-0.00832866732388644,-0.00088733450872656,0.0152192589022242
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",37937,0.0111263821203554,0.0045841325264536,0.00214148236850635,0.0201112818722045,0.0152309272003575
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,40037,0.00428696840386561,0.00177302226183775,0.000811844770663624,0.00776209203706759,0.0156222942821621
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STX5,Syntaxin-5,37593,0.00856729369018568,0.00354422014534142,0.00162062220531649,0.0155139651750549,0.0156514614632327
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,37477,0.0122086969738077,0.00505176876241191,0.00230723019948034,0.022110163748135,0.0156748281701804
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PROCR,Endothelial protein C receptor,37557,-0.00757271077705329,0.00313688900574372,-0.013721013228311,-0.0014244083257956,0.0157884795626583
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSMG4,Proteasome assembly chaperone 4,37593,0.0115192959714189,0.00477245891915752,0.00216527648987016,0.0208733154529676,0.0158049361045196
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,37896,0.00538534509639321,0.0022338075974567,0.00100708220537808,0.00976360798740834,0.0159293059680314
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,F13B,Coagulation factor XIII B chain,37929,0.00526152111110506,0.00218354234963922,0.000981778105812182,0.00954126411639794,0.0159821835053215
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,39975,0.0107470593146085,0.0044602595041059,0.00200495068656095,0.0194891679426561,0.015985330261996
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGB7,Integrin beta-7,40484,-0.00928036821509515,0.00385724680922813,-0.0168405719611823,-0.00172016446900803,0.0161414299928266
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,40039,-0.00650318548693073,0.0027050145986582,-0.0118050141003008,-0.00120135687356066,0.0162229509869986
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMEM25,Transmembrane protein 25,37955,-0.00888485623541021,0.00370831827080741,-0.0161531600461927,-0.00161655242462769,0.0165919613841943
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,40354,0.00643230054502366,0.00268906789695022,0.00116172746700123,0.0117028736230461,0.0167675327123012
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TEF,Thyrotroph embryonic factor,37557,0.00874667560450544,0.0036571952838398,0.00157857284817944,0.0159147783608314,0.0167875339919259
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",37955,0.0139661050957809,0.0058469353729178,0.00250611176486201,0.0254260984266998,0.0169254482200883
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,40446,0.00602151821076646,0.00252767845754981,0.00106726843396884,0.0109757679875641,0.0172196378727844
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPSAB1,Tryptase alpha/beta-1,40493,0.0106281898122795,0.0044675224970892,0.00187184571798468,0.0193845339065744,0.0173717928895725
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37896,-0.00661874387272012,0.00278399286382102,-0.0120753698858093,-0.00116211785963091,0.0174477279225437
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GASK1A,Golgi-associated kinase 1A,37557,0.00872740390544569,0.00367185510985484,0.0015305678901302,0.0159242399207612,0.0174760399341429
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,37536,0.0116191681187969,0.00489822375832523,0.00201864955247949,0.0212196866851144,0.0177007887173474
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPHA2,Ephrin type-A receptor 2,39754,0.00619437292188249,0.00261677611340696,0.00106549173960486,0.0113232541041601,0.0179367161965597
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",37557,0.00805090029897423,0.00340153832036788,0.00138388519105319,0.0147179154068953,0.0179550902955518
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VIT,Vitrin,37985,-0.00736914936256828,0.00311565142747836,-0.0134758261604259,-0.00126247256471071,0.0180341927490775
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GET3,ATPase GET3,37985,0.0112118368515689,0.00474459203438907,0.00191243646416629,0.0205112372389714,0.018137956427198
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GAS2,Growth arrest-specific protein 2,37709,0.0106968335831006,0.00453779560866071,0.00180275419012558,0.0195909129760756,0.0184240451259005
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL28,C-C motif chemokine 28,40273,0.0118222749216986,0.00505222241535158,0.00191991898760946,0.0217246308557877,0.0192953430733887
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,37557,0.00773894315025901,0.00331693408825617,0.00123775233727692,0.0142401339632411,0.0196547156335165
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,40336,0.00545441832887174,0.00234010660390403,0.000867809385219849,0.0100410272725236,0.019774151789792
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL33,Interleukin-33,40039,0.00765218493491367,0.00328417450937303,0.00121520289654254,0.0140891669732848,0.0198179115925858
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,37895,0.00992849238121857,0.00426418173910782,0.00157069617256724,0.0182862885898699,0.019908468769783
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRNN,Cornulin,39852,0.0130981875721339,0.00563301342402005,0.00205748126105462,0.0241388938832132,0.0200713022957667
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,37477,0.0131023585590004,0.00565359058854069,0.00202132100546067,0.0241833961125402,0.0204903684883223
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,40466,0.00533939969789871,0.00231301442503167,0.00080589142483664,0.00987290797096078,0.020988679641941
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNPY2,Protein canopy homolog 2,40037,0.0119511059804536,0.00518687043474648,0.00178483992835047,0.0221173720325567,0.0212297091116167
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,40354,-0.00555030577103555,0.00241394418855104,-0.0102816363805956,-0.000818975161475509,0.0215025961062467
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HEBP1,Heme-binding protein 1,40037,0.0106334258248529,0.00462540686405463,0.00156762837130579,0.0196992232783999,0.021522825673522
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,37955,0.00522974724502996,0.00227507681230248,0.000770596692917094,0.00968889779714283,0.0215364752451471
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,37666,-0.0061004000250165,0.00265916815385178,-0.011312369606566,-0.000888430443467003,0.0218003162611319
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRL,Prolactin,40466,-0.014869138849481,0.00649098647437007,-0.0275914723392464,-0.00214680535971569,0.0219915960091413
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,37709,0.0128836798629222,0.00564411765938442,0.00182120925052878,0.0239461504753157,0.022465347689689
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GDF2,Growth/differentiation factor 2,40354,0.00688560179360899,0.00302768987794405,0.000951329632838644,0.0128198739543793,0.0229666419248993
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,40374,0.00610390253689762,0.00268688222597653,0.00083761337398362,0.0113701916998116,0.0231153946751185
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL17RA,Interleukin-17 receptor A,40327,0.00844684031494762,0.00371844311007511,0.00115869181920041,0.0157349888106948,0.0231235985123386
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,39956,0.0273871985057539,0.0120687831816611,0.00373238346969809,0.0510420135418097,0.0232662388952597
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,40406,0.00510400120568587,0.00224957685105005,0.000694830577627772,0.00951317183374397,0.0232894273177233
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPPK1,Epiplakin,37623,0.0140739532493339,0.00620392620042313,0.00191425789650456,0.0262336486021632,0.0233114595836423
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYOM2,Myomesin-2,37557,-0.00903387819277046,0.00398774452866804,-0.0168498574689598,-0.00121789891658109,0.0235037515303914
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHGB,Secretogranin-1,40401,0.00772262585039395,0.0034105982611175,0.00103785325860365,0.0144073984421843,0.0235688888920022
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL5,Interleukin-5,40039,0.0280508420286789,0.0123887438387629,0.00376890410470366,0.0523327799526541,0.023574263736763
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPHA10,Ephrin type-A receptor 10,39956,0.0125481323844809,0.00554436103419114,0.00168118475746625,0.0234150800114955,0.0236356355966378
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SDK2,Protein sidekick-2,37666,0.00732286213698304,0.00323598884772701,0.000980323995438104,0.013665400278528,0.0236552882769313
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,37896,-0.0331695204040828,0.0146783422843449,-0.0619390712813989,-0.00439996952676675,0.0238521301706827
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL1A,Interleukin-1 alpha,40039,0.0103116781052381,0.00457501501838909,0.00134464866919546,0.0192787075412807,0.0242155793274593
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RBP1,Retinol-binding protein 1,37567,0.0132064172489423,0.00586557281950564,0.00170989452271126,0.0247029399751734,0.0243695044036347
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZPR1,Zinc finger protein ZPR1,37536,0.0185566642833213,0.00824891446690565,0.00238879192818627,0.0347245366384564,0.0244916239747846
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCN1,Ficolin-1,37962,0.0107061615978128,0.00477168489665069,0.00135365920037745,0.0200586639952481,0.0248687572343103
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,37860,0.00592807449736525,0.00264813792945692,0.000737724155629689,0.0111184248391008,0.0251994541994825
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,37937,0.0124107770528671,0.00554922069934501,0.00153430448215087,0.0232872496235833,0.0253359708786968
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NFASC,Neurofascin,40511,-0.00515924393079733,0.00230719572677894,-0.00968134755528405,-0.000637140306310608,0.0253553932740709
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,37955,0.0214561475733954,0.00964072029570195,0.00256033579381958,0.0403519593529712,0.0260590996667549
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRSS53,Serine protease 53,37937,0.00691120841035824,0.00310574909651033,0.000823940181198005,0.0129984766395185,0.0260779051506902
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MKI67,Proliferation marker protein Ki-67,37593,0.00710296448742744,0.00319524662680712,0.0008402810988855,0.0133656478759694,0.026234197215915
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MTSS1,Protein MTSS 1,37896,0.0207387715938116,0.00934868419607139,0.00241535056951162,0.0390621926181115,0.0265467598383545
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCRLB,Fc receptor-like B,39975,0.0114806110321158,0.00517778990908727,0.00133214281030473,0.0216290792539268,0.0266183793962913
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",37985,-0.011858779408964,0.00535322860831473,-0.0223511074812608,-0.00136645133666709,0.0267589856368891
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COMP,Cartilage oligomeric matrix protein,40193,-0.00634740521253213,0.00286953893926845,-0.0119717015334983,-0.000723108891565973,0.0269813299077825
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RPS10,40S ribosomal protein S10,37557,-0.00793565869016983,0.00358974903253994,-0.0149715667939481,-0.000899750586391537,0.0270776765855703
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,37593,0.00805987269803375,0.00365310476831846,0.00089978735212958,0.0152199580439379,0.0273797064082273
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNAPIN,SNARE-associated protein Snapin,37955,0.0106842239317156,0.00484316129002051,0.00119162780327542,0.0201768200601558,0.0273977389948629
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,37567,-0.00736143715679135,0.00333732916187665,-0.0139026023140696,-0.000820271999513111,0.0274161972750046
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,37895,0.0177209515409272,0.00803715182785133,0.00196813395833855,0.0334737691235158,0.0274794207601607
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,40484,0.0114368135055355,0.00519235890485965,0.00125979005201062,0.0216138369590605,0.027635450796048
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,40460,0.00753863780591002,0.00343497202883478,0.000806092629393851,0.0142711829824262,0.028201428409506
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BMP6,Bone morphogenetic protein 6,40019,0.00787213401975946,0.00359021326560779,0.000835316019168184,0.0149089520203507,0.02834628984097
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,40300,0.00489973527282891,0.00223466321477045,0.000519795371878823,0.009279675173779,0.0283502869527064
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD33,Myeloid cell surface antigen CD33,40406,0.0147693125804267,0.00673702650490722,0.0015647406308085,0.0279738845300448,0.0283751450591015
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHAD,Chondroadherin,37666,0.00998575165414267,0.00455878163598488,0.0010505396476123,0.018920963660673,0.0285095296347204
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDIA5,Protein disulfide-isomerase A5,37477,0.011401309926536,0.00521251573888478,0.00118477907832179,0.0216178407747501,0.0287387086329089
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,37536,0.0114260777113224,0.00523888759953534,0.00115785801623315,0.0216942974064117,0.0292002602639202
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTSZ,Cathepsin Z,40340,0.00573948739372323,0.00263265199481435,0.000579489483887102,0.0108994853035594,0.0292634714987433
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTSB,Cathepsin B,40348,0.00995871551101482,0.00457255065689043,0.00099651622350958,0.0189209147985201,0.0294255680245265
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RLN2,Prorelaxin H2,37638,0.0260494218096545,0.0119637253421271,0.0026005201390854,0.0494983234802235,0.0294708591546893
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,37562,0.0109476462320577,0.00502959153513732,0.00108964682318855,0.0208056456409268,0.0295246867009915
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC39A14,Zinc transporter ZIP14,39956,0.0061547743129941,0.00283316581056173,0.000601769324293113,0.0117077793016951,0.0298404739049712
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,37895,0.0120439798936764,0.0055579065860823,0.00115048298495513,0.0229374768023978,0.0302524085290874
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,37557,0.00833873589542375,0.00385619614105095,0.000780591458963887,0.0158968803318836,0.0306034461178661
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SUMF1,Formylglycine-generating enzyme,37593,0.0122714319678573,0.00568196333975916,0.00113478382192938,0.0234080801137853,0.0308126250627126
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRTAP,Cartilage-associated protein,37567,0.00887796145428432,0.00411972806211264,0.000803294452543549,0.0169526284560251,0.031180976372712
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,39956,0.00723694692542983,0.00335946288575135,0.00065239966935719,0.0138214941815025,0.0312400378130125
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,40300,-0.00386478695977176,0.00179593025370055,-0.00738481025702483,-0.000344763662518691,0.0314148214018512
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGR,Tyrosine-protein kinase Fgr,39956,0.0100669595622325,0.00468185101620114,0.000890531570478262,0.0192433875539867,0.0315540798178625
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,37937,0.00831182653247188,0.0038760034722436,0.000714859726874425,0.0159087933380693,0.0320160937679506
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGLON5,IgLON family member 5,37477,0.0171643119372756,0.00801158055519363,0.00146161404909608,0.0328670098254551,0.0321767613458995
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TREH,Trehalase,37993,-0.013410145694969,0.00628545503393197,-0.0257296375614756,-0.00109065382846232,0.0328999919473332
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GSAP,Gamma-secretase-activating protein,39975,0.0161657536053137,0.00758619998935479,0.00129680162617831,0.0310347055844491,0.0331095739371903
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,37623,0.0102184131742669,0.00480601992127067,0.000798614128576416,0.0196382122199575,0.0335076906454941
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ERI1,3'-5' exoribonuclease 1,37709,0.00605794769804318,0.00284948696090756,0.000472953254664362,0.011642942141422,0.0335234872704
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NUP50,Nuclear pore complex protein Nup50,37557,-0.00641468408575673,0.00301762979744885,-0.0123292384887565,-0.000500129682756982,0.0335438993895831
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTSC,Dipeptidyl peptidase 1,40344,0.00766630471461205,0.00361418855939786,0.000582495138192244,0.0147501142910319,0.0339230213081094
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPM3,Tropomyosin alpha-3 chain,37557,-0.00763669908297644,0.00360362104199385,-0.0146997963252844,-0.0005736018406685,0.0340945406199703
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCN4B,Sodium channel subunit beta-4,37623,-0.0074947191430444,0.0035380733275372,-0.0144293428650173,-0.00056009542107149,0.0341679023431459
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,37536,0.00607360944704465,0.0028742204153894,0.000440137432881424,0.0117070814612079,0.0346082857665632
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,37937,0.0110936827349977,0.00526767438354299,0.000769040943253457,0.021418324526742,0.0352234385914945
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NME1,Nucleoside diphosphate kinase A,37593,-0.00391185474127778,0.00185887080461268,-0.00755524151831863,-0.000268467964236922,0.0353603074096792
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MMP10,Stromelysin-2,40336,-0.0106969203769256,0.00508454364196085,-0.0206626259151689,-0.000731214838682354,0.0354105900151617
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ROBO4,Roundabout homolog 4,37623,-0.00317090210184356,0.00150937299729161,-0.00612927317653512,-0.000212531027151996,0.0356768261678196
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HLA_DRA,,40283,0.00641210656425616,0.00305443117687434,0.000425421457582458,0.0123987916709299,0.0358080098473553
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC13A1,Solute carrier family 13 member 1,37895,0.0110280863896584,0.00525972249763421,0.000719030294295328,0.0213371424850214,0.036038337432587
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGB6,Integrin beta-6,40039,-0.00535844894496126,0.00256044228536294,-0.0103769158242726,-0.000339982065649896,0.0363846976675421
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,37937,0.00512330594245511,0.00246426195097385,0.000293352518546373,0.00995325936636385,0.0376322761953888
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,40336,0.0149695799073445,0.00721656764895152,0.000825107315399537,0.0291140524992895,0.0380642642793921
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,QSOX1,Sulfhydryl oxidase 1,37756,0.00784808762380455,0.00379461356170738,0.000410645042858078,0.015285530204751,0.0386388188549882
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,40406,0.015403978678456,0.00745636217005466,0.000789508825148886,0.0300184485317631,0.0388555488192214
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",40305,0.0110294399858583,0.00534054489831816,0.000561971985154739,0.0214969079865619,0.0389177012737795
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APOA2,Apolipoprotein A-II,37982,-0.00823814070577485,0.00402608364748684,-0.0161292646548491,-0.000347016756700645,0.040756758320004
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,40531,0.00390269782230569,0.00191323119031432,0.000152764689289623,0.00765263095532175,0.0413819320493238
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,40314,0.00424200384145303,0.00208297176302619,0.000159379185921691,0.00832462849698437,0.0417152130842257
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,39952,0.00486158756104808,0.0023916766292576,0.000173901367703184,0.00954927375439298,0.0420987314443945
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,37623,-0.00446091418722067,0.00220090757943505,-0.00877469304291336,-0.000147135331527976,0.0426976431954379
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,37477,-0.00453579083783898,0.00224313798091785,-0.00893234128043797,-0.000139240395239994,0.0431891161171967
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENOPH1,Enolase-phosphatase E1,37895,0.00981934660664695,0.00485679265075555,0.000300033011166068,0.0193386602021278,0.0432192742221912
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TCN1,Transcobalamin-1,37761,0.00565608799463986,0.00279958671271196,0.000168898037724408,0.0111432779515553,0.0433691987321334
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,37648,0.00931997197677439,0.00461343958371523,0.000277630392692536,0.0183623135608562,0.0433850290035353
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNC,Tenascin,40398,0.00806899689284316,0.00401040566860047,0.000208601782386235,0.0159293920033001,0.044235128089772
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SAFB2,Scaffold attachment factor B2,37955,0.00470447326552326,0.00234342711335659,0.000111356123344333,0.00929759040770218,0.0447143707743811
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,40223,-0.00481349053192671,0.00239903322229008,-0.00951559564761526,-0.000111385416238152,0.0448275059134061
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PAEP,Glycodelin,40223,-0.0222495442516423,0.011136293115084,-0.0440766787572069,-0.000422409746077716,0.0457412932918613
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,37895,0.00692970611794501,0.0034689405660964,0.000130582608396059,0.013728829627494,0.0457754531333326
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SELE,E-selectin,40531,0.00844822285485182,0.0042311366282459,0.000155195063489865,0.0167412506462138,0.0458768626057265
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAMB1,Laminin subunit beta-1,37623,0.00496487148728458,0.00248955553565832,8.53426373942662e-05,0.0098444003371749,0.0461420127088372
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYOM1,Myomesin-1,37536,0.00791504927726545,0.00397078467239988,0.000132311319361694,0.0156977872351692,0.0462470153264282
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DSG4,Desmoglein-4,40245,0.00859814814588298,0.0043250554909638,0.000121039383593929,0.017075256908172,0.0468305160776058
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYH7B,Myosin-7B,37477,-0.00771365226062091,0.00388577695288392,-0.0153297750882734,-9.75294329684222e-05,0.047154389415959
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDH4,Cadherin-4,37536,0.00832306448894648,0.00420302051420072,8.51442811130726e-05,0.0165609846967799,0.0476954733237096
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,40039,0.00777750802921491,0.0039281412619221,7.83511558475952e-05,0.0154766649025822,0.0477271431859316
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,39975,0.0212671030002749,0.0107424621904087,0.000211877107073811,0.042322328893476,0.047752260093743
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL36A,Interleukin-36 alpha,37593,0.00989076663240084,0.00500739434114973,7.62737237473658e-05,0.0197052595410543,0.0482626945729315
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",40300,0.00703328559591879,0.00356095107398273,5.38214909126308e-05,0.0140127497009249,0.0482724975349549
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAB37,Ras-related protein Rab-37,40039,0.0138768753390757,0.00707347417597067,1.2865954173184e-05,0.0277408847239782,0.0498013416952634
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDCL2,Phosducin-like protein 2,37477,0.00899367976060392,0.00458677210299285,3.60643873793635e-06,0.0179837530824699,0.049925239293898
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,37536,-0.00637930159149991,0.00325765691661555,-0.0127643091480664,5.70596506656394e-06,0.0502220843641671
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD2,T-cell surface antigen CD2,37557,0.00634423015918672,0.00324365194783493,-1.33276585697496e-05,0.0127017879769432,0.050499192410032
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,40327,0.00494814047131775,0.00253513686428435,-2.0727782679573e-05,0.00991700872531507,0.0509766856303733
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,40198,0.00653477928057971,0.003358344306982,-4.75755611050142e-05,0.0131171341222644,0.0516924962183896
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NXPE4,NXPE family member 4,37557,0.00599935249197794,0.00308955616510556,-5.61775916289578e-05,0.0120548825755848,0.0521806676028132
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYL4,Myosin light chain 4,37623,-0.00862699338528635,0.00444275720675193,-0.0173347975105201,8.08107399474407e-05,0.0521813184901436
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,40484,0.00886129438701088,0.00457434648255606,-0.000104424718798995,0.0178270134928208,0.0527419068479436
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VEGFD,Vascular endothelial growth factor D,40478,-0.00545713989229751,0.00282269024019479,-0.0109896127630793,7.53329784842693e-05,0.0532154104762427
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD109,CD109 antigen,40327,-0.00544218875756326,0.00283209499957288,-0.0109930949567261,0.000108717441599582,0.0546724341390447
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,37536,0.0193948528006538,0.0101394361910913,-0.000478442133885083,0.0392681477351927,0.0557937090389677
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,39975,0.00607360914697832,0.00318762777609334,-0.000174141294164623,0.0123213595881213,0.0567504980464519
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37985,0.0118109108295692,0.00620061914555518,-0.000342302695718982,0.0239641243548573,0.056827850528789
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CA1,Carbonic anhydrase 1,39998,0.0101035845108622,0.00530495196205555,-0.000294121334766712,0.020501290356491,0.0568560918266143
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,40511,0.00531724177571235,0.00279229462018427,-0.000155655679848824,0.0107901392312735,0.0568947978312853
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DENR,Density-regulated protein,37593,0.00924991147818039,0.00486530011718291,-0.000286076751498117,0.0187858997078589,0.0572975969550446
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDH1,Cadherin-1,39801,-0.00647432042006916,0.00340649600820669,-0.0131510525961543,0.000202411756015949,0.0573756775141962
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ICAM4,Intercellular adhesion molecule 4,40336,-0.00849321808944668,0.0044698830254525,-0.0172541888193336,0.000267752640440228,0.0574382835947293
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTGR1,Prostaglandin reductase 1,37985,0.0127387842876179,0.00670943656761542,-0.00041171138490829,0.0258892799601442,0.0576334752152846
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,40309,-0.00454065962816308,0.00239393759121779,-0.00923277730694995,0.000151458050623801,0.0578813851309645
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,40037,0.0100494792848624,0.00531686283084505,-0.000371571863593897,0.0204705304333187,0.058761192298559
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,37623,-0.0101181077609559,0.00536184163846752,-0.0206273173723522,0.00039110185044045,0.0591744560054489
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,37896,0.00806618409023917,0.00428127655143375,-0.000325117950570972,0.0164574861310493,0.0595783499387922
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TXK,Tyrosine-protein kinase TXK,37709,0.0121388928624357,0.00644593858987716,-0.000495146773723502,0.024772932498595,0.0596972164496543
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,37567,0.0138876521827355,0.00737645682076945,-0.000570203185972644,0.0283455075514436,0.0597632076751434
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BTLA,B- and T-lymphocyte attenuator,37477,0.0141912775636894,0.00755565637642102,-0.000617808934095758,0.0290003640614746,0.0603717188401822
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,40367,0.00470961363595132,0.00251580121361933,-0.000221356742742562,0.00964058401464521,0.0612230720541359
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,37895,0.00837664408911402,0.00448361562403486,-0.000411242533994306,0.0171645307122224,0.0617449537661607
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,40039,0.00463217544989399,0.00248164693382053,-0.000231852540394244,0.00949620344018223,0.0619799868803467
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,37955,-0.00464917266649298,0.00249282359301911,-0.00953510690881044,0.000236761575824471,0.062199892519118
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,37895,0.00695175822761611,0.00372856845189828,-0.000356235938104519,0.0142597523933367,0.0622792312951875
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,INSL5,Insulin-like peptide INSL5,37896,-0.0147674826405157,0.00794198399028472,-0.0303337712614737,0.000798805980442392,0.062989480689002
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STX3,Syntaxin-3,37937,0.00608006437901889,0.00327384977596109,-0.000336681181864842,0.0124968099399026,0.0633101147045477
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NLGN2,Neuroligin-2,37536,0.00758253272244616,0.00409903577310127,-0.000451577392832333,0.0156166428377247,0.0643601186527329
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,40352,0.00415405779436761,0.0022575557773743,-0.00027075152928602,0.00857886711802124,0.0657767744738069
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,39956,0.00625971400115407,0.00340406200623283,-0.000412247531062282,0.0129316755333704,0.0659496841202907
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TLR4,Toll-like receptor 4,37593,0.00441569592291626,0.00240665871412961,-0.000301355156777787,0.0091327470026103,0.0665604758454923
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ELAVL4,ELAV-like protein 4,37536,0.0135525563484254,0.00738706149055171,-0.000926084173055957,0.0280311968699068,0.0665825857519611
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,37709,0.00825976464493683,0.00450495429715268,-0.000569945777482412,0.0170894750673561,0.0667529336784004
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APOM,Apolipoprotein M,40367,-0.00415178316766811,0.00226836541368635,-0.00859777937849335,0.00029421304315714,0.0672241815206785
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDH23,Cadherin-23,37937,-0.00408774575928552,0.00223642454443577,-0.00847113786637963,0.000295646347808599,0.0676010546855732
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,37567,0.00558622972325878,0.00306672630024834,-0.000424553825227965,0.0115970132717455,0.0685443572136448
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGF5,Fibroblast growth factor 5,40039,-0.00498655744100823,0.00273819035701378,-0.0103534105407552,0.000380295658738768,0.0686086550042954
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,37666,0.00591844847681216,0.00325892302144126,-0.000469040645212706,0.012305937598837,0.0693815258782925
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,40306,0.0134820417264637,0.00742783668803639,-0.00107651818208768,0.028040601635015,0.069532077181596
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",39956,0.00663228396481888,0.00365612240880092,-0.000533715956430921,0.0137982838860687,0.0696937666509155
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,39956,0.00990145140992315,0.00546388673848008,-0.000807766597497797,0.0206106694173441,0.0699804067517156
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,37896,0.00842553044051049,0.00465054538218183,-0.000689538508565906,0.0175405993895869,0.0700503007273743
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BRD1,Bromodomain-containing protein 1,37709,-0.00476622126856211,0.00263216450696468,-0.00992526370221289,0.00039282116508867,0.0702004575222347
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCN3B,Sodium channel subunit beta-3,37536,0.00701762943180206,0.0038953755666179,-0.000617306678769029,0.0146525655423731,0.0716426588032837
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RPA2,Replication protein A 32 kDa subunit,37593,0.00496437427852325,0.0027608969569637,-0.0004469837571256,0.0103757323141721,0.0721837924518953
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,39975,0.00759184448024796,0.00422869118780703,-0.000696390247853824,0.0158800792083497,0.0726225275917685
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACE,Angiotensin-converting enzyme,37982,-0.00387230145876348,0.00216402436160704,-0.00811378920751329,0.000369186289986328,0.0735730558163493
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NDRG1,Protein NDRG1,39956,0.0104365567158436,0.00583356553911846,-0.000997231740828572,0.0218703451725158,0.0736258284498015
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,40354,0.00427329095179043,0.00239417338768118,-0.000419288888064691,0.00896587079164555,0.074301278998388
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,40037,0.00572079795304619,0.00320634489198917,-0.000563638035252591,0.012005233941345,0.0744087261707718
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDHR1,Cadherin-related family member 1,39956,-0.00663668190652516,0.00372854860048014,-0.0139446371634662,0.000671273350415913,0.075101449431438
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRR4,Proline-rich protein 4,37572,0.0103630439415387,0.00583454612360745,-0.00107266646073193,0.0217987543438093,0.0757309479691192
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MMP15,Matrix metalloproteinase-15,37985,0.00748587118592541,0.00421935230500069,-0.000784059331875943,0.0157558017037268,0.0760566161730553
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,39975,0.00527135976118622,0.00297445585313873,-0.000558573710965692,0.0111012932333381,0.0763793512088564
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGB2,Integrin beta-2,40216,0.00429867524287013,0.00242615070899852,-0.000456580146766965,0.00905393063250723,0.0764456105444996
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL24,Interleukin-24,40039,0.00740734637586877,0.00418959201791478,-0.000804253979244197,0.0156189467309817,0.0770745694690957
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGF19,Fibroblast growth factor 19,40417,0.0114466565008109,0.00649665589481718,-0.00128678905303078,0.0241801020546525,0.0781001675132421
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,40300,0.00670762708617579,0.00381503426922954,-0.000769840081514112,0.0141850942538657,0.0787312774158719
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,37477,0.00843595572315808,0.00480091564568776,-0.000973838942389936,0.0178457503887061,0.0789147859537444
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,37477,-0.00666843863669184,0.00379602025997276,-0.0141086383462385,0.000771761072854777,0.0789938077491579
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,37557,0.00776572889892772,0.00442072173522094,-0.000898885702105327,0.0164303434999608,0.0789982112945372
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VWF,von Willebrand factor,40531,0.0106393239792862,0.00605709806721473,-0.00123258823245462,0.0225112361910271,0.0790212259768559
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,37955,0.00459959192416869,0.00262151792567655,-0.000538583210157347,0.00973776705849473,0.0793584904897302
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,37993,0.00457744302008537,0.00261059116973433,-0.000539315672593918,0.00969420171276465,0.0795538623009865
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL2,C-C motif chemokine 2,40198,0.00781628820658971,0.00447749846236925,-0.000959608779654026,0.0165921851928334,0.0808857385017748
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CENPJ,Centromere protein J,37709,0.0108558493225414,0.00622514849103922,-0.00134544171989551,0.0230571403649782,0.081204949882632
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,40037,0.00848399531460704,0.00486519748855561,-0.00105179176296195,0.018019782392176,0.081211394795211
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NPTN,Neuroplastin,39975,0.0124558288622288,0.00717342564499817,-0.00160408540196762,0.0265157431264252,0.0825156180761508
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAMDC2,MAM domain-containing protein 2,37985,0.00498696661343645,0.0028720742474938,-0.000642298911651388,0.0106162321385243,0.0825222330982874
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,37557,0.00598809548837182,0.00346146556845441,-0.000796377025798821,0.0127725680025425,0.0836662051693683
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PMS1,PMS1 protein homolog 1,37567,0.00762897309516608,0.00442355868266833,-0.00104120192286384,0.016299148113196,0.0846189136650511
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MTR,Methionine synthase,37557,0.00957957585011765,0.00555933768572119,-0.00131672601389589,0.0204758777141312,0.0848848905704855
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,37896,0.00397761999366247,0.00230959496823296,-0.000549186144074145,0.00850442613139908,0.0850535084895445
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EVI2B,Protein EVI2B,37477,0.00617057618083456,0.00358388085964434,-0.000853830304068342,0.0131949826657375,0.0851370763831233
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,37666,-0.00531094404682608,0.00309337861972378,-0.0113739661414847,0.000752078047832527,0.0860254695942715
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDCD6,Programmed cell death protein 6,40354,0.010153946660487,0.00591801748644908,-0.00144536761295317,0.0217532609339272,0.086223941240746
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL11,Eotaxin,40511,0.00546336185359466,0.00318738991124032,-0.000783922372436367,0.0117106460796257,0.0865379082271284
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLK7,Kallikrein-7,37347,0.00561438757615402,0.00328370137058983,-0.000821667110202052,0.0120504422625101,0.0873317109443841
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,JAM2,Junctional adhesion molecule B,40466,0.00377551046061217,0.00220892449228451,-0.000553981544265458,0.0081050024654898,0.0874318824420495
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39752,-0.00945229897892553,0.00553174544459157,-0.020294520050325,0.00138992209247393,0.0875199298325776
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,37709,0.0106935853738745,0.00626498561121583,-0.00158578642410858,0.0229729571718575,0.0878675770927383
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,37567,0.0147520968145345,0.00864452346780201,-0.00219116918235742,0.0316953628114265,0.087934019183261
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,37477,0.0204590996032702,0.012036378835034,-0.0031322029133964,0.0440504021199369,0.0891976984457022
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",37567,0.0113340083428236,0.00667660137635055,-0.0017521303548235,0.0244201470404707,0.089612386778385
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FABP9,Fatty acid-binding protein 9,40336,0.00802012011723225,0.00473419974755322,-0.00125891138797207,0.0172991516224366,0.0902694056669293
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NXPH3,Neurexophilin-3,37593,0.00434174495767356,0.0025646690019093,-0.000685006286068666,0.00936849620141579,0.0904969592083935
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",37536,0.0046712997052132,0.00276117890990242,-0.000740610958195549,0.010083210368622,0.0907122625136472
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,37895,0.00577948398682406,0.00341623592779552,-0.000916338431655148,0.0124753064053033,0.0907130944276952
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GBP6,Guanylate-binding protein 6,37557,-0.00680699263266467,0.00403118698812422,-0.0147081191293881,0.00109413386405879,0.0913232184416355
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",37593,0.00883501793369061,0.00523345684829433,-0.00142255748896628,0.0190925933563475,0.0914003818660621
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,37557,0.00858979835813714,0.00509360559107794,-0.00139366860037562,0.0185732653166499,0.0917447800380532
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TLR1,Toll-like receptor 1,37593,0.00372901892420617,0.00221615401182624,-0.000614642938973261,0.00807268078738561,0.0924659779403638
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,37709,0.00613153673022273,0.00365002537737718,-0.00102251300943654,0.013285586469882,0.0930078481748991
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MUC13,Mucin-13,39956,-0.00713551493060066,0.00425028379548254,-0.0154660711697464,0.00119504130854512,0.0932048276597645
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",37536,-0.00653889308330481,0.00389593554651825,-0.0141749267544806,0.00109714058787095,0.0932951787598634
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,40198,0.00477221215806938,0.00284411457299685,-0.000802252405004442,0.0103466767211432,0.093381503531078
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,INSL4,Early placenta insulin-like peptide,37895,-0.00768351913380302,0.00458574335952377,-0.0166715761184696,0.00130453785086358,0.0938548904069418
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CA3,Carbonic anhydrase 3,40495,0.00862156744430671,0.00517100171232539,-0.00151359591185105,0.0187567308004645,0.0954759649061298
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",37455,0.00357810873216108,0.00214775613257775,-0.000631493287691315,0.00778771075201348,0.0957424154246074
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RRP15,RRP15-like protein,37536,0.0128860981109077,0.00773500097410165,-0.00227450379833151,0.028046700020147,0.0957480010752331
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CA4,Carbonic anhydrase 4,40531,0.00329635305808986,0.00197879720830652,-0.000582089470190918,0.00717479558637063,0.0957654192703394
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37955,0.00532519515768896,0.00320128205319882,-0.000949317666580734,0.0115997079819587,0.0962441900269397
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,37895,0.00400054210527926,0.00240736726249129,-0.000717897729203668,0.00871898193976218,0.0965779326131121
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CA11,Carbonic anhydrase-related protein 11,39975,0.00466228495370052,0.00280974718140986,-0.0008448195218628,0.0101693894292638,0.0970704341946652
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HBZ,Hemoglobin subunit zeta,37985,0.0147296207262933,0.00887761007882697,-0.00267049502820759,0.0321297364807941,0.0971011635944426
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,39956,0.00898807614259426,0.00541924673363897,-0.00163364745533812,0.0196097997405266,0.0972273103387979
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,40300,-0.00461995047892437,0.00278624575106049,-0.0100809921510029,0.000841091193154195,0.0973115410861463
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NCF2,Neutrophil cytosol factor 2,40319,0.0116702670437746,0.00703980334926262,-0.00212774752078009,0.0254682816083294,0.097386757620639
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL34,Interleukin-34,39929,0.00504355366566799,0.00304456875784596,-0.000923801099710097,0.0110109084310461,0.0976258882752836
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYOC,Myocilin,40327,-0.00640777303667857,0.0038857101768888,-0.0140237649833806,0.00120821891002348,0.0991549285193786
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,37557,-0.00469256353642943,0.00284743454157881,-0.0102735352379239,0.000888408165065048,0.0993772624656134
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AMPD3,AMP deaminase 3,37937,-0.0100812094714235,0.00612930286532344,-0.0220946430874575,0.00193222414461041,0.10004338668469
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD200,OX-2 membrane glycoprotein,40336,0.00361915649710587,0.00220299678883871,-0.000698717209017992,0.00793703020322974,0.100437220764829
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DGCR6,Protein DGCR6,37536,0.00630295332919589,0.0038502291580567,-0.00124349582059524,0.013849402478987,0.101647561762028
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BCL2L15,Bcl-2-like protein 15,37593,0.0078062062744562,0.00477656074738494,-0.00155585279041827,0.0171682653393307,0.102225405600513
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,37985,-0.00343723163549822,0.00211084432953372,-0.00757448652138431,0.000700023250387867,0.103470128204212
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACTN2,Alpha-actinin-2,37557,-0.00755011563484813,0.00464053242738132,-0.0166455591925155,0.00154532792281926,0.103762540904735
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,37709,0.00748304452309714,0.00461296965266288,-0.00155837599612211,0.0165244650423164,0.104789640040084
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RGS8,Regulator of G-protein signaling 8,40039,0.00915806649646769,0.00564577259370106,-0.00190764778718639,0.0202237807801218,0.104799934360945
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,37536,0.00392533792366551,0.00242065528678712,-0.000819146438437248,0.00866982228576827,0.104912824756996
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,40448,0.00575419301234767,0.00355279867516306,-0.00120929239097193,0.0127176784156673,0.105333085741121
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CILP,Cartilage intermediate layer protein 1,37993,-0.00736303754123745,0.00454697337585769,-0.0162751053579185,0.00154903027544362,0.105400174893965
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLSPN,Claspin,39920,0.00467678817687826,0.00289286779053993,-0.000993232692580007,0.0103468090463365,0.105971746461905
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MMP1,Interstitial collagenase,39752,0.0127331060564185,0.00789188948943402,-0.00273499734287217,0.0282012094557092,0.106669134860207
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BMP10,Bone morphogenetic protein 10,37666,-0.00391831259003392,0.00243388416222274,-0.0086887255479905,0.000852100367922656,0.107443353272925
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,40531,0.00473714178425731,0.00295079408281665,-0.00104641461806333,0.0105206981865779,0.10843014098918
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL13,Interleukin-13,40039,0.00653658234593977,0.00407416744767709,-0.00144878585150732,0.0145219505433869,0.108646814601428
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TFF2,Trefoil factor 2,40391,0.0077481167902678,0.0048341940211407,-0.00172690349116797,0.0172231370717036,0.109004542986304
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,37593,0.00684082858187671,0.00427592431402779,-0.00153998307361776,0.0152216402373712,0.109656366651145
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TFF1,Trefoil factor 1,40256,0.0105350231837009,0.0065853685263271,-0.00237229912790022,0.023442345495302,0.109671351775989
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SOX2,Transcription factor SOX-2,37933,0.00314130336027673,0.00197346571645948,-0.000726689443983842,0.0070092961645373,0.111459858144138
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TUBB3,Tubulin beta-3 chain,37536,0.00373227891827475,0.00235959027754881,-0.000892518025720918,0.00835707586227041,0.113731114984744
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,40336,0.00517437112767817,0.00328079439465947,-0.0012559858858544,0.0116047281412107,0.114776283548087
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SAT1,Diamine acetyltransferase 1,37557,-0.00699867375916942,0.0044375332436533,-0.0156962389167299,0.00169889139839105,0.114784207816166
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,37937,0.00500456924967266,0.00317501614581571,-0.00121846239612613,0.0112276008954714,0.1149952814147
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,37895,-0.0103883186781933,0.00659076352927893,-0.02330621519558,0.00252957783919339,0.115004745378294
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COMMD9,COMM domain-containing protein 9,37895,-0.00523248535047042,0.00332433330436872,-0.0117481786270331,0.00128320792609227,0.115512044066458
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TK1,"Thymidine kinase, cytosolic",37709,0.00596585786086244,0.00379583012393568,-0.00147396918205149,0.0134056849037764,0.116046961911583
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDAN1,Codanin-1,37937,0.00308595864506433,0.00196482604481511,-0.000765100402773285,0.00693701769290194,0.116298713555552
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPGN,Epigen,37895,-0.00654968088069057,0.00419141766907537,-0.0147648595120783,0.00166549775069717,0.118160610216442
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,39956,-0.00915939218075931,0.00587918928639719,-0.0206826031820978,0.00236381882057918,0.119269172360089
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD101,Immunoglobulin superfamily member 2,37896,0.00557918947903214,0.00359673348340642,-0.00147040814844444,0.0126287871065087,0.120881530567456
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STEAP4,Metalloreductase STEAP4,37536,0.00989003635943612,0.00639340184924667,-0.00264103126508735,0.0224211039839596,0.121908414230986
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,37557,0.0110849126822833,0.00716964746917302,-0.00296759635729585,0.0251374217218624,0.122107235146572
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ECE1,Endothelin-converting enzyme 1,39956,0.00462123072262464,0.00298910728887419,-0.00123741956356878,0.0104798810088181,0.122119253445368
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNLZ,DNL-type zinc finger protein,37536,0.0124616684790341,0.0080740255820812,-0.00336342166184507,0.0282867586199132,0.122751409283248
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCN2B,Sodium channel subunit beta-2,37567,-0.00388879192018982,0.00252448008056243,-0.00883677287809218,0.00105918903771255,0.123479017005916
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,REG4,Regenerating islet-derived protein 4,40374,0.00635624854605634,0.00412820997692606,-0.00173504300871874,0.0144475401008314,0.123650790785444
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MDM1,Nuclear protein MDM1,37567,0.00409156503902782,0.00265925081097644,-0.00112056655048599,0.00930369662854163,0.123922268912334
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,37567,-0.00683320535813391,0.00444386825987309,-0.0155431871474852,0.00187677643121735,0.124153311588747
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,37536,0.00644346931282755,0.00419725751752267,-0.00178315542151687,0.014670094047172,0.124768273982958
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",37477,0.0118280815520771,0.00770564575950629,-0.00327498413655521,0.0269311472407094,0.124810816624933
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,37914,0.00492323025457177,0.00323006161116204,-0.00140769050330582,0.0112541510124494,0.127484540891619
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDH3,Cadherin-3,40466,0.00456335382480437,0.00299972411862666,-0.0013161054477039,0.0104428130973126,0.128214890308944
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UPK3A,Uroplakin-3a,37536,0.00645760785521566,0.00424808230023975,-0.00186863345325425,0.0147838491636856,0.128504214247577
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNTN4,Contactin-4,40327,-0.00312581440979565,0.00206006772336509,-0.00716354714759122,0.000911918327999925,0.129201848089696
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FBN2,Fibrillin-2,37567,0.00786894034258744,0.00518712527247685,-0.00229782519146719,0.0180357058766421,0.129287315609713
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,37896,0.00615481148115117,0.00405878709818389,-0.00180041123128926,0.0141100341935916,0.129437596191793
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,37895,0.00877858174410749,0.00579018262934686,-0.00257017620941235,0.0201273396976273,0.129513832205933
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LMOD1,Leiomodin-1,37955,-0.00464344452481185,0.00306671940671801,-0.0106542145619791,0.00136732551235545,0.130013575219868
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,37623,-0.00340842134260787,0.00225243961860014,-0.00782320299506415,0.0010063603098484,0.130249508485303
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPBGL,Trophoblast glycoprotein-like,37567,-0.00537261217684598,0.00355569059063014,-0.012341765734481,0.00159654138078909,0.130815144909809
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,39975,0.0076890815421535,0.00510154900850398,-0.00230995451451429,0.0176881175988213,0.131778399815589
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PITHD1,PITH domain-containing protein 1,37452,0.0105284535076676,0.00698705457383474,-0.00316617345704853,0.0242230804723837,0.131873029409434
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,37593,0.00870563943740233,0.00578114113670254,-0.00262539719053464,0.0200366760653393,0.132124920818785
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,39975,0.00726647414887564,0.00482887103156193,-0.00219811307298575,0.016731061370737,0.132396434126706
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",40336,0.00575147495784555,0.00382471192590806,-0.00174496041693424,0.0132479103326253,0.132661294261858
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,40037,0.00345561626776891,0.00229965717729677,-0.00105171179973276,0.00796294433527057,0.132945498700583
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPE,Carboxypeptidase E,40355,0.00485208148758508,0.00323766105208137,-0.0014937341744944,0.0111978971496646,0.133987449597646
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPSG1,Tryptase gamma,37593,0.00346356347011942,0.00231187159416864,-0.00106770485445111,0.00799483179468995,0.134114590106866
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPR15L,Protein GPR15L,37896,0.00759573516807395,0.00509897281218135,-0.00239825154380149,0.0175897218799494,0.136337150030617
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ESM1,Endothelial cell-specific molecule 1,40352,-0.00427966657050492,0.00287352045230799,-0.00991176665702858,0.00135243351601873,0.136416079898365
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,37895,0.0041807581608695,0.00281207109721531,-0.00133090118967251,0.00969241751141152,0.13711262345
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,37623,0.00777487859319082,0.00523113263550023,-0.00247814137238963,0.0180278985587713,0.137231497904851
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,37709,-0.00574023363683355,0.00386812618449418,-0.0133217609584421,0.00184129368477503,0.137837195281539
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",37536,0.00726725931756274,0.00491487868166125,-0.0023659028984933,0.0169004215336188,0.139264812651906
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SHBG,Sex hormone-binding globulin,37982,-0.0067377497007394,0.00456054052642829,-0.0156764091325389,0.00220090973106004,0.139591303132006
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,40300,0.00697997948236252,0.00472928428930317,-0.00228941772467169,0.0162493766893967,0.139988971920826
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AKAP12,A-kinase anchor protein 12,37666,-0.00273019001907694,0.00184983303176247,-0.00635586276133139,0.000895482723177511,0.139991454199365
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TG,Thyroglobulin,37895,0.0146511704602739,0.00994792508803515,-0.00484676271227504,0.0341491036328227,0.140832007008846
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPR101,Probable G-protein coupled receptor 101,37536,-0.00806084521261906,0.0054798648433391,-0.0188013803055637,0.00267968988032558,0.141316940600924
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,37937,0.00496094456546381,0.00337307972289844,-0.00165029169141713,0.0115721808223447,0.141383068900768
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNTF,Ciliary neurotrophic factor,37536,0.00422260081534689,0.00287447439991059,-0.00141136900847786,0.00985657063917164,0.141857027041242
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,37557,0.00613228239618944,0.00417966541516746,-0.00205986181753877,0.0143244266099177,0.142353637613522
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AMBN,Ameloblastin,40039,-0.00369466997565084,0.00252101586444759,-0.00863586106996811,0.00124652111866643,0.142791614017152
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMOD4,Tropomodulin-4,37477,-0.00521058847530651,0.00356043167320573,-0.0121890345547897,0.00176785760417672,0.143362676307939
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,37895,0.00440439392846322,0.00301808854297495,-0.00151105961576768,0.0103198474726941,0.144497050336361
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,40039,0.00481226764021157,0.00329782823450784,-0.0016514756994238,0.0112760109798469,0.144523822549835
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DCN,Decorin,40037,-0.00281947447434147,0.00193511007891451,-0.00661229022901392,0.000973341280330974,0.145133804061928
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BLVRB,Flavin reductase,40327,0.00818719277037799,0.00562135174276891,-0.00283065664544908,0.0192050421862051,0.145289266522908
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,37709,0.00505117832206055,0.0034986290406481,-0.00180613459760973,0.0119084912417308,0.148830315873644
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,39956,0.00500642689926616,0.00347312360393951,-0.00180089536445528,0.0118137491629876,0.149470240144762
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SULT1A1,Sulfotransferase 1A1,40466,0.0156841847334428,0.0108829078991164,-0.0056463147488254,0.0370146842157111,0.149554543892448
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,37623,-0.004755521953155,0.00330161245304543,-0.011226682361124,0.00171563845481406,0.14978836381925
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",37557,0.0064444418507253,0.00448428750154469,-0.00234476165230229,0.0152336453537529,0.150708875878798
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENG,Endoglin,40531,-0.00207511389092848,0.00144467786604866,-0.00490668250838385,0.000756454726526885,0.150912220552657
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,37593,0.0130779642278162,0.00911570309897746,-0.0047888138461796,0.030944742301812,0.151406878557977
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LPO,Lactoperoxidase,39826,-0.00715959493259496,0.00501624021166743,-0.0169914257474631,0.00267223588227321,0.153518616490766
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL1R1,Interleukin-1 receptor type 1,40298,-0.00269523324738671,0.00189215133739942,-0.00640384986868957,0.00101338337391615,0.154342321185846
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C7,Complement component C7,37673,-0.00380052580708783,0.00266897940580355,-0.00903172544246279,0.00143067382828714,0.154481012371806
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCGB2A2,Mammaglobin-A,37557,-0.00386799163299622,0.00272214032475161,-0.00920338666950938,0.00146740340351694,0.155358683883854
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FEN1,Flap endonuclease 1,39975,0.00745949873464172,0.00525528549891895,-0.00284086084323942,0.0177598583125229,0.155794390100119
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,40281,-0.021559837698328,0.0152485429921344,-0.0514469819629114,0.00832730656625536,0.15741242000882
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,39975,0.00738083289056847,0.0052208179072146,-0.00285197020757214,0.0176136359887091,0.157460909854087
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,40279,0.00417875927735973,0.00296085375756009,-0.00162451408745805,0.00998203264217751,0.158165243393063
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,37593,0.00835360999249733,0.00592430236489498,-0.00325802264269682,0.0199652426276915,0.158546222699088
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,37557,-0.00487900432926791,0.00346786821464997,-0.0116760260299819,0.00191801737144604,0.159475580785651
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,37623,0.00502137987436419,0.00357137521918127,-0.00197851555523111,0.0120212753039595,0.159745526814253
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CYTH3,Cytohesin-3,37477,-0.00877993151564679,0.00627362650313254,-0.0210762394617866,0.00351637643049299,0.161687332408595
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,40300,-0.00650110598927578,0.00464638828544295,-0.015608027028744,0.0026058150501924,0.161780362676238
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,37536,0.00594532009990935,0.00425605828345381,-0.00239655413566012,0.0142871943354788,0.162465054619574
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AHNAK2,Protein AHNAK2,37623,-0.00336954131888383,0.00241698258517059,-0.00810682718581818,0.00136774454805053,0.163307691353006
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37896,0.00929822797896951,0.00670697037029333,-0.00384743394680542,0.0224438899047444,0.165662154132122
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TLR2,Toll-like receptor 2,37709,0.00270369177570181,0.00195211235492992,-0.00112244843996083,0.00652983199136444,0.16607324099417
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,37557,-0.00374052699144113,0.0027019604774152,-0.00903636952717493,0.00155531554429266,0.166267179794836
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC3B,Tetranectin,37676,0.00246430212644221,0.00178090718336658,-0.0010262759529563,0.00595488020584071,0.166463221237995
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINA11,Serpin A11,40531,0.00469558530379809,0.00340379054111396,-0.00197584415678526,0.0113670147643814,0.16775473896224
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,40336,-0.00423767920283829,0.00307433712329744,-0.0102633799645013,0.00178802155882469,0.168097941104036
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,37536,0.00582171677312133,0.00422791707458788,-0.00246500069307091,0.0141084342393136,0.168544949745269
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNPO1,Transportin-1,37709,0.00414627188749193,0.0030139087124243,-0.0017609891888597,0.0100535329638436,0.168933902482538
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLAMF7,SLAM family member 7,40336,0.00671939345302093,0.00488892676670107,-0.00286290300971317,0.016301689915755,0.169333594282758
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAB44,Ras-related protein Rab-44,37895,0.004625608713344,0.00337365492263991,-0.00198675493503021,0.0112379723617182,0.170367555301256
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,37559,0.00443154889264848,0.00323345182690763,-0.00190601668809046,0.0107691144733874,0.170544393430714
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BRD3,Bromodomain-containing protein 3,37557,0.00563045609140737,0.00411110258234765,-0.00242730496999403,0.0136882171528088,0.170843624195564
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",37955,0.00490231809783074,0.00358004201167537,-0.00211456424505298,0.0119192004407145,0.170913754227349
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,39956,0.0078357233962307,0.00573244885788347,-0.0033998763652209,0.0190713231576823,0.171674335666628
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,37536,0.00855633200911551,0.00626536983736973,-0.00372379287212916,0.0208364568903602,0.172070832402645
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,40354,0.00202028813877909,0.00148161255279244,-0.000883672464694089,0.00492424874225226,0.172721028282892
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,37623,-0.00270380241636109,0.00198291045888371,-0.00659030691577315,0.00118270208305098,0.172731770616364
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,37593,0.0049661553445152,0.00364337926984683,-0.00217486802438459,0.012107178713415,0.17288602216714
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGF20,Fibroblast growth factor 20,37593,0.00515612367776625,0.00378700935946303,-0.00226641466678129,0.0125786620223138,0.173369866971032
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,40417,-0.00478665795266196,0.00352053041042507,-0.0116868975570951,0.00211358165177117,0.173962716939597
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,37536,0.0104957621499327,0.00772572060286741,-0.00464665023168738,0.0256381745315529,0.174313288802125
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DKK3,Dickkopf-related protein 3,40531,0.00338889141538331,0.00249481091676,-0.0015009379814663,0.00827872081223291,0.174363445326477
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TF,Serotransferrin,38008,-0.00250154124821269,0.00184598164929115,-0.00611966528082335,0.00111658278439797,0.175399388709647
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,37593,0.00359226680906027,0.00265766243601489,-0.00161675156552891,0.00880128518364945,0.176506071361225
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MSTN,Growth/differentiation factor 8,40037,-0.00585597726922661,0.00433740039237174,-0.0143572820382752,0.002645327499822,0.17699959592563
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EXOSC10,Exosome component 10,37557,0.00718869049250018,0.00533685189597444,-0.00327153922360972,0.0176489202086101,0.178006481745736
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLB,Beta-klotho,39956,-0.00839463256627317,0.0062334872539469,-0.0206122675840091,0.00382300245146275,0.178096801573126
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DPEP1,Dipeptidase 1,40187,-0.00579003473124116,0.00430076936067795,-0.0142195426781699,0.00263947321568762,0.178232004926575
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,39956,0.00439499567620965,0.00327087420362395,-0.0020159177628933,0.0108059091153126,0.17907279526968
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,39956,0.00952547616164012,0.00709750991438778,-0.00438564327055994,0.0234365955938402,0.179587424420381
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,37557,0.00430540456435646,0.00321448482142993,-0.00199498568564619,0.0106057948143591,0.180471451016468
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TSC1,Hamartin,37593,0.00862663633391966,0.00645693821110238,-0.004028962559841,0.0212822352276803,0.181563961098402
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,37895,0.0065073497192486,0.00487327670970494,-0.00304427263177309,0.0160589720702703,0.181796536879525
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,40369,0.00644214595237511,0.00482808869233215,-0.0030209078845959,0.0159051997893461,0.182122799641498
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NOS2,"Nitric oxide synthase, inducible",37557,0.00445210711230034,0.00333755704376509,-0.00208950469347925,0.0109937189180799,0.182246086292068
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",37593,0.00409830421295831,0.00307362505710687,-0.00192600089897115,0.0101226093248878,0.182430881458561
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,40037,0.00372067923563916,0.00279447581045526,-0.00175649335285314,0.00919785182413146,0.183063470955755
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRKCQ,Protein kinase C theta type,40039,0.00501010110988735,0.00376815492412637,-0.00237548254140034,0.012395684761175,0.183672851925896
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PALM3,Paralemmin-3,37557,0.00815073434581716,0.00615871895626034,-0.0039203548084531,0.0202218235000874,0.185710062058914
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,39975,-0.0135954698107457,0.0102844189229526,-0.0337529308997329,0.00656199127824143,0.186204856671366
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL20,Interleukin-20,40039,0.00571658273152749,0.00433318219425286,-0.00277645436920812,0.0142096198322631,0.187102448946872
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,40336,-0.00589685882151107,0.0044947626692536,-0.0147065936532481,0.00291287601022598,0.189559348257136
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",37895,0.00573226920251976,0.00438049928056321,-0.00285350938738413,0.0143180477924236,0.190696287403009
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEPTIN3,Neuronal-specific septin-3,37955,0.00816594340598779,0.00624097370839524,-0.00406636506246689,0.0203982518744425,0.190746178674851
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAB6B,Ras-related protein Rab-6B,39956,0.00539268507337477,0.00413865203246257,-0.00271907291025187,0.0135044430570014,0.192592341408998
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLK11,Kallikrein-11,40255,0.00328702380717425,0.00252513795017767,-0.00166224657517398,0.00823629418952248,0.193030927561575
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,37593,-0.00687558680043944,0.00529235772952379,-0.0172486079503061,0.00349743434942718,0.193913936398023
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AOC3,Membrane primary amine oxidase,40398,0.00334828779581145,0.00257969958538383,-0.00170792339154086,0.00840449898316376,0.19432772401869
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLASP1,CLIP-associating protein 1,37477,0.00787046889145155,0.00606718843517764,-0.00402122044149662,0.0197621582243997,0.194579004177782
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LACRT,Extracellular glycoprotein lacritin,37858,-0.00584164710821013,0.0045037998270263,-0.0146690947691817,0.00298580055276142,0.194636798600099
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,37557,0.00789188226675807,0.00608553234462244,-0.00403576112870192,0.0198195256622181,0.194713572475139
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BCAM,Basal cell adhesion molecule,40327,0.00259615861413233,0.00200766833898634,-0.00133887133028088,0.00653118855854555,0.1959879400747
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ECM1,Extracellular matrix protein 1,37650,0.00402740712799153,0.00313548867069239,-0.00211815066656555,0.0101729649225486,0.199003891076836
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,37567,0.00587935530471593,0.00458105040002117,-0.00309950347932556,0.0148582140887574,0.199371957995786
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AMY2B,Alpha-amylase 2B,39306,0.00522796553059817,0.00407795307427359,-0.00276482249497806,0.0132207535561744,0.199860100809459
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AMY2A,Pancreatic alpha-amylase,39690,0.00511721197547179,0.00399206879017725,-0.00270724285327561,0.0129416668042192,0.199916654490595
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,37536,0.00667522019268743,0.00521168120589855,-0.00353967497087372,0.0168901153562486,0.200279959270738
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TEX101,Testis-expressed protein 101,37567,0.00424901379571049,0.00334421190025367,-0.0023056415287867,0.0108036691202077,0.203908622187219
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,40398,0.00357938892095828,0.00282055201584404,-0.00194889303009604,0.0091076708720126,0.204445878305724
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,40336,0.00365238415929953,0.0028835918295887,-0.00199945582669431,0.00930422414529337,0.205313606846675
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PKLR,Pyruvate kinase PKLR,40369,-0.00715431257248021,0.0056511990946263,-0.0182306627979478,0.00392203765298733,0.205538293381429
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,37955,0.002854378834165,0.00225543846326506,-0.00156628055383452,0.00727503822216453,0.205694693209318
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PCNA,Proliferating cell nuclear antigen,37477,0.00668592123688751,0.00531834996630152,-0.00373804469706347,0.0171098871708385,0.208724754197649
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LYZL2,Lysozyme-like protein 2,37477,0.0038121069668952,0.00304502852623321,-0.00215614894452188,0.00978036287831229,0.210624506332808
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,37593,0.00684097422351447,0.00547128543445208,-0.0038827452280116,0.0175646936750405,0.211197156212702
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEZ6L2,Seizure 6-like protein 2,40300,0.00252191031202855,0.00201763250679885,-0.00143264940129718,0.00647647002535429,0.211341600522261
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL17A,Interleukin-17A,40023,0.0045275239916632,0.00362328353716745,-0.00257411174118501,0.0116291597245114,0.211477710975219
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,39956,0.00592812475525457,0.00474605272717209,-0.00337413859000273,0.0152303881005119,0.211660435752107
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SUSD2,Sushi domain-containing protein 2,40327,-0.00302423163519114,0.00242694172447167,-0.00778103741515562,0.00173257414477333,0.212743116006152
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NEO1,Neogenin,37955,-0.00224704922116602,0.00180528054122982,-0.00578539908197646,0.00129130063964442,0.213260281154864
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TEX33,Testis-expressed protein 33,37709,0.00416616272906529,0.00335444406692475,-0.00240854764210722,0.0107408731002378,0.214264780924255
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PODXL,Podocalyxin,40300,0.0016000533088449,0.00129140738861141,-0.00093110517283347,0.00413121179052326,0.215363975221222
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,40336,-0.00577154478584397,0.00467068628209256,-0.0149260898987454,0.00338300032705746,0.216590143807504
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ABO,Histo-blood group ABO system transferase,37982,0.0150613853062826,0.0122210780291481,-0.00889192763084762,0.0390146982434128,0.217817182713439
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDC123,Cell division cycle protein 123 homolog,37477,-0.00670485565790026,0.00545289620443263,-0.0173925322185882,0.00398282090278769,0.218870893336118
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,37567,0.00427516166393086,0.00351813255221044,-0.0026203781384016,0.0111707014662633,0.224319609465674
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GAST,Gastrin,37937,-0.0133678717738372,0.0110023670847203,-0.034932511259889,0.00819676771221464,0.224387511149352
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,37896,0.00709853078360367,0.00584808893726894,-0.00436372353344344,0.0185607851006508,0.224837563682374
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,40354,0.0068286261330478,0.00562973815155833,-0.00420566064400653,0.0178629129101021,0.225164561904412
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,37993,0.00602150458019496,0.00497897371490183,-0.00373728390101263,0.0157802930614026,0.226535431111302
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SHD,SH2 domain-containing adapter protein D,37526,0.00900621545078927,0.00745884291755753,-0.00561311666762349,0.023625547569202,0.227278897416713
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,40374,-0.00273027319158503,0.0022612917383774,-0.00716240499880475,0.00170185861563468,0.227297850485625
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL17F,Interleukin-17F,40039,0.00813993324829591,0.00674857678783541,-0.00508727725586148,0.0213671437524533,0.227770119961348
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RLN1,Prorelaxin H1,37955,-0.00842376098132288,0.00698725027003973,-0.0221187715106008,0.00527124954795499,0.227996635846407
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,37477,0.00644331991624801,0.00540058813133478,-0.00414183282116815,0.0170284726536642,0.23286077397859
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPM1B,Protein phosphatase 1B,37593,0.00639271282043005,0.00537176197394237,-0.004135940648497,0.0169213662893571,0.234044765565419
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,37567,-0.0038110821657687,0.00320313783586583,-0.0100892323240657,0.00246706799252832,0.234147926121836
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PCDH17,Protocadherin-17,40354,0.00351313230461174,0.00295477545500835,-0.00227822758720463,0.00930449219642811,0.234470167717186
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,38008,0.00191287009439505,0.0016095949584749,-0.00124193602421576,0.00506767621300586,0.234689960953837
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDK1,Cyclin-dependent kinase 1,37477,0.00368165135439645,0.00311124699016848,-0.00241639274633377,0.00977969545512666,0.23669750775503
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CADPS,Calcium-dependent secretion activator 1,37567,0.00453364310389571,0.0038349080118708,-0.00298277659937106,0.0120500628071625,0.23714624948476
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WIF1,Wnt inhibitory factor 1,40484,0.003412425189531,0.00290047717213861,-0.00227251006786067,0.00909736044692266,0.239410700946804
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MEP1B,Meprin A subunit beta,40354,0.0117964177192417,0.0100329622485765,-0.00786818828796827,0.0314610237264516,0.239705925982998
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGB1,Integrin beta-1,40328,0.00218377577935821,0.00185743739802635,-0.00145680152077345,0.00582435307948986,0.239735286289749
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SFRP4,Secreted frizzled-related protein 4,37666,-0.00415534114543994,0.00354538550627486,-0.0111042967377387,0.00279361444685879,0.241201276520642
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAP1A,Ras-related protein Rap-1A,37593,0.00690986112835265,0.00590502089494038,-0.00466397982573049,0.0184837020824358,0.241954954367482
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PGR,Progesterone receptor,37593,0.0102113788419898,0.00877126006023332,-0.00698029087606751,0.0274030485600471,0.244369746665443
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENPEP,Glutamyl aminopeptidase,37557,0.00457373537884104,0.00394023165140744,-0.00314911865791755,0.0122965894155996,0.245753215833703
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,37896,0.0125800007036074,0.0108979815312735,-0.00878004309768865,0.0339400445049035,0.248380393187679
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CX3CL1,Fractalkine,40223,0.00333991540164945,0.00289496475839814,-0.00233421552481089,0.0090140463281098,0.248641437939087
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD207,C-type lectin domain family 4 member K,40024,0.00375666647333719,0.00325858010319256,-0.00263015052892023,0.0101434834755946,0.248988091545758
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,37623,-0.00199372920442128,0.00172979313811551,-0.00538412375512769,0.00139666534628512,0.249102730233255
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,37593,0.00345958246846079,0.00300520075184311,-0.0024306110051517,0.00934977594207329,0.249671545239639
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",40374,0.00335136822103753,0.00291271103308104,-0.00235754540380132,0.00906028184587637,0.249913702028921
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,40300,0.00442517851090871,0.00385695701772701,-0.00313445724383623,0.0119848142656537,0.251265148711975
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LCN15,Lipocalin-15,37955,-0.00618619195958342,0.00540064413638819,-0.0167714544669043,0.00439907054773743,0.252041246699573
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPARCL1,SPARC-like protein 1,40341,-0.00267114132878835,0.00234337130566574,-0.0072641490878932,0.00192186643031649,0.254357171446045
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HCG22,Protein PBMUCL2,37557,0.00515434861152123,0.00453780567565705,-0.00373975051276659,0.0140484477358091,0.256032551627182
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAG,Myelin-associated glycoprotein,37567,0.00450489864368074,0.00396879333537388,-0.00327393629365207,0.0122837335810135,0.256362469996902
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LIPF,Gastric triacylglycerol lipase,37623,-0.00571668479748338,0.00504134579168533,-0.0155977225491866,0.00416435295421987,0.256831938697024
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PGA4,Pepsin A-4,37982,-0.00652755448620129,0.00576009548840464,-0.0178173416434744,0.0047622326710718,0.257134736116547
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COL2A1,Collagen alpha-1(II) chain,37623,0.00784864451058361,0.00694138121601269,-0.00575646267280126,0.0214537516939685,0.258200467576727
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,37557,0.00311806123599563,0.00275894049395916,-0.00228946213216433,0.00852558460415559,0.258426892083046
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CASQ2,Calsequestrin-2,37557,0.00480200050105199,0.0042603519603713,-0.00354828934127575,0.0131522903433797,0.259705181722939
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,37567,0.00345790867494857,0.00306949333072053,-0.00255829825326367,0.00947411560316081,0.259957403005835
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,37709,0.00616870158377507,0.00547791891011825,-0.00456801948005669,0.0169054226476068,0.260142257539137
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,37557,0.00517032554645381,0.00459401018086424,-0.0038339344080401,0.0141745855009477,0.26041930047596
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,37534,0.00390905152502668,0.00348082862326691,-0.00291337257657645,0.0107314756266298,0.261448222927522
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCARB1,Scavenger receptor class B member 1,39956,0.00562924046088411,0.00503010698365744,-0.00422976922708447,0.0154882501488527,0.263110769477404
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,37557,0.0044958040680686,0.00402567656066903,-0.00339452199084271,0.0123861301269799,0.264107921030319
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CST1,Cystatin-SN,36174,-0.00988687024733494,0.00886029970438847,-0.0272530576679363,0.00747931717326646,0.264504156430807
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXCL14,C-X-C motif chemokine 14,40039,-0.00580665109803191,0.00521139411046658,-0.0160209835545464,0.00440768135848259,0.265201046988962
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHGA,Chromogranin-A,37993,-0.00847304770884631,0.007632952943755,-0.0234336354786061,0.0064875400609135,0.266992209012673
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,37477,0.00542661708964563,0.0048949923459207,-0.00416756790835894,0.0150208020876502,0.267620728192299
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NENF,Neudesin,37895,0.0101674509739539,0.00917226247168928,-0.00781018347055708,0.0281450854184649,0.267665863460977
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GKN1,Gastrokine-1,39597,-0.00261709180536295,0.0023694829900913,-0.0072612784659419,0.00202709485521601,0.269394245290631
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPHB4,Ephrin type-B receptor 4,40531,0.00230394155191588,0.00208716362405904,-0.00178689915123983,0.00639478225507159,0.269669329088654
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PCDH1,Protocadherin-1,40470,0.00203557012874926,0.00184578098169513,-0.0015821605953732,0.00565330085287172,0.27012051017161
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PAPPA,Pappalysin-1,40039,0.00440136354919967,0.00399225872063771,-0.00342346354325025,0.0122261906416496,0.270272448290986
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL31,Interleukin-31,37593,0.00543270411975173,0.00493004830754517,-0.0042301905630368,0.0150955988025403,0.270500294330469
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GH2,Growth hormone variant,39975,0.0157913640827937,0.0143322389547649,-0.0122998242685455,0.0438825524341329,0.27056258222197
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,37593,0.00818392375128267,0.00743017125186766,-0.00637921190237794,0.0227470594049433,0.270723274654541
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,37477,-0.00768508351301297,0.00698270587565302,-0.0213711870292929,0.00600102000326695,0.271096273872059
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NGF,Beta-nerve growth factor,40223,-0.00113446346440133,0.00103328976949355,-0.00315971141260869,0.000890784483806023,0.272258738036969
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPQ,Carboxypeptidase Q,37981,-0.00338436199823114,0.00308606861017537,-0.00943305647417487,0.00266433247771259,0.272810418631024
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GAD1,Glutamate decarboxylase 1,37477,-0.00240788085389493,0.00219891070232208,-0.00671774583044621,0.00190198412265634,0.273522214168635
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37985,0.00304979859453244,0.00278940571979477,-0.00241743661626531,0.00851703380533019,0.274259327749284
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FAM3C,Protein FAM3C,40325,0.00274592847806158,0.00251525124645363,-0.00218396396498753,0.00767582092111069,0.274976539724425
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL11,Interleukin-11,40039,0.00591334411234199,0.00542353211519402,-0.00471677883343828,0.0165434670581223,0.275592426205137
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,37993,0.00271232694618208,0.00249741348628116,-0.00218260348692899,0.00760725737929314,0.277474251141948
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,37955,-0.00301982290193104,0.00278065477788587,-0.00846990626658735,0.00243026046272526,0.277493317492691
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,37593,0.00377170231669324,0.00347584130808313,-0.0030409466471497,0.0105843512805362,0.277888748226592
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NOS1,"Nitric oxide synthase, brain",39956,0.00458815234262156,0.00423044535592214,-0.00370352055498584,0.012879825240229,0.278135483238768
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,S100A3,Protein S100-A3,37895,-0.00421420985754498,0.00389125012305261,-0.0118410600987281,0.00341264038363813,0.278829447449082
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KHDC3L,KH domain-containing protein 3,37477,-0.00628213773256196,0.00580265017577563,-0.0176553320770822,0.00509105661195828,0.278991612441559
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,39975,0.00371698154660163,0.00344701310395976,-0.0030391641371595,0.0104731272303628,0.280907940517151
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,37955,0.0071523482373458,0.00664093818739172,-0.00586389060994198,0.0201685870846336,0.281495617597213
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,37895,-0.00435205556710253,0.00405355879759086,-0.0122970308103806,0.00359291967617556,0.283004141353321
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AGT,Angiotensinogen,37982,0.0021996134742814,0.00205082974021871,-0.00182001281654728,0.00621923976511008,0.283493065850211
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,40417,0.00252902383841848,0.00236209217045585,-0.00210067681567498,0.00715872449251195,0.284333524477356
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FMR1,Synaptic functional regulator FMR1,39975,0.00318732661202374,0.00298118901325824,-0.0026558038539624,0.00903045707800989,0.285020465672054
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,37557,0.00353354770049911,0.0033078919995103,-0.00294992061854109,0.0100170160195393,0.285442146392411
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSCA,Prostate stem cell antigen,37896,-0.023475626331121,0.0220079711142763,-0.0666112497151026,0.0196599970528606,0.286132156165613
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,37985,-0.00294625917105473,0.00276300212890276,-0.00836174334370413,0.00246922500159468,0.286295623489855
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,40354,0.00232378883071397,0.0021852054562592,-0.00195921386355407,0.006606791524982,0.287608163455351
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLINT1,Clathrin interactor 1,37477,0.00414369017987591,0.00390570039517309,-0.00351148259466335,0.0117988629544152,0.288739587121122
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CBX2,Chromobox protein homolog 2,37557,-0.0036868028915689,0.00349375917757557,-0.010534570879617,0.00316096509647921,0.291328686328416
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,40037,0.00496513208662238,0.00470529456041932,-0.00425724525179948,0.0141875094250442,0.29133999220253
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TXNL1,Thioredoxin-like protein 1,37520,-0.00853507261966241,0.00808928578737683,-0.024390072762921,0.00731992752359618,0.291395300070151
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPHA4,Ephrin type-A receptor 4,37666,-0.00251554569705746,0.00239088189870612,-0.00720167421852146,0.00217058282440654,0.292753944950772
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PADI2,Protein-arginine deiminase type-2,40039,0.00500742096850834,0.00476219302528102,-0.00432647736104245,0.0143413192980591,0.293047720011883
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NLGN1,Neuroligin-1,37567,0.00622642956170131,0.00592995779760309,-0.00539628772160074,0.0178491468450034,0.293739485725235
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EGFLAM,Pikachurin,37896,-0.00272573789244408,0.00260290331885877,-0.00782742839740727,0.00237595261251911,0.29503015088494
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEP290,Centrosomal protein of 290 kDa,37709,0.0047391243482485,0.00452588059364079,-0.00413160161528745,0.0136098503117845,0.295064930218237
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL1R2,Interleukin-1 receptor type 2,40325,-0.0017329694553119,0.00165532113859489,-0.00497739888695788,0.00151145997633408,0.295157810107101
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,40327,-0.00288165784552728,0.00275424183196669,-0.00827997183618198,0.00251665614512743,0.295456135526325
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,37593,0.00517364191480799,0.0049612760246065,-0.00455045909342074,0.0148977429230367,0.29705794140952
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CYB5A,Cytochrome b5,37477,0.00649849464337422,0.0062401519174097,-0.00573220311474879,0.0187291924014972,0.297709239426147
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCND2,G1/S-specific cyclin-D2,37709,0.00323970244465212,0.00311609626438116,-0.00286784623353495,0.00934725112283919,0.298513599616664
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",37477,0.00437165191091792,0.00421198387096368,-0.00388383647617089,0.0126271402980067,0.299332138758709
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,40511,0.00320385440474463,0.00309461920405393,-0.00286159923520108,0.00926930804469034,0.300545152015977
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SHH,Sonic hedgehog protein,37593,-0.00380444998088114,0.0036803062320079,-0.0110178501956166,0.00340895023385435,0.301280535455329
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,39975,0.00673378311487194,0.0065166711892446,-0.00603889241604747,0.0195064586457914,0.301471959871858
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DLL4,Delta-like protein 4,37623,0.00735278092774236,0.00712212366630184,-0.00660658145820925,0.021312143313694,0.301910272972848
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CAPN3,Calpain-3,37895,-0.00323868383201871,0.00314575612157211,-0.00940436583030004,0.00292699816626263,0.303244206631145
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL21R,Interleukin-21 receptor,37593,0.00483841168124214,0.00474438924548246,-0.00446059123990347,0.0141374146023878,0.307833746039242
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TCP11,T-complex protein 11 homolog,37709,-0.00526558703210789,0.00516362345451047,-0.0153862890029484,0.00485511493873262,0.307867302901679
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,37709,0.00646946990624012,0.00634538308708115,-0.00596748094443893,0.0189064207569192,0.307957948048574
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,37593,0.00317328567719521,0.0031266457734498,-0.0029549400387664,0.00930151139315682,0.310164120849527
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,39956,0.00424454298783715,0.00422015804055467,-0.00402696677165,0.0125160527473243,0.314537969377554
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APOH,Beta-2-glycoprotein 1,40327,0.00302122380397981,0.00300727822169999,-0.00287304151055217,0.00891548911851178,0.31508685321568
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLK15,Kallikrein-15,37875,-0.00434824780765167,0.00433903463864447,-0.0128527556993948,0.00415626008409149,0.316302099590219
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SOX9,Transcription factor SOX-9,37567,0.00231070279304458,0.00231022839081502,-0.00221734485295285,0.00683875043904201,0.317229594712203
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ERVV_1,,37557,0.00410644728507338,0.0041066137803821,-0.00394251572447553,0.0121554102946223,0.317348591700429
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,40327,-0.00263247450431684,0.00266619177349964,-0.00785821038037613,0.00259326137174245,0.323484286486976
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEP350,Centrosome-associated protein 350,37477,0.00313647390812129,0.00318760980516919,-0.00311124131001031,0.0093841891262529,0.325154480942057
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL22,Interleukin-22,37895,-0.00543590573674657,0.00552603435935042,-0.0162669330810734,0.00539512160758025,0.325285572851244
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLNS1A,Methylosome subunit pICln,37567,-0.00280286038683965,0.00286041417236527,-0.00840927216467557,0.00280355139099627,0.327163819873432
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,40352,-0.00316480123402209,0.00324302184268647,-0.00952112404568758,0.0031915215776434,0.329138616211198
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,37709,0.00586832343577333,0.00601855971920686,-0.00592805361387211,0.0176647004854188,0.329559283804475
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLK3,Prostate-specific antigen,37993,0.00471613706990113,0.00483751878427685,-0.00476539974728151,0.0141976738870838,0.329623178783782
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CST6,Cystatin-M,39987,0.00394243129556479,0.0040443449402173,-0.00398448478726112,0.0118693473783907,0.329674183423191
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OXT,Oxytocin-neurophysin 1,40466,0.0108458119242448,0.011177865341358,-0.0110628041448169,0.0327544279933065,0.331914788769608
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,37982,0.00389233758099794,0.00401211562782108,-0.00397140904953137,0.0117560842115273,0.331991108032868
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FOSB,Protein fosB,39956,0.00321421492603943,0.00331597025460688,-0.00328508677299005,0.00971351662506892,0.33240388742558
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OSTN,Osteocrin,37567,-0.00353815063310181,0.00366433292895555,-0.0107202431738547,0.00364394190765107,0.334279835284743
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MMP13,Collagenase 3,39956,-0.00269984819762709,0.00279631297112923,-0.00818062162104038,0.00278092522578619,0.334308058930301
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TBC1D17,TBC1 domain family member 17,39956,0.00375420363216452,0.00389900423005616,-0.00388784465874555,0.0113962519230746,0.335631718605349
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MANSC1,MANSC domain-containing protein 1,40406,0.00223861160925055,0.00232688560124828,-0.00232208416919608,0.00679930738769718,0.336032309068445
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,37896,0.00398220993254722,0.00414717282537416,-0.00414624880518613,0.0121106686702806,0.336960359255776
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMPRSS5,Transmembrane protease serine 5,40154,0.00306116416621507,0.00320219503897945,-0.00321513811018464,0.00933746644261479,0.339108139658886
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,37536,-0.00439796031391136,0.00460487245566724,-0.0134235103270192,0.00462758969919644,0.339561615246278
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,37955,0.00273307070734554,0.00286442408311621,-0.00288120049556223,0.00834734191025332,0.340028250861156
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SUSD5,Sushi domain-containing protein 5,37599,0.0027695894298777,0.00290357996129991,-0.00292142729427013,0.00846060615402553,0.340175424387882
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GUK1,Guanylate kinase,37557,0.003244316772207,0.00341152481582546,-0.00344227186681089,0.0099309054112249,0.341628361052782
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPON2,Spondin-2,40262,-0.00277035239874166,0.00292743035858108,-0.00850811590156057,0.00296741110407726,0.343988275391082
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,37593,-0.00243229833675191,0.00257618787704873,-0.00748162657576742,0.00261702990226359,0.345112233477816
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TTN,Titin,37557,-0.00526291639592046,0.00557641335229817,-0.0161926865664249,0.00566685377458395,0.345298656472191
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MME,Neprilysin,40300,0.00650280192774594,0.00690055036976175,-0.0070222767969871,0.020027880652479,0.346022776874775
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,37477,0.00617472161364481,0.00657155265436285,-0.00670552158890637,0.019054964816196,0.347433115128215
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,37709,-0.00357678475328831,0.00381956590509969,-0.0110631339272837,0.00390956442070709,0.349065035166063
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ESPL1,Separin,37477,-0.00456543581047063,0.00487582968413479,-0.0141220619913748,0.00499119037043356,0.349115367101544
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",37557,-0.0030401891862298,0.00325577436559847,-0.0094215069428028,0.00334112857034321,0.350432659243294
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HSP90B1,Endoplasmin,39873,0.00554764136730766,0.00595828231955232,-0.00613059197901488,0.0172258747136302,0.351826423336723
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ISM1,Isthmin-1,40336,-0.00307194048970742,0.00330079959955789,-0.00954150770484088,0.00339762672542603,0.352040736880918
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,37709,0.00399121144431804,0.00429553075365489,-0.00442802883284554,0.0124104517214816,0.352825975470952
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DUOX2,Dual oxidase 2,40037,0.00570068066380647,0.00615683600334826,-0.00636671790275613,0.0177680792303691,0.354506699291871
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SSB,Lupus La protein,39956,0.0046851036491331,0.00512408943884279,-0.00535811165099877,0.014728318949265,0.36055820793177
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GSN,Gelsolin,37923,0.00146966518531146,0.00161157466836564,-0.00168902116468519,0.00462835153530812,0.361814733496459
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,37557,-0.00311967344628523,0.0034219553358913,-0.00982670590463217,0.00358735901206172,0.361962396263385
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",37593,0.00270957290223097,0.00297475217109979,-0.00312094135312463,0.00854008715758657,0.362387597836714
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDH22,Cadherin-22,37709,0.00227144812126116,0.00250450761670768,-0.0026373868074859,0.00718028305000821,0.364452903343695
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,40406,0.00323732173435982,0.00360493954480284,-0.00382835977345374,0.0103030032421734,0.369186379671235
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PALLD,Palladin,37593,0.0031302528802479,0.00351680933929785,-0.00376269342477588,0.0100231991852717,0.373437512107036
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRND,Prion-like protein doppel,37937,-0.00400217955729074,0.00454278833504715,-0.0129060446939832,0.00490168557940168,0.378335542739322
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HK2,Hexokinase-2,40037,-0.00206707428486473,0.00234927938845617,-0.00667166188623882,0.00253751331650936,0.378940115629537
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",37536,0.00458554554726164,0.00522029933429346,-0.00564624114795355,0.0148173322424768,0.379739217830054
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LUZP2,Leucine zipper protein 2,37895,0.00331823499268842,0.00378280452901844,-0.00409606188418772,0.0107325318695646,0.380399597841679
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,37985,-0.00441595220865011,0.00503550550132178,-0.0142855429912408,0.00545363857394058,0.380522280850045
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PMCH,Pro-MCH,37557,0.00631639028937418,0.00721453428139315,-0.0078240969021564,0.0204568774809048,0.381313016529469
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",37567,0.00314428645866058,0.00359854686906478,-0.00390886540470638,0.0101974383220275,0.38226191719746
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UROS,Uroporphyrinogen-III synthase,37567,-0.00518156518359449,0.00596866455035202,-0.0168801477022844,0.00651701733509546,0.385340115484193
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,37709,0.00277653202279558,0.00320125016604422,-0.00349791830265109,0.00905098234824226,0.385778339640385
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPR158,Probable G-protein coupled receptor 158,37955,0.00269684549750948,0.00312261970095187,-0.00342348911635619,0.00881718011137515,0.387796409567983
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,37452,0.00376867793896599,0.00437383195572074,-0.00480403269424665,0.0123413885721786,0.388900365301947
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SAG,S-arrestin,37536,-0.00390262307768609,0.0045312218455488,-0.0127838178949617,0.00497857173958956,0.389102994127899
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,37623,-0.0191064325401786,0.0221876579827181,-0.0625942421863061,0.0243813771059489,0.389182753755607
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NPTX2,Neuronal pentraxin-2,37993,0.00237636916666663,0.00276126670764948,-0.00303571358032636,0.00778845191365961,0.389469026538014
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,40039,0.00280439997866682,0.00327049914607094,-0.00360577834763221,0.00921457830496586,0.39119075759067
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EDNRB,Endothelin receptor type B,37593,0.00344209163578464,0.00401432727829902,-0.00442598982968143,0.0113101731012507,0.391210950057785
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APLP1,Amyloid-like protein 1,40354,0.00377902659404764,0.00440735500916102,-0.00485938922390795,0.0124174424120032,0.391216673998095
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CBLN4,Cerebellin-4,40484,0.00228682719275763,0.00266830016932617,-0.00294304113912167,0.00751669552463693,0.391438236957243
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TP53BP1,TP53-binding protein 1,37593,0.00642733447168584,0.00752955553678689,-0.00833059438041645,0.0211852633237881,0.393334424846417
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,37477,-0.00184371315578564,0.00217223693090086,-0.00610129754035132,0.00241387122878005,0.396029082596805
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,40327,0.00309410668192988,0.00367392818027889,-0.00410679255141675,0.0102950059152765,0.399700221905378
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VIM,Vimentin,40037,0.00843048791898197,0.0100455858106897,-0.0112588602699698,0.0281198361079337,0.401356984918061
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SAA4,Serum amyloid A-4 protein,38008,-0.00231913529154762,0.00276612022556296,-0.00774073093365102,0.00310246035055578,0.401816793592275
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BTNL10,Butyrophilin-like protein 10,37477,-0.00298398305785017,0.00355977958970457,-0.00996115105367112,0.00399318493797079,0.401906037371534
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL25,C-C motif chemokine 25,40511,-0.00346110567398586,0.00414216699168103,-0.0115797529776807,0.00465754162970896,0.403404500590815
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EBI3_IL27,Interleukin-27,40448,0.00220658353473691,0.00264237743457075,-0.00297247623702177,0.00738564330649558,0.403687911249767
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,37179,-0.0034468841879491,0.00414551536641093,-0.0115720943061145,0.00467832593021633,0.405722061924302
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BEX3,Protein BEX3,37477,0.00337667034680803,0.00406288216022785,-0.00458657868723855,0.0113399193808546,0.405931125448792
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,37623,0.00229106326904768,0.00276635904387988,-0.00313100045695688,0.00771312699505223,0.407579473731149
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLK8,Kallikrein-8,39797,-0.00249651831424366,0.00301751288460929,-0.00841084356807787,0.00341780693959055,0.408055515024171
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,37709,0.00394556193630758,0.00477178334780848,-0.00540713342539703,0.0132982572980122,0.408335438474779
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,37937,-0.00394953275976072,0.00477785809050978,-0.0133141346171599,0.00541506909763845,0.40846001864563
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,40328,-0.00519581086652573,0.00629688133946336,-0.0175376982918739,0.00714607655882246,0.409304312314549
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,40328,0.00676258429511187,0.00821743862033036,-0.00934359540073564,0.0228687639909594,0.410545799757164
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RALY,RNA-binding protein Raly,37895,0.00335453532128614,0.00408541543040575,-0.00465287892230912,0.0113619495648814,0.411603771485616
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,40531,0.00203857814989175,0.00248683032934283,-0.00283560929562019,0.00691276559540369,0.412371023052751
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RASA1,Ras GTPase-activating protein 1,39956,0.00225873801097645,0.00276399130450933,-0.00315868494586183,0.00767616096781473,0.413825807341227
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TET2,Methylcytosine dioxygenase TET2,37692,0.00699063282471331,0.00855839841865676,-0.00978382807585393,0.0237650937252806,0.414048546763649
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,37536,0.00492120817542401,0.00602690729428054,-0.00689153012136586,0.0167339464722139,0.414206478424176
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,39975,-0.00224245763667162,0.00275361446620646,-0.00763954199043628,0.00315462671709304,0.415446214232303
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRG3,Proteoglycan 3,37993,0.00344207799407588,0.00423504279052691,-0.00485860587535687,0.0117427618635086,0.416369337282104
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,37982,0.00240648276057233,0.00296200907017391,-0.00339905501696854,0.0082120205381132,0.416548052349298
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",39525,0.00197076041305347,0.00242744398067341,-0.0027870297890664,0.00672855061517335,0.416881067852429
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EXTL1,Exostosin-like 1,37557,-0.00328626659918237,0.00405265075182765,-0.0112294620727646,0.00465692887439983,0.417441779365562
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,37536,0.005396632844814,0.00666784767369502,-0.00767234859562823,0.0184656142852562,0.418327680420106
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,37895,0.00264466535972752,0.00327243390633896,-0.00376930509669684,0.00905863581615188,0.419010112907314
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,37623,0.00333099003391933,0.00412641926342886,-0.00475679172240124,0.0114187717902399,0.419545684406317
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL3,Interleukin-3,37477,0.00413252565683079,0.0051193779842615,-0.00590145519232176,0.0141665065059833,0.419547581112737
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,37593,0.0029840805684023,0.0037000016474333,-0.00426792266056697,0.0102360837973716,0.419964648508964
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NRTN,Neurturin,40039,0.0033801428349414,0.0042044431954216,-0.00486056582808494,0.0116208514979677,0.421440759745705
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,POSTN,Periostin,37993,-0.00257138374586263,0.00319953405364463,-0.00884247049100611,0.00369970299928086,0.42159912568405
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNTN5,Contactin-5,40362,0.0025168403925983,0.00313459687266949,-0.00362696947783389,0.00866065026303049,0.422031149178387
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ICAM2,Intercellular adhesion molecule 2,40531,0.00211332784465061,0.00264120096595154,-0.0030634260486144,0.00729008173791562,0.423642100650752
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,37709,-0.00576909536648771,0.00721216305654087,-0.0199049349573078,0.0083667442243324,0.423776150349881
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PCARE,Photoreceptor cilium actin regulator,37536,-0.00580793253504584,0.0073113571828689,-0.0201381926134689,0.0085223275433772,0.426993696765253
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PVR,Poliovirus receptor,40466,-0.00246811953617615,0.00310857303303505,-0.00856092268092486,0.00362468360857255,0.42722357396069
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,37567,0.00453376832138843,0.00571739450958086,-0.00667232491739006,0.0157398615601669,0.42780495902633
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,37687,-0.00374864601767756,0.00473066637467531,-0.0130207521120412,0.00552346007668604,0.428133552407858
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KDM3A,Lysine-specific demethylase 3A,37593,-0.00620915010289528,0.00784605448261948,-0.0215874168888295,0.00916911668303891,0.428741058339619
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",37593,-0.00307502863763773,0.00388689283547741,-0.0106933385951735,0.00454328131989799,0.428883747275179
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,YY1,Transcriptional repressor protein YY1,37593,0.00187565817205495,0.0023784962800358,-0.00278619453681522,0.00653751088092513,0.430365954721521
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NRXN3,Neurexin-3,37567,0.00233391200535022,0.00296576911246959,-0.00347899545509017,0.00814681946579061,0.431325355815638
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,37557,-0.00439708381465007,0.00560462034656708,-0.0153821396939215,0.00658797206462141,0.432733842290962
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DAND5,DAN domain family member 5,37593,0.00359330005467064,0.00461167089957659,-0.00544557490849948,0.0126321750178408,0.435890489412067
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SH3GL3,Endophilin-A3,37638,0.00548297523969962,0.00704339518580757,-0.00832207932448322,0.0192880298038825,0.436314037587668
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRTAC1,Cartilage acidic protein 1,40531,-0.00193018283272959,0.00248155976078394,-0.00679403996386611,0.00293367429840693,0.436692277647656
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SKIV2L,Helicase SKI2W,37557,0.00267083401594106,0.00344774081966963,-0.00408673799061143,0.00942840602249354,0.438553349740981
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",37937,-0.00397553004327361,0.00513298586388714,-0.0140361823364924,0.00608512224994518,0.438645005467838
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MORN4,MORN repeat-containing protein 4,37477,-0.00518483450431278,0.00671076011409609,-0.0183379243279411,0.00796825531931555,0.439764232674174
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",40039,0.00379772404174134,0.00491851299757262,-0.00584256143350101,0.0134380095169837,0.440050032867564
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MILR1,Allergin-1,40039,-0.00326851034892682,0.00423809841325716,-0.0115751832389109,0.00503816254105722,0.440587660057307
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,37557,0.00131302389632485,0.00171560711558527,-0.00204956605022227,0.00467561384287198,0.444082495857533
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],40039,0.00371567007032746,0.00487054442333339,-0.00583059699940598,0.0132619371400609,0.445542941455867
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,37557,0.00457352117870845,0.00599576979744639,-0.00717818762428647,0.0163252299817034,0.445601586154527
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL36G,Interleukin-36 gamma,37546,-0.00442974331461872,0.00583140924636767,-0.0158593054374993,0.0069998188082619,0.447486390513453
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,37557,-0.00385620053988952,0.00508997193854782,-0.0138325455394432,0.00612014445966419,0.448699655124297
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DCC,Netrin receptor DCC,37567,0.00150610703336368,0.00198810435787095,-0.00239057750806339,0.00540279157479075,0.448728437323721
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KCNIP4,Kv channel-interacting protein 4,39956,0.0032978180697013,0.00435380926894198,-0.00523564809742497,0.0118312842368276,0.448788350202958
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LGALS4,Galectin-4,40352,-0.00339049214347838,0.00448154181854142,-0.0121743141078196,0.0053933298208628,0.449333165433391
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EFNB2,Ephrin-B2,37567,0.00372881501279658,0.00493068890223813,-0.00593533523559015,0.0133929652611833,0.449515148678587
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,40360,0.00316292517982746,0.0041872519517759,-0.0050440886456533,0.0113699390053082,0.450038095523583
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,37536,0.00350583630868882,0.00465524471432948,-0.00561844333139697,0.0126301159487746,0.451407051153479
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGF16,Fibroblast growth factor 16,37593,0.00312692238540406,0.00415861551044947,-0.0050239640150769,0.011277808785885,0.452116076974559
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EVPL,Envoplakin,37709,0.00220355797117931,0.00293145196015572,-0.0035420878707259,0.00794920381308452,0.452247803363211
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIL1,Nucleotide exchange factor SIL1,37623,-0.00203076791310845,0.00270242931636526,-0.00732752937318436,0.00326599354696746,0.452389207304232
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37896,0.00250243345566394,0.00333366405427811,-0.00403154809072116,0.00903641500204905,0.452873112580171
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPC1,Glypican-1,40484,0.00186653698356161,0.00248798612576581,-0.00300991582293937,0.00674298979006259,0.453133216970227
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HIP1,Huntingtin-interacting protein 1,37557,0.00216905667838904,0.0028916505027451,-0.00349857830699135,0.00783669166376944,0.453201773586469
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,37895,0.00270106085285624,0.00361705089286638,-0.00438835889716187,0.00979048060287434,0.455222851792281
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,37477,-0.00217904390673366,0.00293626975053085,-0.00793413261777413,0.00357604480430681,0.458032265386261
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,37567,0.00311220407124714,0.00422591437463097,-0.00517058810302957,0.0113949962455239,0.461465821219298
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,40039,0.0026215721332459,0.00356804229502466,-0.00437179076500244,0.00961493503149424,0.462510830622417
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,40223,0.00377512031373582,0.00513888363274361,-0.00629709160644165,0.0138473322339133,0.462582632865816
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL9,Interleukin-9,37709,0.00358534689761331,0.00488155289273826,-0.00598249677215368,0.0131531905673803,0.4626762337587
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",37557,-0.00256908445134934,0.00349813988793332,-0.00942543863169865,0.00428726972899996,0.462709328003316
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINA12,Serpin A12,39898,0.00699779266204222,0.00968375420636524,-0.0119823655824337,0.0259779509065181,0.469916817370508
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NCAM2,Neural cell adhesion molecule 2,40327,0.00165262101178,0.00228721951207546,-0.0028303292318879,0.0061355712554479,0.46996957831286
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD93,Complement component C1q receptor,39720,0.00192437686435705,0.00267815144474755,-0.00332479996734814,0.00717355369606225,0.472431263884987
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LTO1,Protein LTO1 homolog,40039,-0.00249953292571822,0.00349592201784845,-0.00935154008070118,0.00435247422926475,0.47462882220893
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,37477,-0.0034219250515439,0.00480176918671549,-0.0128333926575063,0.00598954255441846,0.476082316761297
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADM,Pro-adrenomedullin,40484,0.00161967946948773,0.00228135508963636,-0.00285177650619953,0.006091135445175,0.477736926906388
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLMP,CXADR-like membrane protein,40484,-0.00121953969947208,0.00172828126768436,-0.00460697098413343,0.00216789158518927,0.480423984608027
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RUVBL1,RuvB-like 1,39975,0.00640040818904925,0.00912208183124623,-0.0114788722001934,0.0242796885782919,0.482914854926213
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLK1,Kallikrein-1,40204,-0.00759455504473695,0.0108265260106089,-0.0288145460255304,0.0136254359360565,0.483015973564635
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,37709,-0.004888747661334,0.00700477593519222,-0.0186181084943107,0.00884061317164275,0.485241748526612
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,37567,0.00218904007849864,0.00313691671324847,-0.00395931667946837,0.00833739683646564,0.485294792176358
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,37567,-0.00358795756136892,0.00514510305968872,-0.0136723595583588,0.00649644443562096,0.485593720529036
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,37536,0.00201695149976193,0.00290545944907105,-0.00367774902041733,0.0077116520199412,0.487573099429949
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAGEA3,Melanoma-associated antigen 3,37709,-0.00489197179293819,0.00718218469165942,-0.0189690537885906,0.00918511020271427,0.495803746232566
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,37567,-0.00248015824459209,0.00365450274955187,-0.00964298363371377,0.00468266714452958,0.497366434204834
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,40039,0.00342507507775082,0.00505155696529181,-0.00647597657422112,0.0133261267297228,0.497766764573996
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRC1,Protein regulator of cytokinesis 1,37895,-0.00267890616096947,0.00395355896534212,-0.01042788173304,0.00507006941110108,0.498041080922327
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,37536,0.00325098198952252,0.00481179541161173,-0.00618013701723647,0.0126821009962815,0.499289027125693
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,37567,0.00281500622258305,0.00417333528225635,-0.0053647309306394,0.0109947433758055,0.499991429537442
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,40354,-0.00153285791779126,0.00227837593267117,-0.00599847474582676,0.00293275891024424,0.501093644221635
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMEM132A,Transmembrane protein 132A,37623,-0.00355181861525507,0.00530926851914084,-0.0139579849127711,0.00685434768226098,0.503517058278962
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RYR1,Ryanodine receptor 1,37557,0.001959239582173,0.0029356727697933,-0.00379467904662186,0.00771315821096786,0.504534600317988
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TGFBR1,TGF-beta receptor type-1,37593,0.00121652134544032,0.00182363636155379,-0.00235780592320512,0.00479084861408576,0.504729244443099
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPRING1,SREBP regulating gene protein,37477,0.00325446195631018,0.00489879742834869,-0.00634718100325325,0.0128561049158736,0.506485155253929
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,39975,-0.00174388198168545,0.00262698466503428,-0.00689277192515263,0.00340500796178174,0.506806361684422
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,37477,-0.00164149506558211,0.0024810469555227,-0.00650434709840659,0.00322135696724238,0.508230423206772
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,40511,0.00194982467828535,0.00295818665973074,-0.00384822117478689,0.00774787053135759,0.509822805935107
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,37477,0.00312377284172766,0.0047471601872395,-0.00618066112526175,0.0124282068087171,0.510530615839971
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GRP,Gastrin-releasing peptide,37623,0.00301238522507802,0.00458887465438437,-0.00598180909751535,0.0120065795476714,0.511543509568783
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,37567,-0.00197197586460497,0.00301049143505913,-0.00787253907732087,0.00392858734811092,0.512457005908985
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDH5,Cadherin-5,40531,-0.001675084455934,0.00257373031845576,-0.00671959588010728,0.00336942696823927,0.515159624404021
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGF3,Fibroblast growth factor 3,37593,-0.00166092225678807,0.00258118923507376,-0.00672005315753265,0.0033982086439565,0.519929292945171
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DCLRE1C,Protein artemis,37477,-0.00173095869254792,0.0027008879311435,-0.00702469903758917,0.00356278165249334,0.521608646096826
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,37536,-0.00409150625772543,0.0064121805107709,-0.0166593800588364,0.00847636754338554,0.523430526822894
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PXDNL,Peroxidasin-like protein,37895,0.00315959627517986,0.00496436628133399,-0.00657056163623477,0.0128897541865945,0.524490668773641
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEP152,Centrosomal protein of 152 kDa,37477,0.00224175532212531,0.00353079280253271,-0.00467859857083879,0.00916210921508942,0.525494634677044
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLSTN1,Calsyntenin-1,39956,0.00282450574398936,0.00445947961581643,-0.00591607430301085,0.0115650857909896,0.526500641174212
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FAM171B,Protein FAM171B,37895,0.00148435267024968,0.00234578467612208,-0.0031133852949496,0.00608209063544897,0.52689168962853
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD82,CD82 antigen,37709,0.00223629158480412,0.0035576345488524,-0.00473667213094659,0.00920925530055482,0.529628691012513
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACTA2,"Actin, aortic smooth muscle",40037,0.00232801184523055,0.00370691204329997,-0.0049375357596374,0.00959355945009849,0.530000580459353
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",37955,-0.00231570070139625,0.00369890310985976,-0.00956555079672138,0.00493414939392887,0.531292300958876
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEP164,Centrosomal protein of 164 kDa,40039,-0.00340039057167362,0.00543165054150796,-0.0140464256330292,0.00724564448968198,0.531302694158745
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,37536,0.00353436885509505,0.00565510716114923,-0.00754964118075743,0.0146183788909475,0.531990443471279
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FOS,Proto-oncogene c-Fos,37452,-0.00186685021797818,0.00298835247920202,-0.00772402107721414,0.00399032064125777,0.532173132391695
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,40037,0.0042373720667598,0.0068036077152684,-0.00909769905516627,0.0175724431886859,0.533416842684223
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,37709,0.00190854191723394,0.0030659181802906,-0.00410065771613565,0.00791774155060352,0.533622167499424
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DBH,Dopamine beta-hydroxylase,37962,-0.00555846608215858,0.00893960662057068,-0.0230800950584771,0.01196316289416,0.534097216638288
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MLLT1,Protein ENL,37477,0.00378764675824612,0.00609417225698611,-0.00815693086544664,0.0157322243819389,0.534268760359477
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,37536,0.00302138486639254,0.00488967950314429,-0.00656238695977027,0.0126051566925553,0.536645016422955
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",37623,-0.00190512498835097,0.00308513590132756,-0.00795199135495298,0.00414174137825105,0.536904207674911
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNR,Tenascin-R,40223,0.00220685994409527,0.00359473422094429,-0.00483881912895554,0.00925253901714609,0.539280594153055
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OMP,Olfactory marker protein,37536,-0.0026382802093358,0.00429905571130555,-0.0110644294034947,0.00578786898482308,0.539431987232919
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTX3,Pentraxin-related protein PTX3,40336,-0.00254537315552302,0.00416155731257964,-0.0107020254881791,0.00561127917713307,0.54078500063215
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACTN4,Alpha-actinin-4,40039,0.00167464437881166,0.00275951447535316,-0.00373400399288052,0.00708329275050385,0.54395136011711
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDIA2,Protein disulfide-isomerase A2,37477,0.0021430918406089,0.00353742092564645,-0.00479025317365814,0.00907643685487594,0.544635176392437
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,37557,-0.00267080319102057,0.00442351068759982,-0.0113408841387162,0.00599927775667508,0.546003990115819
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCNE1,G1/S-specific cyclin-E1,37593,0.00478850901216305,0.00793432020242908,-0.0107627585845979,0.020339776608924,0.54617423024192
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGF12,Fibroblast growth factor 12,37593,0.00246435115141133,0.00408356011397979,-0.00553942667198906,0.0104681289748117,0.546199133258839
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SATB1,DNA-binding protein SATB1,37955,0.00153295057815317,0.00254930439159825,-0.0034636860293794,0.00652958718568574,0.547636217988104
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IFNL2,Interferon lambda-2,37536,-0.00330209995336032,0.00549516046974242,-0.0140726144740555,0.00746841456733483,0.547909968845615
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PGM2,Phosphoglucomutase-2,37567,0.00306462787333307,0.00510795793461971,-0.00694696967852155,0.0130762254251877,0.548535766177516
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CORO6,Coronin-6,37536,-0.00185288727867586,0.00309219705474716,-0.0079135935059803,0.00420781894862858,0.549040668062879
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",40429,0.00371583622869789,0.00623021392053474,-0.00849538305555021,0.015927055512946,0.550901841975481
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UBQLN3,Ubiquilin-3,37557,0.00227532658304794,0.00383328209622131,-0.00523790632554582,0.0097885594916417,0.552809065484544
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,39956,0.0040406037764067,0.0068760906826381,-0.00943653396156397,0.0175177415143774,0.556788582810087
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANGPT2,Angiopoietin-2,40484,-0.00192792336962183,0.00328140758571555,-0.00835948223762431,0.00450363549838065,0.55685649796034
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DCUN1D1,DCN1-like protein 1,37536,0.00372428283189718,0.00634691677753169,-0.00871567405206493,0.0161642397158593,0.557357466667006
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,37536,0.00205434488116032,0.00350292490020174,-0.00481138792323508,0.00892007768555573,0.557572803252856
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,37536,-0.00216159521180349,0.00368726390731976,-0.00938863247015023,0.00506544204654324,0.557729165040034
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINI2,Serpin I2,37896,0.00276550171614503,0.00473190443516726,-0.00650903097678279,0.0120400344090729,0.558935906976446
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,37593,0.00144901448479074,0.00249012497396095,-0.00343163046417273,0.0063296594337542,0.560641111255231
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL25,Interleukin-25,37424,0.00172376985735591,0.00297050565723202,-0.00409842123081885,0.00754596094553066,0.56172571533713
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,37870,-0.00132759063462611,0.00229052872710149,-0.00581702693974503,0.00316184567049282,0.562194069645196
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGF23,Fibroblast growth factor 23,40464,-0.00300576714025047,0.00522389543015906,-0.0132446021833622,0.0072330679028613,0.565036952093704
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,39975,-0.00213518819999163,0.00371387461490341,-0.00941438244520231,0.00514400604521906,0.565352386451243
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNNI3,"Troponin I, cardiac muscle",40037,0.00412224374889909,0.00719170883815097,-0.00997350557387681,0.018217993071675,0.566521673558282
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FAP,Prolyl endopeptidase FAP,40531,-0.00131283155882658,0.00229140787219946,-0.00580399098833752,0.00317832787068436,0.566695597326974
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC1A4,Neutral amino acid transporter A,37567,-0.00255814740117087,0.00447299571136482,-0.0113252189954459,0.00620892419310417,0.567393292393386
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TSLP,Thymic stromal lymphopoietin,40037,0.00295607047313602,0.00517323995545882,-0.00718347983956327,0.0130956207858353,0.567726136723655
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,37567,0.00381940154420624,0.00675590465551723,-0.00942217158060753,0.01706097466902,0.571850344613341
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ESR1,Estrogen receptor,37593,0.00278398490396941,0.00493155355456739,-0.00688186006298267,0.0124498298709215,0.57240657701315
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,40300,-0.00170295069606256,0.00301983446376503,-0.00762182624504203,0.00421592485291691,0.572815285520594
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,37536,0.00289481721038888,0.00514774694973331,-0.0071947668110884,0.0129844012318662,0.573889631975512
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,36969,-0.00239285305378643,0.00426065792506444,-0.0107437425869127,0.00595803647933987,0.574387829004599
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",40039,0.00569319582794671,0.0102013888402716,-0.0143015262989857,0.0256879179548791,0.576797455003855
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEP112,Centrosomal protein of 112 kDa,37557,-0.0022242596557842,0.00400977854859451,-0.0100834256110294,0.00563490629946104,0.579103287035807
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNX18,Sorting nexin-18,37896,-0.00212812205451765,0.00384767385529424,-0.00966956281089436,0.00541331870185906,0.58020882335306
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGF6,Fibroblast growth factor 6,37593,0.00200620746457392,0.00364388712130384,-0.00513581129318161,0.00914822622232946,0.581939242909262
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,37617,0.00132742248150818,0.00242015841747942,-0.00341608801675147,0.00607093297976784,0.58336769019292
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ISM2,Isthmin-2,37993,-0.00206161615123682,0.00377083676526384,-0.00945245621115393,0.0053292239086803,0.584575697088655
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,37477,-0.00150972532768859,0.00276776624938703,-0.00693454717648717,0.00391509652110998,0.585441668042749
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,37878,0.00194044792327858,0.00356663149566785,-0.0050501498082304,0.00893104565478757,0.586411844888714
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,37557,0.00446126946461045,0.0082569009306427,-0.0117222563594492,0.0206447952886701,0.588993837630281
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37993,-0.00176707905449239,0.00327474830973822,-0.0081855857415793,0.00465142763259453,0.589476551578684
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLHL41,Kelch-like protein 41,37955,-0.00216811226331685,0.00402103791803722,-0.0100493465826698,0.00571312205603611,0.589763134747643
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IKZF2,Zinc finger protein Helios,39975,0.00428710924259442,0.00795498574405164,-0.0113046628157468,0.0198788813009356,0.589949062709308
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",37557,-0.00187470175946054,0.00349682659576318,-0.00872848188715637,0.00497907836823529,0.591888060644283
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANK2,Ankyrin-2,37557,0.003375635284244,0.0063079745474017,-0.00898799482866333,0.0157392653971513,0.592563690193888
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,37937,-0.00127344488082041,0.00239144083136671,-0.00596066891029916,0.00341377914865835,0.594387751745905
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEMA6C,Semaphorin-6C,37593,0.00120014605094652,0.00225417373810015,-0.00321803447572978,0.00561832657762282,0.594450628896189
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ALPP,"Alkaline phosphatase, placental type",40300,-0.00463441660103945,0.00875348913348605,-0.0217912553026721,0.0125224221005932,0.596510103336161
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,THBS4,Thrombospondin-4,40350,-0.0020247342384062,0.00382811791073034,-0.00952784534343768,0.00547837686662528,0.596874472315505
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRH,Corticoliberin,39942,0.00388845962187412,0.00737209869857146,-0.0105608538273259,0.0183377730710742,0.597884336480515
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATP1B4,Protein ATP1B4,37477,-0.00188978992020381,0.00359614481196872,-0.0089382337516625,0.00515865391125488,0.599241541293886
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DEFB116,Beta-defensin 116,37536,0.00351203360967023,0.00671408156131907,-0.00964756625051514,0.0166716334698556,0.600924142070653
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DCUN1D2,DCN1-like protein 2,37477,-0.00359476523638335,0.00688012290476639,-0.0170798061297255,0.00989027565695877,0.601341146884968
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,37895,-0.0037515906380731,0.00722288420560696,-0.0179084436810627,0.0104052624049165,0.60348800979716
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FZD10,Frizzled-10,37567,0.00266769456432573,0.00518663621799804,-0.00749811242295042,0.0128335015516019,0.607022954447381
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,37567,0.00159216742943269,0.00310941035564611,-0.00450227686763369,0.00768661172649907,0.608626021295008
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,37477,0.00386695296179633,0.00756339693462085,-0.0109573050300605,0.0186912109536532,0.609169285616512
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,37536,0.00247017477143889,0.00485594232717086,-0.007047472189816,0.0119878217326938,0.61097732049492
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,INSL3,Insulin-like 3,37937,0.00256193855246835,0.00504976382176393,-0.00733559853818895,0.0124594756431256,0.611925771814984
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGFL4,Insulin growth factor-like family member 4,37593,-0.00337292235438672,0.00666652807509785,-0.0164393173815785,0.00969347267280506,0.612901029939315
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,37709,0.00392038321883588,0.00778387678019057,-0.0113360152703376,0.0191767817080094,0.614512677818838
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",37557,0.00187201224760589,0.00374953238560063,-0.00547707122817135,0.00922109572338313,0.617600721152031
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARG1,Arginase-1,40222,0.00220545779092792,0.00447114349779944,-0.00655798346475899,0.0109688990466148,0.621832351373214
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FAM171A2,Protein FAM171A2,37955,-0.0066716870122282,0.0136188426808803,-0.0333646186667535,0.0200212446422971,0.624222183689344
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAPT,Microtubule-associated protein tau,39956,0.00219437117013898,0.004508016096354,-0.00664134037871487,0.0110300827189928,0.626427557141003
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,37937,-0.00353697578442869,0.00728633988581529,-0.0178182019606267,0.0107442503917693,0.627382375151525
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,40354,0.00129516985532516,0.00267274329517107,-0.00394340700321014,0.00653374671386045,0.62797781647017
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IFNW1,Interferon omega-1,37557,0.00151339463410555,0.00312672164924056,-0.00461497979840594,0.00764176906661704,0.62838003077729
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPRR1B,Cornifin-B,37709,0.003489075257829,0.00724054869857205,-0.0107024001913722,0.0176805507070302,0.629899183545608
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MSLNL,Mesothelin-like protein,37567,-0.00153468450854511,0.00320152646883445,-0.00780967638746063,0.00474030737037041,0.631690363990831
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,37683,-0.00213352070702537,0.00445805990522268,-0.0108713181212618,0.00660427670721107,0.632248166718503
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRP2BP,LRP2-binding protein,37567,0.00353923054577965,0.00739747319196481,-0.0109598169104714,0.0180382780020307,0.632346634651423
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PEPD,Xaa-Pro dipeptidase,37982,-0.00103248902691164,0.00218660855559693,-0.00531824179588162,0.00325326374205835,0.636800641903776
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRSS22,Brain-specific serine protease 4,37593,0.00141101139112564,0.00298834531974752,-0.0044461454355795,0.00726816821783078,0.636812245211953
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,37567,-0.00281104970642329,0.00596900516612109,-0.0145102998320206,0.00888820041917406,0.637690647711337
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,37557,-0.00152863714095228,0.00325054305709592,-0.00789970153286029,0.00484242725095573,0.638169018375106
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,40039,-0.0014950958863787,0.00318736037837969,-0.00774232222800289,0.00475213045524549,0.639025993376075
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,37567,0.00288600898566445,0.00616983121116968,-0.00920686018822812,0.014978878159557,0.639962987816378
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TERF1,Telomeric repeat-binding factor 1,37593,-0.00117156170175048,0.00251592109763589,-0.00610276705311682,0.00375964364961586,0.641467207717912
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AMOT,Angiomotin,37666,0.00164210605387035,0.00353481363552686,-0.00528612867176229,0.00857034077950299,0.642259701345704
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNTN2,Contactin-2,40484,-0.00176189461549576,0.00380016375553107,-0.00921021557633664,0.00568642634534513,0.642914494865294
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,40460,-0.0025023056338683,0.00541438442599768,-0.0131144991088237,0.00810988784108715,0.643973697240233
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CASP4,Caspase-4,37709,0.00668612185078382,0.0145125457413729,-0.021758467802307,0.0351307115038747,0.645011917805946
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TBR1,T-box brain protein 1,37567,-0.00190256749061528,0.00415396918651034,-0.0100443470961755,0.00623921211494499,0.646951450444195
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,37567,0.00125203970598161,0.00273442725184818,-0.00410743770764081,0.00661151711960404,0.647046201119365
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,37477,0.00191503863185144,0.00419287188229471,-0.00630299025744618,0.0101330675211491,0.647867896803436
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HBQ1,Hemoglobin subunit theta-1,40484,0.00228396775051024,0.00500825461948075,-0.00753221130367203,0.0121001468046925,0.648366915960218
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL17C,Interleukin-17C,40039,-0.00270907414447971,0.00595865829878385,-0.0143880444100961,0.00896989612113663,0.64937099350997
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,37557,0.00187776022928207,0.00413205396509463,-0.00622106554230341,0.00997658600086755,0.649521501198315
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRSS8,Prostasin,40288,0.00155110623479873,0.00342217633126692,-0.00515635937448442,0.00825857184408189,0.650373929873704
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DENND2B,DENN domain-containing protein 2B,37557,-0.00201018833363729,0.0044587252798344,-0.0107492898821127,0.00672891321483813,0.652109640811858
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLK12,Kallikrein-12,39975,0.00548095537756566,0.0121571958591072,-0.0183471485062845,0.0293090592614158,0.652110858882586
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NEB,Nebulin,37557,0.00137483264480941,0.00309375732375649,-0.00468893170975331,0.00743859699937212,0.656768487816805
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OLFM4,Olfactomedin-4,37172,-0.00460736787838114,0.0104467053766811,-0.0250829104166761,0.0158681746599138,0.659194796195997
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HDAC9,Histone deacetylase 9,37536,0.00235436603019161,0.00538280212871813,-0.00819592614209593,0.0129046582024791,0.661838151018661
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDA,Cytidine deaminase,37965,0.00169007451647456,0.003871666741071,-0.00589839229602461,0.00927854132897372,0.662463739848865
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CBLN1,Cerebellin-1,37536,0.00363429869970378,0.00833032107780852,-0.0126931306128009,0.0199617280122085,0.662645472645565
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZNF174,Zinc finger protein 174,37593,-0.00142106117718698,0.00328852108731007,-0.0078665625083147,0.00502444015394075,0.665655666341523
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",37477,0.00206103274022077,0.00477323762980121,-0.00729451301418961,0.0114165784946311,0.665901733741834
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,37557,0.00138956123991396,0.00324445219548831,-0.00496956506324313,0.00774868754307105,0.668448201810379
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,37709,-0.00213987614737285,0.00502134972430361,-0.0119817216070079,0.00770196931226222,0.670001409846298
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RELB,Transcription factor RelB,37593,0.001859579570875,0.00436703865274554,-0.00669981618850627,0.0104189753302563,0.670244789337307
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MUC2,Mucin-2,37993,0.00324212373531544,0.00766682889926742,-0.0117848609072487,0.0182691083778796,0.672391897503144
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,37536,-0.00232920090290421,0.00553411049713915,-0.013176057477297,0.00851765567148852,0.673849032357287
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",39956,0.00197042256445085,0.00468822382044904,-0.00721849612362927,0.011159341252531,0.674278040595301
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD177,CD177 antigen,40311,0.00453817325692465,0.0108318118657202,-0.0166921779998869,0.0257685245137362,0.675245820524152
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,37709,0.00241346224672205,0.00577435201682616,-0.00890426770625722,0.0137311921997013,0.675981349966192
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,37557,-0.00204345810340334,0.00492709496068256,-0.0117005642263412,0.00761364801953448,0.678339817367213
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGF9,Fibroblast growth factor 9,37452,-0.00141197284217701,0.003455573956557,-0.00818489779702872,0.0053609521126747,0.682834582184076
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ALMS1,Alstrom syndrome protein 1,37709,-0.00155951901928617,0.00382839362806727,-0.00906317053029803,0.00594413249172568,0.683753133964401
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINB5,Serpin B5,40037,0.00167411329929025,0.00414319163257704,-0.00644654230056074,0.00979476889914124,0.68617142921115
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,37539,0.00135259887837151,0.00342550277640798,-0.00536138656338813,0.00806658432013115,0.692951601216446
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD209,CD209 antigen,40377,-0.00129918909622615,0.00329435436766764,-0.00775612365685473,0.00515774546440243,0.693314388242013
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EDN1,Endothelin-1,37623,-0.00095970859936645,0.00245649633835914,-0.00577444142255037,0.00385502422381747,0.69603871537159
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",37557,0.00222851881299305,0.00570886984900751,-0.00896086609106167,0.0134179037170478,0.696276139308382
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSMA1,Proteasome subunit alpha type-1,39975,-0.00154333827875098,0.00395374822658465,-0.00929268480285688,0.00620600824535493,0.696284484299828
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,37895,0.0020017299479145,0.00512936262482399,-0.00805182079674052,0.0120552806925695,0.696358425444218
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,40123,0.00577797550663478,0.0148079428252872,-0.0232455924309281,0.0348015434441977,0.696398148468559
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGBL1,Integrin beta-like protein 1,37993,0.00114586950757389,0.00295109347215959,-0.00463827369785891,0.00693001271300669,0.697810192855395
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DUSP29,Dual specificity phosphatase 29,37567,-0.00219642168994703,0.00567515118440051,-0.013319718011372,0.00892687463147796,0.698744462064156
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,37709,0.00133657471073187,0.00347241791217524,-0.00546936439713161,0.00814251381859534,0.700308920405976
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACE2,Angiotensin-converting enzyme 2,40037,-0.00157817947136174,0.00414422647962874,-0.00970086337143408,0.0065445044287106,0.703346459022306
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,37709,-0.00092914084815277,0.00246717070401396,-0.00576479542802013,0.00390651373171459,0.706475601167978
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPA4,Carboxypeptidase A4,37405,-0.00139744511480269,0.00371858130767433,-0.00868586447784437,0.00589097424823899,0.707071290207092
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,37536,0.00225346990601557,0.00602043182674251,-0.00954657647439974,0.0140535162864309,0.708184445607679
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,40336,0.00473086268624377,0.0127464946002004,-0.0202522667301491,0.0297139921026366,0.710530690663714
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,37557,-0.00160439030987901,0.00433451501492191,-0.0101000397391259,0.00689125911936793,0.711281940010275
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,37477,-0.00114011052802595,0.0030969317195136,-0.00721009669827261,0.00492987564222072,0.71277336386093
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,37709,0.00196585509538078,0.00536051155016083,-0.00854074754293445,0.012472457733696,0.713827017835896
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,37985,-0.00091529194590792,0.00249648188078791,-0.00580839643225223,0.00397781254043639,0.713898729087572
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RTKN2,Rhotekin-2,37557,0.00163578835536971,0.0044760009042655,-0.00713717341699068,0.0104087501277301,0.71477578178335
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CGN,Cingulin,37567,0.00130495920579282,0.00357367241201069,-0.00569943872174814,0.00830935713333378,0.714998492531231
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",37557,0.00193160661154139,0.00533796267460624,-0.00853080023068684,0.0123940134537696,0.717460885452508
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,37477,-0.000813805114496591,0.00225298064089074,-0.00522964717064244,0.00360203694164925,0.717946342591276
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,39975,0.00163882724797406,0.00456356845797657,-0.00730576692966002,0.0105834214256081,0.71951700028542
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C9orf40,Uncharacterized protein C9orf40,37896,-0.00249913811052082,0.0069721549171698,-0.0161645617481736,0.011166285527132,0.720015515075468
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TAGLN3,Transgelin-3,37477,-0.00182692727200691,0.00518585727157785,-0.0119912075242995,0.00833735298028567,0.724626253313319
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,METAP1,Methionine aminopeptidase 1,39956,0.000914916450141898,0.00260628117466085,-0.00419339465219337,0.00602322755247716,0.72556094898735
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,40037,-0.00100402780226465,0.00286440834151673,-0.00661826815163744,0.00461021254710813,0.725954427986763
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FH,"Fumarate hydratase, mitochondrial",37536,0.00254496382094266,0.0072622599010858,-0.0116890655851855,0.0167789932270708,0.726016481719876
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SHPK,Sedoheptulokinase,37709,0.00126416410094749,0.00363920862432684,-0.00586868480273313,0.0083970130046281,0.728316364305026
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,37593,-0.00159753635302977,0.00465028567288839,-0.010712096271891,0.00751702356583149,0.731201435686393
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGSF9,Protein turtle homolog A,37985,0.00227790288602126,0.00671658379654801,-0.0108866013552128,0.0154424071272553,0.734504968865891
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,37937,0.0020328186603763,0.00602737155400773,-0.00978082958547885,0.0138464669062314,0.735922741647656
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,40300,-0.00128574234908923,0.00382099499534544,-0.0087748925399663,0.00620340784178783,0.736502740075378
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,40531,0.00199112440789208,0.00594575574824189,-0.00966255685866203,0.0136448056744462,0.737718744330561
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGA2,Integrin alpha-2,37666,-0.000957611386511834,0.00286852218109072,-0.00657991486144964,0.00466469208842597,0.738509819625778
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BSND,Barttin,37477,-0.00097274036233846,0.00291708098140772,-0.0066902190858976,0.00474473836122068,0.738789719808864
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UMOD,Uromodulin,40497,-0.00152712385300764,0.00458705589714997,-0.0105177534114216,0.0074635057054063,0.739198823587602
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,40037,-0.00179126344774663,0.00539342729341656,-0.0123623809428431,0.00877985404734983,0.739803342503898
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPSD1,Tryptase delta,37955,0.00107068288824336,0.00323512577006546,-0.00527016362108495,0.00741152939757167,0.740683182596276
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGF7,Fibroblast growth factor 7,37477,0.00227492999354936,0.00689323779883702,-0.0112358160921712,0.0157856760792699,0.741387564704847
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLK13,Kallikrein-13,40027,-0.00121561506573841,0.00368478127455393,-0.00843778636386412,0.0060065562323873,0.74147878661333
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MATN3,Matrilin-3,40198,-0.000860247720985658,0.00264877994861047,-0.00605185642026218,0.00433136097829086,0.745358477940343
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",37593,0.00132198640535206,0.00411087266646709,-0.00673532402092343,0.00937929683162756,0.747773805259079
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,37477,0.00174120092053369,0.00541751635263304,-0.00887713113062706,0.0123595329716944,0.747910878692472
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CA8,Carbonic anhydrase-related protein,37593,-0.000756072741855405,0.00235623441239907,-0.00537429219015757,0.00386214670644676,0.748305068586359
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,JCHAIN,Immunoglobulin J chain,40039,0.00168125672664604,0.00524400025379846,-0.00859698377079894,0.011959497224091,0.748513464171507
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,40352,-0.00770930517772379,0.0248442241967835,-0.0564039846034195,0.0409853742479719,0.756332539681165
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TJP3,Tight junction protein ZO-3,37536,0.00114963828315937,0.00372985846243729,-0.00616088430321772,0.00846016086953645,0.757915495006216
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PADI4,Protein-arginine deiminase type-4,39929,0.00180994901864212,0.00589175627627998,-0.00973789328286665,0.0133577913201509,0.758695086144699
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",37593,0.000753395066679736,0.00245801078543055,-0.00406430607276414,0.00557109620612361,0.759224264242786
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,37536,0.00128653578895187,0.00428567994447308,-0.00711339690221536,0.0096864684801191,0.764033882325353
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SHC1,SHC-transforming protein 1,37477,-0.00297726251770837,0.00993464869879966,-0.0224491739673557,0.016494648931939,0.764422428918974
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNU13,NHP2-like protein 1,37557,-0.0015847026657413,0.00529452628440083,-0.0119619741831669,0.00879256885168432,0.764708559361997
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNTN1,Contactin-1,40531,0.000698592521704074,0.00233880543613746,-0.00388546613312536,0.0052826511765335,0.76517564320571
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LEG1,Protein LEG1 homolog,37226,0.00175476188543934,0.00591861847048061,-0.00984573031670266,0.0133552540875813,0.766867083658839
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,37557,0.00157308703514611,0.00531978049591666,-0.00885368273685053,0.0119998568071428,0.767459870592098
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,37536,-0.00151273034536786,0.00511751542618402,-0.0115430605806885,0.00851759988995282,0.767541341166334
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,37536,-0.000997051328393657,0.00341016712993353,-0.00768097890306337,0.00568687624627605,0.770003724039819
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,37536,0.0015754050829589,0.00540265010172141,-0.00901378911641506,0.0121645992823329,0.770598186110146
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GLI2,Zinc finger protein GLI2,37593,0.000831369822099942,0.00285119482121039,-0.00475697202747242,0.00641971167167231,0.770607426929752
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,37895,0.00159722199471872,0.00550559725081972,-0.00919374861688793,0.0123881926063254,0.771737508548939
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ICOSLG,ICOS ligand,40300,-0.000470766682071333,0.00162412259421605,-0.00365404696673479,0.00271251360259213,0.771927839302851
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,37993,-0.000610727099074525,0.00211249863491724,-0.00475122442351231,0.00352977022536326,0.772507923234781
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,37567,0.00190967429239494,0.006648230615636,-0.0111208577142516,0.0149402062990415,0.773928891717059
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STC2,Stanniocalcin-2,40304,0.000642118818479324,0.00230148051100372,-0.00386878298308797,0.00515302062004662,0.780246545051449
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPESP1,Sperm equatorial segment protein 1,37985,0.000648410553355835,0.00233396956442071,-0.00392616979290876,0.00522299089962043,0.781159014947228
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",37557,0.00142770300942721,0.00516519352357254,-0.00869607629677497,0.0115514823156294,0.782238744944344
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRYBB2,Beta-crystallin B2,37937,0.00159968550271856,0.0058178970892756,-0.00980339279226162,0.0130027637976987,0.78335164165672
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,39956,0.00108128540742511,0.0039366970722534,-0.00663464085419155,0.00879721166904178,0.783574842052005
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NECTIN1,Nectin-1,37593,0.000731468746991568,0.00270231166698986,-0.00456506212030855,0.00602799961429169,0.786639412011168
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,37557,-0.0016420974565971,0.00611270967528139,-0.0136230084201486,0.0103388135069544,0.788213584090848
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCIN,Adseverin,37536,-0.00167089291373317,0.0062317076695904,-0.0138850399461304,0.010543254118664,0.78860531711176
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIF20B,Kinesin-like protein KIF20B,37536,-0.00175466065375201,0.00662984701589595,-0.0147491608049081,0.011239839497404,0.791274942329003
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TSPAN7,Tetraspanin-7,37536,-0.00205771116954662,0.00777559631726114,-0.0172978799513784,0.0131824576122852,0.791293214513528
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,37964,0.00108301301910705,0.00409457361220357,-0.00694235126081194,0.00910837729902604,0.791399019136643
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OBP2B,Odorant-binding protein 2b,40179,-0.00147355662938115,0.00560880746483148,-0.0124668192604509,0.00951970600168855,0.792768366769423
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",37623,0.00183304941383954,0.00697766746006709,-0.011843178807892,0.015509277635571,0.792784139083209
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PFDN6,Prefoldin subunit 6,37567,0.00147819171123541,0.00563126464951763,-0.00955908700181915,0.01251547042429,0.792942197154142
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRDX2,Peroxiredoxin-2,37758,0.00138060895030636,0.00531474812409798,-0.00903629737292567,0.0117975152735384,0.795045672391177
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",37477,-0.0011158519377572,0.00430259741328516,-0.00954894286779612,0.00731723899228172,0.795374090756346
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,37593,-0.0020598204351204,0.00794451365830758,-0.0176310672054033,0.0135114263351625,0.795426482050335
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DDI2,Protein DDI1 homolog 2,37666,0.00171696185150071,0.0066322028857687,-0.0112821558046059,0.0147160795076074,0.7957298649881
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEZ6,Seizure protein 6 homolog,37567,0.000677842390737418,0.0026605984790758,-0.00453693062825116,0.00589261540972599,0.798904243725005
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,37536,0.000679302173355763,0.00268544940292306,-0.00458417865637344,0.00594278300308496,0.800305718219723
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HDAC8,Histone deacetylase 8,37593,0.00130887158539556,0.00529880365420035,-0.00907678357683713,0.0116945267476282,0.804902285038678
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,37567,0.000900076836890607,0.00365178143739545,-0.00625741478040448,0.0080575684541857,0.805317562863251
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,37593,0.000858765717163761,0.00356377183632833,-0.00612622708203977,0.00784375851636729,0.809581340597768
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRR5,Proline-rich protein 5,37593,0.000978906880048892,0.00408623287490204,-0.0070301095547591,0.00898792331485688,0.810673418655416
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COPE,Coatomer subunit epsilon,39956,-0.000978068011624368,0.00410053783255983,-0.00901512216344164,0.0070589861401929,0.811479496024377
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,37567,0.000783782467569524,0.00330338615444689,-0.00569085439514637,0.00725841933028542,0.812453849993149
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGL1,Fibrinogen-like protein 1,37982,0.00125317950975037,0.00531345535828912,-0.0091611929924963,0.0116675520119971,0.813552482468508
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HMBS,Porphobilinogen deaminase,40484,-0.000893720102132472,0.00385189717853603,-0.00844343857206308,0.00665599836779814,0.816524852739656
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",40305,0.00130110943663061,0.00576030912086205,-0.00998909644025902,0.0125913153135202,0.821301606421978
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,40300,-0.000499843886354324,0.00224309514316404,-0.00489631036695585,0.0038966225942472,0.823665486891956
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OMD,Osteomodulin,40417,0.000836560265677656,0.00376113186437916,-0.00653525818850549,0.00820837871986081,0.823987861092454
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,REST,RE1-silencing transcription factor,37477,-0.000666196745483282,0.00304960293425303,-0.00664341849661922,0.00531102500565266,0.827079128020139
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,37477,0.000765952045259937,0.00350863465164074,-0.00611097187195591,0.00764287596247579,0.827194997247417
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,REN,Renin,40354,0.00131511826037593,0.00604710350690464,-0.0105372046131572,0.013167441133909,0.827837830665532
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,37593,0.000541401629172871,0.00249203521732167,-0.00434298739677759,0.00542579065512334,0.828014711363188
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,37593,-0.000648688321000387,0.00306184298533451,-0.00664990057225602,0.00535252393025525,0.832217946576586
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,40325,0.00130916968760395,0.00618981590918337,-0.0108228694943955,0.0134412088696034,0.832496869876885
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARG2,"Arginase-2, mitochondrial",37895,0.000795772698296086,0.00376684183741049,-0.00658723730302847,0.00817878269962065,0.832689731453306
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,37477,-0.00108285882535936,0.00515720425358576,-0.0111909791623874,0.00902526151166873,0.833694273637623
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,37567,-0.000518317763318599,0.00251049921129574,-0.00543889621745825,0.00440226069082105,0.836434781978681
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDC25A,M-phase inducer phosphatase 1,37477,-0.000718614578443304,0.0034841150040995,-0.00754747998647832,0.00611025082959172,0.836595301361674
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCP2,Non-specific lipid-transfer protein,39975,0.00136373881192364,0.00662317760193219,-0.0116176892878635,0.0143451669117107,0.836868595016864
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MELTF,Melanotransferrin,37985,-0.000502763632801957,0.00246855968972356,-0.00534114062466014,0.00433561335905623,0.838616956692571
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",37593,0.000478667994341658,0.0023861374083881,-0.00419816132609902,0.00515549731478234,0.841011568641704
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITM2A,Integral membrane protein 2A,40336,0.00100137384098199,0.00500923836178283,-0.00881673334811236,0.0108194810300763,0.84155711951571
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TAP1,Antigen peptide transporter 1,37709,0.00104385807441316,0.0052317295582076,-0.00921033185967374,0.0112980480085001,0.841855562895944
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAMA1,Laminin subunit alpha-1,37557,-0.000946793573699115,0.0047690861086299,-0.0102942023466137,0.00840061519921549,0.842635642309306
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,37682,0.000843752298850551,0.00430026565128161,-0.00758476837766141,0.00927227297536251,0.844449328984667
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,37477,-0.00142674110661754,0.00732133071499187,-0.0157765493080016,0.0129230670947665,0.845494189457545
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,37593,-0.000801101627285277,0.00414449297440364,-0.00892430785711642,0.00732210460254586,0.846732467726495
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,40432,-0.00131029509228202,0.00686796629968804,-0.0147715090396706,0.0121509188551065,0.848697589325645
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,40466,-0.000744994800679623,0.00401422629177564,-0.00861287833255988,0.00712288873120063,0.852769712744264
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,37709,-0.00122329503111962,0.00660141212994769,-0.0141620628058171,0.0117154727435778,0.852990232865865
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,37557,0.000820756809887074,0.00443506571162384,-0.00787197198489565,0.00951348560466979,0.85318421111768
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RBM25,RNA-binding protein 25,37477,-0.000722226658891932,0.00394052397445033,-0.00844565364881457,0.00700120033103071,0.854579700725241
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",37937,-0.000398929599889856,0.00220628734639538,-0.00472325279882479,0.00392539359904508,0.856515593894032
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,40375,-0.000714137369055145,0.0040176313772607,-0.00858869486848611,0.00716042013037582,0.858920914153864
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GAGE2A,G antigen 2A,37477,-0.000941215047557383,0.00529765777989229,-0.0113246242961463,0.0094421942010315,0.858987846573535
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZNF75D,Zinc finger protein 75D,37709,-0.000892657720954359,0.00504825670325976,-0.0107872408593435,0.00900192541743477,0.859648594614516
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,37557,-0.000540785839700015,0.00307449834661091,-0.0065668025990574,0.00548523091965737,0.860379929854893
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,37709,-0.000810422963878256,0.00462098144243164,-0.00986754659104427,0.00824670066328776,0.860784542775858
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTNNA1,Catenin alpha-1,37536,0.000534725646928007,0.00307915388998252,-0.00550041597743773,0.00656986727129374,0.86213541722184
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NRP1,Neuropilin-1,40419,0.000413034362493689,0.00238696937283086,-0.00426542560825479,0.00509149433324217,0.862624424811781
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PFDN4,Prefoldin subunit 4,37477,0.000771887432224404,0.00462292837396922,-0.00828905218075526,0.00983282704520407,0.867396742701156
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TP73,Tumor protein p73,37567,0.000491232171820537,0.00297725057958863,-0.00534417896417318,0.00632664330781426,0.868950272112152
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PYDC1,Pyrin domain-containing protein 1,37623,-0.000593706244703848,0.0036062187320475,-0.00766189495951694,0.00647448247010925,0.869234588109194
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,37895,0.00062380024275657,0.00383212865818258,-0.00688717192728129,0.00813477241279443,0.870692800031311
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGAX,Integrin alpha-X,37709,-0.000758090674835442,0.00469300177467473,-0.00995637415319792,0.00844019280352704,0.871673395797304
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,37623,-0.000547162011839822,0.00343693284143999,-0.0072835503810622,0.00618922635738256,0.873513216845747
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,37955,-0.000314712038451395,0.00200067844371734,-0.00423604178813739,0.0036066177112346,0.875008676914655
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,37557,0.00127844937617887,0.00820988030613874,-0.0148129160238531,0.0173698147762108,0.876255475853317
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,39956,-0.000858645840482573,0.0055664272282213,-0.0117688432077963,0.0100515515268312,0.877411165538393
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CENPF,Centromere protein F,37709,0.000705493040663087,0.004631332904093,-0.0083719194513592,0.00978290553268537,0.878928625079754
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,37477,0.000431816446139772,0.00285663499313379,-0.00516718814040246,0.00603082103268201,0.879849772805114
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FRMD7,FERM domain-containing protein 7,37567,0.000425220695763085,0.00283368774239856,-0.00512880727933808,0.00597924867086425,0.880720277891691
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,37536,0.000380570069486046,0.00254497391124854,-0.0046075787965611,0.00536871893553319,0.881131505765341
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRDX1,Peroxiredoxin-1,39948,0.00108866303651024,0.00752560038790304,-0.0136615137237797,0.0158388397968002,0.884980187479997
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HMMR,Hyaluronan mediated motility receptor,37455,-0.000590896325012621,0.00414214202818676,-0.00870949470025867,0.00752770205023342,0.886565048593058
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAYN,Layilin,40187,0.000401359588984209,0.00290856405229663,-0.00529942595351718,0.0061021451314856,0.890248229166717
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,37557,-0.000465001381110152,0.00342420513530239,-0.00717644344630284,0.00624644068408253,0.891982787328121
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,40300,0.000716897788044163,0.00534669774002418,-0.00976262978240322,0.0111964253584916,0.893339160281571
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HRAS,GTPase Hras,37692,0.00110490774634663,0.00836488654093065,-0.0152902698738774,0.0175000853665707,0.894916069200569
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MFGE8,Lactadherin,40327,0.000460567418745653,0.00357062171302554,-0.00653785113878441,0.00745898597627572,0.897368763712746
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",37557,-0.00053684413154655,0.00416368619458414,-0.00869766907293146,0.00762398080983836,0.897411202559935
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TRIM26,Tripartite motif-containing protein 26,37477,0.000592883697980293,0.00467529476461599,-0.00857069404066706,0.00975646143662764,0.899091118308717
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,REG1A,Lithostathine-1-alpha,40269,0.000521611110051268,0.00413842830994636,-0.0075897083774436,0.00863293059754613,0.899701173895676
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,37593,0.000451536247035314,0.00361373583913767,-0.00663138599767452,0.00753445849174515,0.900565055591545
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,37709,0.000696053047508036,0.00571009172029401,-0.0104957267242682,0.0118878328192843,0.902981052593464
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC12A2,Solute carrier family 12 member 2,37557,0.000292178389416304,0.00242907368770108,-0.0044688060384778,0.00505316281731041,0.904260123262921
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPN1,Epsin-1,37709,0.000450555378022938,0.00375637250973114,-0.00691193474105009,0.00781304549709597,0.904529108659536
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SELENOP,Selenoprotein P,38008,-0.000228951424866367,0.0019140527469643,-0.00398049480891639,0.00352259195918366,0.904789079241395
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,37557,-0.000370600123628065,0.00313795798028948,-0.00652099776499544,0.00577979751773931,0.905988393710277
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,37982,-0.000587950215253419,0.00510635804959599,-0.0105964119924616,0.00942051156195473,0.908335219859331
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,37557,0.00114743398172953,0.010151473917594,-0.0187494548967546,0.0210443228602137,0.910007496099495
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,37557,-0.000452883877326383,0.00403182962028836,-0.00835526993309157,0.0074495021784388,0.91056574629976
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,37452,-0.000850387014565638,0.00758235398947161,-0.01571180083393,0.0140110268047987,0.910703484430061
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,37557,-0.000414733399147598,0.00388053112713632,-0.00802057440833478,0.00719110761003959,0.914889448381215
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,37495,-0.000306678863716463,0.00292112748309364,-0.00603208873057999,0.00541873100314706,0.916388158885275
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPT1,Translationally-controlled tumor protein,40039,-0.000581132057699937,0.00564916680000923,-0.011653498985718,0.0104912348703181,0.91806715246752
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,37477,0.000561390470145085,0.00545828910282165,-0.0101368561713853,0.0112596371116755,0.918082814318454
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,37536,0.000366026902465789,0.00361082163439083,-0.00671118350094024,0.00744323730587182,0.919258762307401
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,37536,0.000279709116625998,0.00282004383328263,-0.00524757679660796,0.00580699502985996,0.920992039828773
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,37567,0.000478950491641096,0.00485704580181876,-0.00904085927992367,0.00999876026320587,0.921449893782418
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,37709,-0.000521008026569504,0.00541974028715534,-0.011143698989394,0.010101682936255,0.923417548272966
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MN1,Transcriptional activator MN1,37567,0.000482234840057711,0.00508043511776842,-0.00947541799076839,0.0104398876708838,0.924379830248606
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,H2AP,Huntingtin-interacting protein M,37477,0.000384800708110315,0.00443257533081837,-0.0083030469402937,0.00907264835651433,0.930822287322855
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL4,Interleukin-4,40039,-0.000651109509732508,0.0076313539235336,-0.0156085631998584,0.0143063441803934,0.932007838332262
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,40445,0.000205588421546957,0.00257044035097462,-0.00483247466636329,0.0052436515094572,0.936252739405626
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,REG1B,Lithostathine-1-beta,40531,-0.000352730405152839,0.00473585376997423,-0.00963500379430234,0.00892954298399666,0.940628706387191
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC44A4,Choline transporter-like protein 4,37567,-0.000432060479896424,0.00596636169667712,-0.0121261294053836,0.0112620084455907,0.942271898812803
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRAP1,Proline-rich acidic protein 1,37993,-0.000255780495079233,0.00357243987343198,-0.00725776264700592,0.00674620165684746,0.942922678626339
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AZU1,Azurocidin,39804,0.000432428514635171,0.00658319152925707,-0.0124706268827087,0.013335483911979,0.947628069836227
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,37477,0.000527064801955809,0.008115963082682,-0.0153802228401009,0.0164343524440125,0.948221379945643
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GJA8,Gap junction alpha-8 protein,37477,0.000319516266252781,0.00529787424748761,-0.0100643172588229,0.0107033497913285,0.951909441839424
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CST5,Cystatin-D,40065,0.000274310750731987,0.00466905553238129,-0.00887703809273533,0.00942565959419931,0.95315134801471
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,40336,-0.000321232840183908,0.0055332501574061,-0.0111664031486999,0.010523937468332,0.953705548641106
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,37567,0.000247386333235227,0.00433079081342474,-0.00824096366107727,0.00873573632754772,0.954448348291361
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL2,Interleukin-2,40039,0.000151461189983507,0.0026611751931227,-0.00506444218853699,0.005367364568504,0.954613514046714
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,37895,0.000216034164377625,0.00383509053931099,-0.00730074329267193,0.00773281162142717,0.955079027410031
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",37955,-0.000175200776305455,0.00312534690707181,-0.0063008807141662,0.00595047916155529,0.955296411603152
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,40223,0.000316959604034681,0.00592023348013321,-0.0112866980170264,0.0119206172250958,0.957303644008085
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,40154,-0.000267420265756978,0.00501290812205372,-0.0100927201849823,0.0095578796534683,0.957456643017563
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,37567,0.000290280888899284,0.00561067181481407,-0.0107066358681363,0.0112871976459349,0.958738821183422
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GH1,Somatotropin,40325,-0.0007382038302095,0.0148290271669656,-0.0298030970774622,0.0283266894170432,0.960297532514865
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,37557,-0.000265766812904399,0.0053472245043796,-0.0107463268414884,0.0102147932156796,0.960360760099473
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DHODH,Dihydroorotate dehydrogenase,37557,-0.000199519106444648,0.00410724199003124,-0.00824971340690588,0.00785067519401658,0.961256827082387
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,37593,8.6357582265256e-05,0.00189479050272685,-0.00362743180307937,0.00380014696760988,0.963648634310055
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDSN,Corneodesmosin,40451,0.000164948235401396,0.00366271819921332,-0.00701397943505671,0.0073438759058595,0.964080469206859
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AMIGO1,Amphoterin-induced protein 1,37567,0.000191258803304544,0.0042526748211839,-0.00814398384621589,0.00852650145282498,0.964128904005054
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,37557,-0.000182213376527542,0.00411852282929091,-0.00825451812193772,0.00789009136888264,0.964711850727386
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,40223,0.000255494168559256,0.00590070597600466,-0.0113098895444099,0.0118208778815284,0.965463803990287
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,37536,-0.000262287856945308,0.00619734377932717,-0.0124090816644266,0.0118845059505359,0.966242155075718
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,37477,0.000166932487376408,0.00399622561174597,-0.0076656697116457,0.00799953468639851,0.96668066744486
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRX,Cone-rod homeobox protein,40037,0.000353686600924952,0.00912046609503118,-0.0175224269453362,0.0182298001471861,0.969066730805304
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DLGAP5,Disks large-associated protein 5,37955,0.000171185306723564,0.00455138135381646,-0.0087495221467567,0.00909189276020383,0.969997814837378
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,37895,0.000179300354930591,0.00485780865433273,-0.00934200460756156,0.00970060531742274,0.970557538014895
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,39975,-0.000106957925695598,0.00302716941852195,-0.00604020998599862,0.00582629413460743,0.971814940803247
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DCTN2,Dynactin subunit 2,40300,-0.000281795568213497,0.00798290521930987,-0.0159282897980609,0.0153646986616339,0.971841066398997
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RCC1,Regulator of chromosome condensation,37895,0.000131565108422737,0.00432760815780359,-0.00835054688087231,0.00861367709771778,0.975747423544326
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,37567,0.000125924318400932,0.00420750491701882,-0.00812078531895595,0.00837263395575782,0.976124530286349
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NPHS2,Podocin,37593,0.000235311277525346,0.00888589942105994,-0.0171810515877521,0.0176516741428028,0.978873751352169
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,40037,0.000108401063579994,0.00422878520266911,-0.00818001793365147,0.00839682006081146,0.97954952271792
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYH4,Myosin-4,37557,9.86114424465973e-05,0.00404246340855508,-0.00782461683832136,0.00802183972321455,0.980538786504327
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYL6B,Myosin light chain 6B,37567,-0.000187044656395396,0.00787816000425384,-0.0156282382647329,0.0152541489519421,0.981058625600574
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPLX2,Complexin-2,37477,5.68796775503451e-05,0.00263588362667909,-0.00510945223074066,0.00522321158584135,0.982784132462699
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MUCL3,Mucin-like protein 3,37477,7.76212459554492e-05,0.00382625668565407,-0.00742184185792653,0.00757708434983743,0.983815158744985
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LMOD2,Leiomodin-2,37536,0.000109719068010523,0.00551768651375062,-0.0107049464989407,0.0109243846349617,0.984135432809786
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPB41L5,Band 4.1-like protein 5,37567,0.000100578416145641,0.00542318186333563,-0.0105288580359922,0.0107300148682835,0.985203550742854
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GAD2,Glutamate decarboxylase 2,37593,6.53201622473459e-05,0.00401326742775984,-0.00780068399616193,0.00793132432065662,0.987014407271449
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NCLN,Nicalin,40039,-5.89712163551148e-05,0.00453694102315402,-0.00895137562173699,0.00883343318902676,0.989629544834886
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,40350,3.93113061526356e-05,0.00307708730726462,-0.00599177981608603,0.0060704024283913,0.9898070692706
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,37557,3.77773900685533e-05,0.00302847538130107,-0.00589803435728154,0.00597358913741864,0.990047586404321
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,37477,-2.77789058410065e-05,0.00256734553621958,-0.00505977615683138,0.00500421834514937,0.991367152624564
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LXN,Latexin,40178,1.49335792908897e-05,0.00561808820619036,-0.0109965193048422,0.011026386463424,0.997879159517285
